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Abstract 
 
DNA replication initiation is co-ordinated with progression through the cell cycle via 
a two-step mechanism. The first step, termed origin licensing, involves the 
assembly of a pre-replicative complex (pre-RC) at origins of replication, in which 
the Mcm2-7 replicative helicase is loaded onto DNA in an inactive form. Origin 
unwinding and DNA synthesis is only initiated during the second step of this 
process, origin firing, which requires the recruitment of multiple ‘firing factors’, such 
as Sld3/7 and Cdc45, as well as the activity of two essential cell cycle regulated 
kinases, cyclin-dependent kinase (CDK) and Dbf4-dependent kinase (DDK). 
 
Whilst studies of the mechanism of origin licensing have been greatly furthered by 
the availability of an in vitro pre-RC assembly assay, the subsequent activation of 
the replicative helicase has not been well characterised, and how the firing factor 
proteins catalyse the complex topological changes required for Mcm2-7 helicase 
activation is unknown.  
 
In this study, I used an in vitro biochemical approach to investigate the function of 
DDK and Sld3/7 in origin firing. I reconstituted the recruitment of Sld3/7 to the pre-
RC in vitro, which is thought to be the first step during Mcm2-7 helicase activation. I 
observed recruitment of Sld3/7 to be dependent on phosphorylation of the loaded 
Mcm2-7 complex by DDK, and was subsequently able to map the Mcm2-7 binding 
activity of Sld3/7 to a central domain of Sld3. By isolating a number of point 
mutants in Sld3 that were specifically defective in Mcm2-7 binding, I showed that 
the Sld3-Mcm2-7 interaction is essential for replicative helicase activation. 
Furthermore, I showed that the central portion of Sld3 contains a Cdc45 interacting 
site, which is also required for efficient replication initiation. 
 
Subsequently, I showed that Sld3 can interact with both Mcm6 and Mcm4 in a 
phosphorylation-dependent manner. Sld3 itself was shown to contain a novel 
phosphopeptide binding activity, and can interact with numerous phosphorylated 
residues throughout the N-terminal half of Mcm6. Elimination of these 
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phosphorylation sites resulted in defects in both Sld3/7 recruitment to the pre-RC 
and replicative helicase activation. 
 
Thus, the novel DDK-dependent Sld3-Mcm2-7 interaction described in this study 
helps to explain the function of DDK during the early stages of origin firing. 
Additionally, the observation that Sld3 can interact directly with phosphorylated 
residues on Mcm2-7 indicates that Sld3 is a reader of DDK activity.  As both an 
essential CDK substrate and a DDK reader, Sld3 thus functions as a point of 
intersection for the activities of CDK and DDK during Mcm2-7 helicase activation. 
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Chapter 1. Introduction 
1.1 Overview 
An essential requirement during the proliferation of any cell is the ability to 
duplicate their genomes, to allow genetic information to be propagated to new 
daughter cells. In eukaryotic cells, the completion of genome duplication is co-
ordinated with progression through the cell cycle, which in turn is driven by 
oscillations in the activity of the cyclin-dependent kinases (CDKs). Genome 
duplication occurs primarily during S (synthetic) phase of the cell cycle, before 
chromosome segregation and cell division ensues in the subsequent M (mitosis) 
phase. 
 
The genetic information present in every living cell is stored in the DNA double 
helix. Notably, eukaryotic genomes are much larger than their bacterial 
counterparts; the DNA in the 46 chromosomes present in most of our body’s cells 
has a combined length of approximately 2 m. Importantly, every section of these 
large genomes must be duplicated only once during each S-phase, as over- or 
under-replication can lead to gene amplification or gross chromosomal 
rearrangements, which in turn can instigate genome instability and tumorigenesis 
(Arias and Walter, 2007, Blow and Gillespie, 2008). Thus, the cell not only needs 
DNA replication to occur on a remarkable scale and at great frequency, but also 
requires that high fidelity is maintained during the genome duplication process. 
 
Given these requirements, genome duplication is tightly regulated, primarily during 
the initiation phase of DNA replication. Whilst bacterial genomes can be duplicated 
with sufficient speed from a single site (termed an origin of replication), the larger 
size of eukaryotic genomes demands that replication initiates from numerous 
distinct sites positioned on multiple chromosomes. DNA replication initiation at 
these origins of replication proceeds via a conserved two-step mechanism, as 
depicted in Fig. 1.1 (Blow, 1993, Blow and Laskey, 1988, Diffley et al., 1994). The 
first step, termed origin licensing, occurs in late mitosis and G1 phase of the cell 
cycle, and involves the assembly of pre-replicative complexes (pre-RCs) at the 
origin. This step can only occur when the activity of CDK is low and that of the 
Chapter 1 Introduction 
 18 
Anaphase Promoting Complex / Cyclosome (APC/C) E3 ubiquitin ligase is high 
(Arias and Walter, 2007, Siddiqui et al., 2013). Upon progression into S-phase, 
CDK activity increases and the APC/C is inactivated, which facilitates the second 
step of replication initiation, origin firing. It is only during this second step that DNA 
synthesis is initiated. Importantly, the high CDK activity present during S-phase is 
inhibitory for origin licensing, which provides a potent block to re-replication by 
preventing the assembly of pre-RCs onto replication origins from which DNA 
synthesis has already initiated (Diffley, 2011, Arias and Walter, 2007). Metazoans 
have evolved additional CDK-independent mechanisms to prevent DNA re-
replication (Blow and Dutta, 2005, Arias and Walter, 2007), as will be discussed in 
section 1.3.3. 
 
 
 
Figure 1.1 Cell cycle regulation of DNA replication 
The eukaryotic cell cycle is composed of four distinct phases: G1, S, G2 and M. 
The initiation of DNA replication is co-ordinated with progression through the cell 
cycle via a two-step mechanism, which is controlled by the activities of CDK and 
the APC/C. Origin licensing and origin firing are mutually exclusive steps, which 
prevents re-replication. The details of this mechanism are first discussed in section 
1.1 of the text, and are reviewed throughout the introduction. 
G1
M
G2
S
S-phase
High CDK / low APC/C
Origin Firing
Late M/G1
Low CDK / high APC/C
Origin Licensing
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On a molecular level, the enzyme that underpins this complex two-step mechanism 
is the Minichromosome-maintenance (MCM) replicative helicase (Mcm2-7). This 
hetero-hexameric enzyme is responsible for unwinding the two strands of the DNA 
double helix, to allow the replicative DNA polymerases access to the single-
stranded DNA (ssDNA) template required for DNA synthesis. Origin licensing, or 
pre-RC assembly, involves the loading of this Mcm2-7 complex onto DNA at origins 
of replication. This reaction requires the initial binding of the Origin Recognition 
Complex (ORC) to the origin; this protein complex in turn collaborates with two 
other factors, Cdt1 and Cdc6, to facilitate the stable association of Mcm2-7 with 
DNA. The origin licensing reaction has been reconstituted in vitro with purified 
proteins; these and other studies indicate that the product of the pre-RC assembly 
step is a double hexamer of Mcm2-7 bound around double-stranded DNA (dsDNA) 
(Remus et al., 2009, Evrin et al., 2009, Gambus et al., 2011, Gillespie et al., 2001). 
 
The Mcm2-7 double hexamer produced during pre-RC assembly is inactive as a 
DNA helicase. It is only upon progression into S-phase, when the activities of CDK 
and a second protein kinase, Dbf4-dependent kinase (DDK), increase, that the 
helicase function of Mcm2-7 is activated, and origin unwinding and subsequent 
DNA synthesis (or origin firing) commences. Origin firing requires the extensive 
remodelling of the Mcm2-7 double hexamer into the Cdc45-MCM-GINS (CMG) 
complex, which contains a single copy each of Mcm2-7, Cdc45 and the tetrameric 
GINS complex (Gambus et al., 2006, Costa et al., 2011, Fu et al., 2011), and 
functions as the active DNA helicase at replication forks (Ilves et al., 2010, Pacek 
et al., 2006, Moyer et al., 2006). Notably, formation of the CMG complex requires 
the recruitment of various ‘firing factors’ to the origin of replication (see section 
1.4.1); these factors have been proposed to form a transient pre-initiation complex 
(pre-IC) on the Mcm2-7 double hexamer (Zou and Stillman, 1998, Tanaka and 
Araki, 2013). Although the identity of many firing factors is known, little is 
understood of how they contribute towards activation of the Mcm2-7 complex, or 
how the pre-IC assembles at origins of replication.  
 
Following CMG assembly, additional proteins such as Mrc1 and Ctf4 are also 
recruited, forming a multi-protein assembly called the Replisome Progression 
Complex (RPC) or replisome (Gambus et al., 2006). Origin unwinding facilitates the 
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recruitment of the Polα/Primase complex to ssDNA, and primer synthesis is then 
initiated. At some juncture, Polε and Polδ take responsibility for DNA synthesis on 
the leading and lagging strand templates (Kunkel and Burgers, 2008), respectively, 
and bi-directional DNA synthesis can thereby be initiated from the origin of 
replication.  
 
Work published in the last decade has contributed greatly towards our 
understanding of how CDK and DDK regulate Mcm2-7 helicase activation at the 
G1/S transition. Two firing factors, Sld2 and Sld3, were identified as the minimal 
CDK targets required for origin firing in vivo; phosphorylation of these two proteins 
facilitates their binding to a third firing factor, Dpb11 (Zegerman and Diffley, 2007, 
Tanaka et al., 2007, Masumoto et al., 2002). In contrast, DDK is known to 
phosphorylate the Mcm2-7 helicase itself. A number of genetic alleles that can 
bypass the requirement for DDK activity during replication initiation have been 
identified (Sheu and Stillman, 2010, Hardy et al., 1997, Hayano et al., 2012, 
Matsumoto et al., 2011). More recently, DDK has been proposed to function during 
the early stages of origin firing, promoting the recruitment of Cdc45 and Sld3 (in 
complex with another firing factor, Sld7) to origins of replication (Yabuuchi et al., 
2006, Heller et al., 2011, Tanaka et al., 2011a). In spite of this, the exact 
mechanism by which DDK phosphorylation promotes activation of the replicative 
helicase is still poorly understood.  
 
In this introduction, I will review our existing knowledge of both the regulation and 
mechanism of Mcm2-7 helicase loading and activation. I will primarily focus on the 
description of these events in S. cerevisiae, the model organism utilised in this 
study. Initially, I will briefly explain what is known about origins of replication, the 
chromosomal loci from which DNA replication initiates in every cell cycle. 
1.2 Origins of Replication 
The replicon model, proposed by Jacob and Brenner in 1963, postulated that DNA 
replication would begin when a trans-acting factor, termed the initiator, recognised 
a specific cis-acting DNA sequence in the genome, termed the replicator (Jacob et 
al., 1963). The initiator protein would then recruit the factors necessary for 
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unwinding of the double helix, replisome assembly and DNA synthesis. This model 
was initially proposed for simple bacterial systems, and was subsequently proved 
to be correct in E. coli, with the discovery of oriC (the replicator or origin of 
replication) in 1977 (Yasuda and Hirota, 1977), and DnaA, the initiator protein that 
binds to oriC, in 1983 (Fuller and Kornberg, 1983). The subsequent discovery of 
very similar mechanisms in both bacteriophage and eukaryotic viral systems 
established the replicon model as a paradigm for DNA replication initiation.  
 
As mentioned in the previous section, a prerequisite for the duplication of the large 
genomes of eukaryotic organisms is the use of multiple origins of replication. The 
number of origins used is generally relational to genome size and cell cycle length 
(Leonard and Mechali, 2013). Thus, if all origins were to fire simultaneously, the 
length of S-phase would be proportional to the inter-origin distance, as opposed to 
overall genome size, thereby allowing for the timely completion of DNA replication 
before cells enter mitosis. Notably, in most eukaryotes, replication origins are not 
defined by a unique DNA sequence, contrary to the situation in simpler organisms. 
Instead, factors such as DNA topology and chromatin status appear to determine 
origin activity (Remus et al., 2004, Aggarwal and Calvi, 2004, Eaton et al., 2010). 
Additionally, origin usage can vary tremendously according to conditions such as 
the developmental state of a given organism. For example, in the early embryonic 
stages of Xenopus development, DNA synthesis initiates from approximately 
300,000 sites as close as 5 kb apart (Blow et al., 2001), and any exogenous DNA 
introduced at this stage can be utilised as a site of replication initiation (Harland 
and Laskey, 1980). 
 
S. cerevisiae is thus unique amongst eukaryotes, as its origins of replication share 
readily distinguishable common sequence elements. These origin sequences, 
termed Autonomously Replicating Sequences (ARSs), were initially identified as 
elements that could confer the ability to be maintained extrachromosomally to 
otherwise non-replicating plasmids (Hsiao and Carbon, 1979, Stinchcomb et al., 
1979). The subsequent physical mapping of replication initiation to these sites 
confirmed their relevance as replication origins in vivo (Brewer and Fangman, 1987, 
Huberman et al., 1987).  
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Recent estimates suggest the presence of 350-400 replication origins in the S. 
cerevisiae genome (Raghuraman et al., 2001, Wyrick et al., 2001, Feng et al., 
2006). In S. cerevisiae, individual origins are activated at a distinct and 
reproducible time during each S-phase, and are referred to as early or late firing 
origins accordingly. The most extensively characterised of these origins is ARS1, 
and molecular dissection of this sequence revealed the presence of four distinct 
elements required for replication. The first of these elements is the A element, 
which contains an 11 bp A/T-rich stretch called the ARS Consensus Sequence 
(ACS). The ACS is an essential feature of all known ARSs (Celniker et al., 1984, 
Van Houten and Newlon, 1990), and functions as half of a bipartite binding site for 
the eukaryotic initiator protein, ORC (Rowley et al., 1995, Rao and Stillman, 1995). 
ARS1 also contains three B-elements (B1, B2 and B3), the exact nature of which 
varies between different origins. Whilst individually dispensable for replication 
initiation, the combined deletion of all three B-elements is sufficient to render ARS1 
replication-incompetent (Marahrens and Stillman, 1992). The B1 element 
comprises the second half of the ORC binding site in the origin (Rowley et al., 1995, 
Rao and Stillman, 1995), whilst the B2 element is believed to perform some 
function during pre-RC assembly (Wilmes and Bell, 2002). Finally, the B3 element 
serves as a binding site for the Abf1 transcription factor (Diffley and Stillman, 1988), 
and may help to generate a nucleosome-free region at the origin, required for pre-
RC assembly and/or origin firing (Venditti et al., 1994, Hu et al., 1999). 
 
1.3 Origin Licensing  
The existence of a two-step mechanism for DNA replication initiation was first 
indicated by mammalian cell fusion experiments performed over 40 years ago (Rao 
and Johnson, 1970). These experiments showed that the fusion of a G1 cell with 
an S-phase cell resulted in the rapid initiation of DNA synthesis in the G1 nuclei, 
whereas G2 cells did not undergo replication when fused with S-phase cells in the 
same manner. The presence of some factor(s) in the S-phase cell that could 
promote DNA replication specifically in G1 nuclei was thus inferred. These findings 
were extended by experiments performed in Xenopus egg extracts, which showed 
that permeabilisation of the nuclear envelope was a prerequisite for G2 nuclei to 
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replicate when added to a G1 cell extract (Blow and Laskey, 1988). This implied 
the presence of a specific ‘licensing’ factor in the G1 extract, which was absolutely 
required for DNA to gain competence for replication initiation in S-phase. It was 
additionally supposed that such a factor could potentially gain access to DNA after 
nuclear envelope breakdown during the mitotic stage of a normal cell cycle. 
 
The molecular details of this two-step mechanism began to emerge during the early 
part of the 1990s, when in vivo footprinting experiments performed in S. cerevisiae 
revealed the presence of two different chromatin states at origins of replication at 
different cell cycle stages (Diffley et al., 1994). A pre-replicative state, consisting of 
extensive DNase protection across the replication origin, was detected in G1 phase 
cells. This protection was significantly reduced in S, G2 and M phases of the cell 
cycle, when origins adopted a post-replicative state closely resembling the in vitro 
footprint of purified ORC and Abf1. 
 
Subsequent experiments showed that the extensive origin protection observed in 
G1 was caused by the formation of the pre-replicative complex (pre-RC) 
(Santocanale and Diffley, 1996, Labib et al., 2001, Aparicio et al., 1997, Cocker et 
al., 1996). Work over the ensuing decade helped define the proteins involved in 
pre-RC assembly in budding yeast, culminating in the in vitro reconstitution of this 
process with purified proteins in 2009 (Remus et al., 2009, Evrin et al., 2009). It is 
now clear that pre-RC assembly, or origin licensing, involves the loading of the 
Mcm2-7 replicative helicase onto origins of replication, producing an Mcm2-7 
double hexamer that is inactive as a DNA helicase. This reaction requires the 
combined activity of the ORC, Cdc6 and Cdt1 proteins. In this section, I will 
describe what is known about each of these proteins, and discuss our current 
understanding of the mechanism and regulation of pre-RC assembly. 
 
1.3.1 Components of the pre-RC 
1.3.1.1 ORC 
The Origin Recognition Complex (ORC) was first identified in S. cerevisiae as an 
ARS-interacting factor (Bell and Stillman, 1992, Diffley and Cocker, 1992), and 
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genetic evidence subsequently uncovered an essential function for this protein 
complex in DNA replication in all eukaryotic organisms (Bell et al., 1993, Foss et al., 
1993, Micklem et al., 1993, Gavin et al., 1995, Gossen et al., 1995, Carpenter et al., 
1996, Muzi-Falconi and Kelly, 1995, Rowles et al., 1996). In yeast, ORC binds to 
origins of replication throughout the cell cycle, interacting with both the ACS and B1 
elements of the ARS1 origin (Diffley and Cocker, 1992, Rowley et al., 1995, Diffley 
et al., 1995, Bell and Stillman, 1992, Rao and Stillman, 1995). 
 
Whilst scORC is a sequence-specific DNA binding protein, this activity is not 
conserved in other eukaryotes (Vashee et al., 2003), consistent with the absence of 
specific origin sequences in these organisms. In Drosophila, for example, ORC 
displays a 30-fold higher affinity for negatively supercoiled DNA over relaxed DNA 
in vitro (Remus et al., 2004), whereas human ORC can interact with a WD40-
repeat containing protein call ORCA (Shen et al., 2010), which in turn binds 
specifically to methylated histones. 
 
ORC is a hexameric protein complex consisting of Orc1-6 proteins. As with many 
DNA replication initiator proteins, five out of the six ORC subunits (Orc1-5) exhibit 
homology to the AAA+ superfamily of ATPases. Cdc6 and Mcm2-7 also belong to 
this family of ATPases (see sections 1.3.1.2 and 1.3.1.4), which often exist as 
oligomeric assemblies in which ATPase active sites are formed at the interface 
between neighbouring subunits. Of the ORC subunits, only Orc1 and Orc5 have 
been shown to bind ATP (Klemm et al., 1997), and only Orc1 displays ATP 
hydrolysis activity in vitro (Klemm et al., 1997). ATP hydrolysis by Orc1 is 
dependent on the arginine finger of its neighbouring ORC subunit, Orc4 (Bowers et 
al., 2004). ATP binding by ORC is required for its binding to origins of replication 
(Bell and Stillman, 1992), which in turn is essential for pre-RC assembly. 
 
The exact function of the ATPase activity of ORC during origin licensing remains an 
area of active research. Multiple Mcm2-7 complexes are loaded at each replication 
origin in vivo, and it was proposed that preventing ATP hydrolysis by ORC might 
block the iterative loading of Mcm2-7 (Bowers et al., 2004). Subsequent studies 
suggested a role for ORC ATP hydrolysis in driving the release of Cdt1 during 
Mcm2-7 loading (Fernandez-Cid et al., 2013), although more recent data has 
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indicated that an ATPase-dead ORC mutant exhibits no detectable defects in pre-
RC assembly in vitro (Coster et al., 2014). 
 
1.3.1.2 Cdc6 
Cell Division Cycle 6 (Cdc6) was initially identified in a budding yeast screen for 
mutants that exhibited defects in progression through the cell cycle (Hartwell et al., 
1973). A function for this protein in DNA replication was subsequently indicated by 
defects in minichromosome maintenance in a Cdc6 temperature-sensitive mutant 
(Hogan and Koshland, 1992).  
 
Cdc6 was later shown to be a bona fide component of the pre-RC (Cocker et al., 
1996, Santocanale and Diffley, 1996), and is now known to be essential for Mcm2-
7 loading onto chromatin in all eukaryotes (Donovan et al., 1997, Coleman et al., 
1996, Williams et al., 1997). Genetic interactions between an ORC5-1 allele and 
CDC6 suggested that Cdc6 might collaborate with ORC during pre-RC assembly 
(Liang et al., 1995), and this was subsequently confirmed by the observed physical 
interaction between the ORC and Cdc6 proteins (Speck et al., 2005).  
 
Cdc6 is a AAA+ ATPase, and binds to and hydrolyses ATP in vitro. Whilst ATP 
binding by Cdc6 is critical for its interaction with ORC (and therefore its association 
with replication origins) (Speck et al., 2005, Perkins and Diffley, 1998, Mizushima et 
al., 2000), the exact function of ATP hydrolysis by Cdc6 during pre-RC assembly 
remains contentious. Genetic data as well as experiments performed using an 
extract-based system for in vitro pre-RC assembly indicated that ATP hydrolysis by 
Cdc6 is essential for Mcm2-7 loading (Perkins and Diffley, 1998, Weinreich et al., 
1999, Randell et al., 2006). However, Cdc6 ATPase mutants can support 
productive Mcm2-7 loading in fully reconstituted pre-RC assembly reactions 
(Coster et al., 2014, Kang et al., 2014) 
 
Interestingly, the ATPase activity of Cdc6 has recently been shown to be required 
for a novel ‘proofreading’ activity (see section 1.3.2.2) (Coster et al., 2014, Kang et 
al., 2014), which releases Mcm2-7 from DNA under conditions that are not 
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competent for productive origin licensing (Frigola et al., 2013). It is thus possible 
that the requirement for Cdc6 ATPase activity during Mcm2-7 loading in extracts is 
reflective of the accumulation of non-productive helicase loading intermediates in 
these systems (Randell et al., 2006), perhaps leading to a greater reliance on 
‘proofreading’ than is observed in more efficient reconstituted systems. 
 
1.3.1.3 Cdt1 
Cdt1 (Cdc10 Dependent Transcript 1) was first discovered in the fission yeast S. 
pombe as a gene that is targetted by the transcription factor Cdc10 and is required 
for S-phase entry (Hofmann and Beach, 1994). Despite the relatively weak 
conservation of the primary sequence of Cdt1 throughout evolution, homologues 
have been identified in S. cerevisiae, Xenopus, Drosophila and human cells, and 
Cdt1 is essential for Mcm2-7 loading in each of these organisms (Maiorano et al., 
2000, Tanaka and Diffley, 2002, Nishitani et al., 2000, Nishitani et al., 2001, 
Whittaker et al., 2000). 
 
Cdt1 contains a conserved pair of winged helix domains at its C-terminus, which 
are required for binding to the Mcm2-7 complex (Zhang et al., 2010, Ferenbach et 
al., 2005). In S. cerevisiae, Cdt1 forms a constitutive complex with Mcm2-7, and 
this Cdt1/Mcm2-7 heptamer is transported into the nucleus during late mitosis / G1 
phase of the cell cycle to facilitate pre-RC formation (Tanaka and Diffley, 2002). 
Notably, metazoan Cdt1 does not form a complex with Mcm2-7 away from 
chromatin, and the subtle differences in Cdt1 function observed between different 
model systems may be reflective of this difference in Cdt1/Mcm2-7 complex 
formation (Gillespie et al., 2001). 
 
In S. cerevisiae, Cdt1 recruitment to origins is dependent on both ORC and Cdc6 
(Randell et al., 2006, Remus et al., 2009). Indeed, Cdt1 can interact with Orc6, and 
this interaction was deemed to be responsible for the initial recruitment of Mcm2-7 
during pre-RC assembly (Chen et al., 2007, Chen and Bell, 2011, Takara and Bell, 
2011, Semple et al., 2006). Interestingly, an essential, conserved C-terminal 
domain of Mcm3 has since been shown to direct Mcm2-7 recruitment to ORC/Cdc6, 
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although Cdt1 was required for the stable association of Mcm2/4/6 with the rest of 
the Mcm2-7 ring in these experiments (Frigola et al., 2013). Additionally, Cdt1 
takes part in an essential interaction with the C-terminus of Mcm6 (Yanagi et al., 
2002). This domain has been shown to be inhibitory for Mcm2-7 recruitment and 
loading, and this inhibition is alleviated by the presence of Cdt1 (Fernandez-Cid et 
al., 2013), although the molecular explanation for this relationship remains unclear. 
 
1.3.1.4 Mcm2-7 
The Minichromosome Maintenance (MCM) proteins were initially discovered in a 
number of screens for mutants that were defective in cell cycle progression (Moir et 
al., 1982, Hennessy et al., 1991, Coxon et al., 1992) or the maintenance of 
extrachromosomal plasmids (Maine et al., 1984, Yan et al., 1991, Takahashi et al., 
1994) in yeast. It was subsequently shown that Mcm2, Mcm3, Mcm5 and Mcm7 all 
localise to the nucleus and bind to chromatin during late mitosis and G1 phase 
(Hennessy et al., 1991, Yan et al., 1991, Dalton and Whitbread, 1995), thereby 
exhibiting similar behaviour to the replication licensing factor (RLF) described in 
Xenopus egg extracts (see section 1.3). A Xenopus homologue of Mcm3 was 
subsequently identified and shown to be important for origin licensing (Chong et al., 
1995, Kubota et al., 1995, Madine et al., 1995), and evidence was later obtained 
that all six Mcm2-7 proteins were required for RLF activity in Xenopus egg extracts 
(Thommes et al., 1997).  
 
Several studies showed that Mcm2-7 proteins form a complex that is loaded onto 
chromatin in an ORC and Cdc6-dependent manner (Romanowski et al., 1996, 
Rowles et al., 1996, Donovan et al., 1997). These experiments also showed that 
ORC and Cdc6 are not required for the chromatin association of Mcm2-7 once it 
has been loaded (Donovan et al., 1997, Rowles et al., 1999), suggestive of the 
production of a stably bound Mcm2-7 complex during pre-RC assembly. The stable 
association of Mcm2-7 with DNA was subsequently confirmed by other studies 
(Seki and Diffley, 2000, Edwards et al., 2002), and can now be explained by the 
production of an Mcm2-7 double hexamer, which is topologically bound around 
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dsDNA, during pre-RC assembly in vitro (Remus et al., 2009, Evrin et al., 2009, 
Gambus et al., 2011). 
 
The Mcm2-7 complex is composed of 6 essential subunits, Mcm2-7. All 6 of the 
proteins share common N-terminal OB-fold (typically involved in binding to nucleic 
acids) and C-terminal AAA+ ATPase domains, as well as N and C-terminal 
extensions that are conserved amongst eukaryotes (Fig. 1.2A). Structurally, the 
Mcm2-7 complex forms a toroidal heterohexamer with a positively charged central 
channel (Davey et al., 2003, Remus et al., 2009, Bochman et al., 2008, Costa et al., 
2011), which has recently been shown to be capable of binding ssDNA (Froelich et 
al., 2014). As mentioned previously, the Mcm2-7 heterohexamer is constitutively 
bound to Cdt1 in S. cerevisiae. 
 
Individual Mcm subunits interact in a defined order within the Mcm2-7 ring (Fig. 
1.2B) (Davey et al., 2003, Remus et al., 2009, Bochman et al., 2008, Costa et al., 
2011). As with most AAA+ proteins, the ATPase active sites in Mcm2-7 are located 
at the interfaces between different Mcm subunits, with one subunit contributing the 
Walker A (required for ATP binding) and B motifs, and its neighbour supplying the 
Arginine finger motif (required for ATP hydrolysis). The ATPase function of a 
number of Mcm active sites is required for S-phase progression and cell viability 
(Schwacha and Bell, 2001). Recent biochemical analysis of Mcm ATPase mutants 
suggests that this ATPase activity is critical for Mcm2-7 loading, catalysing Cdt1 
release at an early stage during pre-RC assembly (Coster et al., 2014, Kang et al., 
2014) 
 
Conclusive evidence for the function of Mcm2-7 as a component of the replicative 
helicase was not forthcoming in the years following the initial characterisation of the 
MCM proteins. Initially, genetic analysis indicated that MCM proteins are not 
required for the completion of chromosome replication once origin activation has 
occurred (Hennessy et al., 1991, Nasmyth and Nurse, 1981), and an Mcm4/6/7 
subcomplex was shown to exhibit very poor DNA helicase activity in vitro (Ishimi, 
1997). Subsequently, however, DNA unwinding in Xenopus extracts was shown to 
be entirely dependent on the presence of Mcm2-7 (Walter and Newport, 2000), and 
archaeal relatives of the eukaryotic MCM proteins were shown to function as 3’-5’ 
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DNA helicases in vitro (Chong et al., 2000, Shechter et al., 2000, Kelman et al., 
1999). Notably, the development of conditional degron alleles for Mcm2-7 allowed 
their requirement for replication fork progression throughout S-phase to be 
demonstrated (Labib et al., 2000). 
 
 
 
Figure 1.2 Domain architecture and subunit organisation of the S. cerevisiae 
Mcm2-7 complex 
A. Cartoon depicting the domain organisation in Mcm2-7. All subunits share a 
conserved N-terminal OB-fold like domain (green) and C-terminal AAA+ ATPase 
domain (blue). Mcm2, Mcm4 and Mcm6 have extended N-terminal tails (orange), 
which are known to be targetted by DDK. Adapted from Randell et al., 2010. B. 
Cartoon depicting the subunit organisation in the Mcm2-7 ring. The ring contains a 
single copy of each subunit, which are arranged in a distinct order, as depicted. 
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The functional replicative helicase present at replication forks is now known to be 
the CMG complex, which contains not only Mcm2-7, but also the Cdc45 and GINS 
proteins. This complex was initially isolated from Drosophila embryo extracts 
(Moyer et al., 2006), and was shown to exhibit much higher ATP-dependent DNA 
helicase activity than Mcm2-7 alone (Ilves et al., 2010). Subsequent studies were 
able to localise Mcm2-7, Cdc45 and GINS to sites of DNA unwinding in Xenopus 
extracts (Pacek et al., 2006), and all three proteins were detected as core 
components of the Replisome Progression Complex (RPC) (Gambus et al., 2006), 
thus confirming a role for the CMG complex as the eukaryotic replicative helicase. 
The remodelling of the Mcm2-7 double hexamer into the CMG complex now forms 
the basis of any models proposed for Mcm2-7 helicase activation during origin 
firing, as is described in section 1.4. 
  
1.3.2 Mechanism of pre-RC assembly 
Our understanding of the pre-RC assembly reaction has been extended greatly in 
recent years by experiments utilising a reconstituted system for Mcm2-7 loading in 
vitro (Evrin et al., 2009, Remus et al., 2009). Briefly, purified S. cerevisiae Mcm2-
7/Cdt1, Cdc6 and ORC are incubated with linear origin-containing DNA fragments 
bound to beads. In the presence of ATP, ORC, Cdt1 and Cdc6 collaborate to load 
the Mcm2-7 complex onto DNA, producing a salt-resistant Mcm2-7 double 
hexamer bound around dsDNA (Fig. 1.3). When the poorly hydrolysable ATP 
analogue ATPγS is included in these reactions, all pre-RC components are 
specifically recruited, but Mcm2-7 is not stably loaded onto DNA. The next 
section(s) will describe our current knowledge of the mechanism of Mcm2-7 loading, 
drawing primarily on studies using this in vitro system. A model of origin licensing is 
depicted in Fig. 1.4. 
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Figure 1.3 Pre-RC assembly produces an Mcm2-7 double hexamer bound around 
dsDNA 
3D reconstruction of the Mcm2-7 double hexamer viewed from different angles. In 
the bottom image, dsDNA was modelled into the central channel of a longitudinal 
cross section of the structure. Figure taken from Boos et al., 2012. Original images 
were adapted from Remus et al., 2009. 
 
1.3.2.1 Mcm2-7 recruitment 
The first step in pre-RC assembly is the ATP-dependent binding of ORC to DNA at 
origins of replication (Fig. 1.4, step 1). Subsequently, ATP-bound Cdc6 is recruited 
to the ORC-DNA complex (Fig. 1.4, step 2), inducing a conformational change in 
ORC that stabilises its interaction with DNA (Speck et al., 2005). The Mcm2-7/Cdt1 
complex is recruited to ORC/Cdc6 via a conserved C-terminal domain in Mcm3 (Fig. 
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1.4, step 3b), and this recruitment is independent of ATP hydrolysis (Frigola et al., 
2013). Mcm2-7 binding to both ATP and Cdt1 is required to maintain the integrity of 
the Mcm2-7 ring at this point (Fig. 1.4, step 3a) (Coster et al., 2014), although this 
stabilisation is not dependent on the aforementioned Orc6-Cdt1 interaction (Frigola 
et al., 2013). Recent biochemical and structural analyses of pre-RC assembly 
reactions performed in ATPγS have indicated the presence of a single copy each of 
ORC, Cdc6, Cdt1 and Mcm2-7 bound to DNA (Fig. 1.4, step 4), forming a complex 
that is thought to represent an early intermediate in the helicase loading process 
(Sun et al., 2013, Fernandez-Cid et al., 2013).  
 
Interestingly, numerous previous reports have indicated that the Mcm2-Mcm5 
interface, or Mcm2/5 gate, can be a position of discontinuity in the Mcm2-7 ring 
(Costa et al., 2011, Bochman et al., 2008, Davey et al., 2003). The recently solved 
structure of the aforementioned helicase loading intermediate does indeed contain 
an opening between the N-termini of Mcm2 and Mcm5 (Sun et al., 2013), and the 
presence of some unresolved electron density within the central channel of the 
Mcm2-7 ring suggests that the single Mcm2-7 hexamer may be at least partially 
loaded onto DNA at this juncture. Furthermore, recently published work indicates 
that artificially locking the Mcm2/5 gate in a closed conformation is sufficient to 
prevent pre-RC assembly (Samel et al., 2014), indicating that this interface may be 
a point of DNA entry during Mcm2-7 loading. 
 
1.3.2.2 Quality control during pre-RC assembly 
The binding of Mcm3 to ORC/Cdc6 activates the ATPase activity of ORC/Cdc6. 
When all the pre-RC components are present, and ORC has not been 
phosphorylated by CDK (see section 1.3.3), productive loading of Mcm2-7 and 
formation of the Mcm2-7 double hexamer can proceed (see section 1.3.2.3). 
Notably, however, when these criteria are not met, ATP hydrolysis can lead to the 
release of non-productive helicase loading intermediates from DNA (Fig. 1.4, step 
5a). This recently described proofreading activity is believed to prevent the 
accumulation of ‘dead-end’ complexes during pre-RC assembly (Frigola et al., 
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2013), as has been shown to be dependent on the ATPase activity of Cdc6 (Coster 
et al., 2014, Kang et al., 2014). 
 
1.3.2.3 ATP-dependent Mcm2-7 double hexamer formation 
Following the initial recruitment of pre-RC components to DNA, one of the earliest 
steps during active Mcm2-7 loading is the release of Cdt1 (Fernandez-Cid et al., 
2013), which is dependent on the ATPase activity of Mcm2-7 itself (Coster et al., 
2014, Kang et al., 2014). The resultant ORC/Cdc6/Mcm2-7 (OCM) complex 
contains a single copy of each of its protein components (Fernandez-Cid et al., 
2013) (Fig. 1.4, step 5b). The absence of any DNA-bound Mcm2-7 single 
hexamers at the end of reactions performed in ATP led to the conclusion that the 
loading of the two Mcm2-7 hexamers during pre-RC assembly must somehow be 
concerted (Evrin et al., 2009, Remus et al., 2009). How the reaction proceeds from 
the OCM intermediate to allow recruitment and loading of the second Mcm2-7 
hexamer is the subject of ongoing investigation (Yardimci and Walter, 2014) (Fig. 
1.4, step 6). If Mcm2-7 loading is indeed a concerted process, the observation that 
the C-terminus of Mcm3 is required for the loading of both Mcm2-7 hexamers must 
indicate the involvement of more than one ORC/Cdc6 complex, or the presence of 
multiple Mcm2-7 binding sites on a single ORC/Cdc6 (Frigola et al., 2013). Notably, 
the production of salt-resistant Mcm2-7 double hexamers requires the ATPase 
activity of Mcm2-7 (Coster et al., 2014, Kang et al., 2014), and involves the release 
of Cdc6 (Fig. 1.4, step 7). 
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Figure 1.4 A model for the mechanism of origin licensing in S. cerevisiae 
Details of the model are discussed in section 1.3.2 of the text. The ‘?’ before stage 6 refers to the loading of the second Mcm2-7 
hexamer, which is discussed in the text. The protein names in brackets refer to the components responsible for ATP hydrolysis at a 
given stage. Adapted from Coster et al., 2014.
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1.3.3 Regulation of origin licensing 
Pre-RC assembly is restricted to late mitosis and G1 phase of the cell cycle. The 
low CDK and high APC/C activities present during these times are inhibitory to 
origin firing; the temporal separation of origin licensing and origin firing activities 
prevents re-replication of DNA, and also ensures that a sufficient number of pre-
RCs are assembled onto chromatin before cells are committed to S-phase entry 
(Diffley, 2004). 
 
The mechanisms by which CDKs inhibit pre-RC assembly are now well understood. 
In S. cerevisiae, CDKs target each pre-RC component individually; the presence of 
multiple redundant pathways to prevent origin licensing provides a robust block 
against any potential re-replication. S-phase CDKs (Clb5 and Clb6-CDK) directly 
phosphorylate ORC on its Orc2 and Orc6 subunits (Nguyen et al., 2001), and CDK 
can also directly interact with ORC in a Clb5-dependent manner (Weinreich et al., 
2001, Wilmes et al., 2004). CDK-phosphorylated Orc6 cannot interact with Cdt1, 
which prevents pre-RC assembly (Chen and Bell, 2011). Furthermore, recent 
evidence also suggests that phosphorylation of ORC leads to the proofreading 
activity described in section 1.3.2.2, thereby preventing Mcm2-7 loading during S-
phase (Frigola et al., 2013).  
 
In budding yeast, CDKs target Cdc6 via two distinct mechanisms. Firstly, Cdc6 is 
allosterically inactivated during M-phase via direct binding to the mitotic cyclin Clb2 
(Mimura et al., 2004). Additionally, CDK-mediated phosphorylation of Cdc6 targets 
it for degradation by the 26S proteasome, via the activity of the SCFCdc4 ubiquitin 
ligase (Drury et al., 2000). Finally, the Mcm3 subunit of Mcm2-7 is also 
phosphorylated by CDK, which promotes Mcm2-7/Cdt1 nuclear export (Labib et al., 
1999, Liku et al., 2005, Nguyen et al., 2000), thereby physically separating the 
soluble pool of the replicative helicase from replication origins outside of G1 phase 
of the cell cycle. 
 
Although the two-step mechanism for replication initiation is conserved amongst 
eukaryotes, the mechanisms for preventing pre-RC assembly outside of S-phase 
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are somewhat different between metazoans and yeast. While both Cdc6 and ORC 
are phosphorylated by S-phase CDKs in metazoans (Petersen et al., 1999, 
Siddiqui et al., 2013), the primary regulatory target for pre-RC assembly appears to 
be Cdt1. Cdt1 is bound by an inhibitory protein called geminin, and can only 
interact with Mcm2-7 and promote origin licensing when geminin is degraded by 
the APC/C in late mitosis and G1 phase (Wohlschlegel et al., 2000, Tada et al., 
2001, McGarry and Kirschner, 1998). Additionally, Cdt1 interacts directly with 
chromatin bound PCNA in S-phase in both S. pombe and metazoans (Arias and 
Walter, 2006, Guarino et al., 2011). This direct interaction with PCNA triggers 
ubiquitylation of Cdt1 by the CRL4-Cdt2 ubiquitin ligase, which in turn targets Cdt1 
for degradation (Arias and Walter, 2005, Guarino et al., 2011, Senga et al., 2006). 
There is also a CDK-dependent pathway for Cdt1 degradation in human cells, 
which requires the SCFSkp2 complex (Li et al., 2003, Nishitani et al., 2006). Notably, 
deregulation of Cdt1 alone is sufficient to trigger re-replication in metazoans 
(Davidson et al., 2006, Fujita, 2006), consistent with its role as a major regulatory 
target in these organisms. 
 
1.4 Origin firing 
Upon progression into S-phase, the activities of both CDK and DDK increase, and 
these protein kinases in combination with numerous ‘firing factor’ proteins function 
to activate the Mcm2-7 replicative helicase, thereby triggering origin unwinding and 
DNA synthesis. These firing factors are thought to form a transient pre-initiation 
complex (pre-IC) at the origin of replication (Zou and Stillman, 1998, Tanaka and 
Araki, 2013), although the exact nature of this complex, and how DDK and CDK 
catalyse its formation, remain poorly understood. Indeed, compared with the 
detailed mechanistic information that has emerged for the pre-RC assembly step in 
recent years, relatively little is known about the mechanism of Mcm2-7 activation at 
the G1/S transition. Interestingly, studies performed in Xenopus egg extracts 
indicate that ORC and Cdc6 are not required for any steps in replication initiation 
downstream of origin licensing (Rowles et al., 1999), and models for the 
mechanism of origin firing thus focus on how firing factors alone remodel the 
Mcm2-7 double hexamer into the active CMG replicative helicase. 
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Biochemical studies performed in the last five years have defined the configuration 
of the Mcm2-7 complex both before and after origin firing has occurred. As was 
discussed in section 1.3, the product of pre-RC assembly is a double hexamer of 
Mcm2-7, in which the two hexamers are connected via their N-termini, with the C-
terminal AAA+ ATPase domains facing outwards (Fig. 1.3) (Remus et al., 2009). 
An Mcm2-7 double hexamer has also been detected at licensed origins in Xenopus 
egg extracts (Gambus et al., 2011), consistent with a conserved mechanism of pre-
RC assembly in eukaryotes. The evidence that this complex encircles dsDNA is 
three-fold. Firstly, Mcm2-7 double hexamers have been shown to freely ‘slide’ on 
DNA substrates without the need for ATP hydrolysis. If the Mcm2-7 complex was 
bound around a single DNA strand in the pre-RC, ATP hydrolysis would be 
required to facilitate the obligatory DNA unwinding that would occur as Mcm2-7 
translocated on ssDNA. Secondly, visualisation of DNA-bound Mcm2-7 complexes 
by electron microscopy (EM) following rotary shadowing did not provide any proof 
of ssDNA. Finally, similar EM analyses of Mcm2-7 complexes loaded onto circular 
DNA templates appeared to show DNA in a totally relaxed conformation, 
inconsistent with the presence of any DNA unwinding at this stage (Remus et al., 
2009). 
 
It was initially supposed that the double hexameric form of the replicative helicase 
might be functional for DNA unwinding upon CDK and DDK activation (Remus et 
al., 2009, Evrin et al., 2009), acting in an analogous manner to the RuvAB Holliday 
junction branch migrating enzyme from E. coli. However, recent evidence suggests 
that extensive remodelling of the Mcm2-7 complex must occur upon S-phase entry. 
In 2011, Fu et al. examined the mechanism of Mcm2-7 helicase function in 
Xenopus egg extracts (Fu et al., 2011). In this study, the authors monitored the 
progression of the replisome on plasmid templates in which site-specific biotin-
streptavidin roadblocks were engineered on either the leading or lagging strand 
template. If the helicase translocated on dsDNA, then replisome progression 
should be prevented, irrespective of which strand the roadblock is placed upon. 
Interestingly, however, only roadblocks on the leading strand template impeded 
helicase progression, consistent with Mcm2-7 complex functioning as a 3’ to 5’ 
ssDNA translocase on the leading strand template. 
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Whilst this study indicates that the Mcm2-7 complex must transition from a dsDNA 
to ssDNA binding mode during origin firing, additional work, again performed in 
vitro using Xenopus egg extracts, has shown that the active replicative helicase 
likely contains only a single Mcm2-7 hexamer. Yardimci et al. performed single 
molecule analysis on linear bacteriophage λ DNA that was tethered at both ends to 
a glass slide (Yardimci et al., 2010). Noticeably, this double tethering of the DNA 
substrate had no discernable effect on replication efficiency compared with singly 
tethered DNA, consistent with sister replisomes uncoupling from one another once 
bi-directional replication has been initiated at an origin of replication. In addition to 
this, the CMG complex purified from Drosophila contains only a single copy each of 
Mcm2-7, Cdc45 and GINS (Costa et al., 2011), and the RPC purified from S. 
cerevisiae contains only a single copy of Mcm4 (Gambus et al., 2006). 
 
Thus, it is now clear that a number of steps must occur to remodel the Mcm2-7 
double hexamer into the CMG complex during origin firing (Fig. 1.5). Initial origin 
melting within the double hexamer should allow for the production of ssDNA, and 
each Mcm2-7 ring must then open and re-close around the single stranded leading 
strand template. Additionally, Cdc45 and GINS must stably associate with Mcm2-7, 
and the Mcm2-7 double hexamer must separate, producing two Cdc45/Mcm2-
7/GINS complexes (with 1:1:1 stoichiometry) that can form the basis for complete 
replisome assembly. Finally, the ATPase ‘motor’ of the Mcm2-7 complex must be 
activated to allow DNA unwinding to proceed. As previously mentioned, the 
Mcm2/5 interface has been shown to be a point of discontinuity in the Mcm2-7 ring, 
and may be the point at which ssDNA is extruded from the Mcm2-7 central channel 
during helicase activation. Notably, this interface is ‘locked’ in a closed 
conformation by the combined binding of Cdc45 and GINS in the CMG complex 
(Costa et al., 2011), potentially indicating how the Mcm2-7 ring re-closes around 
the leading strand template once extrusion of a single DNA strand has occurred. 
 
Whilst we have no understanding of the precise order of these predicted steps, 
numerous studies have facilitated the identification of the ‘firing factor’ proteins that 
are required to catalyse these complex topological changes. In S. cerevisiae, the 
known firing factors are Sld3, Sld7, Dpb11, Sld2, and Mcm10, as well as CDK and 
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DDK, and Cdc45 and GINS themselves (Boos et al., 2012, Tanaka and Araki, 
2013). Notably, in addition to is role in DNA synthesis on the leading strand 
template, the replicative DNA polymerase, Polε, also functions during Mcm2-7 
helicase activation. In the following section, I will discuss what is known about each 
of these individual proteins, and discuss what little we understand about how they 
assemble at replication origins during Mcm2-7 helicase activation. 
 
 
 
 
Figure 1.5 Activation of the Mcm2-7 replicative helicase during origin firing 
The Mcm2-7 complex is loaded onto DNA as an inactive double hexamer, which is 
bound around dsDNA. The active CMG complex is bound around the single-
stranded leading strand template. In order to achieve this transition, a number of 
steps must occur, which are listed on the right. For more details, see section 1.4 of 
the text. 
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1.4.1 Firing factor proteins 
1.4.1.1 Sld3/7 
The SLD3 gene was initially isolated in an S. cerevisiae screen for factors 
exhibiting synthetic lethality with a temperature sensitive allele of DPB11 
(Kamimura et al., 1998). Numerous other firing factors were also isolated in this 
screen, as will be discussed in subsequent sections. The requirement for Sld3 for 
the chromatin loading of Cdc45 and the establishment of replication forks at origins 
of replication was subsequently shown (Kamimura et al., 2001, Kanemaki and 
Labib, 2006). Interestingly, early studies indicated that, as with a number of other 
firing factors, Sld3 does not travel with replication forks away from origins 
(Kanemaki and Labib, 2006), and must therefore be released from DNA at some 
point during Mcm2-7 helicase activation. 
 
Sld3 is an essential substrate of CDK (Zegerman and Diffley, 2007, Tanaka et al., 
2007). Phosphorylation of Sld3 facilitates its binding to Dpb11, as will be discussed 
in section 1.4.2.1. Furthermore, the recruitment of Sld3 to origins has been shown 
to be dependent on the activity of DDK in both budding and fission yeast (Tanaka 
et al., 2011a, Heller et al., 2011, Yabuuchi et al., 2006), suggestive of a role for 
Sld3 as a central hub for the regulation of origin firing, a notion that will be 
examined extensively in this thesis. A recent study has shown that Sld3 forms a 
stable complex with a second firing factor, Sld7, throughout the cell cycle (Tanaka 
et al., 2011b). Although Sld7 is not essential, cells lacking this protein do show 
significant defects in S-phase progression, consistent with a function for Sld7 in 
origin firing. 
 
A homologue of Sld3, called Treslin/TICRR, has been identified in metazoans 
(Sanchez-Pulido et al., 2010, Kumagai et al., 2010, Sansam et al., 2010). Treslin is 
a substrate of CDK in these organisms (Kumagai et al., 2010, Boos et al., 2011), 
and is also required for the chromatin binding of Cdc45 (Kumagai et al., 2011), 
indicating that Sld3 function is conserved throughout evolution. Recently, Treslin 
has been shown to constitutively bind to a partner protein, MTBP, throughout the 
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cell cycle (Boos et al., 2013); whether or not MTBP is a functional analogue of Sld7 
is yet to be determined. 
 
1.4.1.2 Cdc45 
Like Cdc6, Cdc45 was initially identified in a screen for mutants that are defective 
in progression through the cell cycle in yeast (Moir et al., 1982). Cdc45 was 
subsequently shown to interact genetically with members of both the ORC and 
Mcm2-7 complexes (Hopwood and Dalton, 1996, Dalton and Hopwood, 1997, Zou 
et al., 1997), and Cdc45 mutants were shown to be defective in minichromosome 
maintenance (Hardy, 1997, Hopwood and Dalton, 1996), consistent with a role for 
Cdc45 in DNA replication.  
 
Early studies indicated that Cdc45 moves away from replication origins with the 
Mcm2-7 complex upon origin firing (Aparicio et al., 1997), and is required for the 
progression of individual replication forks (Tercero et al., 2000). This observation 
can now be explained by the finding that Cdc45 is a core component of the CMG 
replicative helicase, and is thus present at replication forks. Cdc45 has recently 
been shown to contain some weak homology to an archaeal ssDNA exonuclease 
called RecJ (Krastanova et al., 2012, Sanchez-Pulido and Ponting, 2011). Although 
Cdc45 lacks the conserved residues required for exonuclease activity, the protein 
can bind to ssDNA (Bruck and Kaplan, 2013, Szambowska et al., 2014). It has 
been suggested that the Cdc45-ssDNA interaction may be important for replisome 
function upon exposure to hydroxyurea (Bruck and Kaplan, 2013). Cdc45 could 
also conceivably bind to the single-stranded lagging strand template that is not 
encircled by Mcm2-7 during unperturbed replisome progression. This model has 
gained some support by the observation that the binding of Cdc45 and GINS to 
Mcm2-7 helps to create a secondary ‘channel’, separate to that which is present in 
the isolated Mcm2-7 complex, within the CMG replicative helicase (Costa et al., 
2011).  
 
The recruitment of Cdc45 to origins of replication was initially shown to be CDK-
dependent (Zou and Stillman, 1998, Jares and Blow, 2000), but recent work has 
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demonstrated that two modes of pre-RC binding likely exist for this protein. Cdc45 
can be detected at early firing origins in G1 phase of the cell cycle, and this 
recruitment is dependent on the presence of both Sld3/7 and DDK (Yabuuchi et al., 
2006, Kanemaki and Labib, 2006, Heller et al., 2011, Tanaka et al., 2011a). 
Interestingly, however, the stable incorporation of Cdc45 into the replisome is 
dependent on the activity of CDK and GINS (Gambus et al., 2006, Heller et al., 
2011), consistent with some transition of Cdc45 to a stronger mode of Mcm2-7 
interaction occurring during the CDK-dependent step of origin firing. 
 
1.4.1.3 Dpb11 
Dpb11 was first discovered as a putative subunit of DNA polymerase epsilon, as 
the presence of multiple copies of DPB11 was sufficient to suppress mutations in 
the Pol2 and Dpb2 subunits of this enzyme (Araki et al., 1995). Whilst subsequent 
studies have shown that Dpb11 is not in fact a Polε subunit, Dpb11 and Polε do 
physically interact (Masumoto et al., 2000), and Dpb11 is required for the 
recruitment of both DNA Polε and Polα/Primase to origins of replication during 
origin firing (Masumoto et al., 2000). The homology of Dpb11 with the Cut5 protein 
from S. pombe was indicative of a second function for Dpb11 in the cell cycle 
checkpoint. This function was subsequently confirmed by the observation that 
Dpb11 is required for activation of the Mec1 kinase, which in turn phosphorylates 
and activates Rad53, in response to DNA damage in S-phase (Pfander and Diffley, 
2011, Navadgi-Patil and Burgers, 2008, Mordes et al., 2008) 
 
Dpb11 contains two pairs of tandem BRCA1 C-terminus (BRCT) repeats. These 
motifs provide phospho-dependent binding sites for both Sld3 and Sld2, and Dpb11 
thus fulfils an essential role in the CDK-dependent step of origin firing (Tanaka et 
al., 2007, Zegerman and Diffley, 2007), as will be discussed in section 1.4.2.1. In 
2010, Dpb11 was identified as a component of the pre-loading complex (pre-LC), 
an unstable multi-protein assembly that forms off of chromatin and also contains 
Sld2, Polε and GINS (Muramatsu et al., 2010). Given that it is required for the 
origin association of both Polε and GINS (Masumoto et al., 2000, Heller et al., 2011, 
Takayama et al., 2003), and interacts with Sld3, Dpb11 may function as a central 
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scaffold protein during origin firing, facilitating recruitment of the pre-LC to 
replication origins, as will be discussed in section 1.4.3.2. Like Sld3/7, Dpb11 is not 
a replisome component, and is likely released from origins of replication during the 
origin firing process. 
 
1.4.1.4 Sld2 
As was the case for Sld3 and Sld7, Sld2 was isolated in a screen for factors that 
interact genetically with Dpb11 (Kamimura et al., 1998). Initial studies confirmed 
that Sld2 physically interacts with Dpb11, and is essential for origin firing. As 
mentioned in section 1.4.1.3, Sld2 is a component of the pre-loading complex, and 
is required for the recruitment of GINS, and therefore the formation of the CMG 
complex, at replication origins (Heller et al., 2011). The origin association of Sld2 
itself is dependent on both Dpb11 and Cdc45 (Sangrithi et al., 2005). 
 
Sld2 is an essential CDK substrate required for DNA replication initiation 
(Masumoto et al., 2002). Phosphorylation of Sld2 facilitates its binding to a tandem 
pair of BRCT repeats near the C-terminus of Dpb11 (see section 1.4.2.1). Notably, 
homologues of Sld2 have been discovered in a number of other eukaryotes 
(Gaggioli et al., 2014). Whilst the function of Sld2 as a CDK substrate is conserved 
in C. elegans (Gaggioli et al., 2014), the interaction of the human Sld2 homologue, 
RecQL4, with Dpb11 appears to be CDK-independent (Matsuno et al., 2006). 
Interestingly, RecQL4 also contains a DEAD-box helicase domain, which is 
essential for DNA replication in Xenopus egg extracts (Sangrithi et al., 2005). The 
precise mechanistic requirements for the helicase function of RecQL4 during DNA 
replication are yet to be described. 
 
1.4.1.5 GINS 
GINS is a hetero-tetrameric protein complex, the function of which in DNA 
replication was first reported in three separate studies, which were published 
simultaneously in 2003 (Kanemaki et al., 2003, Takayama et al., 2003, Kubota et 
al., 2003). One of these studies made use a novel proteomic technology involving 
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the tagging of essential S. cerevisiae proteins of unknown function with a ‘heat-
inducible’ degron, which allows for the rapid degradation of the tagged protein at 
37 °C (Kanemaki et al., 2003). Three proteins, Cdc101, Cdc102 and Cdc105, were 
identified as essential factors required for the establishment and progression of 
replication forks using this method, and Cdc102 and Cdc105 were shown to 
physically interact with one another. 
 
A second study, also performed using S. cerevisiae, identified the same factors 
using genetic approaches (Takayama et al., 2003). PSF1 (CDC101) was 
discovered as a multicopy suppressor of the SLD5 (CDC105) gene, which had 
been previously identified alongside SLD2 and SLD3 in a genetic screen performed 
in yeast (see sections 1.4.1.1 and 1.4.1.4). PSF2 (CDC102) and PSF3 were then 
identified as interactors of PSF1. The tetrameric complex of Psf1, Psf2, Psf3 and 
Sld5 was named GINS (Go, Ich, Nii, San are the Japanese words for five, one, two, 
three), and homologues were concurrently identified in Xenopus (Kubota et al., 
2003), where the function of GINS in replication initiation was confirmed. 
Homologues of all the GINS subunits in human cells have since been isolated. 
 
GINS is a component of the pre-LC (Muramatsu et al., 2010), and its recruitment to 
origins of replication is dependent on Sld3/7, Cdc45, Dpb11 and Sld2, and requires 
the activity of both CDK and DDK (Takayama et al., 2003, Heller et al., 2011, 
Kanemaki and Labib, 2006, Yabuuchi et al., 2006). As previously mentioned, GINS 
is a core component of the CMG replicative helicase, and is thus required for both 
the initiation and elongation stages of DNA replication. GINS is required for the 
stable association of Cdc45 with the Replisome Progression Complex (RPC) 
(Gambus et al., 2006), although the exact function of GINS during DNA unwinding 
is still to be determined. 
 
1.4.1.6 Mcm10 
Mcm10 was identified in the same yeast genetic screen in which the first members 
of the Mcm2-7 complex were isolated (Maine et al., 1984, Merchant et al., 1997). 
Notably, Mcm10 is not related to other Mcm proteins in its primary sequence. 
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Mcm10 is essential for origin firing in S. cerevisiae (Merchant et al., 1997), and its 
orthologues have also been shown to be required for DNA replication in S. pombe 
(Nasmyth and Nurse, 1981), Xenopus (Wohlschlegel et al., 2002) and mouse (Lim 
et al., 2011). In addition to its function during origin firing, Mcm10 has also been 
shown to travel with replication forks in yeast (Ricke and Bielinsky, 2004), Xenopus 
(Pacek et al., 2006) and human cells (Karnani and Dutta, 2011). Interestingly, 
however, Mcm10 only co-purifies as a component of the RPC under 
unphysiologically high salt concentrations (Gambus et al., 2006, van Deursen et al., 
2012), and what function, if any, Mcm10 fulfils during replication elongation is still 
unclear. 
 
Mcm10 can interact with a number of the subunits in the Mcm2-7 complex 
(Merchant et al., 1997, Homesley et al., 2000). Consistent with this, mutations in 
Mcm2 and Mcm7 can suppress the lethal phenotype associated with a number of 
temperature-sensitive Mcm10 mutants (Homesley et al., 2000, Liachko and Tye, 
2005). Additionally, Mcm10 has been shown to interact directly with the loaded 
form of the replicative helicase during G1 phase of the cell cycle (van Deursen et 
al., 2012). This direct binding of Mcm10 to Mcm2-7 was shown to be independent 
of the activities of both DDK and CDK, despite evidence from both in vitro and in 
vivo studies suggesting that the origin recruitment of Mcm10 in S-phase requires 
the function of both of these protein kinases (Kanke et al., 2012, Heller et al., 2011). 
One explanation for this apparent discrepancy is the existence of two modes of 
Mcm10 origin recruitment; stable origin association appears to require the action of 
DDK and CDK, whilst the (presumably weaker) kinase-independent Mcm10-Mcm2-
7 interaction observed by van Deursen et al. might only be detectable under less 
stringent experimental conditions. 
 
The molecular function of Mcm10 during origin firing remains quite poorly 
characterised, although a number of recent studies indicate that Mcm10 is required 
for initial origin melting and polymerase recruitment (van Deursen et al., 2012, 
Watase et al., 2012, Kanke et al., 2012, Heller et al., 2011). These studies, 
performed in both budding and fission yeast, showed that whilst formation of the 
CMG complex proceeds normally in the absence of Mcm10, the origin recruitment 
of the ssDNA binding protein RPA, a marker of DNA unwinding, is greatly reduced. 
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Interestingly, data from one of these studies indicated that replication origin 
unwinding is largely dependent on the DNA-binding activity of Mcm10 (Kanke et al., 
2012), which is mediated by its OB-fold and Zn-finger domains (Robertson et al., 
2008, Warren et al., 2008, Eisenberg et al., 2009). Furthermore, it was shown that 
the stability of Polα was not affected by the absence of Mcm10 (van Deursen et al., 
2012, Kanke et al., 2012), contrary to previous reports (Ricke and Bielinsky, 2004). 
Further biochemical investigation is required to dissect the role played by Mcm10 
during Mcm2-7 activation. 
 
1.4.2 Regulation of origin firing 
In proliferating budding yeast cells, growth factors actively promote the transcription 
of G1 cyclins, leading to a gradual accumulation of G1 CDK activity. In turn, G1 
CDKs can phosphorylate an inhibitor of the SBF and MBF transcription factors 
called Whi5 (Costanzo et al., 2004, de Bruin et al., 2004), which relieves the 
inhibition of these factors, leading to the increased transcription of both S-phase 
cyclins and specific replication factors (Eser et al., 2011, Spellman et al., 1998, 
Nasmyth and Dirick, 1991). Both G1 and S-phase CDKs can phosphorylate the 
CDK inhibitor, Sic1, which targets Sic1 for poly-ubiquitylation and subsequent 
degradation, thereby creating a positive feedback loop and further increasing the 
CDK activity in the cell (Feldman et al., 1997, Verma et al., 1997, Koivomagi et al., 
2011). Finally, CDK can also phosphorylate the APC/C adaptor protein Cdh1 
(Zachariae et al., 1998, Jaspersen et al., 1999). This prevents the binding of Cdh1 
to the APC/C, thereby rendering the APC/C inactive, and allowing APC/C 
substrates to accumulate. One such substrate is the activating subunit of DDK, 
Dbf4, the levels of which are kept low during G1 phase (Weinreich and Stillman, 
1999, Ferreira et al., 2000, Oshiro et al., 1999). Thus, as cells progress into S-
phase, the activities of both CDK and DDK increase. Whilst CDK fulfils a function in 
preventing origin licensing during S-phase (see section 1.3.3), both these kinases 
also actively stimulate Mcm2-7 helicase activation and origin firing, as will be 
discussed in the next two sections. 
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1.4.2.1 CDK 
In S. cerevisiae, the minimal CDK substrates required for S-phase entry are Sld2 
and Sld3 (Tanaka et al., 2007, Zegerman and Diffley, 2007). Sld3 is 
phosphorylated at two essential sites, Ser 600 and Thr 622, whereas studies 
suggest that Sld2 is phosphorylated at multiple Ser/Thr, although Thr 84 is the 
essential site required for replication initiation (Masumoto et al., 2002). It has been 
hypothesised that phosphorylation of other sites in Sld2 contribute to some 
unknown conformational change, which in turn exposes Thr 84 for phosphorylation 
by CDK. 
 
Phosphorylation of Sld2 and Sld3 facilitates their binding to a third firing factor, 
Dpb11. Dpb11 contains two pairs of tandem BRCT repeats (BRCT I-IV); 
phosphorylated Sld3 interacts with the N-terminal BRCT pair (BRCT I/II), whereas 
BRCT III and IV function as a binding site for phosphorylated Sld2. Importantly, the 
expression of a phospho-mimetic T84D Sld2 mutant, in combination with an ‘SD 
fusion’ protein, containing a non-phosphorylatable Sld3 mutant (T600A, T609A, 
S622A) fused directly to the C-terminal portion of Dpb11 (lacking BRCT I/II), is 
sufficient to bypass the requirement for CDK for DNA replication (Zegerman and 
Diffley, 2007). This not only indicates that Sld2 and Sld3 are the minimal CDK 
substrate required for S-phase entry, but also that the only function of the CDK 
phosphorylation of Sld3 is to promote binding to Dpb11. Phosphorylation of Sld2 
has also been shown to promote the association of Polε with the pre-LC in vitro 
(Muramatsu et al., 2010). However, this effect is not dependent on Thr 84 in Sld2, 
suggesting that it is not an essential process. 
 
Homologues of Sld2, Sld3 and Dpb11 exist in other eukaryotes. In fission yeast, 
they are Drc1, Sld3 and Cut5, respectively, and CDK phosphorylation promotes the 
binding of Sld3 and Drc1 to Cut5, as in S. cerevisiae (Nakajima and Masukata, 
2002, Noguchi et al., 2002, Saka and Yanagida, 1993). The metazoan homologue 
of Dpb11, TopBP1, contains nine BRCT domains (BRCT 0-VIII) (Huo et al., 2010, 
Makiniemi et al., 2001). Treslin (Sld3) binds to BRCT I/II of TopBP1 in a CDK-
dependent manner, indicating that the CDK-dependent regulation of the Sld3-
Dpb11 interaction is conserved from yeast to humans (Kumagai et al., 2010, 
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Kumagai et al., 2011, Boos et al., 2011). BRCT IV/V of TopBP1 are homologous to 
BRCT III/IV of Dpb11, suggesting that this may be the binding site for RecQL4 
(Sld2). However, RecQL4 can bind to both TopBP1 and chromatin in the absence 
of CDK activity (Matsuno et al., 2006, Sangrithi et al., 2005), and a TopBP1 
fragment that contains only BRCT I-III is sufficient to support DNA replication in 
Xenopus egg extracts (Kumagai et al., 2010). Notably, the Sld2-Dpb11 interaction 
is CDK-dependent in C. elegans (Gaggioli et al., 2014); further investigation is 
required to establish if CDK fulfils the same minimal set of functions for S-phase 
entry across all eukaryotes. 
 
1.4.2.2 DDK 
Dbf4-dependent kinase (DDK) is a heterodimer of the Cdc7 catalytic subunit and 
Dbf4 activating subunit (Jackson et al., 1993); both of these proteins are essential 
for S-phase entry (Hartwell, 1973, Hereford and Hartwell, 1973, Johnston and 
Thomas, 1982, Chapman and Johnston, 1989, Bousset and Diffley, 1998). The 
interaction between Cdc7 and Dbf4 is required to stimulate the kinase activity of 
Cdc7 (Kitada et al., 1992, Yoon et al., 1993), and DDK activity is thus kept low 
during G1 phase via the APC/C-mediated degradation of Dbf4 (Weinreich and 
Stillman, 1999, Ferreira et al., 2000, Oshiro et al., 1999). 
 
The first evidence that the Mcm2-7 helicase itself might be the essential target of 
DDK required for replication initiation came from the isolation of the mcm5-bob1 
allele, a single amino acid substitution mutant that bypasses the requirement for 
DDK in vivo (Hardy et al., 1997). DDK has since been shown to phosphorylate 
multiple Ser/Thr in the unstructured N-termini of Mcm2, Mcm4 and Mcm6 (Masai et 
al., 2006, Montagnoli et al., 2006, Sheu and Stillman, 2006, Randell et al., 2010), 
and exhibits a strong substrate preference for Mcm2-7 complexes that have been 
pre-assembled into the pre-RC (Francis et al., 2009). The reason for this substrate 
preference is not currently understood. However, it is known that DDK can interact 
with the pre-RC via the N-terminus of Dbf4 (Francis et al., 2009, Dowell et al., 
1994) and, furthermore, Cdc7 and Dbf4 have been shown to interact with Mcm4 
and Mcm2, respectively (Ramer et al., 2013, Bruck and Kaplan, 2009). Additionally, 
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the N-terminus of Mcm4 has been reported to contain a DDK binding site (Sheu 
and Stillman, 2006). 
 
Although Ser/Thr residues with diverse surrounding amino acid sequences have 
been identified as DDK phosphorylation sites by mass spectrometry (Randell et al., 
2010), DDK does display some preference for phosphorylating Ser/Thr that have 
either a second phosphorylated Ser/Thr or an acidic amino acid (Asp/Glu) in the +1 
position (Randell et al., 2010, Masai et al., 2006, Montagnoli et al., 2006, Cho et al., 
2006, Charych et al., 2008). This preference is suggestive of the existence of 
potential ‘priming’ kinases, which might phosphorylate specific Ser/Thr to promote 
DDK phosphorylation of adjacent residues. Interestingly, a recent study suggested 
that these priming sites conform to either S/T-P or S/T-Q consensus sequences, 
and Mec1 was identified as one of the kinases responsible for the phosphorylation 
of these sites (Randell et al., 2010). 
 
Deleterious phenotypes have been reported for mutants of Mcm2, Mcm4 and 
Mcm6, which lack DDK phosphorylation sites, suggesting that phosphorylation of 
all three of these Mcm subunits is important for origin firing (Randell et al., 2010, 
Bruck and Kaplan, 2009, Sheu and Stillman, 2006). Interestingly, a genetic study 
published in 2010 showed that the removal of amino acids 74-174 from Mcm4 was 
sufficient to allow DDK-independent DNA replication in vivo (Sheu and Stillman, 
2010). It was thus concluded that this section of Mcm4 must be inhibitory for origin 
firing, and that phosphorylation of Mcm2-7 by DDK somehow relieves this inhibition. 
This model, in addition to the existence of a DDK bypass allele in MCM5 (see 
above), which is not a DDK substrate, has lead many to suppose that DDK 
phosphorylation must elicit some conformational change in Mcm2-7 that is required 
for origin firing. However, no gross structural rearrangements were visible when 
DDK-phosphorylated Mcm2-7 double hexamers were recently visualised by 
electron microscopy (On et al., 2014). 
 
The activity of DDK has recently been shown to be required for the association of 
Sld3/7 and Cdc45 with origins of replication, which can occur upstream of CDK 
function in vivo and in vitro (Yabuuchi et al., 2006, Heller et al., 2011, Tanaka et al., 
2011a). The mechanism by which DDK promotes the recruitment of these factors, 
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and thus origin firing, is poorly understood, and will be one of the main focuses of 
this study. 
 
1.4.3 Mechanism of origin firing 
In S. cerevisiae, we now have a good understanding of the identity of the proteins 
that are required for origin firing, and informative models now exist that predict the 
steps, which must proceed to convert the inactive Mcm2-7 double hexamer into the 
active CMG replicative helicase (Fig. 1.5). However, there is still relatively little 
known about the mechanism of Mcm2-7 helicase activation, or what functions the 
individual firing factors fulfil in this process. What little information we do have 
about this process concerns the order of the recruitment of various proteins to 
origins of replication, and comes primarily from chromatin binding experiments 
performed in vivo, as well as recent studies conducted using an extract-based 
system that recapitulates DNA replication initiation in vitro (Heller et al., 2011). 
 
1.4.3.1 DDK-dependent recruitment of Cdc45 and Sld3/7 
The first step in the pre-IC assembly reaction is thought to be the DDK-dependent 
recruitment of Sld3/7 and Cdc45 (Fig. 1.6, step 1), which can be detected at early-
firing replication origins in G1 phase of the cell cycle (Yabuuchi et al., 2006, Tanaka 
et al., 2011a). The recruitment of Sld3 and Cdc45 to replication origins has been 
suggested to be inter-dependent in S. cerevisiae (Kamimura et al., 2001, Kanemaki 
and Labib, 2006), although similar studies performed in S. pombe suggest that 
Sld3 may be able to bind to chromatin in the absence of Cdc45 (Yabuuchi et al., 
2006). DDK-dependent Sld3/7 and Cdc45 origin recruitment has been shown to be 
independent of CDK activity, consistent with studies in Xenopus egg extracts 
showing that DDK functions upstream of CDK in the origin firing process (Jares and 
Blow, 2000, Walter, 2000). 
 
Mcm10 has also been detected at origins of replication in G1 phase of the cell 
cycle (van Deursen et al., 2012), although recent studies suggest that it may 
execute its function at a later step during the origin firing process (see section 
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1.4.1.6). Notably, initial DNA unwinding is not detectable at this stage of the 
reaction (Heller et al., 2011), consistent with the lack of observable ssDNA at 
origins of replication in G1 phase. 
 
1.4.3.2 CDK-dependent pre-LC assembly and GINS recruitment 
The increase in CDK activity at the G1/S transition is required for the binding of 
Sld3 and Sld2 to Dpb11 (Tanaka et al., 2007, Zegerman and Diffley, 2007, 
Masumoto et al., 2002), and also promotes the assembly of the pre-loading 
complex (pre-LC), which contains Dpb11, Sld2, GINS and Polε (Muramatsu et al., 
2010). Thus, a simplistic model has emerged, whereby the CDK-dependent binding 
of Dpb11, a pre-LC component, to Sld3 pre-bound to the pre-RC facilitates the 
CDK-dependent recruitment of GINS to origins of replication (Fig. 1.6, step 2). It is 
as yet unclear whether any of the pre-LC components other than GINS interact 
directly with the Mcm2-7 complex, or whether the pre-LC is indeed an active 
precursor for origin firing. 
 
The presence of Polε in the pre-LC is interesting. Despite its function as the 
primary replicative polymerase on the leading strand template at replication forks 
(Pursell et al., 2007), the N-terminal catalytic domain of the Pol2 subunit of Polε is 
not essential (Kesti et al., 1999, Feng and D'Urso, 2001). Surprisingly, deletion of 
the C-terminal portion of Pol2 is lethal in S. cerevisiae (Dua et al., 1999), whilst 
recent work suggests that the N-terminus of the Dpb2 subunit of Polε is important 
for proper assembly of the CMG replicative helicase (Sengupta et al., 2013). 
Further work is required to ascertain the exact function of Polε during Mcm2-7 
activation. 
 
At some juncture following the recruitment of GINS to the Mcm2-7 double hexamer, 
extensive remodelling must occur to allow two stable CMG complexes to form, 
each containing a single Mcm2-7 ring as well as Cdc45 and the GINS tetramer. 
Recently published data suggests that Mcm10 functions at a late step during origin 
firing to promote ATP-dependent origin unwinding (Fig. 1.6, step 3), which 
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seemingly occurs downstream of CMG assembly (van Deursen et al., 2012, 
Watase et al., 2012, Kanke et al., 2012, Heller et al., 2011).  
 
 
Figure 1.6 Model for multi-step assembly of the pre-initiation complex (pre-IC) 
During origin firing, DDK functions upstream of CDK to promote the recruitment of 
a specific subset of firing factors. Mcm10 functions at a distinct step downstream of 
Cdc45 and GINS recruitment, and is required for origin unwinding. DDK 
phosphorylation sites are shown as light blue hexagons, whilst CDK 
phosphorylation sites are shown as pink hexagons. A full description is given in 
section 1.4.3 of the text. 
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Notably, a number of firing factors, such as Sld3, Sld2 and Mcm10, have been 
shown to bind to ssDNA in vitro (Bruck et al., 2011, Bruck and Kaplan, 2011, 
Robertson et al., 2008, Warren et al., 2008, Eisenberg et al., 2009), but it is not yet 
clear whether such interactions are important during the origin firing process. 
Indeed, it is not known how any of the firing factors discussed herein contribute 
towards origin melting, Mcm2-7 ring opening or separation of the Mcm2-7 double 
hexamer, let alone how other factors such as Ctf4 and Mrc1 associate to form the 
Replisome Progression Complex (RPC) (Gambus et al., 2006) once the active 
CMG replicative helicase is bound around the leading strand template. 
 
1.5 Thesis summary 
The work presented in this thesis attempts to dissect the mechanism of Mcm2-7 
helicase activation, using the budding yeast S. cerevisiae as a model system. In 
recent years, our understanding of the mechanism of Mcm2-7 loading has been 
greatly advanced by studies performed using a reconstituted system for pre-RC 
assembly in vitro. The complete reconstitution of the entire process of DNA 
replication initiation using purified proteins should allow for detailed mechanistic 
insight about Mcm2-7 helicase activation and replisome assembly to be attained. 
Towards this aim, I adopted a primarily biochemical approach during this study, 
and initially developed protocols for the purification of many of the factors known to 
be required for origin firing. Interestingly, I obtained evidence that the Sld3/7 
complex contains multiple copies of Sld3, which has implications for the 
mechanism of pre-IC assembly. 
 
Subsequently, I predominantly focussed on understanding the functions of DDK 
and Sld3/7 during Mcm2-7 activation. I reconstituted the DDK-dependent 
recruitment of Sld3/7 to the pre-RC in vitro, which is believed to be the first step in 
pre-IC assembly. I have shown that Sld3/7 recruitment to the pre-RC is dependent 
on a novel phosphorylation-dependent interaction between a central domain of 
Sld3 and the loaded Mcm2-7 double hexamer. I showed that Sld3 itself contains a 
novel phosphopeptide binding activity, and can interact with a number of Mcm 
subunits in a phospho-dependent manner. I was subsequently able to isolate 
Chapter 1 Introduction 
 54 
mutants in both Sld3 and Mcm2-7 that were defective in Sld3/7 recruitment, which 
allowed the functional significance of this interaction for origin firing to be 
addressed.  
 
In addition to providing a basis upon which future attempts to reconstitute Mcm2-7 
helicase activation will be built, this study also affords significant insight into the 
early steps of the origin firing process. To our knowledge, the Sld3-Mcm2-7 
interaction described herein is the first protein-protein interaction described that is 
directly regulated by DDK, and helps to explain how DDK promotes origin firing. 
Furthermore, the involvement of the essential CDK substrate Sld3 in a DDK-
dependent pathway singles out Sld3 as a point of convergence for the activities of 
CDK and DDK during Mcm2-7 helicase activation.
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Chapter 2. Materials & Methods 
2.1 Enzymes and Reagents 
2.1.1 Enzymes and proteins 
Table 2-1 Enzymes used in this study 
Enzyme Source 
Benzonase, ribonuclease A Sigma-Aldrich 
Restriction enzymes, λ protein 
phosphatase, Phusion DNA polymerase 
New England Biolabs (NEB) 
KOD Hot Start DNA polymerase Novagen 
T4 DNA ligase Roche 
 
 
2.1.2 Antibodies 
Table 2-2 Primary monoclonal antibodies used in this study 
Antibody Source Dilution 
Anti-FLAG Sigma-Aldrich 1:1000 
Anti-Orc6 CRUK 1:1000 
Anti-Myc Santa Cruz Biotechnology 1:1000 
Anti-Cdc6 CRUK 1:1000 
 
 
 Table 2-3 Primary polyclonal antibodies used in this study 
Antibody Source Dilution 
Anti-Mcm2 (yN-19) Santa Cruz Biotechnology 1:1000 
Ant-Mcm4 (yC-19) Santa Cruz Biotechnology 1:1000 
Anti-Mcm6 (20147) Generated in the laboratory 1:500 
Anti-Mcm7 (yN-19) Santa Cruz Biotechnology 1:1000 
Anti-Sld2 Generated in the laboratory 1:1000 
Anti-Sld3 Generated in the laboratory 1:1000 
Anti-Sld7 Generated in the laboratory 1:1000 
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Anti-Cdc45 Generated in the laboratory 1:1000 
Anti-Dpb11 Generated in the laboratory 1:1000 
Anti-Psf1 A gift from Dr. Karim Labib 1:3000 
 
 
Table 2-4 Secondary antibodies used in this study 
Antibody Source Dilution 
Anti-goat-HRP Stratech Scientific 1:5000 
Anti-sheep-HRP Santa Cruz Biotechnology 1:5000 
Anti-mouse-HRP Dako 1:5000 
Anti-rabbit-HRP Jackson ImmunoResearch 1:5000 
 
2.2 Media 
Ultrapure water was used in all media and solutions unless otherwise stated. All 
media was made by Cancer Research UK London Research Institute Cell Services 
 
2.2.1 Media for E. coli cells 
Luria Broth (LB) medium (0.5% bacto-tryptone, 0.25% bacto-yeast extract, 170 mM 
NaCl, pH 7.0) was used for growth in suspension. For growth on solid media, LB 
was supplemented with 2% agar. For selective growth, media was supplemented 
with ampicillin (50 µg/ml), chloramphenicol (35 µg/ml) or kanamycin (50 µg/ml). 
During transformation of E. coli, cells were grown in SOC medium (0.5% bacto-
yeast extract, 2% bacto-tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4, 20 mM glucose).  
 
2.2.2 Media for yeast cells 
For growth in suspension, cells were grown in Yeast Peptone (YP) medium (1% 
yeast extract, 2% peptone) supplemented with 2% glucose (YPD), galactose or 
raffinose. For growth on solid media, 2% agar was added to YPD. 
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For selective growth on solid media, minimal drop-in media (2% agar, 2% glucose, 
1x yeast nitrogen base) was supplemented with amino acids as required (histidine 
10 mg/ml, tryptophan 2 mg/ml, leucine 10 mg/ml, adenine 5 mg/ml, uracil 2 mg/ml). 
For selective growth using the NatNT2 marker, cells were grown on YPD agar 
supplemented with 100 µg/ml Nourseothricin (LEXSY NTC, Jena Bioscience).  
 
2.3 Buffers and Solutions 
2.3.1 Buffers for general manipulation of DNA 
50x TAE: 2 M Tris base, 2 M glacial acetic acid, 50 mM EDTA 
6x DNA Loading Buffer: 0.15% orange G, 60% glycerol, 1 x TAE 
 
2.3.2 Buffers for general manipulation of proteins 
2x Laemmli sample buffer: 100 mM Tris-HCl pH 6.9, 4% (w/v) SDS, 20% (v/v) 
glycerol, 200 mM 2-mercaptoethanol. 0.1% (w/v) bromophenol blue 
5x Laemmli sample buffer: 300 mM Tris-HCl pH 6.8, 20% (w/v) SDS, 50% (w/v) 
glycerol, 0.1% (w/v) bromophenol blue, 2.8 M 2-mercaptoethanol 
TBS: 20 mM Tris-HCl pH 7.5, 150 mM NaCl 
TBST:  20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM Tween 20 
PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 
Western transfer buffer: 48 mM Trizma base, 39 mM glycine, 0.0375% (w/v) SDS, 
20% methanol 
Blocking buffer: 5% (w/v) Marvel milk powder dissolved in TBST 
Probing buffer: 2.5% (w/v) Marvel milk powder dissolved in TBST 
Super blotto buffer: 0.5% (w/v) BSA, 2.5% (w/v) Marvel milk powder, 0.5% (v/v) 
NP-40, 1 mM Tween 20, 1 x TBS 
 
2.3.3 Buffers for protein purification 
Wash buffer I: 25 mM Hepes-KOH pH 7.6, 1 M sorbitol 
Buffer A: 25 mM Hepes-KOH pH 7.6, 0.05% (v/v) NP-40, 10% (v/v) glycerol 
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Buffer B: 45 mM Hepes-KOH pH 7.6, 5 mM Mg(OAc)2, 0.02% (v/v) NP-40, 10% 
(v/v) glycerol 
Buffer C: 50 mM K2HPO4/KH2PO4 pH 7.6, 5 mM MgCl2, 2 mM ATP, 1 mM DTT 
Buffer D: 50 mM K2HPO4/KH2PO4 pH 7.6, 400 mM KOAc, 5 mM MgCl2, 0.1% 
Triton, 15% (v/v) glycerol, 1 mM DTT 
SE buffer I: 50 mM Hepes-KOH pH 7.6, 300 mM K-Glutamate, 2 mM EDTA, 800 
mM sorbitol 
SE buffer II: 100 mM Hepes-KOH pH 7.6, 10 mM Mg(OAc)2, 800 mM sorbitol 
SE buffer III: 50 mM Hepes-KOH pH 7.6, 300 mM K-Glutamate, 5 mM Mg(OAc)2, 
1 mM EDTA, 1 mM EGTA, 10% (v/v) glycerol 
Homemade Protease Inhibitor Cocktail: 1 mM EDTA, 5 mM benzamidine-HCl, 
1.5 µM pepstatin A, 0.5 mM AEBSF, 0.3 µM aprotinin, 3 mM PMSF, 2 µM leupeptin 
 
2.3.4 Buffers for in vitro biochemical assays 
Buffer I: 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 M NaCl  
Buffer II: 10 mM Hepes-KOH pH 7.6, 1 mM EDTA, 1 M KOAc 
Buffer III: 10 mM Hepes-KOH pH 7.6, 1 mM EDTA 
5x Binding Buffer (5x BB): 125 mM Hepes-KOH pH 7.6, 50 mM Mg(OAc)2, 0.1% 
(v/v) NP-40, 25% (v/v) glycerol, 0.325 M KOAc 
20x Replication Buffer (20X RPB): 800 mM Hepes-KOH pH 7.6, 160 mM MgCl2 
Pre-RC Wash Buffer: 45 mM Hepes-KOH pH 7.6, 5 mM Mg(OAc)2, 1 mM EDTA, 1 
mM EGTA, 0.02% (v/v) NP-40, 10% (v/v) glycerol 
Low Salt Wash Buffer: Pre-RC Wash Buffer + 300 mM KOAc / K-Glutamate (as 
indicated) 
High Salt Wash Buffer: Pre-RC Wash Buffer + 500 mM NaCl 
Peptide Array Buffer: 25 mM Hepes-KOH pH 7.6, 10 mM Mg(OAc)2, 0.02% (v/v) 
NP-40, 5% (v/v) glycerol, 0.5 M KOAc, 50 mM KCl, 1 mM DTT 
 
 
 
Chapter 2 Materials and Methods 
 
 59 
2.4 Plasmids 
Table 2-5 Plasmids used in this study 
Name Cloning 
vector 
Insert Use Reference 
p305BP pBR322 ARS305 Template for PCR 
to generate 
biotinylated DNA 
fragment for in vitro 
pre-RC assembly 
assay 
(Huang and 
Kowalski, 
1996) 
pBluescript/ARS1 
WTA 
N/A N/A Template for in vitro 
DNA replication 
assay 
(On et al., 
2014) 
pAM3  pGEX-6p-
1 
CDC6 Expression of Cdc6 
in E. coli for 
purification 
(Frigola et al., 
2013) 
pJF2 pRS303 GAL4-
GAL1-10-
CDT1 
Galactose-inducible 
expression in yeast 
(Frigola et al., 
2013) 
pJF4 pRS305 MCM7-
GAL1-10-
MCM6 
Galactose-inducible 
expression in yeast 
(Frigola et al., 
2013) 
pBP83 pYM21 3XFLAG-
Nat-NT2 
Template for PCR 
to amplify 3xFLAG-
Nat-NT2 for epitope 
tagging in yeast 
Generated 
within the 
laboratory 
pBS1539/TAPTCP N/A N/A Template for PCR 
to amplify TAPTCP-
URA3 for epitope 
tagging in yeast 
(Remus et al., 
2009). 
pFA6a-Nat-NT2 N/A N/A Generation of 
SLD3-Nat-NT2 
(Falbo and 
Shen, 2012) 
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PCR cassettes for 
trannformation 
 
 
Table 2-6 Plasmids generated in this study. 
The subscript SUP indicates that the gene’s codon usage is optimised for 
expression. 
Name Cloning 
vector 
Insert Generation 
of insert 
5’ cloning 
site 
3’ cloning 
site 
pTD2 pJF2 DPB11 PCR SgrA1 NotI 
pTD4 pJF2 CDC45SUP GeneArt Gene 
Synthesis 
SgrA1 NotI 
pTD5 pJF2 SLD2SUP GeneArt Gene 
Synthesis 
SgrA1 NotI 
pTD6a pJF2 SLD3SUP GeneArt Gene 
Synthesis 
SgrA1 NotI 
pTD6b pJF4 SLD7SUP GeneArt Gene 
Synthesis 
SgrA1 NotI 
pTD12 pJF4 MCM6Δ2-
84 
PCR SgrA1 NotI 
pTD24 pJF4 MCM6- 
TEV2  
GeneArt Gene 
Synthesis 
(MCM6-209-
588) 
PshA1 SnaB1 
pTDP1 pJF4 MCM6-
T150A 
GeneArt Gene 
Synthesis 
(MCM6-1-
209) 
SgrA1 PshA1 
pTD29 pTDP1 MCM6-
T150A, 
11S/T-A 
GeneArt Gene 
Synthesis 
(MCM6-209-
588) 
PshA1 SnaB1 
pTD30 pTD12 MCM6Δ2- GeneArt Gene PshA1 SnaB1 
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84, 
11S/T-A 
Synthesis 
(MCM6-209-
588) 
pTD33 pJF4 MCM6Δ2-
84, 
Δ199-260 
GeneArt Gene 
Synthesis 
(MCM6-1-
588) 
SgrA1 SnaB1 
pTD39 pTD12 MCM6Δ2-
84, 
3S/T-A 
GeneArt Gene 
Synthesis 
(MCM6-209-
588) 
PshA1 SnaB1 
pFA6a-
Nat-NT2/ 
SLD3 
2E3 
pFA6a-
Nat-NT2 
SLD3-
K530E, 
R531E 
PCR (pGEX-
6p-1/SLD3 
2E3 template) 
NdeI PvuII 
pFA6a-
Nat-NT2/ 
SLD3 6E 
pFA6a-
Nat-NT2 
SLD3- 
K511E, 
R512E, 
K518E, 
R520E, 
K530E, 
R531E 
PCR (pGEX-
6p-1/SLD3 6E 
template) 
NdeI PvuII 
pGEX-6p-
1/SLD3 
pGEX-
6p-1 
SLD3 PCR BamHI XhoI 
pGEX-6p-
1/SLD7 
pGEX-
6p-1 
SLD7 PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
N0 
pGEX-
6p-1 
FLAG-
SLD3 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
N4 
pGEX-
6p-1 
FLAG-
SLD3-1-
435 
PCR BamHI XhoI 
pGEX-6p- pGEX- FLAG- PCR BamHI XhoI 
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1/SLD3 
N5 
6p-1 SLD3-1-
585 
pGEX-6p-
1/SLD3 
C0 
pGEX-
6p-1 
SLD3-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
C1 
pGEX-
6p-1 
SLD3-
586-668-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
C2 
pGEX-
6p-1 
SLD3-
436-668-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
C3 
pGEX-
6p-1 
SLD3-
326-668-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
C4 
pGEX-
6p-1 
SLD3-
251-668-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
C5 
pGEX-
6p-1 
SLD3-
133-668-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
M3 
pGEX-
6p-1 
SLD3-
251-471-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
M4 
pGEX-
6p-1 
SLD3-
251-486-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
M5 
pGEX-
6p-1 
SLD3-
251-585-
FLAG 
PCR BamHI XhoI 
pGEX-6p-
1/SLD3 
2E1 
pGEX-
6p-
1/SLD3 
N0 
SLD3-
K511E, 
R512E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
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pGEX-6p-
1/SLD3 
2E2 
pGEX-
6p-
1/SLD3 
N0 
SLD3-
K518E, 
R520E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
pGEX-6p-
1/SLD3 
2E3 
pGEX-
6p-
1/SLD3 
N0 
SLD3-
K530E, 
R531E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
pGEX-6p-
1/SLD3 
4E1 
pGEX-
6p-
1/SLD3 
N0 
SLD3- 
K511E, 
R512E, 
K518E, 
R520E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
pGEX-6p-
1/SLD3 
4E2 
pGEX-
6p-
1/SLD3 
N0 
SLD3- 
K511E, 
R512E, 
K530E, 
R531E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
pGEX-6p-
1/SLD3 
4E3 
pGEX-
6p-
1/SLD3 
N0 
SLD3- 
K518E, 
R520E, 
K530E, 
R531E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
pGEX-6p-
1/SLD3 
6E 
pGEX-
6p-
1/SLD3 
N0 
SLD3- 
K511E, 
R512E, 
K518E, 
R520E, 
K530E, 
R531E 
GeneArt Gene 
Synthesis 
(SLD3-492-
668) 
XbaI XhoI 
pGEX-6p-
1/SLD3 
K267E 
pGEX-
6p-
1/SLD3 
SLD3-
K267E 
GeneArt Gene 
Synthesis 
(SLD3-215-
BsrG1 XbaI 
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C0 492) 
pGEX-6p-
1/SLD3 
R269E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
R269E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K267E, 
R269E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K267E, 
R269E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K272E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K272E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K386E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K386E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K404E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K404E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K405E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K405E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K404E, 
K405E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K404E, 
K405E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K416E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K416E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
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pGEX-6p-
1/SLD3 
K418E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K418E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K416E, 
K418E 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K416E, 
K418E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
K301E 
 
pGEX-
6p-
1/SLD3 
C0 
SLD3-
K301E 
 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
3E1 
pGEX-
6p-
1/SLD3 
C0 
SLD3- 
K303E, 
K304E, 
R305E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
3E2 
pGEX-
6p-
1/SLD3 
C0 
SLD3- 
K301E, 
R305E, 
R317E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
4E4 
pGEX-
6p-
1/SLD3 
C0 
SLD3- 
K296E, 
K297E, 
K299E, 
K301E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
4E5 
pGEX-
6p-
1/SLD3 
C0 
SLD3- 
R317E, 
R318E, 
K320E, 
K321E 
GeneArt Gene 
Synthesis 
(SLD3-215-
492) 
BsrG1 XbaI 
pGEX-6p-
1/SLD3 
8E 
pGEX-
6p-
1/SLD3 
SLD3- 
K296E, 
K299E, 
GeneArt Gene 
Synthesis 
(SLD3-215-
BsrG1 XbaI 
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C0 K301E, 
K303E, 
R305E, 
R317E, 
R318E, 
K320E 
492) 
 
2.5 DNA Oligonucleotides 
Table 2-7 Oligonucleotides used in this study 
Name Sequence Use Purpose 
Dpb11 
fwd 
5’-AAGCTCACCGGTGATGAAGCCCTTTC 
AAGGAATA-3’ 
5’ PCR Construction 
of pTD2 
Dpb11 
rev 
5’-CTGAGGCGGCCGCTCAAGAATCTAAT 
TCCTTTGT-3’ 
3’ PCR Construction 
of pTD2 
Mcm6ΔN 
fwd 
5’-GTCGGCACCGGTGATGGGAAATGAA 
CCTGCCAGAAGC-3’ 
5’ PCR Construction 
of pTD12 
Mcm6ΔN 
rev 
5’-AGCTAGCGGCCGCTTAGCTGGAATC 
CTGTGGTTC-3’ 
3’ PCR Construction 
of pTD12 
Sld3 fwd 5’-CTGGACACCGGTGATGGAAACATGG 
GAAGTCATA-3’ 
5’ PCR Construction 
of pGEX-6p-
1/SLD3 
Sld3 rev 5’-AGCACGCGGCCGCCTATGTGGATTC 
TGGAGCAAA-3’ 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 
Sld7 fwd 5’-GTCGGCACCGGTGATGTCACGGAAA 
TTATGCACA-3’ 
5’ PCR Construction 
of pGEX-6p-
1/SLD7 
Sld7 rev 5’-AGCTAGCGGCCGCTCATGATTTGGTA 
AAGAGCTT-3 
3’ PCR Construction 
of pGEX-6p-
1/SLD7 
N fwd 5’-AGTCGGGATCCGACTACAAAGACGAT 
GACGACAAGGAAACATGGGAAGTCATA
5’ PCR Construction 
of pGEX-6p-
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GCA-3’ 1/SLD3 N0, 
N4 and N5 
NR0 5’-CTGAGCTCGAGCTATGTGGATTCTG 
GAGCAAA-3’ 
 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 N0 
NR4 5’-CTGAGCTCGAGCTATGTGCTATCGT 
TGACCTTTTT-3’ 
 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 N4 
NR5 5’-CTGAGCTCGAGCTATAGGCGTATCG 
TTTCATTGAT-3’ 
 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 N5 
C rev 5’-CTGAGCTCGAGCTACTTGTCGTCAT 
CGTCTTTGTAGTCTGTGGATTCTGGAGC
AAATAA-3’ 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 C0 – 
C5 
CF0 5’-AGTCGGGATCCGAAACATGGGAAGT 
CATAGCA-3’ 
 
5’ PCR Construction 
of pGEX-6p-
1/SLD3 C0 
CF1 5’-AGTCGGGATCCCATGAACGTGTAGA 
CTCTGAG-3’ 
 
5’ PCR Construction 
of pGEX-6p-
1/SLD3 C1 
CF2 5’-AGTCGGGATCCAATGTATCGTCACC 
TAATACT-3’ 
 
5’ PCR Construction 
of pGEX-6p-
1/SLD3 C2 
CF3 5’-AGTCGGGATCCAAAGACAAAGGAAT 
CGAGAGA-3’ 
5’ PCR Construction 
of pGEX-6p-
1/SLD3 C3 
CF4 5’-AGTCGGGATCCGATGAAAACAAAAA 
CAGCTCA-3’ 
 
5’ PCR Construction 
of pGEX-6p-
1/SLD3 C4, 
M3, M4 and 
M5 
CF5 5’-AGTCGGGATCCAAAGACCTTAAACT 5’ PCR Construction 
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GGATATG-3’ 
 
of pGEX-6p-
1/SLD3 C5 
NR5+ 
FLAG 
5’-CTGAGCTCGAGCTACTTGTCGTCAT 
CGTCTTTGTAGTCTAGGCGTATCGTTTC
ATTGAT-3’ 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 M5 
NR6+ 
FLAG 
5’-CTGAGCTCGAGCTACTTGTCGTCAT 
CGTCTTTGTAGTCTCTCAATGCGGGTGA
AGATGG-3’ 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 M3 
NR7+ 
FLAG 
5’-CTGAGCTCGAGCTACTTGTCGTCAT 
CGTCTTTGTAGTCGGGCGAAGCTATAG
ATTTTCT-3’ 
3’ PCR Construction 
of pGEX-6p-
1/SLD3 M4 
Sld3 NdeI 
fwd 
5’-GCTGACATATGGAAACATGGGAAG 
TCATAGCA-3’ 
5’ PCR Construction 
of pFA6a-
Nat-NT2/ 
SLD3 2E3, 
6E 
Sld3 
PvuII rev 
5’-TACGTCAGCTGCTATGTGGATTCT 
GGAGC-3’ 
3’ PCR Construction 
of pFA6a-
Nat-NT2/ 
SLD3 2E3, 
6E 
 
2.6 Strains 
2.6.1 E. Coli strains 
Table 2-8 E. coli strains used in this study 
Name Source Use Genotype 
NEB 5-alpha 
competent E. coli 
NEB Cloning E. coli 
fhuA2Δ(argF-
lacZ)U169 phoA 
glnV44 φ80 
Δ(lacZ)M15 
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gyrA96 recA1 
relA1 endA1 thi-1 
hsdR17 
BL21-CodonPlus 
(DE3)-RIL 
Stratagene Protein expression E. coli B F- ompT 
hsdS(rB-mB-) dcm+ 
Tetr gal λ(DE3) 
endA Hte [argU 
ileY BB leuW 
Camr] 
 
2.6.2 Yeast strains 
Table 2-9 Yeast strains used in this study.  
The subscript SUP indicates that the gene’s codon usage is optimised for 
expression. 
Name Genotype Reference 
ySDORC MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX,  
his3::HIS3pRS303/ORC3 SUP, ORC4 SUP, 
trp1::TRP1pRS304/ORC5 SUP, ORC6 SUP, 
ura3::URA3pRS306/CBP-ORC1 SUP, ORC2 SUP 
(Frigola et 
al., 2013) 
yAM33 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6, MCM7, 
ura3::URA3pRS306/MCM2, CBP-MCM3 
(Frigola et 
al., 2013) 
yJF38 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6, MCM7, 
ura3::URA3pRS306/MCM2, 3xFLAG-MCM3 
(Frigola et 
al., 2013) 
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ySDK8 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, pep4::KanMX, 
trp1::TRP1pRS304/CDC7 SUP, CBP-DBF4 SUP 
(On et al., 
2014) 
yKO3 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
his3::HIS3pRS303/SLD3-13MYC, 
trp1::TRP1pRS304/SLD2, leu2::LEU2pRS305/ 
SLD7, CDC45, ura3::URA3pRS306/ DPB11 
(On et al., 
2014) 
yJY16 MATα  ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: KanMX, 
trp1::TRP1pRS304/SLD2, ura3::URA3pRS306/ 
DPB11 
Generated in 
the 
laboratory 
yMD7 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
Generated in 
the 
laboratory 
yTD2 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/DPB11-TCP, GAL4 
This study 
yTD4 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/CDC45SUP-TCP, GAL4 
This study 
yTD6 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/SLD3SUP-TCP, GAL4, 
leu2::LEU2pRS305/SLD7 SUP 
This study 
yTD7 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/CDC45SUP-3XFLAG, GAL4 
This study 
yTD8 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
his3::HIS3pRS303/SLD2SUP-3XFLAG, GAL4 
This study 
yTD11 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, bar1::Hyg pep4::KanMX, 
This study 
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his3::HIS3pRS303/SLD3SUP-3XFLAG, GAL4, 
leu2::LEU2pRS305/SLD7 SUP 
yTD13 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6Δ2-84, MCM7, 
ura3::URA3pRS306/MCM2, CBP-MCM3 
This study 
yTD24 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6TEV2, MCM7, 
ura3::URA3pRS306/MCM2, CBP-MCM3 
This study 
yTD29 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6T150A+11S/T-A, 
MCM7, ura3::URA3pRS306/MCM2, CBP-MCM3 
This study 
yTD30 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6Δ2-84+11S/T-A, 
MCM7, ura3::URA3pRS306/MCM2, CBP-MCM3 
This study 
yTD33 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
This study 
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his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6Δ2-84+Δ199-260, 
MCM7, ura3::URA3pRS306/MCM2, CBP-MCM3 
yTD39 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-
3,112 can1-100, cdc7-4, pep4:: Hyg, 
MCM6::MCM6-3xFLAG (Nat-NT2) 
his3::HIS3pRS303/CDT1,GAL4, 
trp1::TRP1pRS304/MCM4, MCM5, 
leu2::LEU2pRS305/MCM6Δ2-84+3S/T-A, 
MCM7, ura3::URA3pRS306/MCM2, CBP-MCM3 
This study 
 
2.7 Molecular Biology Methods for E. coli 
2.7.1 Transformation of E. coli with heat-shock method 
Chemically competent DH5α cells (NEB) were thawed rapidly at room temperature 
and placed on ice. 1 aliquot (50 µl) of cells was typically used for 2 transformations. 
The DNA or ligation reaction was mixed with the cells and left on ice for 30 min. 
The cells were then incubated at 42 °C for 45 s, and then placed back on ice for 2 
min. Following this, the cells were resuspended in 200 µl of SOC medium and 
incubated at 37 °C for 1 h, with shaking at 1000 rpm. When transforming ligation 
reactions, 100% of the transformation mixture was plated onto LB agar plates 
containing the appropriate antibiotic and grown overnight at 37 °C. When re-
transforming a plasmid, 10% of the transformation mixture was plated. 
 
2.7.2 Isolation of plasmid DNA 
Single E. coli colonies were used to inoculate 2 ml LB cultures containing the 
appropriate antibiotic for selection. The cultures were grown overnight at 37 °C with 
shaking at 250 rpm. Plasmids were isolated using the QIAprep Spin Miniprep kit 
(QIAGEN) according to the manufacturer’s instructions. The concentration of the 
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isolated DNA was estimated using the Nanodrop (ND-1000 spectrophotometer, 
Thermo Scientific) as described in 2.9.2. 
 
2.8 Molecular Biology Methods for Yeast 
2.8.1 Transformation of yeast cells 
50 ml YPD cultures were grown at 30 °C to a cell density of ~ 1 x 107 cells/ml. Cells 
were harvested by centrifugation at 3500 rpm, 2 min in an A-4-81 rotor (Eppendorf). 
The supernatant was removed and the cell pellet was resuspended in 25 ml of 
sterile distilled water, before being centrifuged at 3500 rpm for 2 min in an A-4-81 
rotor. The supernatant was removed and the cell pellet was resuspended in 1 ml of 
sterile distilled water. The sample was transferred to a microfuge tube and cells 
were then pelleted at maximum speed for 10 s in an FA-45-24-11 rotor (Eppendorf) 
(20238g). Approximately 900 µl of sterile distilled water was added to the resultant 
cell pellet to give a final volume of ~1 ml.  
 
10% of the 1 ml suspension was pelleted at maximum speed for 10 s in an FA-45-
24-11 rotor. 240 µl 50% PEG 4000, 36 µl 1 M LIOAc, 5 µl 10 mg/ml salmon sperm 
DNA (Invitrogen) and 2-3 µg of linearised integrative plasmid DNA was added (in 
that order) to the resultant cell pellet and mixed thoroughly by vortexing. The 
mixture was incubated at 42 °C for 20 min and the cells were then pelleted at 
maximum speed for 10 s in an FA-45-24-11 rotor. The cell pellet was resuspended 
in 200 µl of sterile distilled water and plated on plates lacking the appropriate amino 
acids for selection. For selection using the natNT2 marker, cells were resuspended 
in 1 ml YPD, grown overnight at 25 °C, and subsequently plated on YPD 
supplemented with nourseothricin (as described in section 2.2.2).  
 
2.8.2 Isolation of genomic DNA from yeast 
Single colonies of the relevant strain were used to inoculate 4 ml YPD cultures, 
which were grown to saturation at 30 °C. Cells were harvested by centrifugation at 
3500 rpm, 2 min in an A-4-81 rotor (Eppendorf). Cell pellets were then processed 
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using buffers from the QIAprep Spin Miniprep kit (QIAGEN) as follows. 250 µl of 
buffer P1 was added to each sample alongside 250 µl fine glass beads. Cells were 
then disrupted by incubating for 1 min on setting 5.5 on a FastPrep-24 cell disruptor 
(Zymo Research). 250 µl buffer P2 was added and samples were incubated at 
60 °C for 5 min. 350 µl buffer N3 was then added and the samples were 
centrifuged at maximum speed for 10 min in an FA-45-24-11 rotor (Eppendorf). The 
supernatant was recovered and then processed and washed as in 2.7.2 according 
to the manufacturer’s instructions. DNA was finally eluted in 50 µl buffer EB. 
 
2.8.3 Sporulation and tetrad dissection 
Single colonies were patched onto rich sporulation media and incubated at 25 °C 
for 2-3 days. The presence of tetrads was checked microscopically. For asci 
digestion, cells were incubated in 20 µl of 1 mg/ml zymolyase solution made up in 1 
M sorbitol and incubated for 10 min at 37 °C. The sample was then diluted back to 
1 ml with sterile distilled water and 15 µl was plated onto YPD agar. The tetrads 
were dissected using a tetrad dissection microscope (Singer), and then grown at 
30 °C. 
 
2.8.4 TCA extraction of protein 
Cells were harvested from 1 ml of log phase yeast culture (cell density of ~ 107 
cells/ml) by centrifugation at 3600 rpm for 3 min in an FA-45-24-11 rotor 
(Eppendorf) (1217g). The supernatant was removed and 200 µl of 20% (w/v) TCA 
was added to the cell pellet along with 200 µl of fine glass beads. The sample was 
vortexed vigorously for 30 s, allowed to settle, and the supernatant was then 
removed and retained. 200 µl of 5% (w/v) TCA was added to the glass beads and 
then sample was vortexed again for 5 s. The supernatant was removed and added 
to the supernatant retained from the previous step and the glass beads discarded. 
The sample was centrifuged at maximum speed in an FA-45-24-11 rotor 
(Eppendorf) (20238g) for 10 min. The supernatant was removed and discarded and 
the pellet was resuspended in 50 µl of 2x Laemmli sample buffer. 2-3 µl of 2 M Tris 
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base was added for neutralisation and the sample was then incubated at 95 °C for 
4 min for protein denaturation. 
 
2.9 General Methods for Manipulation of DNA 
2.9.1 DNA standards 
The commercially available Hyperladder I (Bioline) was used for all DNA gels in this 
study. 
 
2.9.2 Determination of DNA concentration 
DNA concentration was determined by measuring the absorbance of purified DNA 
samples at 260 nm using the Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific). The calculations were based on a 50 µg/ml solution of dsDNA giving an 
absorbance of 1 at 260 nm.  
 
2.9.3 Agarose gel electrophoresis 
Agarose gels were made in TAE buffer. 1/6 of the sample volume of 6x DNA 
loading buffer was added to each sample. Mini-gels (8 x 10 cm) were run in TAE 
buffer at 80 V (8 V/cm) for 1 h in Bio-Rad horizontal gel electrophoresis apparatus 
for both analytical and preparative purposes. For analysis of in vitro DNA 
replication assays, mini-gels were run in TAE buffer at 100 V (10 V/cm) for 90 min 
in TAE buffer, and medium sized gels (15 x 10 cm) were run at 110 V (11 V/cm) for 
90 min.  
 
2.9.4 Visualisation of DNA by gel staining 
For most agarose gels, SYBR Safe DNA gel stain (Life Technologies) was added 
to the gel before it set. For analysis of in vitro DNA replication assays, agarose gels 
were stained after running by incubation in TAE containing 0.5 µg/ml ethidium 
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bromide for 15 min at room temperature. Gels were then destained in TAE for 15 
min before visualisation at 254 nm using a BioDoc UV transilluminator (UVP).  
 
2.9.5 Phosphorimager analysis 
Dried agarose gels were exposed for 16 h to Amersham Bioscience phosphor 
screens. The screens were analysed on Typhoon Trio (GE Healthcare) using 
ImageQuant software. 
 
2.10  General Methods for Manipulation of Proteins 
2.10.1 Molecular weight standards 
The commercially available BenchMark Protein Ladder (Invitrogen) and PageRuler 
Plus Prestained Protein Ladder (Thermo Scientific) were used for immunoblotting, 
silver staining and Coomassie staining. For molecular weight estimation of purified 
proteins, a mix of proteins of known molecular weights (MW standard for gel 
filtration – Bio-Rad) was applied to the glycerol gradient or gel filtration column and 
used to plot a standard curve.  
 
2.10.2 SDS-PAGE 
For this study, pre-cast Bis-Tris Nu-PAGE 4-12%, Tris-Acetate Nu-PAGE 3-8% 
(both Invitrogen), 4-12% Criterion XT Bis-Tris or 3-8% Criterion XT Tris-Acetate 
(both Bio-Rad) gels were used. Gel samples were supplemented with 2x or 5x 
Laemmli sample buffer and incubated at 95 °C for 4 min prior to loading. Nu-PAGE 
4-12% gels were run in MOPS buffer (Invitrogen) at a constant voltage of 200 V for 
1h. Nu-PAGE 3-8% gels were run in Tris-Acetate (Invitrogen) buffer at a constant 
voltage of 150 V for 80 min. 4-12% Criterion gels were run in MOPS buffer (Bio-
Rad) at a constant voltage of 200 V for 1h. Criterion 3-8% gels were run in XT-
Tricine (Bio-Rad) buffer at a constant voltage of 150 V for 80 min. 
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2.10.3 Determination of protein concentration 
The protein samples to be analysed were subjected to SDS-PAGE alongside 
samples of know BSA concentrations. Following coomassie staining, the intensity 
of the BSA bands was analysed using ImageJ software (NIH) and this was then 
used to plot a BSA standard curve. Using this standard curve, the concentration of 
protein sample of interest could be estimated. 
 
2.10.4 Coomassie blue staining 
Gels were incubated in Instant Blue staining solution (Expedeon) for 30 min 
following SDS-PAGE. Gels were destained in distilled water. 
 
2.10.5 Silver staining  
Gels were silver stained using the SilverQuest Silver Staining Kit (Invitrogen) 
according to the manufacturer’s instructions. 
 
2.10.6 Immunoblotting 
SDS-PAGE was carried out as described in 2.10.2. In order to transfer proteins 
from the gel onto nitrocellulose membrane (Fisher), 2 pieces of Whatman gel 
blotting paper (Fisher) and 1 piece of nitrocellulose membrane (both cut to the size 
of the gel) were initially soaked in western transfer buffer. 1 piece of Whatman 
paper was then placed on the cathode plate, and the gel, nitrocellulose membrane 
and 2nd piece of Whatman paper was sequentially laid on top of this (in that order). 
The whole stack was then covered by the anode plate.  
 
For NuPage gels, the Mini-Trans Blot Cell apparatus (Bio-Rad) was used. For 
Criterion gels, the Criterion Blotter apparatus (Bio-Rad) was used. In both 
instances, transfer conditions were set at a constant voltage of 80 V for 90 min at 
4 °C. After the transfer, the membrane was incubated in blocking buffer for 30 min 
at room temperature. Primary antibody incubations were typically performed 
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overnight at 4 °C in probing buffer, except in the case of the anti-Cdc45 antibody, 
which was incubated in super blotto buffer overnight. All secondary antibody 
incubations were performed in probing buffer for 1 h at room temperature.  
 
Following incubation with the secondary antibody, three consecutive 10 min 
washes in TBST were performed followed by application of the ECL 
chemiluminescence reagent (Pierce). Membranes were exposed to Amersham 
hyperfilm ECL (GE Healthcare) and the film was then developed using an 
automatic X-ray film processor (JP-33 model, Jungwon Precision Industry). 
 
2.11  Protein Purification  
2.11.1  Purification of ORC 
10 L of Saccharomyces cerevisiae (ySDORC) were grown in YP-raffinose at 30 °C 
to a cell density of 4 x 107 cell per ml and arrested for 3 h with 100 ng/ml α-factor. 
Protein expression was induced by adding galactose to a final concentration of 2% 
for 3 h at 30 °C. Cells were harvested and washed twice with ice-cold wash buffer I, 
then washed once in ice-cold buffer A / 100 mM KCl / 2 mM β-mercaptoethanol. 
The cell pellet was resuspended with 1 volume of ice-cold buffer A / 100 mM KCl / 
2 mM β-mercaptoethanol / protease inhibitors (Roche cOmplete, EDTA-free) and 
frozen drop-wise in liquid nitrogen (popcorn). Frozen popcorn was crushed under 
liquid nitrogen using a freezer mill (SPEX CertiPrep 6850 Freezer Mill) with 6 
cycles of 2 min crushing at a rate setting of 15. Frozen cell powder was thawed at 
room temperature, then resuspended with buffer A / 100 mM KCl / 2 mM β-
mercaptoethanol / protease inhibitors (Roche cOmplete, EDTA-free) and the 
concentration of KCl adjusted to 500 mM. The suspension was centrifuged for 1 h 
at 45,000 RPM at 4 °C using a Ti45 rotor (Beckman).  
 
The clear phase was recovered and subjected to calmodulin affinity purification by 
adding 2 mM CaCl2 and incubating the extract with 4 ml packed beads of 
calmodulin affinity resin (Stratagene). After 2 h rotation at 4 °C, the beads were 
recovered, and washed with 15 column volumes (CVs) of buffer A / 300 mM KCl / 2 
mM CaCl2 / 2 mM β-mercaptoethanol. Bound protein was eluted in 8 fractions of 1 
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column volume (CV) each of buffer A / 300 mM KCl / 2 mM EGTA / 1 mM EDTA / 2 
mM β-mercaptoethanol.  
 
Peak fractions were pooled, concentrated using an Amicon Ultra 100,000 MWCO 
centrifugal filter (Millipore), and fractionated over a 120 ml Superdex 200 16/60 PG 
column (GE Healthcare) pre-equilibrated in buffer A / 300 mM KCl / 2 mM EGTA / 1 
mM EDTA / 2 mM β-mercaptoethanol. Peak fractions containing ORC were pooled 
and dialysed against buffer A / 150 mM KCl / 2 mM EGTA / 1 mM EDTA / 2 mM β-
mercaptoethanol for 3 h. The dialysed sample was then fractionated over a 1 ml 
MonoQ column using a 20 ml gradient of 150 mM – 500 mM KCl. Peak fractions 
containing ORC were dialysed against buffer A / 300 mM K-Glutamate / 2 mM 
EGTA / 1 mM EDTA / 2 mM β-mercaptoethanol, concentrated and stored in 
aliquots at -80 °C.  
 
2.11.2 Purification of Cdc6 
The pGEX-6p-1/Cdc6 (yAM3) plasmid was transformed into BL21 CodonPlus RIL 
cells (Stratagene). The resultant colonies were used to inoculate a 10 ml LB / 
ampicillin (50 µg/ml) culture, which was grown overnight at 37 °C with shaking at 
250 rpm. The following morning, the culture was diluted 1:100 in 1 L of LB / 
ampicillin (50 µg/ml) / chloramphenicol (35 µg/ml) and left to grow at 37 °C for ~3 h 
until the culture reached an OD600 of 0.6. Cdc6 expression was then induced by the 
addition of 1 mM IPTG for 5 h at 18 °C. Cells were harvested by centrifugation at 
6000 rpm for 10 min in an SLA-3000 rotor (Thermo Scientific), and then washed 
once in ice-cold PBS. 
 
For lysis, cells were resuspended in 50 ml ice-cold buffer C / 150 mM KOAc / 1% 
Triton X-100 / protease inhibitors (Roche cOmplete, EDTA-free). Cells were 
disrupted by passing through a French pressure cell press (2 PLUS, Constant Cell 
Disruption Systems) three times at 25 kpsi. 
 
The suspension was then centrifuged at 15000 rpm for 15 min in an SS-34 rotor 
(Sorvall). The supernatant was transferred to a disposable gravity flow column 
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containing 2 ml packed bead volume of glutathione sepharose resin (GE 
Healthcare) that had been pre-washed in ice-cold buffer C / 150 mM KOAc / 1% 
Triton X-100. The column was rotated at 4 °C for 2 h. Glutathione beads and bound 
protein was recovered in the column and washed with 15 column volumes buffer C 
/ 150 mM KOAc / 1% Triton X-100 / protease inhibitors (Roche cOmplete, EDTA-
free) followed by 5 column volumes buffer C / 150 mM KOAc / 1% Triton X-100 
without protease inhibitors. A 50% slurry was prepared using buffer C / 150 mM 
KOAc / 1% Triton X-100 and 50 µl preScission protease (GE Healthcare) was 
added. The mixture was rotated at 4 °C for 2 h. The flow-through was collected and 
diluted 2-fold with buffer C / 0.1% Triton X-100 to give a final KOAc concentration 
of 75 mM. 
 
The diluted flow-through fraction was then applied to 2 ml hydroxyapatite pre-
washed in a disposable gravity flow column with buffer C / 75 mM KOAc / 0.1% 
Triton X-100. The column was rotated at 4 °C for 15 min, and then washed with 5 
column volumes buffer C / 75 mM KOAc / 0.1% Triton X-100. Cdc6 was finally 
eluted in 8 column volumes buffer D. Peak fractions containing Cdc6 were pooled 
and concentrated using a Centricon Plus-20 centrifugal filter (Millipore). The 
concentrated sample was aliquoted and stored at -80 °C. 
 
2.11.3 Purification of Mcm2-7/Cdt1 
4 L of Saccharomyces cerevisiae (yJF38/yAM33) were grown in YP-raffinose at 
30 °C to a cell density of 4 x 107 cell per ml and arrested for 3 h with 100 ng/ml α-
factor. Protein expression was induced by adding galactose to a final concentration 
of 2% for 3 h at 30 °C. Cells were harvested and washed twice with ice-cold wash 
buffer I, then washed once in ice-cold buffer B / 100 mM KOAc / 2 mM β-
mercaptoethanol. The cell pellet was resuspended with 1 volume of ice-cold buffer 
B / 100 mM KOAc / 2 mM β-mercaptoethanol / protease inhibitors (Roche 
cOmplete, EDTA-free) and frozen drop-wise in liquid nitrogen (popcorn). Frozen 
popcorn was crushed under liquid nitrogen using a freezer mill (SPEX CertiPrep 
6850 Freezer Mill) with 6 cycles of 2 min crushing at a rate setting of 15. Frozen 
cell powder was thawed at room temperature, then resuspended with buffer B / 100 
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mM KOAc / 2 mM β-mercaptoethanol / protease inhibitors (Roche cOmplete, 
EDTA-free) and the concentration of KOAc adjusted to 500 mM. The suspension 
was centrifuged for 1 h at 45,000 RPM at 4 °C using a Ti45 rotor (Beckman). The 
clear phase was recovered and dialysed for 3 h against buffer B / 100 mM KOAc / 
2 mM β-mercaptoethanol, then centrifuged for 30 min at 45,000 RPM at 4 °C using 
a Ti45 rotor (Beckman). 
 
When purifying Mcm2-7/Cdt1 from yAM33, the clear phase was subjected to 
calmodulin affinity purification by adding 2 mM CaCl2 and incubating the extract 
with 2 ml packed beads of calmodulin affinity resin (Stratagene). After 2 h rotation 
at 4 °C, the beads were recovered, and washed with 15 column volumes (CVs) of 
buffer B / 100 mM KOAc / 2 mM CaCl2 / 2 mM β-mercaptoethanol. Bound protein 
was eluted in 8 fractions of 1 column volume (CV) each of buffer B / 100 mM KOAc 
/ 2 mM EGTA / 1 mM EDTA / 2 mM β-mercaptoethanol. When using yJF38, the 
clear phase was subjected to anti-FLAG immunoprecipitation by adding 3 ml 
packed bead volume of washed anti-FLAG M2 agarose (Sigma) per 50 ml of 
extract. After 1 h rotation at 4 °C, the beads were recovered, and washed with 15 
column volumes (CVs) of buffer B / 100 mM KOAc / 2 mM β-mercaptoethanol. The 
washed beads were resuspended with 1 volume buffer B / 100 mM KOAc / 2 mM 
β-mercaptoethanol containing 1 mg/ml 3xFLAG peptide. After 30 min rotation at 
4 °C the eluate fraction was collected. 
 
For both yAM33 and yJF38, peak fractions were then pooled, concentrated using 
an Amicon Ultra 100,000 MWCO centrifugal filter (Millipore), and fractionated over 
a 120 ml Superdex 200 16/60 PG column (GE Healthcare) pre-equilibrated in 
buffer B/ 100 mM KOAc / 2 mM β-mercaptoethanol. Peak fractions containing 
Mcm2-7/Cdt1 were pooled, concentrated and stored in aliquots at -80 °C. 
 
Purification of Mcm2-7/Cdt1 complexes containing mutant or TEV-cleavable 
versions of Mcm6 was performed as with yAM33, except that samples were 
subjected to FLAG immunoprecipitation to deplete endogenous Mcm6-3xFLAG 
prior to gel filtration. Briefly, peak fractions from the calmodulin affinity purification 
step were incubated with 0.5 ml packed bead volume of washed anti-FLAG M2 
agarose (Sigma). After 1 h rotation at 4 °C, the beads were recovered, and the flow 
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through was collected, concentrated and subjected to gel filtration as described 
above. 
2.11.4 Purification of DDK 
2 L of Saccharomyces cerevisiae (ySDK8) were grown in YP-raffinose at 30 °C to a 
cell density of 2 x 107 cell per ml. Protein expression was induced by adding 
galactose to a final concentration of 2% for 6 h at 30 °C. Cells were harvested and 
washed twice with ice-cold wash buffer I, then washed once in ice-cold buffer A / 
400 mM NaCl / 2 mM β-mercaptoethanol. The cell pellet was resuspended with 1 
volume of ice-cold buffer A / 400 mM NaCl / 2 mM β-mercaptoethanol / protease 
inhibitors (Roche cOmplete, EDTA-free) and frozen drop-wise in liquid nitrogen 
(popcorn). Frozen popcorn was crushed under liquid nitrogen using a freezer mill 
(SPEX CertiPrep 6850 Freezer Mill) with 6 cycles of 2 min crushing at a rate setting 
of 15. Frozen cell powder was thawed at room temperature, then resuspended with 
buffer A / 400 mM NaCl / 2 mM β-mercaptoethanol / protease inhibitors (Roche 
cOmplete, EDTA-free) and the concentration of NaCl adjusted to 500 mM. The 
suspension was centrifuged for 1 h at 45,000 RPM at 4 °C using a Ti45 rotor 
(Beckman).  
 
The clear phase was recovered and subjected to calmodulin affinity purification by 
adding 2 mM CaCl2 and incubating the extract with 2 ml packed beads of 
calmodulin affinity resin (Stratagene). After 2 h rotation at 4 °C, the beads were 
recovered, and washed with 15 column volumes (CVs) of buffer A / 400 mM NaCl / 
2 mM CaCl2 / 2 mM β-mercaptoethanol. Bound protein was eluted in 8 fractions of 
1 column volume (CV) each of buffer A / 400 mM NaCl / 2 mM EGTA / 1 mM EDTA 
/ 2 mM β-mercaptoethanol. Peak fractions were pooled and dephosphorylated by 
the addition of 200 µg lambda phosphatase (4 °C, 16 h). 
 
Subsequently, the sample was concentrated using an Amicon Ultra 30,000 MWCO 
centrifugal filter (Millipore), and fractionated over a 24 ml Superdex 200 10/300 
column (GE Healthcare) pre-equilibrated in buffer A / 400 mM KCl / 2 mM EGTA / 1 
mM EDTA / 2 mM β-mercaptoethanol. Peak fractions containing DDK were pooled 
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and dialysed against buffer A / 200 mM K-Glutamate / 2 mM β-mercaptoethanol. 
The dialysed sample was concentrated and stored in aliquots at -80 °C.  
 
2.11.5 Purification of Sld3/7 from S. cerevisiae  
10 L of Saccharomyces cerevisiae (yTD6) were grown in YP-raffinose at 30 °C to a 
cell density of 4 x 107 cell per ml and arrested for 3 h with 100 ng/ml α-factor. 
Protein expression was induced by adding galactose to a final concentration of 2% 
for 3-4 h at 30 °C. Cells were harvested and washed twice with ice-cold wash 
buffer I, then washed once in ice-cold buffer A / 500 mM KCl / 1 mM DTT. The cell 
pellet was resuspended with 1 volume of buffer A / 500 mM KCl / 1 mM DTT / 
homemade protease inhibitor cocktail and frozen drop-wise in liquid nitrogen 
(popcorn). Frozen popcorn was crushed under liquid nitrogen using a freezer mill 
(SPEX CertiPrep 6850 Freezer Mill) with 6 cycles of 2 min crushing at a rate setting 
of 15. Frozen cell powder was thawed at room temperature, then resuspended with 
1 volume of buffer A / 500 mM KCl / 1 mM DTT / homemade protease inhibitor 
cocktail. The suspension was centrifuged for 1 h at 45,000 RPM at 4 °C using a 
Ti45 rotor (Beckman).  
 
When purifying Sld3/7 from yTD6, the clear phase was recovered and subjected to 
IgG affinity purification using 1 ml packed beads of IgG sepharose 6 Fast Flow 
slurry (GE Healthcare) per 10 ml of extract. IgG beads were rotated at 4 °C for 45 
min with the extract, recovered, and washed with 15 column volumes (CVs) of 
buffer A / 500 mM KCl / 1 mM DTT / homemade protease inhibitor cocktail. The 
washed IgG beads were resuspended with 1 volume buffer A / 500 mM KCl / 1 mM 
DTT and bound protein was eluted by adding 0.6 mg HIS6-TEV protease per 1 ml 
of packed IgG beads. After 2 h rotation at 4 °C the eluate fraction was collected, 
and incubated with 1 ml packed Ni2+-NTA beads (Qiagen) for 5 min on ice to 
deplete HIS6-TEV protease. When purifying Sld3/7 from yTD11, the clear phase 
was subjected to anti-FLAG immunoprecipitation by adding 3 ml packed bead 
volume of washed anti-FLAG M2 agarose (Sigma). After 1 h rotation at 4 °C, the 
beads were recovered, and washed with 15 column volumes (CVs) of buffer A / 
500 mM KCl / 1 mM DTT / homemade protease inhibitor cocktail. The washed 
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beads were resuspended with buffer A / 500 mM KCl / 1 mM DTT containing 1 
mg/ml 3 x FLAG peptide. After 30 min rotation at 4 °C the eluate fraction was 
collected. This elution was repeated two more times to give a final eluate fraction of 
9 ml.  
 
For both yTD6 and yTD11, the resulting fraction was concentrated using an Amicon 
Ultra 30,000 MWCO centrifugal filter (Millipore), and fractionated over a 24 ml 
Superdex 200 10/300 GL column (GE Healthcare) pre-equilibrated in buffer A / 500 
mM KCl / 1 mM DTT. Peak fractions containing Sld3/7 were pooled, concentrated 
and stored in aliquots at -80 °C.   
 
2.11.6 Purification of Sld3 and Sld7 from E. coli 
The relevant pGEX-6p-1/Sld3 or pGEX-6p-1/Sld7 plasmid (see Table 2-6) was 
transformed into BL21 CodonPlus RIL cells (Stratagene). The resultant colonies 
were used to inoculate a 50 ml LB / ampicillin (50 µg/ml) culture, which was grown 
overnight at 37 °C with shaking at 250 rpm. The following morning, the culture was 
diluted 1:10 in 250 ml of LB / ampicillin (50 µg/ml) / chloramphenicol (35 µg/ml) and 
left to grow at 25 °C for ~3-4 h until the culture reached an OD600 of 0.7. Expression 
was then induced by the addition of 1 mM IPTG for 4 h at 25 °C. Cells were 
harvested by centrifugation at 3500 rpm for 15 min in an SLA-3000 rotor (Thermo 
Scientific), and then washed once in ice-cold PBS. 
 
For lysis, the cell pellets were resuspended in 10 ml buffer A / 500 mM KCl / 1 mM 
DTT / homemade protease inhibitor cocktail and lysozyme was added to a final 
concentration of 500 µg/ml. The mixture was left on ice for 20 min, and then 
sonicated for 2 min (25 s on, 5 s off) at setting 5 on a Sonicator Ultrasonic 
Processor XL (Misonix). The suspension was then centrifuged at 15000 rpm for 15 
min in an SS-34 rotor (Sorvall). The supernatant was subjected to GST affinity 
purification by incubation with 0.8 ml packed bead volume of glutathione sepharose 
resin (GE Healthcare) that had been pre-washed in buffer A / 500 mM KCl / 1 mM 
DTT. The sample was rotated at 4 °C for 2 h. Glutathione beads and bound protein 
was recovered in a disposable gravity flow column and washed with 15 column 
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volumes buffer A / 500 mM KCl / 1 mM DTT / homemade protease inhibitor cocktail 
followed by 5 column volumes buffer A / 500 mM KCl / 1 mM DTT without protease 
inhibitors. A 50% slurry was prepared using buffer A / 500 mM KCl / 1 mM DTT and 
50 µl preScission protease (GE Healthcare) was added. The mixture was rotated at 
4 °C overnight. When preparing GST-Sld3, the tagged protein was eluted in 6 
fractions of 1 column volume (CV) each of buffer A / 500 mM KCl / 1 mM DTT / 10 
mM glutathione. 
 
The following morning, the flow-through was collected and one further column 
volume of buffer A / 500 mM KCl / 1mM DTT was flowed over the column to elute 
any remaining cleaved protein. The two flow-through fractions were pooled, 
concentrated using an Amicon Ultra 30,000 MWCO centrifugal filter (Millipore), and 
fractionated over a 24 ml Superdex 200 10/300 GL column (GE Healthcare) pre-
equilibrated in buffer A / 500 mM KCl / 1 mM DTT. Peak fractions containing Sld3 
or Sld7 were pooled, concentrated and stored in aliquots at -80 °C.   
 
Purification of FLAG-tagged wild type or mutant versions of Sld3 or Sld3 fragments 
was performed as described above except the final gel filtration step was omitted.  
 
2.11.7 Purification of Dpb11 
Dpb11 was purified as described for Sld3/7 in 2.11.5 barring two notable 
differences. Firstly, yTD2 was used in place of yTD6 in the initial culture. Secondly, 
for Dpb11, the final 24 ml Superdex 200 10/300 GL column was run in buffer A / 
300 mM K-Glutamate / 1 mM DTT.  
 
2.11.8 Purification of Sld2 
10 L of Saccharomyces cerevisiae (yTD8) were grown in YP-raffinose at 30 °C to a 
cell density of 4 x 107 cell per ml and arrested for 3 h with 100 ng/ml α-factor. 
Protein expression was induced by adding galactose to a final concentration of 2% 
for 3-4 h at 30 °C. Cells were harvested and washed twice with ice-cold wash 
buffer I, then washed once in ice-cold buffer A / 500 mM KCl / 1 mM DTT. The cell 
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pellet was resuspended with 1 volume of buffer A / 500 mM KCl / 1 mM DTT / 
homemade protease inhibitor cocktail and frozen drop-wise in liquid nitrogen 
(popcorn). Frozen popcorn was crushed under liquid nitrogen using a freezer mill 
(SPEX CertiPrep 6850 Freezer Mill) with 6 cycles of 2 min crushing at a rate setting 
of 15. Frozen cell powder was thawed at room temperature, then resuspended with 
1 volume of buffer A / 500 mM KCl / 1 mM DTT / homemade protease inhibitor 
cocktail. The suspension was centrifuged for 1 h at 45,000 RPM at 4 °C using a 
Ti45 rotor (Beckman).  
 
The clear phase was recovered and subjected to anti-FLAG immunoprecipitation 
by adding 5 ml packed bead volume of washed anti-FLAG M2 agarose (Sigma) per 
50 ml of extract. After 1 h rotation at 4 °C, the beads were recovered, and washed 
with 15 column volumes (CVs) of buffer A / 500 mM KCl / 1 mM DTT / homemade 
protease inhibitor cocktail. The washed beads were resuspended with buffer A / 
500 mM KCl / 1 mM DTT containing 1 mg/ml 3xFLAG peptide. After 30 min rotation 
at 4 °C the eluate fraction was collected.  
 
2.11.9 Purification of Cdc45 
10 L of Saccharomyces cerevisiae (yTD4 or yTD7) were grown in YP-raffinose at 
30 °C to a cell density of 4 x 107 cell per ml and arrested for 3 h with 100 ng/ml α-
factor. Protein expression was induced by adding galactose to a final concentration 
of 2% for 3-4 h at 30 °C. Cells were harvested and washed twice with ice-cold 
wash buffer I, then washed once in ice-cold buffer A / 500 mM KCl / 1 mM DTT. 
The cell pellet was resuspended with 1 volume of buffer A / 500 mM KCl / 1 mM 
DTT / homemade protease inhibitor cocktail and frozen drop-wise in liquid nitrogen 
(popcorn). EDTA was omitted from the protease inhibitor cocktail throughout when 
using yTD4. Frozen popcorn was crushed under liquid nitrogen using a freezer mill 
(SPEX CertiPrep 6850 Freezer Mill) with 6 cycles of 2 min crushing at a rate setting 
of 15. Frozen cell powder was thawed at room temperature, then resuspended with 
1 volume of buffer A / 500 mM KCl / 1 mM DTT / homemade protease inhibitor 
cocktail. The suspension was centrifuged for 1 h at 45,000 RPM at 4 °C using a 
Ti45 rotor (Beckman).  
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When using yTD4, the clear phase was recovered and subjected to calmodulin 
affinity purification by adding 2 mM CaCl2 and incubating the extract with 2 ml 
packed beads of calmodulin affinity resin (Stratagene). After 2 h rotation at 4 °C, 
the beads were recovered, and washed with 15 column volumes (CVs) of buffer A / 
500 mM KCl / 2 mM CaCl2 / 1 mM DTT / homemade protease inhibitor cocktail. 
Bound protein was eluted in 8 fractions of 1 column volume (CV) each of buffer A / 
500 mM KCl / 2 mM EGTA / 1 mM ETDA / 1 mM DTT. When using yTD7, the clear 
phase was recovered and subjected to anti-FLAG immunoprecipitation by adding 3 
ml packed bead volume of washed anti-FLAG M2 agarose (Sigma) per 50 ml of 
extract. After 1 h rotation at 4 °C, the beads were recovered, and washed with 15 
column volumes (CVs) of buffer A / 500 mM KCl / 1 mM DTT / homemade protease 
inhibitor cocktail. The washed beads were resuspended with buffer A / 500 mM KCl 
/ 1 mM DTT containing 1 mg/ml 3xFLAG peptide. After 30 min rotation at 4 °C the 
eluate fraction was collected.  
 
2.12  Preparation of S-phase Whole Cell Extract  
4 L of Saccharomyces cerevisiae (yKO3) were grown in YP-raffinose at 25 °C to a 
cell density of 1 x 107 cell per ml and galactose was then added to a final 
concentration of 2% for 2 h. Cells were shifted to 37 °C and then grown for a further 
5 h at 37 °C. Cells were harvested by centrifugation at 4000 rpm for 15 min, and 
then washed twice in SE buffer I / 3 mM DTT. The cell pellet was resuspended in 
0.3 volumes of SE buffer II / 1.5 M K-Glutamate / 5 mM DTT / protease inhibitors 
(Roche cOmplete, EDTA-free) and frozen drop-wise in liquid nitrogen (popcorn). 
Frozen popcorn was crushed under liquid nitrogen using a freezer mill (SPEX 
CertiPrep 6850 Freezer Mill) with 6 cycles of 2 min crushing at a rate setting of 15. 
Frozen cell powder was transferred to an ultracentrifuge tube and allowed to thaw 
completely for ~ 1-2 h on ice. 
 
The thawed lysate was centrifuged at 50,000 rpm for 1 h at 4 °C in a Ti70 rotor 
(Beckman). The clear phase was recovered and dialysed against SE buffer III / 3 
mM DTT / protease inhibitors (Roche cOmplete, EDTA-free) for 3.5 h at 4 °C. The 
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dialysed extract was subsequently recovered and centrifuged for 30 min at 90,000 
rpm in a TLA 100.3 rotor (Beckman). The supernatant was recovered, aliquoted 
and stored at -80.  
 
 
2.13  Preparation of DNA Substrates for In Vitro Biochemical 
Assays 
2.13.1 1 kb photocleavable linear DNA beads 
A 1048 bp linear DNA fragment containing the ARS305 DNA replication origin was 
amplified by PCR using primers ARS305-F-PC-Bio and ARS305-R and p305bp as 
a template. The product of this PCR reaction had a biotin group at the 5’ end, which 
was coupled to the DNA via a photocleavable linker. 16 x 50 µl PCR reactions were 
set up and the products were purified to a final volume of 400 µl using the High 
Pure PCR Purification Kit (Roche). 
 
The beads from 400 µl slurry of streptavidin-coated M-280 dynabeads (Invitrogen) 
were isolated on a magnetic rack and the supernatant removed. The beads were 
washed twice in 500 µl buffer I, and then resuspended in 400 µl buffer I. 400 µl 
purified PCR product from the first step was added to this suspension and the 
mixture was rotated overnight at 4 °C. 
 
The following morning, the beads were washed twice in 500 µl buffer II and then 
twice more in 500 µl buffer III. Finally, the beads were resuspended in 200 µl buffer 
III and stored at 4 °C. 
 
2.13.2 Purification of plasmid DNA template for in vitro replication assays 
Plasmid DNA was purified from E. coli using the QIAGEN Plasmid Plus Maxiprep 
kit (QIAGEN) according to the manufacturer’s instructions. 
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2.14  Protein-Protein and Protein-DNA interaction Assays 
2.14.1 In vitro pre-RC assembly assay 
2 µl of photocleavable DNA beads were used per 40 µl reaction. Reactions were 
assembled on ice in 25 mM Hepes-KOH pH 7.6, 10 mM Mg(OAc)2, 0.02% (v/v) NP-
40, 5% glycerol, 0.1 M KOAc, 1 mM DTT and 5 mM ATP. Purified ORC, Cdc6 and 
Mcm2-7/Cdt1 were added to this mixture (in that order) to final concentrations of 50 
nM, 50 nM and 100 nM, respectively. Samples were incubated for 30 min at 30 °C 
with agitation at 1000 rpm. Following the incubation, beads were isolated on a 
magnetic rack, the supernatant was removed, and each sample was then washed 
in 400 µl of low salt wash buffer by vortexing. The beads were re-isolated on the 
magnetic rack and washed in 400 µl of either low salt or high salt wash buffer (as 
indicated). The wash buffer was then removed and the beads and bound proteins 
were resuspended in 20 µl of low salt wash buffer. Protein-DNA complexes were 
then eluted from the beads via UVA irradiation at 330 nm for 10 min. The 20 µl 
eluate fraction was supplemented with 5 x Laemmli sample buffer and incubated at 
95 °C for 4 min for subsequent analysis by SDS-PAGE.  
 
2.14.2 Sld3/7 recruitment assay 
Pre-RC assembly reactions were first set up as described in 2.14.1. After 30 min 
incubation at 30 °C, each 40 µl sample was split into 2 x 20 µl aliquots, and the 
beads were then isolated on a magnetic rack. The supernatant was removed and 
replaced with a 20 µl reaction mixture containing 25 mM Hepes-KOH pH 7.6, 10 
mM Mg(OAc)2, 0.02% (v/v) NP-40, 5% glycerol, 0.1 M KOAc, 1 mM DTT and 5 mM 
ATP. Purified DDK was added to a final concentration of 50 nM and the samples 
were incubated for 30 min at 25 °C with agitation at 1000 rpm. Beads were re-
isolated and the supernatant removed. A 40 µl reaction mixture containing 25 mM 
Hepes-KOH pH 7.6, 10 mM Mg(OAc)2, 0.02% (v/v) NP-40, 5% glycerol, 0.5 M 
KOAc, 50 mM KCl and 1 mM DTT was added, and purified Sld3/7 was then added 
to a final concentration of 5 nM. Samples were incubated at 25 °C for 5 min with 
agitation at 1000 rpm. Beads were isolated on a magnetic rack, the supernatant 
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removed, and each sample was then subjected to 2 x 400 µl washes in pre-RC 
wash buffer / 0.5 M KOAc. The wash buffer was then removed and the beads and 
bound proteins were resuspended in 10 µl of pre-RC wash buffer / 0.5 M KOAc. 
Protein-DNA complexes were then eluted from the beads via UVA irradiation at 330 
nm for 10 min. The 10 µl eluate fraction was supplemented with 10 µl 2x Laemmli 
sample buffer and incubated at 95 °C for 4 min for subsequent analysis by SDS-
PAGE. 
 
2.14.3 Replisome assembly assay 
Pre-RC assembly reactions were first set up as described in 2.14.1, except the 
incubation was performed at 25 °C for 30 min. Each 40 µl sample was split into 2 x 
20 µl aliquots, and the beads were then isolated on a magnetic rack. The 
supernatant was removed and replaced with a 15 µl reaction mixture containing 25 
mM Hepes-KOH pH 7.6, 10 mM Mg(OAc)2, 0.02% (v/v) NP-40, 5% glycerol, 0.1 M 
K-Glutamate, 1 mM DTT and 5 mM ATP. Purified DDK was added to a final 
concentration of 100 nM and the samples were incubated for 30 min at 25 °C with 
agitation at 1000 rpm. Beads were re-isolated and the supernatant removed. A 40 
µl reaction mixture containing 40 mM Hepes-KOH pH 7.6, 8 mM MgCl2, 40 mM 
creatine phosphate, 10 µg creatine phosphokinase, 1 mM DTT and 5 mM ATP was 
added. 500 µg yKO3 S-phase extract was then added and SE buffer III / 3 mM DTT 
was used to adjust the final concentration of K-Glutamate to 150 mM. Samples 
were incubated at 25 °C for 15 min with agitation at 1000 rpm. Beads were isolated 
on a magnetic rack, the supernatant removed, and each sample was then 
subjected to 3 x 175 µl washes in low salt wash buffer. The wash buffer was then 
removed and the beads and bound proteins were resuspended in 20 µl 2x Laemmli 
sample buffer and incubated at 95 °C for 4 min for subsequent analysis by SDS-
PAGE.  
 
When using extract made from yJY16 (as in Fig. 4.8), endogenous Cdc45 was 
initially depleted by incubation with Sld3-FLAG beads. 60 pmol FLAG-Sld3 was 
initially coupled to 37.5 µl magnetic anti-FLAG resin (Sigma), and 2.5 µl of this 
Sld3-coupled resin was used to deplete 1 mg of yJY16 extract. 2 x 1 h rounds of 
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depletion with fresh Sld3-FLAG beads were routinely performed. Recombinant 
FLAG-Sld3, Sld7 and Cdc45 were added to the depleted extract to final 
concentrations of 50 nM, 50 nM and 100 nM, respectively. Extract was then used in 
the replisome assembly reaction as described above. 
 
2.14.4 Interaction of Sld3/7 with individual Mcm subunits 
A 120 µl pre-RC assembly reaction (using 6 µl of photocleavable DNA beads) was 
prepared per sample. Reactions were performed exactly as in 2.14.1, with all 
reaction components scaled up 3-fold. After the pre-RC assembly step, each 
sample was subjected to sequential 400 µl wash steps using low salt wash buffer, 
high salt wash buffer and pre-RC wash buffer / 0.1 M KOAc (in that order). Beads 
were then resuspended in a 120 µl reaction mixture containing 25 mM Hepes-KOH 
pH 7.6, 10 mM Mg(OAc)2, 0.02% (v/v) NP-40, 5% glycerol, 0.1 M KOAc, 1 mM DTT 
and 5 mM ATP. Purified DDK was added to a final concentration of 50 nM and the 
samples were incubated for 30 min at 25 °C with agitation at 1000 rpm. Beads 
were re-isolated, the supernatant removed and each sample washed in 400 µl high 
salt wash buffer. The wash buffer was removed and each beads sample was 
resuspended in 65 µl high salt wash buffer and incubated on ice overnight. 
 
The following morning, the beads were isolated on a magnetic rack and a 60 µl 
supernatant fraction was recovered from each sample. A 10 µl input fraction was 
removed at this point, and 75 µl pre-RC wash buffer was added to the remaining 50 
µl sample to adjust the concentration of NaCl to 200 mM. The resultant 125 µl 
sample was then added to 2.5 µl magnetic anti-FLAG beads (Sigma), which had 
been pre-coupled to Sld3-3xFLAG/Sld7 in high salt wash buffer and then washed in 
pre-RC wash buffer / 0.2 M NaCl. Samples were incubated for 1 h at 8 °C with 
agitation at 1100 rpm. Next, beads were isolated on a magnetic rack, the 
supernatant removed, and each sample was then subjected to 2 x 200 µl washes in 
pre-RC wash buffer / 0.2 M NaCl. In early experiments, the beads and bound 
proteins were then resuspended in 10 µl 2x Laemmli sample buffer and incubated 
at 95 °C for 4 min for subsequent analysis by SDS-PAGE. Later, input and beads 
samples were routinely dephosphorylated with lambda phosphatase (1 h, 30 °C) 
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prior to the addition of Laemmli sample buffer to prevent the masking of epitopes 
by phosphorylation during immunoblotting. 
 
2.14.5 Immunoprecipitation of FLAG-Sld3 from S-phase extract 
20 µl reactions were assembled containing 40 mM Hepes-KOH pH 7.6, 8 mM 
MgCl2, 40 mM creatine phosphate, 10 µg creatine phosphokinase, 1 mM DTT and 
5 mM ATP. 250 µg yKO3 S-phase extract, which had been depleted of Sld3-13Myc 
(see 2.15), was then added and SE buffer III / 3 mM DTT was used to adjust the 
final concentration of K-Glutamate to 150 mM. 0.5 pmol wild type or mutant FLAG-
Sld3 and 0.5 pmol Sld7 were then added and the reaction incubated on ice for 15 
min. The reaction mixture was then added to 2.5 µl magnetic anti-FLAG beads 
(Sigma), which had been pre-washed in SE buffer III / 3 mM DTT. Samples were 
incubated for 1 h on ice with occasional agitation. Next, beads were isolated on a 
magnetic rack, the supernatant removed, and each sample was subjected to 2 x 
200 µl washes in pre-RC wash buffer / 0.15 M K-Glutamate. The beads were then 
resuspended in 10 µl 2x Laemmli sample buffer and incubated at 95 °C for 4 min 
for subsequent analysis by SDS-PAGE. 
 
2.14.6 Interaction of Sld3 with Mcm6 peptides 
N-terminally biotinylated peptides and peptide arrays were synthesised by the 
Peptide Synthesis Laboratory at the CRUK London Research Institute. Peptides 
bound to membranes were initially solubilised by washing in 50% EtOH / 10% 
acetic acid for 1 h. The membranes were washed briefly in TBST, then incubated at 
4 °C overnight in TBST / 3% BSA. The following morning, membranes were 
washed briefly in Peptide Array Buffer, and then incubated with 40 ml Peptide Array 
Buffer / 3% BSA containing FLAG-Sld3 at a final concentration of 2 nM for 1 h at 
room temperature. Membranes were subsequently washed for 3 x 3 min in Peptide 
Array Buffer, then probed with anti-FLAG antibody (Sigma) for 3 h at room 
temperature. Three consecutive 10 min washes in Peptide Array Buffer were then 
performed followed by application of the ECL chemiluminescence reagent (Pierce). 
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N-terminally biotinylated peptides were initially coupled to streptavidin-coated M-
280 dynabeads (Invitrogen) by incubation of 40 pmol of peptide with 4 µl beads for 
30 min at 20 °C with agitation at 1250 rpm. Peptide-coupled beads were 
subsequently washed in Peptide Array Buffer. An 80 µl reaction mixture containing 
Peptide Array Buffer and FLAG-Sld3 at a final concentration of 5 nM was then 
added, and the reaction incubated at 25 °C for 10 min with agitation at 1000 rpm. 
Beads were isolated on a magnetic rack, the supernatant removed, and each 
sample was then subjected to 2 x 200 µl washes in Peptide Array Buffer. The 
beads were then resuspended in 20 µl 2x Laemmli sample buffer and incubated at 
95 °C for 4 min for subsequent analysis by SDS-PAGE. 
 
2.14.7 Interaction of Sld3 and Sld7 
A 40 µl reaction was prepared containing 10 pmol each of full-length or truncated 
Sld3-FLAG, GST-Sld3 and Sld7. The concentration of KCl was adjusted to 0.2 M 
by the addition of 60 µl buffer A, and samples incubated on ice for 30 min. BSA 
was added to a final concentration of 100 µg/ml, and the mixture then incubated 
with 5 µl magnetic anti-FLAG resin (Sigma) pre-washed in buffer A / 0.2 M KCl for 
30 min on ice. Beads were then washed twice with 500 µl of buffer A / 0.2 M KCl. 
Bound proteins were eluted either by boiling in 2x Laemmli sample buffer, or by 
incubation with buffer A / 0.2 M KCl containing 1 mg/ml 3xFLAG peptide for 30 min 
at 8 °C. 
 
2.15  In Vitro DNA Replication Assay 
Pre-RC assembly reactions were performed on soluble plasmid DNA, with 1 µg of 
template DNA used per 25 µl reaction. Reactions were assembled on ice in 25 mM 
Hepes-KOH pH 7.6, 10 mM Mg(OAc)2, 0.02% (v/v) NP-40, 5% glycerol, 0.1 M K-
Glutamate, 2 mM DTT and 5 mM ATP. Purified ORC, Cdc6 and Mcm2-7/Cdt1 were 
added to this mixture (in that order) to final concentrations of 75 nM, 75 nM and 
150 nM, respectively. Samples were incubated for 20 min at 25 °C. The Pre-RC 
assembly reaction was subsequently split into 5 µl aliquots, and the volume 
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adjusted to 15 µl using the same conditions as in the first step. Purified DDK was 
added to a final concentration of 100 nM, and reactions were incubated for 30 min 
at 25 °C. Next, a reaction mixture containing 40 mM Hepes-KOH pH 7.6, 8 mM 
MgCl2, 2 mM DTT, 5 mM ATP, 100 µM dATP/dTTP/dGTP, 200 µM CTP/GTP/UTP, 
5 µCi 32P-α-dCTP, 40 mM creatine phosphate and 10 µg creatine phosphokinase 
was added to the 15 µl DDK reaction. 1 mg of yKO3 S-phase extract was added to 
the reaction and the final volume adjusted to 50 µl. Samples were incubated for 45 
min at 25 °C. Replication was quenched by the addition of 20 mM EDTA, and 
proteins were then denatured and digested by the addition of 0.5% SDS and 20 µg 
proteinase K. Samples were incubated for 30 min at 37 °C with agitation at 1000 
rpm. 55 µl phenol/chloroform was added to the reaction and phenol/chloroform 
extraction was performed. Unincorporated radioactive dCTP was subsequently 
removed from the aqueous layer by passing through an Illustra Microspin S-400 
HR column (GE Healthcare) according to manufacturer’s instructions. Finally, RNA 
was digested by the addition of 2 units of RNase A (Sigma) for 15 min at 30 °C. 
Samples were analysed by gel electrophoresis and autoradiography. 
 
For depletion of Sld3-13Myc, yKO3 extract was incubated with anti-Myc magnetic 
beads (Origene) from an equal volume of slurry as extract. 2 x 1 h depletions were 
performed on ice with fresh anti-Myc beads added each time.
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Chapter 3.  Results 1 
3.1 Introduction 
In G1 phase of the cell cycle, the Mcm2-7 replicative helicase is loaded onto DNA 
at origins of replication as a double hexamer, forming a pre-RC (Remus et al., 2009, 
Evrin et al., 2009, Gambus et al., 2011). In the pre-RC, the Mcm2-7 complex 
encircles dsDNA and is inactive as a helicase (Remus et al., 2009, Evrin et al., 
2009). DNA synthesis is only initiated at the origin upon progression into S-phase, 
when the activities of CDK and DDK increase and the Mcm2-7 double hexamer is 
converted into its active form, the CMG complex (Boos et al., 2012). This activation 
of the replicative helicase requires not only the activities of the aforementioned 
protein kinases, but also a whole host of specific ‘firing factors’, namely Sld3, Sld7, 
Cdc45, Dpb11, Sld2, GINS, Polε and Mcm10 (Boos et al., 2012, Tanaka and Araki, 
2013). Whilst many years of in vivo studies have confirmed the absolute 
requirement of these proteins for origin firing, relatively little is known about how 
they contribute mechanistically towards the formation of the active replicative 
helicase. 
 
The availability of a reconstituted system that recapitulates origin firing in vitro with 
purified proteins would be highly beneficial for our understanding of the Mcm2-7 
activation process. The first step towards this was to reconstitute the Mcm2-7 
loading reaction in vitro (Remus et al., 2009, Evrin et al., 2009). Importantly, it has 
recently been shown that pre-RCs assembled in vitro can support DNA replication 
in an S-phase extract (On et al., 2014, Gros et al., 2014), consistent with the 
formation of an active precursor for DNA replication during the pre-RC assembly 
step. Mass spectrometry analysis of the proteins recruited to the loaded Mcm2-7 
complex in this S-phase extract did not detect any new factors that had not been 
previously shown to be involved in replication initiation (On et al., 2014). We thus 
decided to proceed with attempts to reconstitute Mcm2-7 activation with the 
minimal set of proteins mentioned above.  
 
The ability to purify sufficient amounts of the firing factor proteins is a prerequisite 
for the progress of this project. In this chapter, I will discuss progress made in 
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purifying a number of the proteins required for Mcm2-7 activation, and will describe 
the characterisation of the in vitro behaviour of one of these factors, the Sld3/7 
complex. I will finally show how I was able to reconstitute the recruitment of Sld3/7 
to the pre-RC in vitro, forming a complex that may represent an early intermediate 
in the helicase activation process. 
 
3.2 Results 
3.2.1 Strain construction 
Separate S. cerevisiae strains were initially constructed in which second copies of 
SLD3, SLD7, CDC45, DPB11 or SLD2 were placed under the control of the 
GAL1,10 galactose-inducible promoter. Evidence suggests that Sld3 and Sld7 form 
a constitutive complex throughout the cell cycle (Tanaka et al., 2011b), and SLD3 
and SLD7 were thus co-expressed from separate promoters in the same strain. 
The GAL1,10 promoter has been used extensively in the past to overexpress 
proteins for subsequent purification, and we aimed to further increase expression 
levels through optimisation of the codon usage in the genes of interest. The codon-
optimised genes were expressed to markedly higher levels than the wild type 
versions (data not shown), allowing for improved yields during protein purification. 
Protein expression was confirmed by immunoblot analysis, using antibodies raised 
against the firing factors of interest (Fig. 3.1). 
 
3.2.2 Optimisation of extract conditions 
For purification, yeast cells expressing Sld3/7, Sld2, Dpb11 or Cdc45 were arrested 
in G1 with the α-factor mating pheromone, allowing for the purification of a 
homogenous protein sample that should not carry any S-phase specific post-
translational modifications. Modifications required for replication initiation, such as 
phosphorylation by DDK and CDK, could then be performed in vitro using purified 
proteins. 
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Figure 3.1 Construction of S. cerevisiae strains for firing factor purification 
Immunoblot analysis showing galactose-inducible overexpression of Sld3/Sld7 (A), 
Dpb11 (B), Cdc45 (C) and Sld2 (D). Cultures of individual transformant clones 
were grown in YP-raffinose to log phase, arrested in G1 with α-factor, and 
galactose added to 2% for 3 h. Samples taken before and after galactose addition 
were TCA extracted, and analysed by immunoblot. The parental strain (-vector) 
was included as a control. 
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Having confirmed protein expression under these conditions, I next set out to 
optimise conditions for protein extraction and purification. As these proteins had not 
been extensively characterised before, I first tested their solubility in a cell lysate 
after overexpression. Notably, Sld3, Sld7 and Sld2 were not extracted at salt 
concentrations lower than 0.5 M KCl (Fig. 3.2A and D). Cells were therefore 
routinely lysed at 0.5 M KCl for purification of Sld3/7 and Sld2. Dpb11 was soluble 
at salt concentrations as low 0.2 M KCl (Fig. 3.2B), and Cdc45 was soluble under 
all salt concentrations trialled (Fig. 3.2C). 
 
 
 
Figure 3.2 Solubility of firing factor proteins in cell lysates 
Immunoblot analysis of Sld3-TCP, Sld7 (both A), Dpb11-TCP (B), Cdc45-TCP (C) 
and Sld2-TCP (D) under different salt concentrations. Powdered extract from G1-
arrested yeast cells overexpressing the respective proteins was thawed and 
resuspended, and the salt concentration adjusted. Lysates were centrifuged at 42 
krpm for 1 h in a Ti45 rotor, and samples taken of the pellet (P) and supernatant (S) 
fractions. In C and D, an input sample (inp) was taken before centrifugation, and 
subsequently compared with the supernatant (sup) samples. 
 
3.2.3 Purification of Dpb11, Sld2 and Cdc45 
For purification, Dpb11, Sld2 and Cdc45 were tagged at their C-termini with either a 
TCP (Dpb11, Cdc45) or 3xFLAG tag (Sld2, Cdc45). The TCP tag contains both 
calmodulin binding peptide (CBP) and protein A, as well as a cleavage site for TEV 
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protease. The position of the TEV cleavage sequence between the C-terminus of 
the tagged protein and the CBP section of the tag allows for complete removal of 
the tag during purification. 
 
For Dpb11, initial attempts to purify the protein via calmodulin affinity 
chromatography proved unsuccessful (data not shown), perhaps indicating that the 
CBP section of the TCP tag was occluded by another part of the protein. I therefore 
purified Dpb11-TCP using an IgG sepharose column (Fig. 3.3A), which binds the 
protein A epitope in the TCP tag. Bound Dpb11-TCP was eluted from the IgG 
column by cleavage with TEV protease, allowing highly purified untagged Dpb11 to 
be recovered. Dpb11 was subsequently subjected to size exclusion 
chromatography (Fig. 3.3B), eluting from a gel filtration column as a single well-
defined peak close to the 158 kDa molecular weight marker, higher than the 
predicted molecular weight of Dpb11 (87 kDa). 
 
Sld2 was purified via anti-FLAG immunoprecipitation (Fig. 3.3C), and a relatively 
pure sample was obtained after this first affinity purification step. The Sld2 
purification protocol has subsequently been developed by a colleague in the lab (Dr. 
Joe Yeeles), and highly pure Sld2 can now be obtained via a further ion exchange 
chromatography step. 
 
Cdc45 could be purified by either calmodulin affinity chromatography or anti-FLAG 
immunoprecipitation (Fig. 3.3D and E). Interestingly, when either TCP or 3xFLAG-
tagged Cdc45 was subsequently subjected to size exclusion chromatography (Fig. 
3.4), the protein did not elute from the gel filtration column as a well-defined peak, 
with at least a portion of the protein eluting directly after the void volume before the 
670 kDa molecular weight marker. This behaviour was refractory to any changes in 
buffer conditions, which I attempted (Fig. 3.4A and B and data not shown) and is 
consistent with aggregation of the protein into species of a molecular weight much  
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Figure 3.3 Purification of Dpb11, Sld2 and Cdc45 
Purified Dpb11 (A, B), Sld2-3xFLAG (C), Cdc45-3xFLAG (D) and Cdc45-TCP (E) 
analysed by SDS-PAGE and coomassie staining. Input (inp), flow-through (FT) and 
eluate (E) fractions were collected for each purification. A. Dpb11 was purified 
using IgG and Ni-NTA beads, and B. gel filtration. Elution positions of molecular 
weight standards are shown. C. Sld2 was purified using anti-FLAG affinity resin. D. 
Cdc45 was purified using anti-FLAG affinity resin or E. calmodulin beads. 
Molecular weight markers (kDa) are shown to the left of each gel. 
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higher than the 75 kDa predicted for Cdc45. Subsequently, a colleague in the lab 
(Dr. Joe Yeeles) observed that the sequences of the N- and C-termini of Cdc45 are 
highly conserved between different species, and are not predicted to be surface-
exposed. Thus, the tagging of the C-terminus of Cdc45 may be detrimental for 
protein folding and/or function. Indeed, Dr. Yeeles has since been able to purify an 
active form of Cdc45 through the use of an internal tag. 
 
 
 
Figure 3.4 Gel filtration analysis of Cdc45 
Purified Cdc45-TCP (A, B) and Cdc45-3xFLAG (C) analysed by SDS-PAGE and 
coomassie staining. Peak eluate fractions from affinity chromatography (Fig. 3.3D 
and E) were concentrated and loaded onto a Superdex 200 10/300 gel filtration 
column. A. Gel filtration was performed under 0.5 M KCl. B. 0.2 M K-Glutamate 
was used in place of 0.5 M KCl. C. Gel filtration of Cdc45-3xFLAG under the same 
conditions as in A. Molecular weight markers (kDa) are shown to the left of each 
gel. Elution positions of molecular weight standards are shown. 
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3.2.4 Purification of Sld3/7  
As Sld3 and Sld7 had previously been reported to form a stable complex (Tanaka 
et al., 2011b), I set out to purify the Sld3/7 complex from a strain in which both 
proteins were overexpressed and Sld3 was TCP-tagged at the C-terminus. After 
IgG affinity purification, Sld3 co-eluted with a second polypeptide, which ran at 
approximately 29 kDa on an SDS-PAGE gel (Fig. 3.5A), consistent with the 
predicted molecular weight of Sld7. Sld3 subsequently co-eluted with this 29 kDa 
protein from a gel filtration column (Fig. 3.5B), and the presence of Sld7 was 
confirmed by immunoblotting using an antibody raised against Sld7 (Fig. 3.6A). The 
fact that these proteins co-elute under 0.5 M KCl indicates that they form a very 
stable complex, even at high salt concentrations. 
 
 
 
Figure 3.5 Purification of Sld3/7 
A. Sld3/7 was purified using IgG and Ni-NTA (Ni2+) beads. Input (inp), flow-through 
(FT) and eluate (E) fractions were collected. B. Gel filtration of the Sld3/7 complex. 
The Ni-NTA FT fraction from A was loaded onto a Superdex 200 10/300 gel 
filtration column. Elution positions of molecular weight standards are shown. 
Molecular weight markers (kDa) are shown to the left of each gel. Proteins were 
analysed by SDS-PAGE and coomassie staining.  
 
3.2.5 Characterisation of the Sld3/7 complex 
The Sld3/7 complex eluted from a gel filtration column between the positions of the 
670 kDa and 158 kDa molecular weight markers (Fig. 3.5B, 3.6A) Comparison with 
220
Sld3
Sld7
inp  FT     E     FT
40
50
60
70
80
90
100
120
160
15
20
30
25 HIS6-TEV
IgG          Ni2+
1      2      3       4 
Void 670kDa 158kDa
Sld3
Sld7
15                                                                 27
fraction
20
25
30
40
50
60
70
80
90
100
120
A       B
Chapter 3 Results 
 
 103 
known standards (Fig. 3.6B) allowed the Stokes radius of the complex to be 
estimated at 68 Å.  
 
Whilst gel filtration analysis can be used to give a fairly accurate approximation of 
molecular weight for proteins that have average hydration levels and are roughly 
spherical, molecular weight can be more precisely estimated using the Siegel and 
Monty formula (Siegel and Monty, 1966). This formula combines Stokes radius 
data obtained from size exclusion chromatography with sedimentation coefficients 
derived from density gradient centrifugation. The Sld3/7 complex migrated between 
the 44 kDa and 158 kDa markers on a 15-35% glycerol gradient (Fig. 3.6C), and 
the sedimentation coefficient of the complex was estimated at 5.8 S by comparison 
with known standards (Fig. 3.6D). I was subsequently able to use the Siegel and 
Monty formula (Equation 1) to obtain an approximate molecular weight of 163 kDa 
for the Sld3/7 complex. Given the predicted molecular weights of Sld3 and Sld7 (77 
kDa and 29.5 kDa, respectively), it would appear likely that the Sld3/7 complex 
contains more than one copy of one or both of its subunits. 
 
Ma = 6πηNas 
            1-vρ 
η = viscosity of the medium 
a = Stokes radius 
s = sedimentation coefficient 
v = partial specific volume 
ρ = density of the medium 
Ma = molecular weight 
 
Equation 1 The Siegel and Monty formula (Siegel and Monty, 1966).  
 
To further investigate the subunit stoichiometry of Sld3/7, I next reconstituted the 
Sld3/7 complex from its individual components in vitro. To do this, I developed 
bacterial expression systems for the purification of either Sld3 or Sld7 after 
overexpression in E. coli. SLD3 or SLD7 were cloned into the pGEX-6p1 vector, 
which introduced a GST tag at the N-terminus of either protein. Both GST-Sld3 and 
GST-Sld7 were visible as major bands in the E. coli cell lysate after 4 h expression 
(Fig. 3.7A and 3.7D, lane 2), and both proteins were purified using GST-affinity 
chromatography (Fig. 3.7A and 3.7D). Sld3 was eluted from the glutathione beads  
Chapter 3 Results 
 
 104 
 
 
Figure 3.6 Molecular weight estimation of Sld3/7 
A. Size exclusion chromatography of Sld3/7. Purified Sld3/7 was loaded onto a 
Superdex 200 10/300 gel filtration column, and fractions analysed by immunoblot. 
B. Protein standards (myoglobulin, ovalbumin, g-globulin, thyroglobulin) of known 
Stokes Radius were analysed by size exclusion chromatography as in A, and a 
standard curve plotted. Kav = (Ve – V0) / (Vt – V0), where Ve is elution volume, V0 
is the void volume of the column (8 ml), and Vt is the total volume of the column (24 
ml). C. Sld3/7 was loaded onto a 3.4 ml 15-35% glycerol gradient, and centrifuged 
in a SW55 Ti swinging bucket rotor at 42 krpm for 16 h. The gradient was 
fractionated and samples analysed by immunoblot. Positions of molecular weight 
standards are shown. D. The protein standards used in B were loaded onto a 15-
35% glycerol gradient as in C, and their migration on the gradient was used to plot 
a standard curve. 
 
via preScission-protease mediated removal of the GST tag (Fig. 3.7A, lane 5), and 
was subsequently purified further by gel filtration (Fig. 3.7B). Sld3 eluted from the 
gel filtration column as a single peak close to the position of the 670 kDa marker, 
much bigger than the expected molecular weight of Sld3. Alternatively, GST-Sld3 
still containing the GST tag could be obtained via glutathione elution (Fig. 3.7C). 
 
Purified Sld7 could also be obtained by removal of the GST tag (Fig. 3.7D, lane 5) 
and, as with Sld3, Sld7 was then purified further by gel filtration (Fig. 3.7E). 
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Figure 3.7 Purification of Sld3 and Sld7 after expression in E. coli 
A. Sld3 was purified using glutathione beads. Cell lysate fractions were taken 
before and after induction with IPTG, and Input (inp), flow-through (FT) and eluate 
(E) fractions were collected during affinity purification. B. Gel filtration of Sld3. The 
eluate fraction from A was loaded onto a Superdex 200 10/300 gel filtration column. 
Elution positions of molecular weight standards are shown. C. As in A, but elution 
was performed in buffer containing 20 mM glutathione. D. Sld7 was purified using 
glutathione beads as for Sld3 in A. E. Gel filtration of Sld7 performed as for Sld3 in 
B. Molecular weight markers (kDa) are shown to the left of each gel. Proteins were 
analysed by SDS-PAGE and coomassie staining.  
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Sld7 eluted from the gel filtration column across a broad range of fractions, 
potentially indicating the existence of multiple conformationally distinct populations 
of Sld7 within the eluate fraction from the initial affinity purification step. Peak 
fractions 25-28 were pooled and used in subsequent experiments. 
 
To test for the presence of multiple Sld3 molecules within the Sld3/7 complex, I 
next attempted to reconstitute the Sld3/7 complex using a mixture of GST-Sld3, 
Sld3-FLAG and Sld7 (for this experiment, a single FLAG tag was introduced at the 
C-terminus of Sld3 by PCR, and Sld3-FLAG was purified as shown in Fig. 3.7A). 
Purified GST-Sld3, Sld3-FLAG and Sld7 were incubated together in vitro, and 
proteins bound to Sld3-FLAG were then isolated by FLAG immunoprecipitation. 
Notably, both GST-Sld3 and Sld7 were enriched in the FLAG IP sample in an Sld3-
FLAG-dependent manner (Fig. 3.8, compare lanes 7 and 8). The interaction of 
Sld3-FLAG with GST-Sld3 was independent of Sld7 (Fig. 3.8, compare lanes 7 and 
9), and the interaction of Sld3-FLAG with Sld7 was independent of GST-Sld3 (Fig. 
3.8, compare lanes 7 and 10). These data could be consistent with either the 
formation of separate Sld3-FLAG/Sld7 and Sld3-FLAG/GST-Sld3 complexes during 
the reaction, or, more likely, the formation of an Sld3/7 complex containing multiple 
copies of Sld3. 
 
Yeast two-hybrid data from a previous report suggests that the N-terminus of Sld3 
is required for Sld7 binding (Tanaka et al., 2011b). To test the requirement for the 
N-terminus of Sld3 for the interaction with Sld7 in vitro, I purified two Sld3 
fragments lacking either the first 132 or 250 residues of the protein, and included 
these fragments in the experiment in place of full-length Sld3 (Fig. 3.8, lanes 5 and 
6). Removal of the N-terminal 250 amino acids of Sld3 resulted in less GST-Sld3 
and Sld7 being bound to the Sld3-FLAG beads at the end of the reaction (Fig. 3.8, 
lane 12), consistent with this section of Sld3 being required for both Sld7 binding 
and Sld3 multimerisation. The small amount of Sld7 observed in lane 12 may be 
bound via the N-terminus of the full-length GST-Sld3 present in the reaction. 
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Figure 3.8 In vitro reconstitution of the Sld3/7 complex with purified proteins 
Purified full-length or truncated Sld3-FLAG, GST-Sld3 and Sld7 were mixed 
together as indicated and isolated via FLAG immunoprecipitation. Bead-bound 
proteins were eluted by incubation with buffer containing 3xFLAG peptide, and 
analysed alongside input (inp) samples by SDS-PAGE and coomassie staining. 
Positions of proteins are indicated in the right. Molecular weight markers are 
indicated to the left. 
 
3.2.6 Purification of pre-RC proteins  
A prerequisite for the reconstitution of replication initiation steps downstream of 
pre-RC assembly was to first be able to reconstitute the Mcm2-7 loading reaction in 
vitro, as had been demonstrated previously (Remus et al., 2009, Evrin et al., 2009). 
Given this, I purified the ORC, Cdc6 and Mcm2-7/Cdt1 licensing proteins to 
homogeneity (Fig. 3.9A, B and C). The Mcm2-7/Cdt1 heptamer and ORC hexamer 
were both purified from yeast cells arrested in G1 with the mating pheromone α-
factor. Cdc6 was purified following overexpression in E. coli. 
 
To test the activity of the purified licensing proteins, in vitro pre-RC assembly 
reactions were performed, as described previously (Remus et al., 2009, Evrin et al., 
2009). ORC, Cdc6 and Mcm2-7/Cdt1 were incubated with an origin-containing 
linear DNA fragment coupled to magnetic beads.  
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Figure 3.9 Purification of pre-RC proteins 
A. Purified ORC analysed by SDS-PAGE and coomassie staining. The final ion 
exchange chromatography step of the purification is shown. B. Purified Mcm2-
7/Cdt1 analysed by SDS-PAGE and coomassie staining. The final gel filtration step 
of the purification is shown. C. Purified Cdc6 from E. coli analysed by SDS-PAGE 
and coomassie staining. Elution fractions from the final hydroxyapatite (HTP) 
column are shown. D. In vitro pre-RC Mcm2-7 loading assay. Proteins bound to 
DNA were visualised by silver staining. All reactions were performed in the 
presence of ATP, and washed with either low salt wash (lane 1) or high salt wash 
(lane 2) as indicated. 
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In the presence of ATP, Mcm2-7 is loaded around double-stranded DNA. This 
loaded form of the Mcm2-7 complex is topologically linked to the DNA and is thus 
resistant to challenge with a high salt wash, which is sufficient to remove ORC, 
Cdc6 and Cdt1 from the DNA (Fig. 3.9D). Although not shown, in the presence of 
the slowly-hydrolysable ATP analogue ATPγS, Mcm2-7 is ‘recruited’ to DNA in a 
form that is not resistant to high salt washing. 
 
3.2.7 Purification of DDK 
The activity of DDK is absolutely required for replication initiation in vivo and in vitro 
(Bousset and Diffley, 1998, Heller et al., 2011, Hartwell et al., 1974, Hereford and 
Hartwell, 1974, Patterson et al., 1986, Buck et al., 1991), and evidence suggests 
that phosphorylation of the loaded Mcm2-7 complex by DDK is the most upstream 
event after pre-RC assembly during Mcm2-7 activation (Heller et al., 2011, 
Yabuuchi et al., 2006, Jares and Blow, 2000, On et al., 2014, Gros et al., 2014). I 
therefore purified DDK from a yeast strain, in which Cdc7 and Dbf4 are both 
overexpressed. The DDK recovered after the initial affinity chromatography step 
(Fig. 3.10A) was phosphorylated on both subunits, as shown by the mobility shift in 
an SDS-PAGE gel upon treatment with lambda phosphatase (Fig. 3.10B). This 
hyper-phosphorylation has recently been shown to decrease the kinase activity of 
DDK (On et al., 2014), and the phosphatase treatment was therefore performed as 
a standard during DDK purifications. 
 
As the loaded form of the Mcm2-7 complex has previously been shown to be the 
preferred substrate for DDK in vitro (Francis et al., 2009), I used Mcm2-7 pre-
assembled into the pre-RC as a substrate to test the kinase activity of purified DDK 
(Fig. 3.10D). Mcm6 was phosphorylated as DDK was titrated into the reaction, 
resulting in the formation of a slower migrating form of the protein on an SDS-
PAGE gel (Fig 3.10D, lanes 5 and 6). This indicates that purified DDK has protein 
kinase activity in vitro. 
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Figure 3.10 Purification of DDK 
Purified DDK analysed by SDS-PAGE and coomassie staining (A, B, C). DDK was 
subjected to sequential calmodulin affinity chromatography (A), lambda 
phosphatase treatment (B) and gel filtration (C) steps. Molecular weight markers 
(kDa) are shown to the left of each gel. D. Purified DDK was tested for in vitro 
kinase activity using loaded Mcm2-7 as a substrate. DDK was added to the final 
concentrations of 6.25, 12.5, 25, 50 and 100 nM, and samples were then analysed 
by SDS-PAGE and immunoblot. 
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3.2.8 Reconstitution of Sld3/7 recruitment to the pre-RC in vitro 
Data from both in vivo and in vitro studies suggests that recruitment of the Sld3/7 
complex to the pre-RC is required for Cdc45 recruitment (Heller et al., 2011, 
Kanemaki and Labib, 2006, Tanaka et al., 2011a, Kamimura et al., 2001), and is 
upstream of the CDK-dependent recruitment of Dpb11, Sld2, GINS and Polε in the 
form of the pre-loading complex (Muramatsu et al., 2010, Heller et al., 2011, 
Yabuuchi et al., 2006). Notably, this recruitment of Sld3/7 has been shown to be 
somehow dependent on the activity of DDK (Heller et al., 2011, Tanaka et al., 
2011a, Yabuuchi et al., 2006). To test the hypothesis that this DDK-dependence 
was due to the direct regulation of an interaction between Sld3/7 and a pre-RC 
component, I attempted to reconstitute binding of Sld3/7 to pre-RCs assembled in 
vitro.  
 
Pre-RCs were first assembled onto linear DNA coupled to beads in vitro, and then 
phosphorylated with DDK. Following the removal of the DDK reaction mixture, 
purified Sld3/7 was added, as is described in Fig. 3.11A. Recruitment of proteins to 
the DNA was monitored by immunoblotting or silver staining. In the complete 
reaction, when all pre-RC components and DDK were present (Fig. 3.2B, lane 1 
and Fig. 3.2C, lane 3), the Mcm2-7 complex was phosphorylated, as indicated by 
the formation of a slower migrating form of Mcm4 in an SDS-PAGE gel, and Sld3 
and Sld7 were both recruited to the DNA. Strikingly, if DDK was omitted from the 
reaction (Fig. 3.2B, lane 2 and Fig. 3.2C, lane 2), Sld3/7 recruitment was reduced 
to background levels, and this was also observed upon omission of ORC, Cdc6 or 
Mcm2-7/Cdt1 (Fig. 3.2B, lanes 3-5). The DDK-independent binding of Sld3/7 to the 
pre-RC was increased in the presence of lower salt concentrations (Fig. 3.2E, 
compare lanes 1 and 3), and the Sld3/7 recruitment step was therefore performed 
under 0.5 M salt as a standard. These data suggests that recruitment of Sld3/7 to 
the pre-RC is directly regulated by DDK phosphorylation of one or more pre-RC 
component.  
 
Sld3/7 was not recruited when Mcm2-7/Cdt1 was omitted from the reaction (Fig. 
3.2B, lane 5) despite the presence of both ORC and Cdc6 on the DNA. This is 
consistent with an interaction between Sld3/7 and the Mcm2-7 complex being  
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Figure 3.11 Reconstitution of Sld3/7 recruitment to the pre-RC in vitro 
A. Schematic of experimental setup for Sld3/7 recruitment reaction. DNA-bound 
samples were analysed by either immunoblot (B) or silver staining (C) with the 
indicated proteins omitted. The lower band (*) on the anti-Cdc6 immunoblot in B is 
Orc6. Visible bands are annotated on the right in C. ‘P’ indicates the position of 
proteins after phosphorylation D. Immunoblot analysis of Sld3/7 recruitment 
reactions with increasing amounts of DDK. E. Immunoblot analysis of Sld3/7 
recruitment reactions performed at either 0.3 M or 0.5 M salt. F. Reactions were 
performed as described in A, with a high salt wash step included before addition of 
Sld3/7 as indicated. Samples were analysed by immunoblot. 
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required for Sld3/7 recruitment. To test this premise, I included a high salt wash 
before adding Sld3/7 in the recruitment reaction, which results in the removal of 
ORC and Cdc6 from the DNA, leaving behind only loaded Mcm2-7 complexes. The 
loaded Mcm2-7 complexes alone were sufficient for DDK-dependent recruitment of 
Sld3/7 to the pre-RC (Fig. 3.2F, lane 3), indicating that ORC and Cdc6 are not 
required for this interaction. 
 
3.3 Discussion 
3.3.1 Towards reconstitution of Mcm2-7 activation in vitro 
The early work presented in this chapter described the purification of numerous 
firing factors known to be required for the activation of the Mcm2-7 replicative 
helicase. In addition to the Sld3/7 complex (Fig. 3.5), which I went on to 
characterise extensively (Fig. 3.6 and 3.8), I also established purification strategies 
for Dpb11, Cdc45 and Sld2 (Fig. 3.3), all based upon galactose-inducible 
overexpression in yeast (Fig. 3.1). These strategies have subsequently been 
developed by colleagues within the lab. The purification of these proteins 
represents significant progress towards the reconstitution of DNA replication 
initiation in vitro.  
 
With the aim of understanding how the Mcm2-7 complex is activated, I also purified 
the Cdc6, ORC and Cdt1/Mcm2-7 licensing factors (Fig. 3.9), and showed that 
these purified proteins were competent for pre-RC assembly in vitro (Fig. 3.9D), as 
had been previously described (Remus et al., 2009, Evrin et al., 2009). Additionally, 
I was also able to reconstitute quantitative phosphorylation of the loaded Mcm2-7 
complex with purified DDK (Fig. 3.10D). These DDK-phosphorylated Mcm2-7 
complexes can support the replication of a plasmid template in an S-phase extract 
(On et al., 2014, Gros et al., 2014), and will therefore likely represent the basis for 
future reconstitution efforts. 
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3.3.2 Sld3/7 contains multiple copies of Sld3 
In section 3.2.4 of this chapter, I described the purification of the Sld3/7 complex 
following overexpression in yeast. This complex remained stable during gel 
filtration under 0.5 M KCl (Fig. 3.5B), consistent with previous data indicating that 
Sld3 and Sld7 are stably bound to one another throughout the cell cycle (Tanaka et 
al., 2011b). Through a combination of gel filtration and density gradient 
centrifugation (Fig. 3.6), I was able to estimate the molecular weight of the complex 
at 163 kDa, indicative of the presence of more than one copy of Sld3 and/or Sld7 in 
the complex. The estimated Stokes Radius of Sld3/7 was 68 Å; this relatively large 
Stokes radius for a complex of this size suggests that Sld3/7 adopts an extended 
conformation. 
 
Subsequently, I was able to reconstitute the Sld3/7 complex in vitro from 
individually purified subunits, and showed that a complex can be formed containing 
more than one copy of Sld3 (Fig. 3.8, lane 7). Interestingly, the abundance of the 
second copy of Sld3 in the complex was reduced upon deletion of residues 1-250 
of Sld3 (Fig. 3.8, compare lanes 7 and 12). This data is suggestive of a novel role 
for this section of the protein, previously shown to be required for Sld7 binding 
(Tanaka et al., 2011b), in Sld3 multimerisation. The Sld7 binding activity previously 
ascribed to this section of Sld3 was shown to reside within residues 91-121 
(Tanaka et al., 2011b). The precise location of the Sld3 multimerisation function is 
still to be determined, but the fact that both Sld7 and a second copy of Sld3 could 
be simultaneously bound to Sld3-beads (Fig. 3.8, lane 7) could suggest that the 
Sld3 and Sld7 binding sites in Sld3 do not overlap. Whether or not the complex 
contains more than one copy of Sld7 is yet to be examined; determination of the 
Sld3 binding site on Sld7 would allow for a clearer understanding of the exact 
architecture of the Sld3/7 complex. 
 
One notable limitation of this analysis is the relatively broad peaks observed for 
Sld3/7 during gel filtration (Fig. 3.6B), making determination of an exact elution 
volume very difficult. One explanation for this behaviour may be the existence of 
multiple different multimeric forms of Sld3/7 in the purified sample. Alternative 
means of molecular weight estimation, such as analytical ultracentrifugation or 
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multi-angle light scattering, could potentially be used to obtain a more accurate 
estimate of the size of the complex.  
 
In spite of these limitations, the notion that Sld3/7 likely contains two Sld3 
molecules is intriguing. During DNA replication initiation, an Mcm2-7 double 
hexamer must be converted into a pair of divergent bi-directional replication forks, 
each containing only a single Mcm2-7 hexamer in the form of the CMG complex 
(Gambus et al., 2006, Yardimci et al., 2010, Costa et al., 2011, Boos et al., 2012, 
Raschle et al., 2008). Sld3 recruitment to the pre-RC has been previously shown to 
be upstream of the recruitment of all other known firing factors (Heller et al., 2011, 
Yabuuchi et al., 2006). The presence of two Sld3 molecules (in the form of a single 
Sld3/7 complex) bound to the pre-RC would allow for the CDK-dependent 
recruitment of two copies of Dpb11, and potentially, two copies of GINS. Thus, the 
stoichiometry of the Sld3/7 complex could conceivably determine the number of 
molecules of all other firing factors that are subsequently recruited, leading to the 
downstream formation of two CMG complexes from a single Mcm2-7 double 
hexamer (discussed further in section 6.6). 
 
3.3.3 DDK directly regulates Sld3/7 binding to the Mcm2-7 double hexamer 
In the final part of this chapter, I described a reconstituted system for studying the 
recruitment of the Sld3/7 complex to the pre-RC in vitro (Fig. 3.11). In addition to 
the requirement for ORC, Cdc6 and Mcm2-7 (Fig. 3.11B, lanes 3-5), the 
recruitment of Sld3/7 in this system was dependent on the presence of DDK (Fig. 
3.11B, compare lanes 1 and 2). Furthermore, I was able to show that the loaded 
Mcm2-7 complex is both necessary and sufficient for Sld3/7 recruitment (Fig. 3.11B, 
lane 5 and 3.11F, lane 3). Although consistent with previous data suggesting that 
DDK is required for Sld3/7 recruitment to replication origins in vivo (Heller et al., 
2011, Tanaka et al., 2011a), this is the first evidence of a direct role for DDK in 
regulating a protein-protein interaction between Sld3/7 and the pre-RC.  
 
Although the Mcm2, 4 and 6 subunits of Mcm2-7 are themselves phosphorylation 
targets for DDK (Masai et al., 2006, Montagnoli et al., 2006, Sheu and Stillman, 
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2006, Randell et al., 2010), the essential function of this kinase in DNA replication 
can be bypassed by alleles in a number of genes that have not been shown to be 
DDK substrates, namely mcm5-bob1 (Hardy et al., 1997) and, in S. pombe, by 
deletion of mrc1 or rif1 (Hayano et al., 2012, Matsumoto et al., 2011). Based upon 
these observations, it has previously been proposed that DDK might promote origin 
firing by eliciting some conformational change in the Mcm2-7 double hexamer, 
which is required for its activation. The binding of Sld3/7 to the Mcm2-7 complex 
described in this chapter is the first example of a DDK-regulated interaction 
involving proteins required for DNA replication initiation, and is suggestive of a 
novel function for DDK during activation of the replicative helicase. Investigating the 
mechanism of Sld3/7 recruitment, and examining how phosphorylation of the 
Mcm2-7 complex by DDK promotes this event, will provide the basis of the rest of 
this thesis. 
 
  
 
Chapter 4 Results 
 
 117 
Chapter 4. Results 2 
4.1 Introduction 
The requirement for Sld3 during DNA replication initiation was first described over 
10 years ago (Kamimura et al., 2001). Originally, the SLD3 gene was isolated in a 
screen for factors exhibiting synthetic lethality with the dpb11-1 allele (Kamimura et 
al., 1998), and was subsequently shown to be required for the chromatin 
association of Cdc45 in S-phase (Kamimura et al., 2001, Kanemaki and Labib, 
2006). Since then, it has become increasingly clear that Sld3 has a central role in 
the regulation of replication origin firing. 
 
In 2007, two papers showed that, in yeast, Sld3 is one of two critical CDK 
substrates required for the G1/S transition (Tanaka et al., 2007, Zegerman and 
Diffley, 2007). Phosphorylation of Sld3 and Sld2 generates binding sites for another 
protein, Dpb11, via its tandem BRCT repeats, and formation of the Sld3-Dpb11-
Sld2 complex is required for activation of the loaded Mcm2-7 helicase. This 
function of Sld3 has since been shown to be conserved with its human homologue, 
Treslin (Kumagai et al., 2010, Kumagai et al., 2011, Boos et al., 2011).  
 
In addition to its function as an essential CDK substrate, Sld3 is also a substrate of 
the Rad53 DNA damage checkpoint kinase (Lopez-Mosqueda et al., 2010, 
Zegerman and Diffley, 2010). Phosphorylation of Sld3 by Rad53 in S-phase acts to 
block Sld3 binding to both Dpb11 and Cdc45, thereby preventing further origin 
firing in the presence of DNA damage. Most recently, Sld3 has been shown to form 
a constitutive complex throughout the cell cycle with a second protein involved in 
replication initiation, Sld7 (Tanaka et al., 2011b). 
 
In the previous chapter, I presented evidence that the Sld3/7 complex likely 
contains multiple copies of Sld3. I also described a reconstituted system for 
studying the recruitment of Sld3/7 to the pre-RC in vitro, and showed data 
supporting the notion that DDK directly regulates binding of Sld3/7 to the loaded 
Mcm2-7 complex. In the following section, I will present work showing that Sld3/7 
recruitment to the pre-RC is mediated via a distinct domain of Sld3, which also 
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contains a Cdc45 binding site. By isolating a number of Sld3 mutants specifically 
defective in pre-RC or Cdc45 binding, I have examined the functional significance 
of these interactions for replication initiation. This work indicates that Sld3, an 
essential CDK substrate, has an important function in the DDK-dependent 
regulation of replication initiation, thereby providing a point of intersection for the 
activities of DDK and CDK during origin firing. 
 
4.2 Results 
4.2.1 The N-terminus of Sld3 is required for Sld7 recruitment to the pre-RC 
As a first step towards understanding how the Sld3/7 complex is recruited to the 
pre-RC during replication initiation, I first examined the individual pre-RC binding 
activities of both Sld3 and Sld7. To do this, I purified Sld3 and Sld7 after 
overexpression in E. coli, as described in the previous chapter. I then tested these 
individually purified, recombinant proteins for their ability to recruit to in vitro 
reconstituted pre-RCs in a DDK-dependent fashion, using the system described in 
3.2.8. 
 
Whilst Sld3 alone could be recruited to the pre-RC to the same levels as in the 
Sld3/7 complex purified from yeast (Fig. 4.1B, compare lanes 2 and 4), individually 
purified Sld7 exhibited no detectable pre-RC binding activity (Fig. 4.1B, lane 6). 
Importantly, the bacterially expressed Sld3 and Sld7 could be used to make a 
recombinant Sld3/7 complex in vitro, and this complex was competent for DDK-
dependent Sld7 recruitment to the pre-RC (Fig. 4.1B, lane 8).  
 
Consistent with previously published data (Tanaka et al., 2011b), I demonstrated 
the involvement of the N-terminus of Sld3 in Sld7 binding in the previous chapter 
(Fig. 3.8). To test the requirement for this section of Sld3 for Sld7 recruitment to the 
pre-RC, I next replaced full-length Sld3 with an Sld3 fragment lacking residues 1-
250 in an Sld3/7 recruitment assay (Fig. 4.1C). Whilst this Sld3 fragment could bind 
to the pre-RC to the same levels as full-length Sld3 (Fig. 4.1C, compare lanes 7 
and 9), it was not competent for Sld7 recruitment in this system (Fig. 4.1C, lane 15). 
This indicates that, whilst dispensable for the binding of Sld3 to the Mcm2-7 double 
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hexamer, the N-terminus of Sld3 is essential for Sld7 recruitment to the pre-RC, in 
agreement with previous data (Fig. 3.8, Tanaka et al., 2011b). 
 
 
 
Figure 4.1 The N-terminus of Sld3 is required for Sld7 recruitment to the pre-RC 
A. Purified Sld3/7, Sld3 and Sld7 analysed by silver staining. The 3+7 complex in 
lane 4 was made by mixing of the purified proteins in lanes 2 and 3 under 0.5 M 
KCl. Each lane contains 50% of the amount of input protein used in B. In B and C, 
indicated proteins were tested for their ability to bind to the pre-RC in vitro. DDK 
was omitted as indicated. The presence of full-length (F.L.) or truncated Sld3 is 
indicated in C. DNA-bound proteins were analysed by immunoblot. 
 
4.2.2 Mapping the Mcm2-7 binding site on Sld3 
Despite its essential role in the regulation of origin firing, Sld3 has no known 
enzymatic activity, and there is little functional annotation of the protein’s primary 
sequence. Whilst protein-protein interactions with Sld7, Cdc45 and Dpb11 have 
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been mapped (Fig. 4.2A), the only described domain within Sld3 is the Sld3-Treslin 
Domain (S.T.D.), which is the section of the protein that shares sequence 
homology with the human Sld3 homologue, Treslin (Sanchez-Pulido et al., 2010).  
 
Given the observation that Sld3 alone can be recruited to the pre-RC (Fig. 4.1), I 
next wanted to map the Mcm2-7 binding site on Sld3. To do this, I made bacterial 
expression constructs for the expression and purification of various Sld3 fragments. 
The positions of the N and C-termini or these fragments were chosen based on a 
secondary structure prediction performed using the Phyre2 server (Kelley and 
Sternberg, 2009). The fragments were all purified via an N-terminal GST tag (Fig. 
4.2B), and the tag was subsequently removed via preScission protease mediated 
cleavage during elution from glutathione beads. 
 
Following purification, fragments of Sld3 were tested for their ability to bind to DDK-
phosphorylated loaded Mcm2-7 complexes in vitro. The initial analysis indicated 
that the first 250 residues (containing the Sld7 binding site) (Fig. 4.2C, lane 10) and 
last 82 residues (containing the two essential CDK phosphorylation sites) (Fig. 
4.2C, lane 16) of Sld3 were dispensable for Mcm2-7 binding. Deletion of residues 
1-326 (Fig. 4.2C, lane 12) or 435-668 (Fig. 4.2C, lane 18) produced Sld3 fragments 
that were not competent for pre-RC binding. Indeed, upon purification of a fragment 
containing only Sld3 251–585, I could show that this portion of the protein alone 
was sufficient for recruitment to the pre-RC (Fig. 4.2D, lane 8). 
 
4.2.3 Isolation of Mcm2-7 binding mutants in Sld3 
Having mapped a minimal Mcm2-7 interacting portion of Sld3/7 to residues 251-
585 of Sld3, I next set out to try and isolate point mutants in Sld3 that were 
specifically defective in DDK-dependent pre-RC binding, with the aim of using any 
such mutants to examine the functional importance of this interaction for Mcm2-7 
helicase activation.  
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Figure 4.2 Sld3 residues 251-585 are necessary and sufficient for recruitment to 
the pre-RC  
A. Schematic of Sld3 from S. cerevisiae. Residue numbers are shown and 
positions of known interaction sites for other proteins are depicted. Two essential 
CDK phosphorylation sites are shown by red vertical bars. The Sld3-Treslin 
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Domain (S.T.D.) is shown in green. B. Representative example of purified Sld3 
fragments visualised by SDS-PAGE and coomassie staining. To test solubility, 
purified proteins were centrifuged at 21,000 g for 5 min, and input (I) and 
supernatant (S) samples taken before and after centrifugation, respectively. 
Molecular weight markers (kDa) are indicated to the left. In C and D, full-length 
(F.L.) or fragments of Sld3 were tested for their ability to bind to the pre-RC in vitro. 
DDK was omitted as indicated. Input and DNA-bound proteins were analysed by 
immunoblot. 
 
Given the phosphorylation-dependence of the Sld3-Mcm2-7 interaction, we initially 
targetted conserved positively charged amino acids for mutagenesis, hypothesising 
that such residues may be involved in co-ordinating phosphorylated Ser or Thr on 
the Mcm2-7 complex. The observation that Sld3 251-585 can bind to the pre-RC in 
vitro but Sld3 251-486 cannot (Fig 4.2D, lanes 8 and 10) may suggest that the 
Mcm2-7 binding activity resides within residues 486-585 of Sld3. Given this, I 
initially focussed on this region of Sld3 as a target for mutagenesis, generating 
seven different amino acid substitution mutants in which Arg or Lys were replaced 
with Glu residues in full-length Sld3 (Fig. 4.3A). These mutant proteins were 
purified from E. coli alongside wild type Sld3 as previously described (Fig. 4.3B), 
and then tested for their ability to bind to loaded Mcm2-7 (Fig. 4.4A). Strikingly, 
mutation of 3 distinct pairs of Lys/Arg within residues 511-531 (K511/R512, 
K518/R520 or K530/R531) rendered Sld3 completely defective for DDK-dependent 
binding to the pre-RC (Fig. 4.4A, lanes 4, 6, 8). 
 
As a control for the specificity of the binding defect observed, I next tested the Sld3 
mutants for other protein-protein interactions, which have been previously reported 
for Sld3 (Fig. 4.2A). To do this, I incubated the purified Sld3 mutants in an S-phase 
protein extract, which has previously been used in the development of an in vitro 
DNA replication assay (see 4.2.5). Recombinant Sld3 was then re-isolated from the 
extract via immunoprecipitation of the FLAG tag on its N-terminus. Upon addition of 
wild type Sld3 to the S-phase extract, I observed a specific enrichment of both 
Cdc45 and Sld7 on the anti-FLAG beads at the end of the reaction (Fig. 4.4B, lane 
11). The reported CDK-dependent interaction between Sld3 and Dpb11 was not 
observed in this system. Reassuringly, all of the mutants tested were able to bind 
Cdc45 and Sld7 to the same level as wild type Sld3 (Fig. 4.4B lanes 12-18), 
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indicating that mutations in residues 511-531 do not affect the Cdc45 or Sld7 
binding activities of Sld3. 
 
 
 
Figure 4.3 Purification of Sld3 Mcm2-7 binding mutants 
A. Schematic showing position of amino acid substitution mutations in Sld3. 
Sequence of Sld3 509-532 is shown. Residues highlighted in red were replaced 
with Glu. Names of mutants are shown to the right. B. Purified Sld3 mutants 
visualised by SDS-PAGE and coomassie staining. Mutant and wild type Sld3 were 
purified after overexpression in E. coli. Molecular weight markers (kDa) are shown 
to the left. 
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Figure 4.4 Mutations in Sld3 residues 511-531 specifically disrupt binding to the 
pre-RC 
A. Wild type (wt) or mutant Sld3 was tested for binding to the pre-RC in vitro. DDK 
was omitted as indicated. Input and DNA-bound proteins were analysed by 
immunoblot. B. Wild type or mutant FLAG-tagged Sld3 was added to an S-phase 
protein extract and tested for interactions with Cdc45 and Sld7. Immunoprecipitated 
proteins were eluted from anti-FLAG beads by boiling in Laemmli sample buffer, 
and then analysed by immunoblot. 
 
4.2.4 One Mcm2-7 binding site on Sld3/7 is sufficient for recruitment to the 
pre-RC 
The data presented thus far shows that Sld3/7 is recruited to the pre-RC via an 
interaction between the central portion of Sld3 and the loaded Mcm2-7 double 
hexamer. Interestingly, biochemical analyses shown in the previous chapter 
indicates that the Sld3/7 complex likely contains two copies of Sld3. If the Mcm2-7 
binding activity of only one of these Sld3 molecules was required for Sld3/7 
recruitment, then the Sld3 2E3 mutant should be recruited to the pre-RC in the 
presence of wild type Sld3. To test this, I used untagged wild type and FLAG-
tagged mutant versions of Sld3, which were distinguishable in immunoblot analysis.  
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The mutant and wild type Sld3 proteins were mixed together in the presence or 
absence of Sld7, and tested for their ability to bind to the DDK phosphorylated 
Mcm2-7 double hexamer, as depicted in Fig. 4.5A. In the absence of wild type Sld3, 
the Sld3 2E3 mutant was not recruited to the pre-RC above background levels (Fig. 
4.5B, lane 4), as had been observed previously, but this recruitment defect was 
partially rescued upon the inclusion of wild type Sld3. Sld7 recruitment was 
decreased in the sample where both wild type and mutant Sld3 was present (Fig 
4.5B, lane 6), which likely represents the uptake of a portion of the Sld7 pool into 
Sld3/7 complexes containing only mutant Sld3 molecules, which would be 
incompetent for pre-RC binding. Strikingly, the rescue of the recruitment defect of 
Sld3 2E3 was dependent upon the inclusion of Sld7 in the reaction (Fig 4.5B, 
compare lanes 6 and 8). Given the lack of observable pre-RC binding activity in 
Sld7, the simplest explanation for this observation is that, in the context of 
recruitment to the pre-RC, Sld7 acts as a ‘bridge’ between the multiple Sld3 
molecules present in Sld3/7 (discussed further in section 4.3.1). Taken together, 
these data supports a model in which recruitment of the Sld3/7 complex only 
requires the Mcm2-7 binding activity of one Sld3 molecule.  
 
 
 
Figure 4.5 One Mcm2-7 binding site on Sld3/7 is sufficient for recruitment to the 
pre-RC 
A. Schematic of experimental setup. Untagged wild type (wt) and FLAG-tagged 
Sld3 2E3 (mut) were mixed together with Sld7 (7) in various combinations, and 
tested for recruitment to DDK-phosphorylated pre-RCs. B. DNA-bound proteins 
were analysed by immunoblotting, with the indicated proteins omitted. Although 
indistinguishable from wild type Sld3 in its migration during SDS-PAGE, FLAG-
tagged Sld3 could be specifically detected by anti-FLAG immunoblotting. 
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4.2.5 Mcm2-7 binding mutants of Sld3 are defective for DNA replication in 
vitro 
I next wanted to test the functional significance of the Sld3-Mcm2-7 interaction for 
DNA replication initiation. To do this, I made use of a recently developed in vitro 
DNA replication assay (On et al., 2014, Gros et al., 2014). In this assay, pre-RCs 
are initially assembled onto a soluble plasmid DNA template using purified proteins. 
Following phosphorylation with purified DDK, these pre-RCs are then incubated in 
an S-phase protein extract, in which Sld3, Sld7, Cdc45, Sld2 and Dpb11 have all 
been overexpressed. This system supports the complete replication of input 
plasmids, resulting in the synthesis of covalently closed, circular products. 
 
In order to test the functionality of the Sld3 Mcm2-7 binding mutants in this assay, I 
first developed an immunodepletion protocol to remove Sld3 from the S-phase 
extract. The overexpressed second copy of Sld3 present in the extract is C-
terminally tagged with 13Myc, and I therefore attempted immunodepletion using 
anti-Myc beads (Fig. 4.6A). Repeated rounds of depletion were performed, with 
fresh anti-Myc beads incubated with extract for 1 h at a time. 2 x 1 h incubations 
with anti-Myc beads from Origene were sufficient to completely deplete Sld3-13Myc 
from the extract (Fig. 4.6A, lanes 6-9). A significant proportion of the Sld7 present 
was co-depleted with Sld3 (Fig. 4.6B), and recombinant Sld7 was therefore 
routinely added back to the Sld3-depleted extracts in subsequent experiments. 
 
Depletion of Sld3-13Myc almost completely abolished the replication activity 
observed in the undepleted extract (Fig. 4.6C, compare lanes 1 and 2), indicating 
that any endogenous untagged Sld3 left after depletion of Sld3-13Myc was not 
sufficient to support DNA synthesis in this system. This defect was rescued by the 
addition of wild type recombinant Sld3 (and Sld7) to the extract (Fig. 4.6C, lane 3), 
and the Mcm2-7 binding mutants of Sld3 were subsequently tested. Of the three 
double point mutants examined, 2E1 and 2E2 both showed a partial defect in DNA 
replication activity compared with wild type Sld3 (Fig. 4.6C, compare lanes 4/5 with 
lane 3). The functional relevance of the K511/R512 and K518/R520 residues was 
confirmed by the absence of DNA replication observed in the 4E1 mutant (Fig. 
4.6C, lane 8), in which all four of these residues are mutated. Strikingly, 2E3-
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complemented extracts showed no appreciable increase in replication activity 
relative to the Sld3-depleted extract (Fig. 4.6C, lane 6), and this was also the case 
for the 4E2, 4E3 and 6E mutants (Fig. 4.6C, lanes 7, 9 and 10), indicating that 
binding of Sld3 to Mcm2-7 is essential for DNA replication initiation in this in vitro 
system.  
 
 
 
Figure 4.6 Mcm2-7 binding mutants of Sld3 are defective for DNA replication in 
vitro 
A. Immunodepletion of Sld3-13Myc from S-phase extracts. Samples were 
subjected to repeated 1 h rounds of depletion using the beads indicated. Samples 
were taken at the start of the experiment and after each round of depletion, and 
analysed by immunoblot against Myc. Anti-Psf1 immunoblot is shown as control for 
the specificity of the depletion. B. Co-depletion of Sld7 with Sld3-13Myc. Extract 
samples were taken before and after Sld3 depletion and analysed by immunoblot. 
C. In vitro DNA replication assay. Wild type or mutant Sld3 was tested for its ability 
to support replication of a 3.2 kb plasmid template in an S-phase protein extract 
depleted of Sld3-13Myc. Recombinant proteins were added back at the same 
concentration as in Fig. 4.7A. Incorporation of 32P-α-dCTP was monitored and 
samples were analysed by gel electrophoresis and autoradiography. Ethidium 
bromide staining is shown as a loading control. 
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4.2.6 Mcm2-7 binding mutants of Sld3 are defective for CMG assembly in 
vitro 
To investigate the replication defects described in 4.2.5 in more detail, I next 
examined the activities of the Sld3 mutants in an in vitro replisome assembly assay. 
This assay is performed in a similar manner to the in vitro replication assay 
described above, except it makes use of linear DNA coupled to beads rather than a 
soluble plasmid template. The use of DNA beads allows one to follow the 
recruitment of specific replisome components to the DNA following addition of an 
S-phase extract to DDK-phosphorylated pre-RCs (On et al., 2014, Gros et al., 
2014). I used this system to test for the recruitment of Cdc45 and the Psf1 subunit 
of GINS, two essential components of the CMG replicative helicase (Fig. 4.7A). 
 
Upon addition of an undepleted extract, Sld3-13Myc, Cdc45 and GINS were all 
recruited to the DNA in a DDK-dependent manner (Fig. 4.7A, lanes 1 and 2) 
consistent with previously reported data (On et al., 2014, Gros et al., 2014). Sld3-
13Myc depletion resulted in a loss of detectable Cdc45 and GINS recruitment (Fig. 
4.7A, lane 3), and this could be rescued by the addition of wild type recombinant 
Sld3 (Fig. 4.7A, lane 5). This indicates that Cdc45 and GINS recruitment is Sld3-
dependent in this system. Addition of the 2E1 and 2E2 mutants, both of which 
showed a partial defect in DNA replication activity (Fig. 4.6C), resulted in a partial 
loss of GINS recruitment (Fig. 4.7A, lanes 6 and 7). Notably, the absence of DNA 
replication activity observed for the 2E3, 4E1, 4E2, 4E3 and 6E mutants correlated 
with a severe defect in GINS recruitment in this assay (Fig. 4.7A, lanes 8-12). 
 
Interestingly, immunoblotting against Sld3 indicated that the 2E3, 4E1, 4E2, 4E3 
and 6E mutants all migrated differently to wild type Sld3 in an SDS-PAGE gel (Fig. 
4.7A, lanes 8-12). This unusual migration was not observed in the input samples 
for this experiment (Fig. 4.7A, input samples 8-12), consistent with some post-
translational modification occurring during incubation of recombinant mutant Sld3 in 
the S-phase extract. To test the possibility that this behaviour was caused by 
phosphorylation of the Sld3 mutants, I repeated the replisome assembly assay as 
before, this time splitting the beads in two at the end of the reaction, and subjecting 
half the sample to treatment with lambda phosphatase (Fig. 4.7B). All the Sld3 
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mutant proteins tested migrated as a single band in an SDS-PAGE gel upon 
phosphatase treatment.  
 
 
 
Figure 4.7 Mcm2-7 binding mutants of Sld3 are defective for CMG assembly in 
vitro 
A. Pre-RCs were assembled onto linear DNA coupled to beads, treated with DDK 
as indicated, and an S-phase extract containing wild type or mutant Sld3 then 
added. DNA-bound proteins were eluted from beads by boiling in Laemmli sample 
buffer, and analysed alongside input samples by immunoblot. B. As in A, but each 
sample was split in two at the end of the reaction, and half the sample was then 
treated with lambda phosphatase. 
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Whilst we are yet to ascertain if this phosphorylation has any functional significance, 
the phosphatase treatment did reveal that all of the Sld3 mutants were being 
recruited to the DNA in a DDK-dependent manner in this experiment, albeit at 
reduced levels relative to wild type Sld3 (Fig. 4.7B). The small amount of DDK-
dependent recruitment of these Sld3 mutants appears sufficient for normal levels of 
Cdc45 recruitment (Fig. 4.7A, compare lanes 8-12 with lane 5). Although we are 
still investigating the exact mechanism by which these Sld3 mutants can be 
recruited to the DNA in this system (see 4.2.7), it is clear that the recruitment 
observed is not functional for proper formation of the active CMG replicative 
helicase, or for replication initiation. 
 
4.2.7 Cdc45 is not required for Sld3 recruitment in vitro 
Previously published chromatin immunoprecipitation data has shown that the 
association of Sld3 with origins of replication is reduced at the restrictive 
temperature in a cold-sensitive CDC45 mutant, consistent with Sld3 recruitment to 
the pre-RC being dependent on Cdc45 in vivo (Kamimura et al., 2001). Given this, 
the presence of Cdc45 in the S-phase extract provided a potential explanation as to 
why the Sld3 2E1, 2E2, 2E3, 4E1, 4E2, 4E3 and 6E mutants were recruited to DNA 
in this system, despite the absence of any detectable Mcm2-7 binding activity. 
 
To test whether Sld3 recruitment was dependent upon Cdc45 in the extract system, 
I made use of a Cdc45 depletion protocol developed in collaboration with a 
colleague in the lab, Dr. Joe Yeeles. In this protocol, an S-phase extract is made 
from a strain derived from yKO3, in which the vector from which Cdc45 is 
overexpressed has been removed (yJY16). Any remaining endogenous Cdc45 can 
then be depleted from the extract by incubation with Sld3-FLAG beads, as 
described in 4.2.3. This Cdc45-depleted extract was complemented with purified 
recombinant Cdc45 (a gift from Dr. Yeeles), and Sld3 recruitment to loaded pre-
RCs was then tested (Fig. 4.8). Notably, the absence of Cdc45 in the S-phase 
extract had no effect on the levels of Sld3 recruitment observed in this system (Fig. 
4.8, compare lanes 4 and 6). Significantly, the purified Cdc45 added in this 
experiment was recruited to DNA beads in a DDK-dependent manner (Fig. 4.8, 
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lanes 1 and 2), and was sufficient to restore replication activity to Cdc45-depleted 
extracts (personal communication from Dr. Joe Yeeles). This experiment indicates 
that Sld3 recruitment to the pre-RC is independent of Cdc45 in this in vitro system. 
 
 
 
Figure 4.8 Sld3 recruitment to the pre-RC is independent of Cdc45 in vitro 
Pre-RCs were assembled onto linear DNA coupled to beads, treated with DDK as 
indicated, and a Cdc45-depleted extract was then added. Purified Cdc45 was 
added as indicated. DNA-bound proteins were eluted by boiling in Laemmli sample 
buffer, and analysed by immunoblot. 
 
4.2.8 Mcm2-7 binding mutations in Sld3 affect cell viability 
In order to examine the requirement for the Mcm2-7 binding activity of Sld3 for 
DNA replication in vivo, sld3-2E3 and sld3-6E were next tested for their ability to 
support cell growth. A single copy of SLD3 in a diploid W303 yeast strain was 
replaced with a PCR cassette containing the nourseothricin-resistance marker 
(NAT) and sld3-2E3 or sld3-6E. The resultant heterozygotes were subjected to 
sporulation, tetrads were dissected, and the spores were germinated on rich media. 
 
An SLD3+/sld3-2E3 heterozygote produced tetrads in which two out of four spores 
exhibited a marked growth defect (Fig. 4.9A, upper panel). The presence of sld3-
2E3 in these slow-growing spores was confirmed by replica plating onto plates 
containing nourseothricin (Fig. 4.9A, lower panel). Thus, sld3-2E3 can support 
viability, although cell growth was reduced relative to spores containing wild type 
SLD3. The inability of sld3-2E3 to support DNA replication in vitro (Fig. 4.6C) likely 
reflects the relative inefficiency of the reconstituted DNA replication system 
compared with DNA replication in vivo. 
Cdc45
Mcm7
Sld3
–        +      –      +       DDK+ 
Cd
c4
5
- C
dc
45 +               –           Cdc45
8% inp beads
1     2        3       4       5      6  
Chapter 4 Results 
 
 132 
 
When tetrads from an SLD3+/sld3-6E heterozygote were dissected, only two viable 
spores were produced (Fig. 4.9B). This indicates that sld3-6E is unable to support 
cell growth when present as a single copy, consistent with the in vitro DNA 
replication defects described in sections 4.2.5 and 4.2.6. 
 
 
 
Figure 4.9 Mcm2-7 binding mutations in Sld3 affect cell viability 
Representative tetrads from A. SLD3+/sld3-2E3 and B. SLD3+/sld3-6E 
heterozygotes. The numbers indicate different tetrads that were dissected. The 
presence of sld3-2E3 in the spores circled in A was confirmed by replica plating 
onto plates containing nourseothricin (NAT). 
 
4.2.9 Mutations within the Sld3-Treslin Domain of Sld3 specifically disrupt 
Cdc45 binding 
Given its position within Sld3 residues 251-585 and conservation with the human 
homologue of Sld3, Treslin, we thought that the Sld3-Treslin Domain (S.T.D.) of 
Sld3 represented an interesting additional target for mutagenesis. Whilst none of 
the 11 single or double point mutants initially tested showed any discernable 
deficiencies in pre-RC binding (Fig. 4.10), I was subsequently able to isolate 
another Sld3 mutant (8E) (Fig. 4.11A), which was completely defective in pre-RC 
binding in vitro (Fig. 4.12A, lane 8). This 8E mutant contained eight amino acid 
substitutions within residues 296-320 (Fig. 4.11A); attempts to isolate the Mcm2-7 
binding defect to a smaller subset of these residues proved unsuccessful, as all 
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other mutants tested for this region were wild type for recruitment to the loaded 
Mcm2-7 complex (Fig. 4.12A and B). 
 
 
 
Figure 4.10 Testing Sld3 S.T.D. mutants for binding to the pre-RC 
Wild type or mutant Sld3 was tested for binding to the pre-RC in vitro. DDK was 
omitted as indicated, and proteins were analysed by immunoblot. 
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Figure 4.11 Purification of Sld3 S.T.D. mutants 
A. Schematic showing position of amino acid substitution mutations in Sld3. 
Sequence of Sld3 294-326 is shown. Residues highlighted in red were replaced 
with Glu. Names of mutants are shown to the right. B. Sld3 mutants were purified 
after expression in E. coli and visualised by SDS-PAGE and coomassie staining. 
Molecular weight markers (kDa) are shown to the left. 
 
As a control for the specificity of this Mcm2-7 binding defect, I next went on to test 
the Sld3 mutants for binding to Cdc45 in an S-phase extract, as previously 
described in 4.2.3 (Fig. 4.12C). In this instance, all of the proteins tested, which 
carried mutations in residues 296-320, were defective in Cdc45 binding (Fig. 4.12C, 
lanes 9-12). The Cdc45-binding defect was present in even those mutants 
containing only three (3E1) or four (4E4, 4E5) point mutations (Fig. 4.12C, lanes 9-
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11), all of which were wild type for binding to the pre-RC (Fig. 4.12A and B). The 
position of this Cdc45 binding activity is in agreement with previous yeast two-
hybrid data, which indicates that residues 151-400 of Sld3 are involved in the 
interaction with Cdc45 (Tanaka et al., 2011b). 
 
 
 
Figure 4.12 Mutations in Sld3 residues 296-320 disrupt binding to both the pre-
RC and Cdc45 
In A and B, wild type or mutant Sld3 was tested for binding to the pre-RC in vitro. 
DDK was omitted as indicated, and DNA-bounds proteins were analysed by 
immunoblot. C. Wild type or mutant FLAG-tagged Sld3 was added to an S-phase 
protein extract and tested for interactions with Cdc45. Bead-bound proteins were 
eluted by boiling in Laemmli sample buffer, and then analysed by immunoblot. 
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Having isolated a number of Sld3 mutants (3E1, 4E4 and 4E5) that exhibited an 
apparently specific defect in Cdc45 binding, I next wanted to test the effect of 
disrupting this interaction on DNA replication initiation. To do this, I made use of the 
in vitro DNA replication assay described in 4.2.5, again examining the ability of the 
purified Sld3 mutants to rescue the replication activity of an Sld3-depleted extract 
(Fig 4.13). 
 
 
 
Figure 4.13 Cdc45 binding mutants of Sld3 are defective for DNA replication in 
vitro 
A. In vitro DNA replication assay. Wild type or mutant Sld3 was tested for its ability 
to support replication of a 3.2 kb plasmid template in an S-phase protein extract 
depleted of Sld3-13Myc. Recombinant Sld3 was visualised by immunoblot. * 
indicates a non-specific band. B. Quantification of A, performed using ImageJ 
software. 
 
Addition of either the Sld3 3E1 or 4E5 mutants resulted in significant replication 
defects compared to wild type Sld3 (Fig. 4.13A, compare lanes 2 with 4 and 5), 
consistent with an interaction between Sld3 and Cdc45 being required for efficient 
replication initiation. Notably, the extract complemented with the Sld3 4E4 mutant 
was almost as active for DNA replication as the extract containing wild type Sld3 
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Cdc45 binding activity in the previous analysis (Fig. 3.12C, lane 9), which appears 
sufficient to support near wild type levels of replication in this in vitro assay. Taken 
together, these data indicate that Sld3 residues 251-585 contain both Cdc45 and 
Mcm2-7 binding activities, both of which are important for activation of the Mcm2-7 
replicative helicase. 
 
4.3 Discussion 
4.3.1 A function for Sld7 during DNA replication initiation? 
sld7Δ mutant yeast cells exhibit a marked growth defect consistent with slow 
progression through S-phase of the cell cycle (Tanaka et al., 2011b). However, 
apart from its role as a constitutive binding partner of Sld3, the exact function of 
Sld7 during origin firing has not been well characterised. The CDK-dependent 
interaction between Sld3 and Dpb11 can occur in vitro in the absence of Sld7 
(Zegerman and Diffley, 2007). Furthermore, in the first section of this chapter, I 
showed that Sld7 is not required for direct binding of Sld3 to the Mcm2-7 complex 
(Fig. 4.1B). In these experiments, Sld7 recruitment was totally dependent on the N-
terminal 250 residues of Sld3 (Fig. 4.1C), consistent with previous data showing 
that Sld7 origin recruitment is reduced at the restrictive temperature in an sld3-5 
temperature-sensitive mutant, and that the N-terminus of Sld3 is an Sld7 binding 
site (Fig. 3.8, Tanaka et al., 2011b). 
 
The data presented in Fig. 4.5 indicates that, whilst not required for the direct 
interaction between Sld3 and Mcm2-7, Sld7 is required for the recruitment of a 
second molecule of Sld3, if the Mcm2-7 binding activity of that copy of Sld3 is 
disrupted (Fig. 4.5B, compare lanes 6 and 8). This observation is suggestive of a 
novel role for Sld7 as a ‘bridge’ between multiple Sld3 molecules when Sld3/7 is 
recruited to the pre-RC. Notably, the multimerisation of Sld3 per se is not 
dependent on Sld7 (Fig. 3.8). One possible explanation for this discrepancy is that 
the conformation of Sld3 bound to the Mcm2-7 double hexamer is not competent 
for binding to a second molecule of Sld3. Whether or not this bridging function of 
Sld7 has any functional relevance is still to be examined. Although speculative at 
present, one intriguing possibility is that Sld7 associates with multiple Sld3 
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molecules, which themselves are bound to different Mcm2-7 hexamers within the 
pre-RC. By interacting with multiple Sld3 molecules across the interface of the 
Mcm2-7 double hexamer, Sld7 may co-ordinate the formation of two replisomes, 
each containing a single Mcm2-7 hexamer, during origin firing. To test this 
hypothesis, it may be informative to use DNA fibre analysis to look for bi-directional 
replication initiation (i.e. the co-ordinated activation of two Mcm2-7 hexamers) in 
the presence and absence of Sld7 in vitro and in vivo. 
 
4.3.2 Sld3 residues 251-585 are functional for both Cdc45 and Mcm2-7 
binding during DNA replication initiation 
In section 4.2.2 of this chapter, I used purified fragments of Sld3 to map the Mcm2-
7 binding activity of the protein to residues 251-585 (Fig. 4.2). Mutation of 3 distinct 
pairs of Lys/Arg within residues 511-531 specifically disrupted the Sld3-Mcm2-7 
interaction (Fig. 4.4A). I subsequently showed that these mutants exhibit defects in 
DNA replication (Fig. 4.6C) and CMG assembly (Fig. 4.7A) in vitro. Furthermore, 
sld3-6E was incapable of supporting cell viability (Fig. 4.9B). Collectively, these 
data are consistent with a functional requirement for the novel Mcm2-7 binding 
activity of Sld3 during activation of the replicative helicase. 
 
The central section of Sld3 contains the Sld3-Treslin Domain (S.T.D.), which is 
conserved with Treslin, the human Sld3 homologue, and I was able to show that 
mutations within this domain can disrupt binding to both the pre-RC and Cdc45 (Fig. 
4.12). The charge reversal that these Arg/Lys to Glu mutations introduced may be 
consistent with the existence of a negatively charged Sld3 binding site on Cdc45.  
Whilst these observation could be consistent with a model in which residues 296-
320 of Sld3 are involved in both Mcm2-7 and Cdc45 binding, the Cdc45 binding 
defects of the 3E1, 4E4 and 4E5 mutants (Fig. 4.12C), all of which were competent 
for pre-RC binding (Fig. 4.12A and B), argue that this region likely represents a 
bona fide Cdc45 binding site, consistent with yeast two-hybrid data (Tanaka et al., 
2011b). Only extensive mutation of the S.T.D., as in the 8E mutant, can lead to a 
likely non-specific disruption of the Mcm2-7 binding activity of Sld3, which resides 
C-terminal of the S.T.D. in residues 511-531.  
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Thus, the central section of Sld3 is a multi-functional region, containing binding 
sites for both Cdc45 and Mcm2-7, and the disruption of either of these interactions 
results in deficient DNA replication initiation. This section of Sld3 has previously 
been shown to be a target of the Rad53 DNA damage checkpoint kinase (Lopez-
Mosqueda et al., 2010, Zegerman and Diffley, 2010). Phosphorylation of Sld3 by 
Rad53 disrupts the interaction between Sld3 and Cdc45, thereby helping to prevent 
late origin firing in response to DNA damage in S-phase. Given the likely ionic 
nature of the Sld3-Mcm2-7 interaction, and the fact that a number of Rad53 
phosphorylation sites are located between residues 511-531 of Sld3 (Lopez-
Mosqueda et al., 2010, Zegerman and Diffley, 2010), it seems likely that Rad53 
phosphorylation might also block the interaction between Sld3 and Mcm2-7. Whilst 
experiments to test this hypothesis are ongoing, such a mechanism would 
represent an additional level of redundancy in the intra-S phase checkpoint, and 
provide a potentially potent block to further origin firing under conditions of DNA 
damage. 
 
4.3.3 Mcm2-7 binding mutants of Sld3 are recruited to the pre-RC in an S-
phase extract 
Despite the lack of any detectable Mcm2-7 binding activity, all of the Sld3 Mcm2-7 
binding mutants discussed in this chapter were recruited to pre-RCs in a DDK-
dependent manner when added to an S-phase extract (Fig. 4.7). This is unlikely to 
be caused by Cdc45-dependent Sld3/7 recruitment, as Cdc45 was not required for 
DDK-dependent Sld3/7 recruitment in this in vitro system (Fig. 4.8). This lack of 
dependency on Cdc45 is consistent with the observed pre-RC binding activity of 
Sld3/7 alone, as well as previously published data in S. pombe, which shows that 
Sld3 can be recruited to origins of replication that are not bound by Cdc45 in vivo 
(Yamada et al., 2004). 
 
Given this, it seems likely that the Sld3/7 recruitment observed with these mutants 
may be explained by one of two reasons. Firstly, the extract-based replisome 
assembly assay is performed in much lower salt concentrations (0.15 M K-
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Glutamate) than the Sld3/7 recruitment assay, which is performed in 0.5 M KOAc. 
Thus, it may be that the Mcm2-7 binding defect observed for these mutants under 
0.5 M KOAc is simply not manifested at lower salt conditions. Additionally, work 
presented in this chapter suggests that wild type Sld3 can rescue the recruitment 
defect of an Mcm2-7 binding mutant of Sld3 (Fig. 4.5). The Sld3 immunodepletion 
protocol, which I developed, only removes the 13Myc-tagged second copy of Sld3 
from the extract (Fig. 4.6A). Whilst insufficient to support any DNA replication (Fig. 
4.6C), the small amount of endogenous Sld3 remaining in the extract after Sld3-
13Myc depletion may be sufficient to allow for a small amount of recruitment of the 
exogenously added mutant Sld3. Importantly, despite the fact that some of the Sld3 
mutants, such as Sld3 2E3, are recruited to DNA to near wild type levels (Fig. 4.7B), 
they all exhibit defects in DNA replication (Fig. 4.6C), consistent with the direct 
binding of Mcm2-7 by Sld3 being required for activation of the replicative helicase 
during replication initiation. 
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Chapter 5. Results 3 
5.1 Introduction 
The requirement for Cdc7 kinase activity during DNA replication initiation was first 
shown over 40 years ago (Hereford and Hartwell, 1974, Hartwell et al., 1974), and 
much work has since been published on how this kinase promotes replicative 
helicase activation upon S-phase entry. Unlike the case of CDK (Zegerman and 
Diffley, 2007, Tanaka et al., 2007), however, it has proved difficult to pinpoint a 
minimal set of functions for DDK, despite the identification of a number of alleles 
that overcome the inviability phenotype caused by cdc7 or dbf4 deletion in vivo 
(Sheu and Stillman, 2010, Hardy et al., 1997, Hayano et al., 2012, Matsumoto et al., 
2011).  
 
The Mcm2-7 complex itself is a DDK target; its Mcm2, Mcm4 and Mcm6 subunits 
have all been identified as DDK substrates in vitro and in vivo (Masai et al., 2006, 
Montagnoli et al., 2006, Sheu and Stillman, 2006, Randell et al., 2010). In S. 
cerevisiae, the majority of mapped DDK phosphorylation sites are located within 
the N-terminal regions of these subunits (Randell et al., 2010), which are rich in 
Ser/Thr residues and predicted to be in a disordered conformation. An N-terminal 
deletion of Mcm4 can bypass the requirement for DDK in vivo (Sheu and Stillman, 
2010), and it was thus proposed that DDK promotes origin firing by alleviating 
some intrinsic inhibitory activity that resides within this section of Mcm4. It is 
notable that DDK activity can also be bypassed by the mcm5-bob1 allele (Hardy et 
al., 1997) and, in S. pombe, by deletion of mrc1 or rif1 (Hayano et al., 2012, 
Matsumoto et al., 2011), none of which have been shown to be DDK substrates. 
This may indicate that DDK phosphorylation induces a conformational change in 
the Mcm2-7 complex that is required for its activation, with this conformational 
change somehow being constitutively adopted in the context of the aforementioned 
DDK bypass alleles. 
 
In the previous two chapters I have presented data, which shows that DDK 
regulates recruitment of Sld3/7 to the pre-RC during Mcm2-7 helicase activation. 
This recruitment is mediated by a direct interaction between Sld3 and the loaded 
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Mcm2-7 complex, and is essential for replication initiation. In the following section, I 
will discuss work towards an explanation for the role of DDK in regulating this 
interaction. I will describe a number of novel phosphorylation-dependent binding 
sites for Sld3 on the Mcm2-7 complex, and show data, which illustrates the 
functional consequences of disrupting the binding of Sld3 to a specific Mcm subunit, 
Mcm6. 
 
5.2 Results 
5.2.1 Interaction of Sld3/7 with individual Mcm subunits 
In order to better understand how DDK regulates binding of Sld3/7 to the Mcm2-7 
complex, I first wanted to examine the interaction of Sld3/7 with individual Mcm 
subunits. The presumed phosphorylation-dependence of any such interactions 
presented us with a significant technical obstacle, namely that DDK exhibits a 
strong substrate preference for only those Mcm complexes that have been 
assembled into the pre-RC in vitro (Randell et al., 2010). Consistent with this, we 
were never able to reconstitute quantitative phosphorylation of individually 
expressed and purified Mcm subunits (data not shown). 
 
Because of this issue, we decided to develop an approach that took advantage of 
the fact that loaded Mcm2-7 complexes have the ability to slide on dsDNA in vitro 
(Remus et al., 2009), and will dissociate from linear DNA fragments relatively 
rapidly if incubated in high salt buffers. We hypothesised that once dissociated from 
the DNA, these Mcm2-7 complexes would be significantly destabilised, potentially 
dissociating into individual subunits. Such a scenario would allow us to first 
phosphorylate Mcm2-7 in the context of the pre-RC, and then, having affected 
dissociation of the double hexamer, examine interactions between Sld3/7 and 
individual phosphorylated Mcm subunits (Fig. 5.1A). 
 
The confirm the validity of this approach, I initially tested whether the Mcm2-7 
complex remains intact after dissociation from DNA under high salt conditions. 
Mcm2-7 was loaded onto DNA and phosphorylated with DDK, and then incubated 
in a buffer containing 0.5 M NaCl overnight. Those complexes that dissociated from 
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the DNA beads were then subjected to calmodulin affinity chromatography (Fig. 
5.1B). No Mcm subunits other than CBP-Mcm3 were recovered on the calmodulin 
beads during this reaction (Fig. 5.1B, lanes 3 and 6), consistent with the fact that 
the Mcm2-7 ring is unstable under the experimental conditions used. 
 
 
 
Figure 5.1 The Mcm2-7 double hexamer is disrupted by prolonged incubation in 
0.5 M NaCl 
A. Schematic of experimental setup. Mcm2-7 loaded onto linear DNA bound to 
beads was phosphorylated with DDK and then left in buffer containing 0.5 M NaCl 
overnight. Under these conditions, Mcm2-7 dissociates from DNA into individual 
Mcm subunits. In later experiments, interactions with Sld3/7 beads were examined. 
B. Phosphorylated Mcm2-7 was subjected to calmodulin affinity chromatography 
after dissociation from DNA under different [NaCl] as indicated. Input (inp), flow-
through (FT) and beads (B) samples were collected and analysed by SDS-PAGE 
and silver staining. Visible bands are annotated to the left. 
 
Subsequently, I went on to test for interactions between Sld3/7 and phosphorylated 
Mcm subunits (Fig. 5.2). Sld3/7 was coupled to anti-FLAG resin via a C-terminal 
3xFLAG tag on Sld3, and then incubated with a sample of phosphorylated Mcm2-7 
complexes that had been disrupted as described above. Whilst Mcm3 is bound 
non-specifically to the anti-FLAG resin under these conditions, we observed an 
Sld3/7-dependent enrichment of phosphorylated Mcm6 on the beads (Fig. 5.2A, 
lane 2). The phosphorylation-dependence of the Sld3/7-Mcm6 interaction was 
confirmed by either omission of DDK during the initial phosphorylation of the pre-
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RC, or by treatment of the dissociated Mcm proteins with lambda phosphatase 
before incubation with Sld3/7 beads (Fig. 5.2B). 
 
By performing immunoblot analysis, we observed a second, weaker DDK-
dependent Sld3/7-Mcm interaction with Mcm4 (Fig. 5.2C), which was not 
detectable by silver staining. Notably, mutations in Sld3 that were shown to disrupt 
pre-RC binding in the previous chapter could be seen to disrupt binding to both 
Mcm4 and Mcm6 (Fig. 5.2C), consistent with these interactions being important in 
the context of the Sld3/7 recruitment to the pre-RC.  
 
 
Figure 5.2 Sld3/7 interacts with phosphorylated Mcm6 and Mcm4 
A. A mixture of phosphorylated Mcm2-7 subunits was incubated with Sld3/7-
3xFLAG-coupled or empty anti-FLAG beads as indicated. Proteins were eluted by 
boiling in Laemmli sample buffer and visualised by SDS-PAGE and silver staining. 
Visible bands are annotated. B. Samples were prepared as in A and analysed by 
immunoblot. Lambda phosphatase / DDK were included as indicated. C. Mcm6 and 
Mcm4 were tested for interaction with wild type or 6E mutant Sld3. Samples were 
treated with lambda phosphatase before gel loading to prevent epitope masking of 
Mcm6 (as seen in B, lane 1). 
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5.2.2 Mapping the interaction between Sld3/7 and Mcm6 
As a first step towards identifying the phosphorylation sites on Mcm6 that are 
important for Sld3/7 binding, I next set out to determine the region of Mcm6 to 
which Sld3/7 binds. In order to do this, I engineered a cleavage site for TEV 
protease into Mcm6 between Ala 497 and Asn 498, in a region of the protein that is 
poorly conserved between species (Fig. 5.3). The aim was to proteolytically cleave 
Mcm6 following its dissociation from DNA, and then examine the binding of Sld3/7 
to the resultant two fragments. A 9Myc tag was introduced at the N-terminus of 
Mcm6 in this construct, allowing detection by immunoblot. The C-terminal fragment 
produced after cleavage could be detected using an antibody raised against the 
extreme C-terminus of Mcm6. 
 
 
Figure 5.3 Schematic of TEV-cleavable Mcm6TEV2 
The domain architecture of Mcm6 and alignment of Mcm6 residues 465-503. The 
alignment was generated in Jalview using Clustal (Sievers et al., 2011). Mcm6 from 
various eukaryotic species is included (S.C., Saccharomyces cerevisiae, D.M., 
Drosophila melanogaster, H.S., Homo sapiens, M.M., Mus musculus, S.P., 
Schizosaccharomyces pombe, X.L., Xenopus laevis). Residue numbers above the 
alignment correspond to S. cerevisiae Mcm6. The red vertical line indicates the 
position where the TEV cleavage site (red) and linker sequences (black) were 
inserted. 
 
After overexpression in yeast, an Mcm2-7/Cdt1 heptamer containing the TEV-
cleavable version of Mcm6 (Mcm6TEV2) was purified to homogeneity (Fig. 5.4A). 
As the ATG codon at the start of Mcm6 had not been destroyed during cloning of 
the 9Myc tag, some untagged TEV-cleavable Mcm6 was present in the final 
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sample (Fig. 5.4A, lane 1). As a control for whether the insertion of the TEV 
cleavage site into Mcm6 had affected the activity of the Mcm2-7 complex, the 
Mcm6TEV2 complex was initially tested for pre-RC assembly in vitro (Fig. 5.4B). 
Reassuringly, the Mcm6TEV2 complex could be recruited to DNA and loaded into a 
salt resistant form in a manner that was indistinguishable from a wild type Mcm2-7 
complex (Fig. 5.4B, compare lanes 2 and 4). 
 
The addition of TEV protease to reactions during the overnight incubation in 0.5 M 
NaCl buffer resulted in complete cleavage of Mcm6 into N and C-terminal 
fragments (Fig. 5.4C). Upon incubation with Sld3/7 beads, the Mcm6 N-terminal 
fragment was specifically bound in a manner that was sensitive to phosphatase 
treatment or the omission of DDK (Fig. 5.4D, compare lanes 5 with 6 and 7), 
whereas Mcm6 487-1017 was never detected on the beads at the end of the 
reaction (Fig. 5.4D, lane 5). This indicates that Mcm6 1-486 is both necessary and 
sufficient for DDK-dependent Sld3/7 binding. 
 
 
 
Figure 5.4 Mcm6 1-486 is necessary and sufficient for Sld3/7 binding 
A. Purified Mcm2-7/Cdt1 visualised by SDS-PAGE and coomassie staining. The 
presence of TEV-cleavable Mcm6 is indicated. B. Mcm2-7 loading assay 
performed with wild type or TEV-cleavable Mcm2-7. Samples were analysed by 
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silver staining. C. Purified TEV protease was added to TEV-cleavable Mcm2-7 
dissociated from DNA under 0.5 M NaCl, and the products analysed by SDS-PAGE 
and immunoblotting. Full-length Mcm6 and cleavage products are annotated. 
Molecular weight markers are indicated on the right. D. N and C-terminal fragments 
of TEV-cleavable Mcm6 produced after proteolysis were tested for interaction with 
Sld3/7 beads. Proteins were omitted as indicated. Immunoblotting was performed 
against Myc, Mcm6 and Sld3. 
 
5.2.3 Sld3 interacts with multiple phosphopeptides in the N-terminal portion 
of Mcm6 
In an attempt to identify the Mcm6 phosphorylation sites that are involved in Sld3/7 
binding, I next analysed the interaction between Mcm6 and Sld3/7 using a 
phosphopeptide array screen. A membrane was spotted with 18-residue peptides 
covering the entire sequence of Mcm6. A two-residue start increment was used 
between peptides, with unphosphorylated and singly phosphorylated versions of 
each peptide spotted next to one another. This array was then probed with full-
length FLAG-tagged Sld3, and bound Sld3 was detected using an anti-FLAG 
antibody (Fig. 5.5). Given the observation that Mcm6 1-486 is sufficient for the 
interaction with Sld3/7, I initially focussed on Sld3-bound phosphopeptides located 
in this section of Mcm6. 
 
The results from the peptide array are summarised in table 5-1. A total of 18 
potential sites were identified in peptides that interacted with Sld3 in a 
phosphorylation-dependent manner. These sites were positioned throughout the N-
terminal portion of Mcm6. Notably, in a number of cases, the residue immediately 
downstream of the phosphorylated Ser/Thr was either an additional Ser/Thr (as 
with Ser 65 and Ser 226) or a Glu residue (as with Thr 259 and Thr 480), 
consistent with the predicted consensus sequence for DDK phosphorylation sites 
(Randell et al., 2010).  
 
Chapter 5. Results 
 
 148 
 
Figure 5.5 Sld3 can bind to multiple phosphopeptides in Mcm6 1-486 
Peptide array assay for interaction of full-length Sld3 with Mcm6. 18-residue 
peptides covering Mcm6 residues 1-486 were spotted on 3 separate membranes 
(A, B, C) and incubated with purified FLAG-Sld3. Interactions were detected with 
an anti-FLAG antibody. Position references are given to the left and top of each 
array. Phosphopeptides exhibiting strong interactions with Sld3 (summarised in 
Table 5-1) are highlighted in red. 
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Site Sequence Array Total 
Peptides 
Peptide References 
S37 SSGLDSQIGSR Part 1 4 H4 (G30), H17 (H13), 
I7 (I6), I13 (I12) 
S41 DSQIGSRLHFP Part 1 4 H5 (G30), H18 (H13), 
I8 (I6), I14 (I12) 
S65 PFVNDSTQFSS Part 1 3 N19 (N17), N25 (N23), 
N30 (N29) 
S66 PFVNDSTQFSS Part 1 1 O1 (N29) 
T150 IYDLNTIYIDY Part 2 3 C12 (C11), C14 (C13), 
C18 (C17) 
S226 DDMNGSSLPRD Part 2 1 F1 (E37) 
S227 DDMNGSSLPRD Part 2 1 F2 (E37) 
T247 TSAMATRSITT Part 2 3 G25 (G20), G31 (G27), 
H10 (H7) 
S255 ITTSTSPEQTE Part 2 1 J1 (I35) 
T259 TSPEQTERVFQ Part 2 2 I33 (I27), J2 (I35) 
T272 FFNLPTVHRIR Part 2 1 J16 (J13) 
S324 DNVEQSFKYTE Part 2 2 M33 (M32), N2 (N1) 
S351 LNVTRSRFLDW Part 2 1 P2 (P1) 
T376 GSMPRTLDVIL Part 2 2 P30 (P27), P34 (P31) 
T398 DRCKFTGVEIV Part 2 2 Q23 (Q22), Q27 (Q26) 
T423 SSTLDTRGISK Part 2 1 R26 (R22) 
S475 SPDANSNNRET Part 3 1 A26 (A21) 
T480 SNNRETELQMA Part 3 2 B21 (B20), B23 (B22) 
 
Table 5-1 Summary of Mcm6 phosphopeptides that bind to Sld3 
Table showing phosphorylation sites in Mcm6 that interact with Sld3 when 
incorporated into 18-residue peptides. The site is shown in the first column, and the 
local sequence surrounded the site (highlighted in red) is shown in column 2. The 
array on which the peptide was spotted is shown in column 3. The number of Sld3-
interacting peptides that contained the site is shown in column 4. The position of 
the Sld3-interacting peptides on the array is shown in column 5. The position of the 
corresponding unphosphorylated peptides is shown in italics in brackets after each 
peptide reference. 
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To validate the interactions observed on the peptide array, I next designed a set of 
phosphorylated 30-residue peptides containing a subset of the sites observed to 
interact with Sld3. The peptides were coupled to streptavidin beads via an N-
terminal biotin group, and these beads were then tested for interaction with Sld3 
(Fig. 3.6). Of the 15 phosphorylated peptides tested, four showed significant 
binding to Sld3 (Fig. 5.6A and B). The interaction between Sld3 and S351P was 
subsequently shown to be independent of phosphorylation (data not shown). Sld3 
binding to peptides containing phosphorylated Thr 150, Ser 255 or Thr 259 was 
reduced upon the addition of lambda phosphatase (Fig. 5.6 C and D, compare 
lanes 3 and 4), or when the phosphopeptide was replaced with the corresponding 
unphosphorylated version (Fig. 5.6 C and D, compare lanes 2 and 3). These data 
not only indicate that Sld3 can interact directly with multiple phosphorylation sites in 
the N-terminal half of Mcm6, but also uncover a novel phosphopeptide binding 
activity resident within Sld3.  
 
 
 
Figure 5.6 Interactions of Sld3 with 30-residue Mcm6 phosphopeptides 
30-residue phosphorylated peptides were bound to beads and used to pulldown 
Sld3. Bound proteins were eluted by boiling in Laemmli buffer and analysed by 
immunoblot. In C and D (lane 4), peptide-coupled beads were dephosphorylated 
with lambda phosphatase before incubation with Sld3. 
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5.2.4 Identification of phosphorylation sites in Mcm6 
The finding that the Sld3/7 binding site on Mcm6 is located within the first 487 
residues of the protein is consistent with a previous report showing that this region 
of Mcm6 is phosphorylated by DDK in vitro (Randell et al., 2010). Notably, this 
region of Mcm6 also contains a number of phosphopeptides, which Sld3 can 
interact with (see table 5-1). In collaboration with the Protein Analysis and 
Proteomics Facility at the LRI we performed our own mass spectrometry analysis 
to map phosphorylation sites on Mcm6. Mcm2-7 was loaded onto DNA and 
phosphorylated with DDK to a level that was saturating for Sld3/7 recruitment (Fig. 
5.7). The mass spectrometry analysis was performed twice using either AspN or 
trypsin for proteolytic digestion, and 76% peptide coverage of Mcm6 was achieved 
across the two experiments. 
 
 
 
Figure 5.7 Preparation of phosphorylated Mcm2-7 for mass spectrometry 
analysis 
40 x 40 µl pre-RC assembly assays were prepared and each sample was 
phosphorylated with DDK. After elution from DNA beads via photocleavage, 
samples were TCA precipitated and separated by SDS-PAGE, then stained with 
coomassie. Bands corresponding to Mcm6 (*) were excised from the gel and 
digested by trypsin or AspN. Positions of known proteins are annotated to the right 
(O refers to ORC subunits). Molecular weight markers are shown on the left. 
 
The results of the mass spectrometry analysis are summarised in table 5-2. All but 
one of the phosphorylation sites detected clustered in two S. cerevisiae specific 
regions of Mcm6 (Fig. 5.8), as was observed in Randell, 2010. 11 potential sites 
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were localised to the extreme N-terminus of the protein, which is highly Ser/Thr rich 
and is predicted to be disordered in secondary structure prediction (Fig. 5.8). In 
addition to this, four phosphorylated sites were detected between residues 226 – 
251, again in a region of Mcm6 that is not conserved in other species. 
 
 
 
Figure 5.8 Summary of phosphorylation sites identified in Mcm6 
Secondary structure prediction for Mcm6 residues 1-294. Phosphorylated residues 
identified by mass spectrometry are shown in yellow.  The prediction was 
performed using DPSS (Kabsch and Sander, 1983) and PSIPRED (McGuffin et al., 
2000). Mcm6 from various eukaryotic species is included (Sc, Saccharomyces 
cerevisiae, Dm, Drosophila melanogaster, Dr, Danio rerio, Hs, Homo sapiens, Mm, 
Mus musculus, Sp, Schizosaccharomyces pombe, Xl, Xenopus laevis). Predicted 
α-helices are shown in red and β-strands are shown in blue. 
. . . . . . . . . 10 . . . . . . . . . 20 . . . . . . . . . 30 . . . . . . . . . 40 . . . . . . . . . 50
(PRED) Mcm6Hs -- ---- ---- - -------- - - ---- --- -- -- ---- -- -- - --- --- ---
(PRED) Mcm6Mm ---- --- --- --- ---- --- -- ------- - ---- ---- -- - -- -- -- -- -
(PRED) Mcm6Dr ----- --- -- ---- ------ --- ------- ----- --- -- -- --- --- --
(PRED) Mcm6Xl -- ----- --- -- --- ----- ----- ---- - -- ---- --- - - -- -- -- -- -
(PRED) Mcm6Dm --- ----- -- ------- --- - ----- ---- ------ -- -- --- --- --- -
(PRED) Mcm6Sc MSSPF PADT P S SNRPSNS SP PP SSIGA GFG S SSGLDS QI G S RL HF PS SSQ
(PRED) Mcm6Sp -- ---- ---- -- ------- - - --- ----- - --M SSL AS Q G N NAS TPA Y-R
. . . . . . . . . 60 . . . . . . . . . 70 . . . . . . . . . 80 . . . . . . . . . 90 . . . . . . . . . 100
(PRED) Mcm6Hs -- ---- ---- ----- ----- ----- --- -- -- --MDL AAA A EP GAG SQ H L
(PRED) Mcm6Mm --- -- --- -- ------- --- ------ ---- --- -MDL AA A A E PG AGS Q HP
(PRED) Mcm6Dr ----- ---- - - --- ---- -- --- ---- --- - --- ---- -- M EPG VE AAGV
(PRED) Mcm6Xl -- ---- ---- -- ------- - - -------- - ----MDL V DP SQ SAA A AA GT
(PRED) Mcm6Dm --- ----- -- --- ------- --- ------- ----MD VAD A QV GQ LR -- --
(PRED) Mcm6Sc PHVS NSQTG P FVNDS TQF SS QRLQ TD GSAT N DMEG NE PA R SFK SRA LNH V
(PRED) Mcm6Sp Y GFQTS EVGD RPTVSM ---- - -PSQ PESSA ML EDDGMVK R K PF AA IG EA I
. . . . . . . . . 110 . . . . . . . . . 120 . . . . . . . . . 130 . . . . . . . . . 140 . . . . . . . . . 150
(PRED) Mcm6Hs E -VR DEVAEK CQK LFLDFLE EF Q------- ---- SSDG EI KYL QL AEEL I
(PRED) Mcm6Mm E- VRD EV AEK CQKL FLDFLE EFQ- ---- -- - ---G SDGE I KY LQ F AE ELI
(PRED) Mcm6Dr H-VR DEL SEK CQKL FL EFLE EF Q-- ----- ----DK NG DA L YL SDA Q EL I
(PRED) Mcm6Xl Q LVKD EVAEK CQKL FQD FLE EFR--- ---- - ---GSD G EL KY Q SD AEEL I
(PRED) Mcm6Dm -- VKDE VGIR A QKLFQDFL E EFK----- -- -- --- E DG EI KY TR PAA SLE
(PRED) Mcm6Sc KKV DDVTG EK VR EAFEQF LE DF SVQ- --- - -ST DTGEV EK V YR AQ IE FM K
(PRED) Mcm6Sp PKVID TTGE S VREA FEEF LL SFS DDRVAGG D ALPSAS QEK Y YV QQ IH GLA
. . . . . . . . . 160 . . . . . . . . . 170 . . . . . . . . . 180 . . . . . . . . . 190 . . . . . . . . . 200
(PRED) Mcm6Hs RPE RNTL VV S FVD LEQ FN-Q QLSTT IQEEF YRVYPY LC RA LKT FVK DRK E
(PRED) Mcm6Mm R PER NTLVV S FADLEQFN -Q QLSTTIQ EEF Y RVY PYL CRA L KT FV KD RK E
(PRED) Mcm6Dr R PERNT LTVS F SNIEHYN- Q Q LATT IQE EY YR VYPF LC RA V RHF ARD HGN
(PRED) Mcm6Xl RP ERNTL LVS FVD LEQF N-Q QL ATTIQEE F YRVY PYLC RA V KA FA RD HG N
(PRED) Mcm6Dm SPDR CTLE VS FEDV EKYD-Q NLA TAIIEEY YHIYP FLC QS VS NYV KDR IG
(PRED) Mcm6Sc IY DLNTI YID YQHLS MRENG ALAMA ISEQ Y YR FLPF LQK G L RR VV RK YAP
(PRED) Mcm6Sp MYEI HTV YVD YKHLTSY -ND V LAL AIVEQ Y YRFSPF LL R A L QK LIEK FE P
. . . . . . . . . 210 . . . . . . . . . 220 . . . . . . . . . 230 . . . . . . . . . 240 . . . . . . . . . 250
(PRED) Mcm6Hs IPLA- ---- - ---- ---- -- --- ------- ----- --- -- -- --- --- --
(PRED) Mcm6Mm I P FA-- ---- -- --- ----- - --- ------ ------ --- - - -- -- -- -- -
(PRED) Mcm6Dr IPP S---- -- ------ ---- ------ ---- --- --- -- -- --- --- --- -
(PRED) Mcm6Xl IPQN- ---- - -------- -- ------- --- - ------ --- - -- -- -- -- -
(PRED) Mcm6Dm L KTQ-- ---- -- ---- --- - - ---- --- -- -- ---- -- -- - --- --- ---
(PRED) Mcm6Sc ELL NTSD SLK RSE GDEGQAD ED EQQDDDMN GSSL PRDS GS S AA PG NGTS A
(PRED) Mcm6Sp E YYR SS LSRE N ASL SPNFK A SD-- -- ---- ------ - -- - - -- -- -- ---
. . . . . . . . . 260 . . . . . . . . . 270 . . . . . . . . . 280 . . . . . . . . . 290 . . . . . . . . . 300
(PRED) Mcm6Hs --- ---- --- --- ---KDFY VA FQD LPTRH KIRE LTSS RI G LL TR ISGQ V
(PRED) Mcm6Mm ---- -- ---- - --- --KDFY VAFQ DL PTRH K IREL TSSRI GL LTR IS G QV
(PRED) Mcm6Dr - ----- ---- ------ KEFY VAFSE FP SRQ K IRELS TV R I G TL LRIS GQV
(PRED) Mcm6Xl --- ---- --- ------K EFY V AFQEL PTR H KIRELTT PRI GSL LR I SG QV
(PRED) Mcm6Dm - --- ------ - -- ---KD CY VA FTEVPT RH KVRDL T T SK I G TLI RISG QV
(PRED) Mcm6Sc MA TRS ITTST SP EQT ERVFQ ISFF NLP TVH R IRDI RSEK I G SL L SI SGT V
(PRED) Mcm6Sp --- ---- --- ------KT FA LAFYN LPFR S TIRD LRT DRI GRL TT I TG TV
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Peptide Sequence  Protease Used Modified 
Residues 
Site 
Probabilities 
DTPSSNRPSNSSPPPSSIGA
GFGSSSGL 
AspN S31, S32, 
S33 
S31 (49.8%) 
S32 (49.8%) 
S33 (0.5%) 
DSQIGSRLHFPSSSQPHVSN
SQTGPFVN 
AspN S37, S48, 
S49, S56 
S37 (25%) 
S48 (25%) 
S49 (25%) 
S56 (25%) 
DSTQFSSQRLQT AspN S69, S70 S69 (50%) 
S70 (50%) 
DSTQFSSQRLQTDGSATN AspN S78, T80 S78 (50%) 
T80 (50%) 
DDMNGSSLPR AspN S226, 
S227 
S226 (50%) 
S227 (50%) 
DDGTGSGVITSEPPA AspN T870 T870 
SITTSTSPEQTER Trypsin S249, T251 S249 (50%) 
T251 (50%) 
Table 5-2 Identification of phosphorylation sites in Mcm6 
Table showing Mcm6 peptides identified as being modified with one or more 
phosphate. The peptide sequence is shown in the first column, with modified 
residues coloured red. Two different proteases were used for proteolysis, as 
indicated in column 2. Where the sites of phosphorylation were ambiguous, the 
probabilities for each site are shown in column 4. 
 
5.2.5 The N-terminus of Mcm6 is required for Sld3/7 binding  
Thus far, I have presented evidence that the extreme N-terminus of Mcm6 is not 
only positioned within the region of Mcm6 that is sufficient for Sld3/7 binding, but is 
also highly phosphorylated and contains a number of phosphopeptides that bind 
Sld3 directly. Given these observations, I next set out to test the idea that the 
extreme N-terminus of Mcm6 is an Sld3/7 binding site. To do this, I generated a 
truncated form of Mcm6 in which the first 84 residues had been deleted. An Mcm2-
7/Cdt1 complex containing this truncated version of Mcm6 (6ΔN) was purified after 
overexpression in yeast (Fig. 5.9A), and was indistinguishable from a wild type 
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Mcm2-7/Cdt1 complex in its ability to be assembled into the pre-RC in vitro (Fig. 
5.9B). Strikingly, Mcm6 lacking the N-terminal 84 amino acids showed a distinct 
defect in DDK-dependent Sld3/7 binding compared with the full-length protein (Fig. 
5.9C, compare lanes 12-15 with 17-20). This binding defect could be partially 
suppressed under high concentrations of DDK (Fig. 5.9C, lanes 19 and 20), 
indicating that Sld3/7 can bind to Mcm6 lacking the N-terminus, albeit at much 
reduced levels compared to the wild type. Notably, when using a concentration of 
DDK under which Sld3/7 cannot bind to Mcm6ΔN (50 nM), deletion of the N-
terminus of Mcm6 was sufficient to significantly disrupt recruitment of Sld3/7 to the 
pre-RC (Fig. 5.9D), consistent with the Mcm6-Sld3/7 interaction being important for 
binding of Sld3/7 to the Mcm2-7 double hexamer. 
 
 
Figure 5.9 The N-terminus of Mcm6 is required for Sld3/7 binding 
A. Purified Mcm2-7/Cdt1 complex lacking the first 84 residues of Mcm6 (6ΔN) 
visualised by SDS-PAGE and coomassie staining. The final gel filtration step of the 
purification is shown, with the elution positions of molecular weight markers 
indicated. B. Mcm2-7 loading performed with wild type or mutant (6ΔN) Mcm2-7. 
High salt wash was included as indicated. Proteins were visualised by silver 
staining. C. Sld3/7 binding assay performed with wild type Mcm6 or Mcm6ΔN 
across a range of DDK concentrations. DDK was included at 0, 25, 50, 100 and 
200 nM. Proteins were eluted from beads by boiling in Laemmli sample buffer, and 
visualised by immunoblot. D. Sld3/7 recruitment assay performed using loaded 
Mcm2-7 complexes containing full-length Mcm6 or Mcm6ΔN. DDK was included at 
50 nM as indicated. Samples were analysed by immunoblot. 
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5.2.6  Mapping a second Sld3/7 binding site on Mcm6 
The observation that Sld3/7 can still bind weakly to Mcm6ΔN implied that 
phosphorylation sites other than those located in the first 84 amino acids of Mcm6 
may be involved in Sld3/7 binding. To address this point, I returned to the 
phosphopeptide array screen, aiming to test the effect of mutating additional sites 
(other than those in the extreme N-terminus of Mcm6) on the Sld3/7-Mcm6 
interaction.  
 
To do this, I generated a yeast strain that expressed an Mcm6 allele, which both 
lacked the first 84 residues and also had 11 Ser/Thr (all of which interacted with 
Sld3 on the peptide array – see table 5-1) mutated to Ala between residues 237-
486 (6ΔN + 11S/T-A). Further strains were made in which these 11 S/T-A 
mutations were combined with mutation of Thr 150 to Ala (T150A + 11S/T-A), as 
this site interacted with Sld3 in the peptide binding analysis (Fig. 5.6A and D), and 
in which deletion of the N-terminus was combined with mutation of three selected 
sites (Ser 255, Thr 259 and Thr 272) that interacted with Sld3 when phosphorylated 
in 30-residue peptides (6ΔN + 3S/T-A) (Fig. 5.6). A final mutant was analysed in 
which both the S. cerevisiae specific regions of Mcm6 that were shown to be 
phosphorylated in the mass spectrometry analysis (Fig. 5.8) were deleted from the 
protein (6ΔN + Δ199-260). 
 
Upon testing the Mcm6 mutants for interaction with Sld3/7, we again observed 
significantly less Sld3/7 binding in the absence of the Mcm6 N-terminus (Fig. 
5.10B). The small amount of DDK-dependent Sld3/7 binding recovered with 6ΔN 
under high DDK concentrations was lost in the combined 6ΔN + 11S/T-A mutant 
(Fig. 5.10B, lanes 20, 21), indicating that some or all of the phosphopeptide 
interactions detected in the peptide array are involved in Mcm6 binding to Sld3/7. 
The loss of Mcm6 binding in these mutants had no effect on the amount of Mcm4 
recovered (Fig. 5.10B), indicating that the DDK-dependent Sld3/7-Mcm4 interaction 
observed is not caused by complex formation between Mcm4 and Mcm6. 
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Figure 5.10 The Sld3/7-Mcm6 interaction is disrupted by mutation of multiple 
distinct sites in Mcm6 
A. Purified Mcm2-7/Cdt1 mutants visualised by SDS-PAGE and coomassie 
staining. The presence of mutant Mcm6 is indicated. B and C. Sld3/7 binding assay 
performed with wild type or mutant Mcm6 across a range of DDK concentrations. 
DDK was included at 0, 50 (+) and 250 (++) nM. Proteins were eluted from beads 
by boiling in Laemmli sample buffer, and visualised by immunoblot against Mcm4, 
Mcm6 and Sld3. 
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The additive effect on Sld3/7 binding was not observed upon combining mutation of 
Ser 255, Thr 259 and Thr 272 with an N-terminal deletion of Mcm6 (6ΔN + 3S/T-A) 
(Fig. 5.10C), suggesting that some or all of the eight sites (Ser 247, Ser 324, Ser 
351, Thr 376, Thr 398, Thr 423, Ser 475, Thr 480) in the 11 S/T-A mutant that did 
not bind Sld3 in the context of 30-residue peptides (Fig. 5.6A and B) are likely to be 
involved in the interaction between Sld3/7 and Mcm6. The lack of Sld3 binding 
observed for these sites in the phosphopeptide pulldown experiments may have 
been because the peptides folded in such a way as to occlude the phosphorylated 
Ser/Thr. Combined deletion of Mcm6 residues 2-84 and 199-260 was also not 
sufficient to disrupt Sld3/7 binding to the same extent as the 6ΔN + 11S/T-A mutant 
(Fig. 5.10B, compare lanes 21 and 24), indicating that phosphorylation sites other 
than those detected in the mass spectrometry analysis must be involved in the 
Sld3/7-Mcm6 interaction in this in vitro assay. 
 
5.2.7 Sld3/7 binding mutants in Mcm6 are defective for DNA replication 
Having isolated a number of Mcm6 mutants that prevented Sld3/7 binding, I next 
wanted to examine the functional consequences of disrupting this interaction on 
DNA replication. To do this, I utilised the in vitro replication assay introduced in the 
previous chapter. As a control for the activity of the Mcm2-7 complex in the 
presence of mutant Mcm6, I first tested the T150A + 11S/T-A and 6ΔN + 11S/T-A 
Mcm2-7 complexes for pre-RC assembly in vitro (Fig. 5.11A). The extensive 
mutation of the N-terminal portion of Mcm6 did not affect the activity of the Mcm2-7 
complex in this assay, as all mutants could be loaded onto DNA in a salt resistant 
manner (Fig. 5.11A, lanes 2, 4, 6 and 8). 
 
Loaded Mcm2-7 complexes containing mutant Mcm6 were then tested for their 
ability to support DNA replication in an S-phase extract in vitro (Fig. 5.11B). Notably, 
all the mutants tested showed reduced replication activity compared with wild type 
Mcm2-7 (Fig. 5.11B and C). Deletion of the Mcm6 N-terminus was alone sufficient 
to reduce replication activity by 30-40% (Fig. 5.11C). Although, the T150A + 11S/T-
A mutant alone showed mild defects in DNA replication (Fig. 5.11B, lanes 8 and 9), 
the combined 6ΔN + 11S/T-A mutant did not show significantly reduced activity  
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Figure 5.11 The interaction between Mcm6 and Sld3/7 is required for efficient 
DNA replication initiation in vitro 
A. Mcm2-7 loading assay performed with wild type or mutant Mcm2-7, as indicated. 
Proteins were analysed by silver staining. B. In vitro DNA replication assay. Wild 
type or mutant Mcm2-7 was loaded onto a 3.2 kb plasmid and tested for ability to 
support DNA replication in an S-phase protein extract. DDK was included at 
concentrations of 0, 33 (+) and 133 (++) nM. DNA synthesis was monitored by 
incorporation of 32P-α-dCTP and samples were analysed by gel electrophoresis 
and autoradiography. The identity of DNA species is shown on the right. Ethidium 
bromide staining of the gel is shown as a loading control. C. Quantification of B, 
performed using ImageJ software. D. Sld3/7 binding assay performed with wild 
type or mutant Mcm6. DDK was included at 0, 50 (+) and 250 (++) nM. Bead-bound 
proteins were eluted by boiling in Laemmli sample buffer and visualised by SDS-
PAGE and immunoblotting. 
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relative to the 6ΔN complex (Fig. 5.11B, compare purple and red bars). The pattern 
of DNA replication activity exhibited in this assay broadly correlates with the Sld3/7 
binding activity of these mutants (Fig. 5.11D), with the T150A + 11S/T-A mutant 
showing a mild Sld3/7 binding defect (Fig. 5.11D, compare lanes 3 and 9), and 6ΔN 
and 6ΔN + 11S/T-A showing stronger effects, as discussed previously. Whilst these 
data do suggest that DDK-dependent binding of Sld3/7 to Mcm6 is important for 
efficient DNA replication initiation, it is clear that disrupting this interaction alone is 
not terminal for Mcm2-7 helicase activation. The partial replication defects 
observed in the absence of the extreme N-terminus of Mcm6 are consistent with 
previously reported data (Randell et al., 2010), which showed that an Mcm6 mutant 
containing 22 S/T-A mutations in this region exhibited a slow growth phenotype in 
vivo. 
 
5.3 Discussion 
5.3.1 The extreme N-terminus of Mcm6 is an Sld3/7 binding site 
In the first part of this chapter, I showed that Sld3 can interact directly with the N-
terminal half of phosphorylated Mcm6 (Fig. 5.4C). Subsequently, I used a 
phosphopeptide array screen to show that Sld3 can bind to multiple phosphorylated 
Ser/Thr throughout this region (Fig. 5.5), uncovering a novel phosphopeptide 
binding activity in Sld3. Of the Sld3-bound phosphopeptides detected in the peptide 
array analysis, four were located within the first 84 amino acids of Mcm6 (Table 5-
1), and consistent with previously published data (Randell et al., 2010), multiple 
phosphorylation sites were detected in this region by mass spectrometry (Table 5-
2). Furthermore, deletion of the residues 1-84 of Mcm6 was sufficient to disrupt 
Sld3/7 binding to both Mcm6 alone and the Mcm2-7 double hexamer (Fig. 5.9C 
and D). Taken together, these data indicate that the extreme N-terminus of Mcm6 
represents a bona fide DDK-dependent binding site for Sld3/7 in the pre-RC.  
 
I am yet to determine if the phosphorylation-dependence of this interaction can be 
attributed to a small subset of phosphorylated Ser/Thr within the N-terminus of 
Mcm6. It is possible that mutation of Ser 37, Ser 41, Ser 65 and Ser 66 alone, all of 
which interacted with Sld3 as phosphopeptides (Table 5-1), would be sufficient to 
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disrupt the Mcm6-Sld3 interaction. Alternatively, the highly phosphorylated nature 
of the Mcm6 N-terminus may allow Sld3 to interact with Mcm6 via a large number 
of redundant phosphopeptides. Whilst sufficient to show that Sld3 is a 
phosphopeptide binding protein, one significant limitation of the peptide array 
analysis was the lack of any doubly phosphorylated peptides, especially given that 
DDK has previously been reported to have a preference for sites contain two 
adjacent Ser/Thr in vitro (Randell et al., 2010). Indeed, it is possible that Sld3 can 
interact with many more phosphopeptides other than the four sites mentioned 
above, but only when two neighbouring Ser/Thr are modified.  
 
Consistent with the presence of multiple phosphorylation sites being a functional 
feature of the Mcm6 N-terminus, previous work indicates that only the wholesale 
elimination of 22 phosphorylation sites from this domain can produce a deleterious 
phenotype in vivo (Randell et al., 2010). Any mutant tested that contained less than 
this number of mutations was indistinguishable from the wild type. In addition to this, 
data in the previous chapter showed that mutation of six separate Arg/Lys in Sld3 
residues 511-531 can disrupt binding to the pre-RC (Fig. 4.4A), consistent with the 
presence of multiple phospho-binding sites within this small section of Sld3. If Sld3 
does indeed bind to Mcm6 via multiple redundant phosphorylation sites, this would 
potentially produce an interaction of high avidity (discussed further in section 6.5). 
High specificity might be achieved through some other means, such as strict 
requirements for the relative conformations of the Sld3/7 and Mcm2-7 complexes 
during Sld3/7 recruitment.  
 
5.3.2 Implications for the function of DDK during origin firing 
Although sufficient to significantly reduce the recruitment of Sld3/7 to the pre-RC, 
deletion of the N-terminal 84 residues of Mcm6 resulted in only a partial loss of 
activity in an in vitro replication assay (Fig. 5.11B). By isolating the 6ΔN + 11S/T-A 
mutant, which was entirely defective for Sld3/7 binding even under high DDK 
concentrations (Fig. 5.10B), I was able to test the hypothesis that the residual 
replication activity observed for the 6ΔN Mcm2-7 complex was attributable to the 
small amount of Sld3/7 binding still possible in the absence of the Mcm6 N-
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terminus (Fig. 5.9C). Notably, the 6ΔN + 11S/T-A mutant was still able to support 
some replication in an S-phase extract (Fig. 5.11B), indicating that Sld3/7 binding 
to Mcm6 per se is not essential for Mcm2-7 helicase activation. Given the fact that 
DDK is essential for DNA replication in vivo and in vitro, there must therefore be 
phosphorylation sites elsewhere in the Mcm2-7 complex that are also important for 
origin firing. 
 
Consistent with this idea, I showed that Sld3/7 can interact directly with 
phosphorylated Mcm4 (Fig. 5.2C). This interaction was markedly reduced by 
mutations in residues 511-531 of Sld3 (Fig. 5.2C), consistent with the same site on 
Sld3 being involved in phosphorylation-dependent binding to both Mcm4 and Mcm6. 
Although yet to be examined, it is tempting to speculate that an interaction between 
Sld3 and Mcm4 could allow for some replication initiation in the absence of a 
cognate Sld3 binding site on Mcm6. Although this putative Sld3-Mcm4 interaction 
was not sufficient for Sld3/7 recruitment to the pre-RC using purified proteins (Fig. 
5.9D), it may be that the less stringent buffer conditions used in the extract-based 
in vitro replication assay allowed for some Sld3/7 recruitment, and therefore some 
replication initiation, in the absence of the Mcm6 extreme N-terminus.  
 
The notion that Mcm6 is not the only DDK substrate required for DNA replication 
initiation is consistent with the previously reported slow growth phenotypes for 
phosphorylation site mutants in the N-termini of Mcm2 and Mcm4 (Randell et al., 
2010). One can envisage how phosphorylation of Mcm4 might provide a second 
binding site on the loaded Mcm2-7 complex for Sld3 511-531, and it is possible that 
combining the deletion of the N-terminus of Mcm6 with an Mcm4 phosphorylation 
site mutant would lead to an additive reduction in Sld3/7 recruitment to the pre-RC, 
thereby preventing replication initiation. Importantly, the combination of Mcm4 and 
Mcm6 mutants, both of which contain multiple alanine substitutions at DDK 
phosphorylation sites, has previously been shown to be incapable of supporting cell 
growth (Randell et al., 2010). It is pertinent to note that the Sld3-Mcm2-7 interaction 
itself is essential for replication initiation (Fig. 4.6C), and it should thus be possible 
to isolate an Sld3-binding mutant in Mcm2-7 that causes an equally deleterious 
phenotype as that observed for the Sld3 mutants discussed in the previous chapter.  
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It is possible to bypass the essential function of DDK in replication initiation by 
deletion of an internal domain of Mcm4 (Sheu and Stillman, 2010) or with a single 
point mutation in Mcm5 (Hardy et al., 1997), as previously mentioned. Given the 
involvement of the N-terminus of Mcm6 in DDK-dependent Sld3/7 recruitment to 
the pre-RC (Fig. 5.9D), it is difficult to predict how these DDK bypass mutants 
function for proper Mcm2-7 helicase activation. One possibility is that the Mcm2-7 
double hexamers produced in these mutants have a higher than normal affinity for 
some firing factor, such as Cdc45, which is normally recruited downstream of 
Sld3/7 binding to Mcm2-7. Thus, rather than bypassing the requirement for DDK for 
the Sld3/7-Mcm2-7 interaction, these mutants might actually bypass the 
requirement for Sld3 itself during replication initiation, thereby allowing for formation 
of the active CMG complex even in the absence of DDK-dependent Sld3/7 
recruitment to the pre-RC.
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Chapter 6. Discussion 
6.1 Introduction 
During the origin licensing step of DNA replication initiation, the Mcm2-7 replicative 
helicase is loaded onto DNA at origins of replication, forming a pre-RC (Blow, 1993, 
Blow and Laskey, 1988, Diffley et al., 1994). The product of this pre-RC assembly 
step is a double hexamer of Mcm2-7 bound around dsDNA (Remus et al., 2009, 
Evrin et al., 2009, Gambus et al., 2011), in which the Mcm2-7 complex is inactive 
as a helicase. Upon progression into S-phase, the replicative helicase is activated 
by the combined activities of two protein kinases, DDK and CDK, and a whole host 
of specific firing factors (Boos et al., 2012). In S. cerevisiae, the known firing factors 
are Sld3, Sld7, Cdc45, Dpb11, Sld2, Polε, GINS and Mcm10, and these are 
believed to assemble into a transient pre-initiation complex (pre-IC) on the pre-RC 
(Tanaka and Araki, 2013, Zou and Stillman, 1998), leading to extensive 
remodelling of the Mcm2-7 replicative helicase into its active form, the CMG 
complex. The CMG complex itself contains a single copy each of Mcm2-7, Cdc45 
and the tetrameric GINS complex (Gambus et al., 2006, Costa et al., 2011, Fu et 
al., 2011), and forms the basis for the assembly of the Replisome Progression 
Complex (RPC) and the establishment of two divergent replication forks from a 
single Mcm2-7 double hexamer. There is currently little understanding of the 
precise mechanism of replicative helicase activation, or how individual firing factors 
contribute towards this process. 
 
6.2 Key Conclusions 
In this study, I adopted a primarily biochemical approach to attempt to dissect the 
mechanism of Mcm2-7 helicase activation, principally focussing on the function of 
DDK and the Sld3/7 complex during this process. I purified the Sld3/7 complex 
after overexpression in yeast (Fig. 3.5), and was subsequently able to reconstitute 
the complex from individually purified Sld3 and Sld7 (Fig. 3.8), obtaining evidence 
that Sld3/7 is likely to contain at least two copies of Sld3 in the process (Fig. 3.6 
and 3.8). Given its position upstream of the recruitment of all other known firing 
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factors (Yabuuchi et al., 2006, Heller et al., 2011), the stoichiometry of the Sld3/7 
complex could have considerable implications for the mechanism of pre-IC 
assembly (see section 6.6). 
 
Previous studies have indicated a function for DDK in promoting the recruitment of 
Sld3/7 to replication origins (Yabuuchi et al., 2006, Heller et al., 2011, Tanaka et al., 
2011a), which is thought to be one of the earliest events during conversion of the 
pre-RC into two RPCs. I was able to reconstitute the recruitment of Sld3/7 to the 
pre-RC in vitro (Fig. 3.11), and discovered a requirement for prior phosphorylation 
of the loaded Mcm2-7 complex by DDK during this reaction. This is the first 
example of a DDK-regulated protein-protein interaction, and implies a novel 
function for both Sld3/7 and DDK during replication initiation. 
 
I subsequently mapped the Mcm2-7 binding activity of Sld3/7 to the central portion 
of Sld3 (Fig. 4.2), and isolated a number of amino acid substitution mutants in Sld3 
that specifically disrupted recruitment to the pre-RC (Fig. 4.4). Addition of these 
mutant proteins to an S-phase extract resulted in severe defects in DNA replication 
initiation (Fig. 4.6), likely arising from deficient assembly of the CMG complex in the 
absence of the Mcm2-7 binding activity of Sld3 (Fig. 4.7). Notably, Mcm2-7 binding 
mutants of Sld3 were also unable to support cell viability (Fig. 4.9). During the 
course of mutagenising the central portion of Sld3, I also isolated a number of 
mutants that were specifically defective in Cdc45 binding (Fig. 4.12), consistent 
with previous mapping of the Cdc45 interaction site on Sld3 (Tanaka et al., 2011b). 
These mutants also exhibited replication defects in vitro (Fig. 4.13), indicating that 
the central portion of Sld3 is functional for both Mcm2-7 and Cdc45 binding. 
 
The final section of this study was dedicated to understanding the role of DDK in 
promoting Sld3/7 recruitment. I initially showed that Sld3 can interact with both 
Mcm6 and Mcm4 in a phosphorylation-dependent manner (Fig. 5.2C), and 
subsequently discovered multiple phosphopeptides throughout the N-terminal half 
of Mcm6 to which Sld3 can bind (Fig. 5.5). The phosphopeptide binding activity of 
Sld3 was suggestive of a direct interaction with phosphorylated Ser/Thr on Mcm2-7 
during Sld3/7 recruitment. This notion was strengthened by the observation that the 
binding of Sld3/7 to the pre-RC was largely dependent on the heavily 
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phosphorylated extreme N-terminus of Mcm6 (Fig. 5.9D), a domain which itself 
contains a number of phosphopeptides to which Sld3 can bind (Fig. 5.5A). Notably, 
deletion of this section of Mcm6 only resulted in a partial defect in DNA replication 
initiation in vitro (Fig. 5.11), consistent with the previously reported in vivo 
phenotype of an Mcm6 mutant lacking DDK phosphorylation sites in this domain 
(Randell et al., 2010). This observation implies that Sld3/7 may be able to interact 
with Mcm subunits other than Mcm6 in the pre-RC, and that any such interactions 
are sufficient to support a sub-optimal level of CMG formation and origin firing.  
 
6.3 The function of Sld3 during origin firing 
The requirement for Sld3 during DNA replication initiation was first revealed over 
10 years ago and, since then, Sld3 has been shown to fulfil important functions in 
both the CDK and Rad53-dependent regulation of origin firing (Tanaka et al., 2007, 
Zegerman and Diffley, 2007, Zegerman and Diffley, 2010, Lopez-Mosqueda et al., 
2010, Kamimura et al., 2001). CDK phosphorylates Sld3 at two conserved sites 
located near its C-terminus, creating a binding site for a second protein, Dpb11, 
and this interaction is essential for replication initiation (Tanaka et al., 2007, 
Zegerman and Diffley, 2007). Additionally, in response to DNA damage, Sld3 is 
phosphorylated by the Rad53 DNA damage checkpoint kinase at multiple Ser/Thr 
positioned throughout its C-terminal half. This not only blocks the Sld3-Dpb11 
interaction, but also inhibits binding of Sld3 to Cdc45, thereby preventing further 
origin firing in the presence of DNA damage (Lopez-Mosqueda et al., 2010, 
Zegerman and Diffley, 2010). 
 
Work presented in this study contributes significantly to our understanding of Sld3 
function during Mcm2-7 helicase activation. In chapter 3, I showed that Sld3 
binding to Sld7 is dependent on the N-terminus of Sld3 (Fig. 3.8), consistent with 
previously published data (Tanaka et al., 2011b). Notably, Sld3 multimerisation was 
also reduced in the absence of the N-terminal 250 residues (Fig. 3.8). Thus, the N-
terminal portion of Sld3 appears to be important for interactions within Sld3/7, 
thereby aiding the establishment of the overall architecture of the complex. 
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Sld3 residues 251-585, which represent the minimal portion of Sld3 required for 
recruitment to the pre-RC, contain both Mcm2-7 and Cdc45 binding activities (Fig. 
4.4 and 4.12). This central portion of Sld3 includes the Sld3 Treslin Domain 
(S.T.D.), which is conserved between Sld3 and its higher eukaryotic homologue, 
Treslin (Sanchez-Pulido et al., 2010). The interaction between Sld3 and Cdc45 was 
dependent on a highly basic patch of amino acids within the S.T.D. itself (Fig. 4.12), 
whereas Mcm2-7 binding could be abolished by mutation of six separate basic 
residues C-terminal of the S.T.D. (Fig. 4.4), all of which are conserved between 
different fungal species (Fig. 6.1). 
 
Thus, in spite of the absence of any known enzymatic or protein-protein interaction 
domains, Sld3 is a vital component of the replicative helicase activating machinery. 
It seems likely that Sld3 functions as a central scaffold protein, interacting with Sld7, 
Cdc45, Mcm2-7 and Dpb11 during origin firing (Fig. 6.1). Notably, the binding sites 
for these various proteins are located in distinct sections of Sld3 (Fig. 6.1); whether 
or not Sld3 can interact with all its binding partners simultaneously, or whether the 
release of certain factors is co-ordinated with binding to others, represents an 
interesting avenue for future investigation. 
 
The function of Sld3 as a CDK substrate is conserved in Treslin, and an interaction 
between Treslin and Cdc45 has also been reported (Boos et al., 2011, Kumagai et 
al., 2010, Kumagai et al., 2011). Despite its location within the S.T.D., the basic 
stretch of residues shown to be required for Cdc45 binding in this study is not 
conserved with Treslin (Sanchez-Pulido et al., 2010); it will be interesting to 
determine if this binding activity is localised to a different region of the protein in 
higher eukaryotes. 
 
The Mcm2-7 binding activity of Sld3 is located between the S.T.D and the two 
essential CDK target sites (Fig. 6.1). Upon performing a multiple sequence 
alignment of Treslin from various higher metazoan species, it is clear that there are 
a number of highly conserved residues within this region (Fig. 6.2). Two of the most 
conserved areas within this region are conspicuous by the presence of a number of 
basic amino acids, analogous to the Mcm2-7 binding residues described for S. 
cerevisiae Sld3. Any DDK dependency of Treslin recruitment to replication origins 
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is yet to be examined in higher eukaryotes, but if, as with other Sld3 functions, this 
activity is conserved between yeast and humans, the regions highlighted in figure 
6.2 would undoubtedly represent good candidate Mcm2-7 binding sites. 
 
 
 
Figure 6.1 Sld3 interacts with multiple partner proteins during replication 
initiation 
Schematic of S. cerevisiae Sld3 showing positions of interacting regions for other 
replication proteins. Two essential CDK target sites are shown as vertical red bars. 
The conserved Sld3 Treslin Domain (S.T.D.) is shown in green. Sequence 
alignments, generated in Jalview using Clustal (Sievers et al., 2011), are shown for 
Cdc45 and Mcm2-7 interacting regions, with residues essential for these 
interactions marked by red lines. Sld3 from various fungal species is included 
(S.C., Saccharomyces cerevisiae, S.M., Saccharomyces mikatae, S.B., 
Saccharomyces bayanus, S.Ca., Saccharomyces castellii, S.Ku., Saccharomyces 
kudriavzevii). Residue numbers correspond to S. cerevisiae Sld3. 
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Figure 6.2 Treslin contains conserved basic residues between the S.T.D. and 
CDK phosphorylation sites 
Sequence alignment of Treslin generated in Jalview. For Homo sapiens Treslin, the 
S.T.D. ends at residue 792, and CDK consensus sites are Thr 969 and Ser 1001. 
Treslin from various eukaryotic species is included (H.S., Homo sapiens, G.G., 
Gallus gallus, X.L., Xenopus laevis, D.R., Danio rerio, B.F., Branchiostoma 
floridae). Residue numbers above the alignment correspond to Homo sapiens 
Treslin. Conserved basic residues are indicated in red boxes. 
 
6.4 Convergence of the DDK and CDK-regulated pathways of 
replicative helicase activation 
The observation that Sld3 is recruited to the pre-RC in a DDK-dependent manner 
denotes a function for Sld3 as a reader of the phosphorylation ‘status’ of Mcm2-7. 
The phosphopeptide binding activity ascribed to Sld3 in this study likely indicates 
that this reader function is direct, and that Sld3 binds directly to phosphorylated 
peptides within Mcm2-7 (Fig. 5.5 and 5.6). 
 
Phosphorylation of Mcm2-7 by DDK is likely to be the most upstream step during 
replicative helicase activation, and previous work also indicates that DDK must 
function before CDK for productive origin firing to occur (Yabuuchi et al., 2006, 
Jares and Blow, 2000, Heller et al., 2011). Given this, the first step during pre-IC 
assembly is likely to be DDK-dependent recruitment of unphosphorylated Sld3/7 to 
the pre-RC, as has been detected at early-firing replication origins as early as G1 
phase of the cell cycle (Tanaka et al., 2011a).  
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Previous work has shown that DDK itself specifically binds to and phosphorylates 
only those Mcm2-7 complexes that have been assembled into the pre-RC (Randell 
et al., 2010). This specificity for the DNA-bound form of the replicative helicase was 
proposed to spatially constrain the helicase activation process, preventing 
inappropriate pre-IC assembly on Mcm2-7 that is free in solution. The involvement 
of Sld3, an essential CDK substrate, as a reader of DDK activity could extend this 
spatial restriction to CDK-regulated processes; Sld3 pre-bound to Mcm2-7 could be 
phosphorylated by CDK, and formation of the CDK-dependent Sld3-Dpb11-Sld2 
complex would thus only occur at the origin of replication. The downstream 
recruitment of GINS, potentially as part of the pre-loading complex (Muramatsu et 
al., 2010), would then allow for productive assembly of the CMG replicative 
helicase and subsequent formation of the Replisome Progression Complex 
(Gambus et al., 2006). Notably, even if CDK dependent binding of Sld3 to Dpb11 
were to occur before the recruitment of Sld3 to the pre-RC, Sld3 would still provide 
a point of convergence for the CDK and DDK-dependent pathways through 
subsequent DDK-dependent binding to Mcm2-7 (Fig. 6.3). 
 
 
 
Figure 6.3 DDK and CDK-dependent regulation of origin firing converges at Sld3 
Sld2 and Sld3 are the two essential CDK substrates required for origin firing. DDK 
phosphorylates Mcm2-7, promoting an interaction between Mcm2-7 and Sld3. 
Sld3, as an essential CDK substrate and a reader of the DDK pathway, thereby 
allows the integration of CDK and DDK activities during replication initiation. 
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Previous work in S. cerevisiae has indicated that Cdc45 can also be recruited to 
the pre-RC in a manner that is independent of CDK activity but dependent on DDK 
(Sheu and Stillman, 2006, Heller et al., 2011, Tanaka et al., 2011a), suggestive of a 
role for Cdc45 as a second DDK reader. Work presented in this study, however, 
suggests that, whilst Sld3 alone can bind to Mcm2-7 (Fig. 3.11 and 4.8), DDK-
dependent recruitment of Cdc45 is downstream of Sld3/7 (Fig. 4.7). This sequential 
DDK-dependent recruitment of Sld3/7 followed by Cdc45 to the pre-RC has since 
been reconstituted with purified proteins (Dr. Joe Yeeles), lending weight to the 
argument that, of the known firing factors, Sld3 is the only protein that can directly 
read DDK phosphorylation of Mcm2-7 during replicative helicase activation. 
 
6.5 The function of DDK during origin firing 
The work presented in this study indicates that one essential function of DDK 
during replication initiation is to catalyse the binding of Sld3 to the loaded Mcm2-7 
complex. Sld3/7 recruitment is at least partly dependent on the N-terminal tail of 
Mcm6, which is phosphorylated by DDK in vitro (Fig. 5.8 and 5.9). Deletion of this 
section of Mcm6, however, only partially reduces the ability of Mcm2-7 to support 
DNA replication (Fig. 5.11B and C), indicating that phosphorylation-dependent 
interactions with other Mcm subunits must be involved in Sld3/7 recruitment. 
Consistent with this, Sld3 can also bind to Mcm4 in a phosphorylation-dependent 
manner (Fig. 5.2C). The precise nature of this interaction, as well as its functional 
significance, is still to be determined. However, deleterious phenotypes have been 
reported for mutants of Mcm4 in which DDK phosphorylation sites have been 
removed (Randell et al., 2010). 
 
The protein kinase activity of DDK is atypical in a number of ways. Firstly, the 
specificity of DDK towards the Mcm2-7 double hexamer appears to be primarily 
determined by the conformation of this substrate (Randell et al., 2010). Cdc7 has 
been reported to bind Mcm4, whilst Dbf4 can interact with Mcm2 (Ramer et al., 
2013, Bruck and Kaplan, 2009). The relative position of these Mcm subunits in the 
loaded Mcm2-7 double hexamer compared with Mcm2-7 that is in solution is one 
potential explanation for this. Despite its absolute specificity for Mcm2-7 complexes 
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loaded onto DNA, DDK is somewhat promiscuous in vitro, phosphorylating S. 
cerevisiae Mcm2, Mcm4 and Mcm6 at many different sites throughout their N-
termini, with only moderate specificity for any single consensus sequence (Randell 
et al., 2010). Additionally, many of the DDK phosphorylation sites that have been 
mapped are not conserved between yeast and humans, despite the fact that DDK 
is absolutely essential for S-phase entry across all eukaryotes.  
 
Notwithstanding the lack of conservation of individual DDK target sites between 
different species, the N-termini of Mcm2, Mcm4 and Mcm6 in higher eukaryotes are 
relatively rich in Ser/Thr residues, similar to yeast (Masai et al., 2006). Notably, 
only the comprehensive elimination of multiple phosphorylation sites from the N-
termini of Mcm2, Mcm4 or Mcm6 is sufficient to cause defects in DNA replication in 
S. cerevisiae (Randell et al., 2010). This observation, coupled with the fact that the 
highly phosphorylated N-terminus of Mcm6 is a bona fide Sld3 binding site (Fig. 
5.9), suggests that poly-phosphorylation may well be a functionally significant 
feature of DDK activity.  
 
If this is true, then DDK-catalysed phosphorylation would be operating in a very 
similar way to another post-translational modification, SUMOylation, during the 
DNA damage response (Psakhye and Jentsch, 2012). In that situation, DNA 
damage leads to a wave of SUMOylation of multiple DNA repair proteins at many 
different sites. Just as DDK specifically targets a conformationally unique form of 
Mcm2-7 in the pre-RC, specificity in the SUMO-dependent DNA damage response 
is achieved by the arrangement of DNA repair proteins and the SUMO modifying 
enzymes around the site of damage. The numerous SUMOylated sites created 
during this response are said to act as a ‘glue’, stabilising multiple protein-protein 
contacts, and producing interactions of high avidity. 
 
Although it was previously hypothesised that extensive modification of the N-termini 
of Mcm2, Mcm4 and Mcm6 might promote separation of the Mcm2-7 double 
hexamer during origin firing (Remus and Diffley, 2009), this has since been shown 
to not be the case (On et al., 2014). Alternatively, this phosphorylation may 
generate multiple redundant phosphopeptide binding sites for Sld3 on Mcm2-7. 
Indeed, Sld3 itself contains multiple Mcm2-7 binding residues (Fig. 4.4), and there 
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are multiple Sld3 molecules within the Sld3/7 complex (Fig. 3.8), consistent with a 
mode of binding involving numerous phosphorylated Ser/Thr. Although further 
investigation of the interactions between Sld3 and Mcm4/Mcm6 is required to prove 
the existence of this system, one can envisage how such a mechanism would 
produce an additive effect on the affinity of the final complex. Thus, a stable Sld3/7-
Mcm2-7 complex could form as the first step during pre-IC assembly, which in turn 
would facilitate the downstream recruitment of other firing factors, whilst reducing 
the possibility of any non-productive release of Sld3 from the origin before Mcm2-7 
helicase activation has occurred. 
 
6.6 A model for replicative helicase activation 
During activation of the replicative helicase, a single Mcm2-7 double hexamer must 
be converted into a pair of bi-directional replication forks, each containing a single 
CMG complex made up of one copy each of Mcm2-7, Cdc45 and GINS (Gambus 
et al., 2006, Costa et al., 2011, Fu et al., 2011). Two molecules each of Cdc45 and 
the GINS tetramer must therefore be recruited to each double hexamer, which 
imposes strict stoichiometric constraints on the recruitment of other firing factors.  
 
Notably, the recruitment of both Cdc45 and GINS to the pre-RC is dependent on 
Sld3 (Fig. 4.7A and Heller et al., 2011). Whilst the initial recruitment of Cdc45 is 
CDK-independent and likely occurs via a direct interaction with Sld3 (Kanemaki 
and Labib, 2006, Heller et al., 2011, Gros et al., 2014), GINS recruitment requires 
both the activity of CDK and the presence of Dpb11 and Sld2 (Kanemaki and Labib, 
2006, Heller et al., 2011, Takayama et al., 2003). Given that GINS is a component 
of the pre-loading complex (pre-LC), which also contains Dpb11 and Sld2 
(Muramatsu et al., 2010), the likeliest explanation for CDK-dependent GINS 
recruitment is that phosphorylation-dependent binding of Dpb11 to Sld3 facilitates 
pre-LC recruitment to the pre-RC. 
 
Assuming that each Sld3 molecule can only interact with a single copy of Cdc45, 
and that each Sld3-Dpb11 interaction is only sufficient to recruit a single GINS 
tetramer, the simplest way to recruit the two Cdc45 and GINS molecules required 
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for replicative helicase activation would be to initially recruit two Sld3 molecules to 
the Mcm2-7 double hexamer. Work presented in this thesis supports the idea that 
the Sld3/7 contains two molecules of Sld3 (Fig. 3.6 and 3.8). Although possible, the 
presence of multiple Sld3/7 complexes would potentially allow for the futile 
recruitment of more than two Cdc45 and/or GINS molecules to the pre-RC. Thus, 
to fulfil the stoichiometric requirements of the helicase activation process, the first 
step in pre-IC assembly should be the recruitment of a single Sld3/7 complex to 
each Mcm2-7 double hexamer.  
 
Sld3 itself can interact with multiple Mcm subunits in a phosphorylation-dependent 
manner (Fig. 5.2C). Importantly, mutations in residues 511-531 of Sld3 disrupt 
binding to both Mcm4 and Mcm6 (Fig. 5.2C), and are sufficient to abolish DNA 
replication activity in vitro (Fig. 4.6C). In contrast, Mcm6 mutants, which disrupt 
Sld3 binding, only cause a partial DNA replication defect (Fig. 5.11B), consistent 
with Sld3 binding to both Mcm4 and Mcm6 being important during Mcm2-7 
activation.  
 
Given these predictions, it is possible to devise a provisional model for assembly of 
the pre-IC, as depicted in figure 6.4. In this model, a single Sld3/7 molecule is 
bound to the Mcm2-7 double hexamer, with each Sld3 molecule concurrently 
interacting with phosphorylated residues at the N-termini of both Mcm4 and Mcm6. 
Sld7 may connect the two Mcm-bound Sld3 molecules, enabling Sld3/7 to bridge 
the hexamer-hexamer interface within the double hexamer.  
 
The high-resolution structure of a dimeric form of the CMG complex has recently 
been determined by electron microscopy (Costa et al., 2014). In this structure, the 
two Mcm2-7 hexamers are arranged in a similar manner to the Mcm2-7 double 
hexamer, with their N-terminal regions facing towards each other in a head-to-head 
arrangement. Although the physiological relevance of this dimeric assembly is 
unclear, the structure does allow one to visualise the potential relative arrangement 
of individual Mcm subunits within the Mcm2-7 double hexamer. The two Mcm 
hexamers within the CMG dimer are staggered relative to one another, positioning 
Mcm4/6 of one hexamer opposite the Mcm2 and Mcm5 subunits of the other, as is 
shown in figure 6.4. Importantly, a previously solved structure of the CMG complex 
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indicates that Cdc45 and GINS contact Mcm2 and Mcm5, respectively (Costa et al., 
2011). Given the aforementioned dependence of Cdc45 and GINS recruitment on 
Sld3/7, one can envisage how an Sld3 molecule bound to Mcm4/6 on one hexamer 
might direct the recruitment of Cdc45 and GINS to Mcm2/5 on the opposite side. 
Although Sld3 might also be able recruit Cdc45 to the same Mcm hexamer to which 
Sld3 itself is bound, we favour the mechanism depicted in figure 6.4, as it 
potentially allows for the co-ordinate formation of two CMG complexes from a 
single Mcm2-7 double hexamer, thereby facilitating bi-directional replication 
initiation from the pre-RC.  
 
 
 
 
Figure 6.4 A model for Sld3/7-dependent CMG formation 
For full details see text in section 6.6. Mcm subunits are shown in green and 
numbered, and subunits from different Mcm2-7 hexamers are outlined with either 
complete or dashed lines. GINS, Cdc45 (45), Sld3 (3) and Sld7 (7) are also shown. 
P represents phosphorylated Ser/Thr on Mcm4/6. 
 
Although speculative at present, this model provides a basic framework within 
which to develop our understanding of the Mcm2-7 activation process. Work 
presented herein contributes towards our knowledge of the early DDK-dependent 
steps of pre-IC assembly, yet we still have little understanding of how Dpb11 and 
Sld2 direct recruitment of GINS and Polε to the pre-RC. Furthermore, nothing is 
known about how the recruitment of these various firing factors is co-ordinated with 
double hexamer separation or the melting of origin DNA, or how complete 
replisome assembly and DNA synthesis is subsequently initiated. The development 
of a fully reconstituted system for DNA replication initiation will greatly aid future 
attempts to further dissect this intriguing process.
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Chapter 7. Appendix 
7.1 Peptides used in Mcm6 phosphopeptide arrays 
7.1.1 Part 1 
Nr. Pos. Mol. Weight Sequence 
1 A 1 1879.1  M-S-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S  
2 A 2 2049.1 M-pS-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S  
3 A 3 2049.1 M-S-pS-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S  
4 A 4 2049.2 M-S-S-P-F-P-A-D-pT-P-S-S-N-R-P-S-N-S  
5 A 5 2049.1 M-S-S-P-F-P-A-D-T-P-pS-S-N-R-P-S-N-S  
6 A 6 2049.1 M-S-S-P-F-P-A-D-T-P-S-pS-N-R-P-S-N-S  
7 A 7 2049.1 M-S-S-P-F-P-A-D-T-P-S-S-N-R-P-pS-N-S  
8 A 8 2049.1 M-S-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-pS  
9 A 9 1835   S-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-S  
10 A10 2005  pS-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-S  
11 A11 2005  S-pS-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-S  
12 A12 2005.1 S-S-P-F-P-A-D-pT-P-S-S-N-R-P-S-N-S-S  
13 A13 2005  S-S-P-F-P-A-D-T-P-pS-S-N-R-P-S-N-S-S  
14 A14 2005  S-S-P-F-P-A-D-T-P-S-pS-N-R-P-S-N-S-S  
15 A15 2005  S-S-P-F-P-A-D-T-P-S-S-N-R-P-pS-N-S-S  
16 A16 2005  S-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-pS-S  
17 A17 2005  S-S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-pS  
18 A18 1845   S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-S-P  
19 A19 2015  pS-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-S-P  
20 A20 2015.1 S-P-F-P-A-D-pT-P-S-S-N-R-P-S-N-S-S-P  
21 A21 2015  S-P-F-P-A-D-T-P-pS-S-N-R-P-S-N-S-S-P  
22 A22 2015  S-P-F-P-A-D-T-P-S-pS-N-R-P-S-N-S-S-P  
23 A23 2015  S-P-F-P-A-D-T-P-S-S-N-R-P-pS-N-S-S-P  
24 A24 2015  S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-pS-S-P  
25 A25 2015  S-P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-pS-P  
26 A26 1855   P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-S-P-P  
27 A27 2025.1 P-F-P-A-D-pT-P-S-S-N-R-P-S-N-S-S-P-P  
28 A28 2025  P-F-P-A-D-T-P-pS-S-N-R-P-S-N-S-S-P-P  
29 A29 2025  P-F-P-A-D-T-P-S-pS-N-R-P-S-N-S-S-P-P  
30 A30 2025  P-F-P-A-D-T-P-S-S-N-R-P-pS-N-S-S-P-P  
31 B 1 2025  P-F-P-A-D-T-P-S-S-N-R-P-S-N-pS-S-P-P  
32 B 2 2025  P-F-P-A-D-T-P-S-S-N-R-P-S-N-S-pS-P-P  
33 B 3 1855   F-P-A-D-T-P-S-S-N-R-P-S-N-S-S-P-P-P  
34 B 4 2025.1 F-P-A-D-pT-P-S-S-N-R-P-S-N-S-S-P-P-P  
35 B 5 2025  F-P-A-D-T-P-pS-S-N-R-P-S-N-S-S-P-P-P  
36 B 6 2025  F-P-A-D-T-P-S-pS-N-R-P-S-N-S-S-P-P-P  
37 B 7 2025  F-P-A-D-T-P-S-S-N-R-P-pS-N-S-S-P-P-P  
38 B 8 2025  F-P-A-D-T-P-S-S-N-R-P-S-N-pS-S-P-P-P  
39 B 9 2025  F-P-A-D-T-P-S-S-N-R-P-S-N-S-pS-P-P-P  
40 B10 1794.9  P-A-D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-S  
41 B11 1965  P-A-D-pT-P-S-S-N-R-P-S-N-S-S-P-P-P-S  
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42 B12 1964.9 P-A-D-T-P-pS-S-N-R-P-S-N-S-S-P-P-P-S  
43 B13 1964.9 P-A-D-T-P-S-pS-N-R-P-S-N-S-S-P-P-P-S  
44 B14 1964.9 P-A-D-T-P-S-S-N-R-P-pS-N-S-S-P-P-P-S  
45 B15 1964.9 P-A-D-T-P-S-S-N-R-P-S-N-pS-S-P-P-P-S  
46 B16 1964.9 P-A-D-T-P-S-S-N-R-P-S-N-S-pS-P-P-P-S  
47 B17 1964.9 P-A-D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-pS  
48 B18 1784.9  A-D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-S-S  
49 B19 1955  A-D-pT-P-S-S-N-R-P-S-N-S-S-P-P-P-S-S  
50 B20 1954.9 A-D-T-P-pS-S-N-R-P-S-N-S-S-P-P-P-S-S  
51 B21 1954.9 A-D-T-P-S-pS-N-R-P-S-N-S-S-P-P-P-S-S  
52 B22 1954.9 A-D-T-P-S-S-N-R-P-pS-N-S-S-P-P-P-S-S  
53 B23 1954.9 A-D-T-P-S-S-N-R-P-S-N-pS-S-P-P-P-S-S  
54 B24 1954.9 A-D-T-P-S-S-N-R-P-S-N-S-pS-P-P-P-S-S  
55 B25 1954.9 A-D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-pS-S  
56 B26 1954.9 A-D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-S-pS  
57 B27 1827   D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-S-S-I  
58 B28 1997.1 D-pT-P-S-S-N-R-P-S-N-S-S-P-P-P-S-S-I  
59 B29 1997  D-T-P-pS-S-N-R-P-S-N-S-S-P-P-P-S-S-I  
60 B30 1997  D-T-P-S-pS-N-R-P-S-N-S-S-P-P-P-S-S-I  
61 C 1 1997  D-T-P-S-S-N-R-P-pS-N-S-S-P-P-P-S-S-I  
62 C 2 1997  D-T-P-S-S-N-R-P-S-N-pS-S-P-P-P-S-S-I  
63 C 3 1997  D-T-P-S-S-N-R-P-S-N-S-pS-P-P-P-S-S-I  
64 C 4 1997  D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-pS-S-I  
65 C 5 1997  D-T-P-S-S-N-R-P-S-N-S-S-P-P-P-S-pS-I  
66 C 6 1769   T-P-S-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G  
67 C 7 1939.1 pT-P-S-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G  
68 C 8 1939  T-P-pS-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G  
69 C 9 1939  T-P-S-pS-N-R-P-S-N-S-S-P-P-P-S-S-I-G  
70 C10 1939  T-P-S-S-N-R-P-pS-N-S-S-P-P-P-S-S-I-G  
71 C11 1939  T-P-S-S-N-R-P-S-N-pS-S-P-P-P-S-S-I-G  
72 C12 1939  T-P-S-S-N-R-P-S-N-S-pS-P-P-P-S-S-I-G  
73 C13 1939  T-P-S-S-N-R-P-S-N-S-S-P-P-P-pS-S-I-G  
74 C14 1939  T-P-S-S-N-R-P-S-N-S-S-P-P-P-S-pS-I-G  
75 C15 1739   P-S-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A  
76 C16 1909  P-pS-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A  
77 C17 1909  P-S-pS-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A  
78 C18 1909  P-S-S-N-R-P-pS-N-S-S-P-P-P-S-S-I-G-A  
79 C19 1909  P-S-S-N-R-P-S-N-pS-S-P-P-P-S-S-I-G-A  
80 C20 1909  P-S-S-N-R-P-S-N-S-pS-P-P-P-S-S-I-G-A  
81 C21 1909  P-S-S-N-R-P-S-N-S-S-P-P-P-pS-S-I-G-A  
82 C22 1909  P-S-S-N-R-P-S-N-S-S-P-P-P-S-pS-I-G-A  
83 C23 1699   S-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A-G  
84 C24 1869  pS-S-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A-G  
85 C25 1869  S-pS-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A-G  
86 C26 1869  S-S-N-R-P-pS-N-S-S-P-P-P-S-S-I-G-A-G  
87 C27 1869  S-S-N-R-P-S-N-pS-S-P-P-P-S-S-I-G-A-G  
88 C28 1869  S-S-N-R-P-S-N-S-pS-P-P-P-S-S-I-G-A-G  
89 C29 1869  S-S-N-R-P-S-N-S-S-P-P-P-pS-S-I-G-A-G  
90 C30 1869  S-S-N-R-P-S-N-S-S-P-P-P-S-pS-I-G-A-G  
91 D 1 1759.1  S-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A-G-F  
Appendix 
 
 177 
92 D 2 1929.1 pS-N-R-P-S-N-S-S-P-P-P-S-S-I-G-A-G-F  
93 D 3 1929.1 S-N-R-P-pS-N-S-S-P-P-P-S-S-I-G-A-G-F  
94 D 4 1929.1 S-N-R-P-S-N-pS-S-P-P-P-S-S-I-G-A-G-F  
95 D 5 1929.1 S-N-R-P-S-N-S-pS-P-P-P-S-S-I-G-A-G-F  
96 D 6 1929.1 S-N-R-P-S-N-S-S-P-P-P-pS-S-I-G-A-G-F  
97 D 7 1929.1 S-N-R-P-S-N-S-S-P-P-P-S-pS-I-G-A-G-F  
98 D 8 1729.1  N-R-P-S-N-S-S-P-P-P-S-S-I-G-A-G-F-G  
99 D 9 1899.1 N-R-P-pS-N-S-S-P-P-P-S-S-I-G-A-G-F-G  
100 D10 1899.1 N-R-P-S-N-pS-S-P-P-P-S-S-I-G-A-G-F-G  
101 D11 1899.1 N-R-P-S-N-S-pS-P-P-P-S-S-I-G-A-G-F-G  
102 D12 1899.1 N-R-P-S-N-S-S-P-P-P-pS-S-I-G-A-G-F-G  
103 D13 1899.1 N-R-P-S-N-S-S-P-P-P-S-pS-I-G-A-G-F-G  
104 D14 1702.1  R-P-S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S  
105 D15 1872.1 R-P-pS-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S  
106 D16 1872.1 R-P-S-N-pS-S-P-P-P-S-S-I-G-A-G-F-G-S  
107 D17 1872.1 R-P-S-N-S-pS-P-P-P-S-S-I-G-A-G-F-G-S  
108 D18 1872.1 R-P-S-N-S-S-P-P-P-pS-S-I-G-A-G-F-G-S  
109 D19 1872.1 R-P-S-N-S-S-P-P-P-S-pS-I-G-A-G-F-G-S  
110 D20 1872.1 R-P-S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-pS  
111 D21 1633   P-S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S  
112 D22 1803  P-pS-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S  
113 D23 1803  P-S-N-pS-S-P-P-P-S-S-I-G-A-G-F-G-S-S  
114 D24 1803  P-S-N-S-pS-P-P-P-S-S-I-G-A-G-F-G-S-S  
115 D25 1803  P-S-N-S-S-P-P-P-pS-S-I-G-A-G-F-G-S-S  
116 D26 1803  P-S-N-S-S-P-P-P-S-pS-I-G-A-G-F-G-S-S  
117 D27 1803  P-S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-pS-S  
118 D28 1803  P-S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-pS  
119 D29 1623   S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S  
120 D30 1793  pS-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S  
121 E 1 1793  S-N-pS-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S  
122 E 2 1793  S-N-S-pS-P-P-P-S-S-I-G-A-G-F-G-S-S-S  
123 E 3 1793  S-N-S-S-P-P-P-pS-S-I-G-A-G-F-G-S-S-S  
124 E 4 1793  S-N-S-S-P-P-P-S-pS-I-G-A-G-F-G-S-S-S  
125 E 5 1793  S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-pS-S-S  
126 E 6 1793  S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-pS-S  
127 E 7 1793  S-N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-pS  
128 E 8 1593   N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G  
129 E 9 1763  N-pS-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G  
130 E10 1763  N-S-pS-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G  
131 E11 1763  N-S-S-P-P-P-pS-S-I-G-A-G-F-G-S-S-S-G  
132 E12 1763  N-S-S-P-P-P-S-pS-I-G-A-G-F-G-S-S-S-G  
133 E13 1763  N-S-S-P-P-P-S-S-I-G-A-G-F-G-pS-S-S-G  
134 E14 1763  N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-pS-S-G  
135 E15 1763  N-S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-pS-G  
136 E16 1592.1  S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L  
137 E17 1762.1 pS-S-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L  
138 E18 1762.1 S-pS-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L  
139 E19 1762.1 S-S-P-P-P-pS-S-I-G-A-G-F-G-S-S-S-G-L  
140 E20 1762.1 S-S-P-P-P-S-pS-I-G-A-G-F-G-S-S-S-G-L  
141 E21 1762.1 S-S-P-P-P-S-S-I-G-A-G-F-G-pS-S-S-G-L  
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142 E22 1762.1 S-S-P-P-P-S-S-I-G-A-G-F-G-S-pS-S-G-L  
143 E23 1762.1 S-S-P-P-P-S-S-I-G-A-G-F-G-S-S-pS-G-L  
144 E24 1620.1  S-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L-D  
145 E25 1790.1 pS-P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L-D  
146 E26 1790.1 S-P-P-P-pS-S-I-G-A-G-F-G-S-S-S-G-L-D  
147 E27 1790.1 S-P-P-P-S-pS-I-G-A-G-F-G-S-S-S-G-L-D  
148 E28 1790.1 S-P-P-P-S-S-I-G-A-G-F-G-pS-S-S-G-L-D  
149 E29 1790.1 S-P-P-P-S-S-I-G-A-G-F-G-S-pS-S-G-L-D  
150 E30 1790.1 S-P-P-P-S-S-I-G-A-G-F-G-S-S-pS-G-L-D  
151 F 1 1620.1  P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L-D-S  
152 F 2 1790.1 P-P-P-pS-S-I-G-A-G-F-G-S-S-S-G-L-D-S  
153 F 3 1790.1 P-P-P-S-pS-I-G-A-G-F-G-S-S-S-G-L-D-S  
154 F 4 1790.1 P-P-P-S-S-I-G-A-G-F-G-pS-S-S-G-L-D-S  
155 F 5 1790.1 P-P-P-S-S-I-G-A-G-F-G-S-pS-S-G-L-D-S  
156 F 6 1790.1 P-P-P-S-S-I-G-A-G-F-G-S-S-pS-G-L-D-S  
157 F 7 1790.1 P-P-P-S-S-I-G-A-G-F-G-S-S-S-G-L-D-pS  
158 F 8 1651.1  P-P-S-S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q  
159 F 9 1821.1 P-P-pS-S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q  
160 F10 1821.1 P-P-S-pS-I-G-A-G-F-G-S-S-S-G-L-D-S-Q  
161 F11 1821.1 P-P-S-S-I-G-A-G-F-G-pS-S-S-G-L-D-S-Q  
162 F12 1821.1 P-P-S-S-I-G-A-G-F-G-S-pS-S-G-L-D-S-Q  
163 F13 1821.1 P-P-S-S-I-G-A-G-F-G-S-S-pS-G-L-D-S-Q  
164 F14 1821.1 P-P-S-S-I-G-A-G-F-G-S-S-S-G-L-D-pS-Q  
165 F15 1667.2  P-S-S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I  
166 F16 1837.2 P-pS-S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I  
167 F17 1837.2 P-S-pS-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I  
168 F18 1837.2 P-S-S-I-G-A-G-F-G-pS-S-S-G-L-D-S-Q-I  
169 F19 1837.2 P-S-S-I-G-A-G-F-G-S-pS-S-G-L-D-S-Q-I  
170 F20 1837.2 P-S-S-I-G-A-G-F-G-S-S-pS-G-L-D-S-Q-I  
171 F21 1837.2 P-S-S-I-G-A-G-F-G-S-S-S-G-L-D-pS-Q-I  
172 F22 1627.2  S-S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G  
173 F23 1797.2 pS-S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G  
174 F24 1797.2 S-pS-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G  
175 F25 1797.2 S-S-I-G-A-G-F-G-pS-S-S-G-L-D-S-Q-I-G  
176 F26 1797.2 S-S-I-G-A-G-F-G-S-pS-S-G-L-D-S-Q-I-G  
177 F27 1797.2 S-S-I-G-A-G-F-G-S-S-pS-G-L-D-S-Q-I-G  
178 F28 1797.2 S-S-I-G-A-G-F-G-S-S-S-G-L-D-pS-Q-I-G  
179 F29 1627.2  S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-S  
180 F30 1797.2 pS-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-S  
181 G 1 1797.2 S-I-G-A-G-F-G-pS-S-S-G-L-D-S-Q-I-G-S  
182 G 2 1797.2 S-I-G-A-G-F-G-S-pS-S-G-L-D-S-Q-I-G-S  
183 G 3 1797.2 S-I-G-A-G-F-G-S-S-pS-G-L-D-S-Q-I-G-S  
184 G 4 1797.2 S-I-G-A-G-F-G-S-S-S-G-L-D-pS-Q-I-G-S  
185 G 5 1797.2 S-I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-pS  
186 G 6 1696.3  I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-S-R  
187 G 7 1866.3 I-G-A-G-F-G-pS-S-S-G-L-D-S-Q-I-G-S-R  
188 G 8 1866.3 I-G-A-G-F-G-S-pS-S-G-L-D-S-Q-I-G-S-R  
189 G 9 1866.3 I-G-A-G-F-G-S-S-pS-G-L-D-S-Q-I-G-S-R  
190 G10 1866.3 I-G-A-G-F-G-S-S-S-G-L-D-pS-Q-I-G-S-R  
191 G11 1866.3 I-G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-pS-R  
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192 G12 1696.3  G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-S-R-L  
193 G13 1866.3 G-A-G-F-G-pS-S-S-G-L-D-S-Q-I-G-S-R-L  
194 G14 1866.3 G-A-G-F-G-S-pS-S-G-L-D-S-Q-I-G-S-R-L  
195 G15 1866.3 G-A-G-F-G-S-S-pS-G-L-D-S-Q-I-G-S-R-L  
196 G16 1866.3 G-A-G-F-G-S-S-S-G-L-D-pS-Q-I-G-S-R-L  
197 G17 1866.3 G-A-G-F-G-S-S-S-G-L-D-S-Q-I-G-pS-R-L  
198 G18 1776.3  A-G-F-G-S-S-S-G-L-D-S-Q-I-G-S-R-L-H  
199 G19 1946.3 A-G-F-G-pS-S-S-G-L-D-S-Q-I-G-S-R-L-H  
200 G20 1946.3 A-G-F-G-S-pS-S-G-L-D-S-Q-I-G-S-R-L-H  
201 G21 1946.3 A-G-F-G-S-S-pS-G-L-D-S-Q-I-G-S-R-L-H  
202 G22 1946.3 A-G-F-G-S-S-S-G-L-D-pS-Q-I-G-S-R-L-H  
203 G23 1946.3 A-G-F-G-S-S-S-G-L-D-S-Q-I-G-pS-R-L-H  
204 G24 1852.4  G-F-G-S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F  
205 G25 2022.4 G-F-G-pS-S-S-G-L-D-S-Q-I-G-S-R-L-H-F  
206 G26 2022.4 G-F-G-S-pS-S-G-L-D-S-Q-I-G-S-R-L-H-F  
207 G27 2022.4 G-F-G-S-S-pS-G-L-D-S-Q-I-G-S-R-L-H-F  
208 G28 2022.4 G-F-G-S-S-S-G-L-D-pS-Q-I-G-S-R-L-H-F  
209 G29 2022.4 G-F-G-S-S-S-G-L-D-S-Q-I-G-pS-R-L-H-F  
210 G30 1892.4  F-G-S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P  
211 H 1 2062.4 F-G-pS-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P  
212 H 2 2062.4 F-G-S-pS-S-G-L-D-S-Q-I-G-S-R-L-H-F-P  
213 H 3 2062.4 F-G-S-S-pS-G-L-D-S-Q-I-G-S-R-L-H-F-P  
214 H 4 2062.4 F-G-S-S-S-G-L-D-pS-Q-I-G-S-R-L-H-F-P  
215 H 5 2062.4 F-G-S-S-S-G-L-D-S-Q-I-G-pS-R-L-H-F-P  
216 H 6 1832.3  G-S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S  
217 H 7 2002.3 G-pS-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S  
218 H 8 2002.3 G-S-pS-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S  
219 H 9 2002.3 G-S-S-pS-G-L-D-S-Q-I-G-S-R-L-H-F-P-S  
220 H10 2002.3 G-S-S-S-G-L-D-pS-Q-I-G-S-R-L-H-F-P-S  
221 H11 2002.3 G-S-S-S-G-L-D-S-Q-I-G-pS-R-L-H-F-P-S  
222 H12 2002.3 G-S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-pS  
223 H13 1862.3  S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S  
224 H14 2032.3 pS-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S  
225 H15 2032.3 S-pS-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S  
226 H16 2032.3 S-S-pS-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S  
227 H17 2032.3 S-S-S-G-L-D-pS-Q-I-G-S-R-L-H-F-P-S-S  
228 H18 2032.3 S-S-S-G-L-D-S-Q-I-G-pS-R-L-H-F-P-S-S  
229 H19 2032.3 S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-pS-S  
230 H20 2032.3 S-S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-pS  
231 H21 1862.3  S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S  
232 H22 2032.3 pS-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S  
233 H23 2032.3 S-pS-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S  
234 H24 2032.3 S-S-G-L-D-pS-Q-I-G-S-R-L-H-F-P-S-S-S  
235 H25 2032.3 S-S-G-L-D-S-Q-I-G-pS-R-L-H-F-P-S-S-S  
236 H26 2032.3 S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-pS-S-S  
237 H27 2032.3 S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-pS-S  
238 H28 2032.3 S-S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-pS  
239 H29 1903.3  S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S-Q  
240 H30 2073.3 pS-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S-Q  
241 I 1 2073.3 S-G-L-D-pS-Q-I-G-S-R-L-H-F-P-S-S-S-Q  
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242 I 2 2073.3 S-G-L-D-S-Q-I-G-pS-R-L-H-F-P-S-S-S-Q  
243 I 3 2073.3 S-G-L-D-S-Q-I-G-S-R-L-H-F-P-pS-S-S-Q  
244 I 4 2073.3 S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-pS-S-Q  
245 I 5 2073.3 S-G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-pS-Q  
246 I 6 1913.3  G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P  
247 I 7 2083.3 G-L-D-pS-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P  
248 I 8 2083.3 G-L-D-S-Q-I-G-pS-R-L-H-F-P-S-S-S-Q-P  
249 I 9 2083.3 G-L-D-S-Q-I-G-S-R-L-H-F-P-pS-S-S-Q-P  
250 I10 2083.3 G-L-D-S-Q-I-G-S-R-L-H-F-P-S-pS-S-Q-P  
251 I11 2083.3 G-L-D-S-Q-I-G-S-R-L-H-F-P-S-S-pS-Q-P  
252 I12 1993.3  L-D-S-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H  
253 I13 2163.3 L-D-pS-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H  
254 I14 2163.3 L-D-S-Q-I-G-pS-R-L-H-F-P-S-S-S-Q-P-H  
255 I15 2163.3 L-D-S-Q-I-G-S-R-L-H-F-P-pS-S-S-Q-P-H  
256 I16 2163.3 L-D-S-Q-I-G-S-R-L-H-F-P-S-pS-S-Q-P-H  
257 I17 2163.3 L-D-S-Q-I-G-S-R-L-H-F-P-S-S-pS-Q-P-H  
258 I18 1979.2  D-S-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V  
259 I19 2149.2 D-pS-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V  
260 I20 2149.2 D-S-Q-I-G-pS-R-L-H-F-P-S-S-S-Q-P-H-V  
261 I21 2149.2 D-S-Q-I-G-S-R-L-H-F-P-pS-S-S-Q-P-H-V  
262 I22 2149.2 D-S-Q-I-G-S-R-L-H-F-P-S-pS-S-Q-P-H-V  
263 I23 2149.2 D-S-Q-I-G-S-R-L-H-F-P-S-S-pS-Q-P-H-V  
264 I24 1951.2  S-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S  
265 I25 2121.2 pS-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S  
266 I26 2121.2 S-Q-I-G-pS-R-L-H-F-P-S-S-S-Q-P-H-V-S  
267 I27 2121.2 S-Q-I-G-S-R-L-H-F-P-pS-S-S-Q-P-H-V-S  
268 I28 2121.2 S-Q-I-G-S-R-L-H-F-P-S-pS-S-Q-P-H-V-S  
269 I29 2121.2 S-Q-I-G-S-R-L-H-F-P-S-S-pS-Q-P-H-V-S  
270 I30 2121.2 S-Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-pS  
271 J 1 1978.2  Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N  
272 J 2 2148.2 Q-I-G-pS-R-L-H-F-P-S-S-S-Q-P-H-V-S-N  
273 J 3 2148.2 Q-I-G-S-R-L-H-F-P-pS-S-S-Q-P-H-V-S-N  
274 J 4 2148.2 Q-I-G-S-R-L-H-F-P-S-pS-S-Q-P-H-V-S-N  
275 J 5 2148.2 Q-I-G-S-R-L-H-F-P-S-S-pS-Q-P-H-V-S-N  
276 J 6 2148.2 Q-I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-pS-N  
277 J 7 1937.2  I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S  
278 J 8 2107.2 I-G-pS-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S  
279 J 9 2107.2 I-G-S-R-L-H-F-P-pS-S-S-Q-P-H-V-S-N-S  
280 J10 2107.2 I-G-S-R-L-H-F-P-S-pS-S-Q-P-H-V-S-N-S  
281 J11 2107.2 I-G-S-R-L-H-F-P-S-S-pS-Q-P-H-V-S-N-S  
282 J12 2107.2 I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-pS-N-S  
283 J13 2107.2 I-G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-pS  
284 J14 1952.1  G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q  
285 J15 2122.1 G-pS-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q  
286 J16 2122.1 G-S-R-L-H-F-P-pS-S-S-Q-P-H-V-S-N-S-Q  
287 J17 2122.1 G-S-R-L-H-F-P-S-pS-S-Q-P-H-V-S-N-S-Q  
288 J18 2122.1 G-S-R-L-H-F-P-S-S-pS-Q-P-H-V-S-N-S-Q  
289 J19 2122.1 G-S-R-L-H-F-P-S-S-S-Q-P-H-V-pS-N-S-Q  
290 J20 2122.1 G-S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-pS-Q  
291 J21 1996.1  S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-T  
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292 J22 2166.1 pS-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-T  
293 J23 2166.1 S-R-L-H-F-P-pS-S-S-Q-P-H-V-S-N-S-Q-T  
294 J24 2166.1 S-R-L-H-F-P-S-pS-S-Q-P-H-V-S-N-S-Q-T  
295 J25 2166.1 S-R-L-H-F-P-S-S-pS-Q-P-H-V-S-N-S-Q-T  
296 J26 2166.1 S-R-L-H-F-P-S-S-S-Q-P-H-V-pS-N-S-Q-T  
297 J27 2166.1 S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-pS-Q-T  
298 J28 2166.2 S-R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-pT  
299 J29 1966.1  R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-T-G  
300 J30 2136.1 R-L-H-F-P-pS-S-S-Q-P-H-V-S-N-S-Q-T-G  
301 K 1 2136.1 R-L-H-F-P-S-pS-S-Q-P-H-V-S-N-S-Q-T-G  
302 K 2 2136.1 R-L-H-F-P-S-S-pS-Q-P-H-V-S-N-S-Q-T-G  
303 K 3 2136.1 R-L-H-F-P-S-S-S-Q-P-H-V-pS-N-S-Q-T-G  
304 K 4 2136.1 R-L-H-F-P-S-S-S-Q-P-H-V-S-N-pS-Q-T-G  
305 K 5 2136.2 R-L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-pT-G  
306 K 6 1809.9    L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-T-G  
307 K 7 1979.9   L-H-F-P-pS-S-S-Q-P-H-V-S-N-S-Q-T-G  
308 K 8 1979.9   L-H-F-P-S-pS-S-Q-P-H-V-S-N-S-Q-T-G  
309 K 9 1979.9   L-H-F-P-S-S-pS-Q-P-H-V-S-N-S-Q-T-G  
310 K10 1979.9   L-H-F-P-S-S-S-Q-P-H-V-pS-N-S-Q-T-G  
311 K11 1979.9   L-H-F-P-S-S-S-Q-P-H-V-S-N-pS-Q-T-G  
312 K12 1980    L-H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-pT-G  
313 K13 1793.8    H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-T-G-P  
314 K14 1963.8   H-F-P-pS-S-S-Q-P-H-V-S-N-S-Q-T-G-P  
315 K15 1963.8   H-F-P-S-pS-S-Q-P-H-V-S-N-S-Q-T-G-P  
316 K16 1963.8   H-F-P-S-S-pS-Q-P-H-V-S-N-S-Q-T-G-P  
317 K17 1963.8   H-F-P-S-S-S-Q-P-H-V-pS-N-S-Q-T-G-P  
318 K18 1963.8   H-F-P-S-S-S-Q-P-H-V-S-N-pS-Q-T-G-P  
319 K19 1963.9   H-F-P-S-S-S-Q-P-H-V-S-N-S-Q-pT-G-P  
320 K20 1803.9    F-P-S-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F  
321 K21 1973.9   F-P-pS-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F  
322 K22 1973.9   F-P-S-pS-S-Q-P-H-V-S-N-S-Q-T-G-P-F  
323 K23 1973.9   F-P-S-S-pS-Q-P-H-V-S-N-S-Q-T-G-P-F  
324 K24 1973.9   F-P-S-S-S-Q-P-H-V-pS-N-S-Q-T-G-P-F  
325 K25 1973.9   F-P-S-S-S-Q-P-H-V-S-N-pS-Q-T-G-P-F  
326 K26 1974    F-P-S-S-S-Q-P-H-V-S-N-S-Q-pT-G-P-F  
327 K27 1803.9    F-P-S-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F  
328 K28 1973.9   F-P-pS-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F  
329 K29 1973.9   F-P-S-pS-S-Q-P-H-V-S-N-S-Q-T-G-P-F  
330 K30 1973.9   F-P-S-S-pS-Q-P-H-V-S-N-S-Q-T-G-P-F  
331 L 1 1973.9   F-P-S-S-S-Q-P-H-V-pS-N-S-Q-T-G-P-F  
332 L 2 1973.9   F-P-S-S-S-Q-P-H-V-S-N-pS-Q-T-G-P-F  
333 L 3 1974    F-P-S-S-S-Q-P-H-V-S-N-S-Q-pT-G-P-F  
334 L 4 1755.8    P-S-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V  
335 L 5 1925.8   P-pS-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V  
336 L 6 1925.8   P-S-pS-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V  
337 L 7 1925.8   P-S-S-pS-Q-P-H-V-S-N-S-Q-T-G-P-F-V  
338 L 8 1925.8   P-S-S-S-Q-P-H-V-pS-N-S-Q-T-G-P-F-V  
339 L 9 1925.8   P-S-S-S-Q-P-H-V-S-N-pS-Q-T-G-P-F-V  
340 L10 1925.9   P-S-S-S-Q-P-H-V-S-N-S-Q-pT-G-P-F-V  
341 L11 1772.8    S-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N  
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342 L12 1942.8   pS-S-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N  
343 L13 1942.8   S-pS-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N  
344 L14 1942.8   S-S-pS-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N  
345 L15 1942.8   S-S-S-Q-P-H-V-pS-N-S-Q-T-G-P-F-V-N  
346 L16 1942.8   S-S-S-Q-P-H-V-S-N-pS-Q-T-G-P-F-V-N  
347 L17 1942.9   S-S-S-Q-P-H-V-S-N-S-Q-pT-G-P-F-V-N  
348 L18 1800.8    S-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D  
349 L19 1970.8   pS-S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D  
350 L20 1970.8   S-pS-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D  
351 L21 1970.8   S-S-Q-P-H-V-pS-N-S-Q-T-G-P-F-V-N-D  
352 L22 1970.8   S-S-Q-P-H-V-S-N-pS-Q-T-G-P-F-V-N-D  
353 L23 1970.9   S-S-Q-P-H-V-S-N-S-Q-pT-G-P-F-V-N-D  
354 L24 1800.8    S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D-S  
355 L25 1970.8   pS-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D-S  
356 L26 1970.8   S-Q-P-H-V-pS-N-S-Q-T-G-P-F-V-N-D-S  
357 L27 1970.8   S-Q-P-H-V-S-N-pS-Q-T-G-P-F-V-N-D-S  
358 L28 1970.9   S-Q-P-H-V-S-N-S-Q-pT-G-P-F-V-N-D-S  
359 L29 1970.8   S-Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D-pS  
360 L30 1814.8    Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D-S-T  
361 M 1 1984.8   Q-P-H-V-pS-N-S-Q-T-G-P-F-V-N-D-S-T  
362 M 2 1984.8   Q-P-H-V-S-N-pS-Q-T-G-P-F-V-N-D-S-T  
363 M 3 1984.9   Q-P-H-V-S-N-S-Q-pT-G-P-F-V-N-D-S-T  
364 M 4 1984.8   Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D-pS-T  
365 M 5 1984.9   Q-P-H-V-S-N-S-Q-T-G-P-F-V-N-D-S-pT  
366 M 6 1814.8    P-H-V-S-N-S-Q-T-G-P-F-V-N-D-S-T-Q  
367 M 7 1984.8   P-H-V-pS-N-S-Q-T-G-P-F-V-N-D-S-T-Q  
368 M 8 1984.8   P-H-V-S-N-pS-Q-T-G-P-F-V-N-D-S-T-Q  
369 M 9 1984.9   P-H-V-S-N-S-Q-pT-G-P-F-V-N-D-S-T-Q  
370 M10 1984.8   P-H-V-S-N-S-Q-T-G-P-F-V-N-D-pS-T-Q  
371 M11 1984.9   P-H-V-S-N-S-Q-T-G-P-F-V-N-D-S-pT-Q  
372 M12 1864.9    H-V-S-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F  
373 M13 2034.9   H-V-pS-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F  
374 M14 2034.9   H-V-S-N-pS-Q-T-G-P-F-V-N-D-S-T-Q-F  
375 M15 2035    H-V-S-N-S-Q-pT-G-P-F-V-N-D-S-T-Q-F  
376 M16 2034.9   H-V-S-N-S-Q-T-G-P-F-V-N-D-pS-T-Q-F  
377 M17 2035    H-V-S-N-S-Q-T-G-P-F-V-N-D-S-pT-Q-F  
378 M18 1814.9    V-S-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S  
379 M19 1984.9   V-pS-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S  
380 M20 1984.9   V-S-N-pS-Q-T-G-P-F-V-N-D-S-T-Q-F-S  
381 M21 1985    V-S-N-S-Q-pT-G-P-F-V-N-D-S-T-Q-F-S  
382 M22 1984.9   V-S-N-S-Q-T-G-P-F-V-N-D-pS-T-Q-F-S  
383 M23 1985    V-S-N-S-Q-T-G-P-F-V-N-D-S-pT-Q-F-S  
384 M24 1984.9   V-S-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-pS  
385 M25 1802.9    S-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S  
386 M26 1972.9   pS-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S  
387 M27 1972.9   S-N-pS-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S  
388 M28 1973    S-N-S-Q-pT-G-P-F-V-N-D-S-T-Q-F-S-S  
389 M29 1972.9   S-N-S-Q-T-G-P-F-V-N-D-pS-T-Q-F-S-S  
390 M30 1973    S-N-S-Q-T-G-P-F-V-N-D-S-pT-Q-F-S-S  
391 N 1 1972.9   S-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-pS-S  
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392 N 2 1972.9   S-N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-pS  
393 N 3 1843.9    N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S-Q  
394 N 4 2013.9   N-pS-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S-Q  
395 N 5 2014    N-S-Q-pT-G-P-F-V-N-D-S-T-Q-F-S-S-Q  
396 N 6 2013.9   N-S-Q-T-G-P-F-V-N-D-pS-T-Q-F-S-S-Q  
397 N 7 2014    N-S-Q-T-G-P-F-V-N-D-S-pT-Q-F-S-S-Q  
398 N 8 2013.9   N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-pS-S-Q  
399 N 9 2013.9   N-S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-pS-Q  
400 N10 1886     S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R  
401 N11 2056    pS-Q-T-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R  
402 N12 2056.1   S-Q-pT-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R  
403 N13 2056    S-Q-T-G-P-F-V-N-D-pS-T-Q-F-S-S-Q-R  
404 N14 2056.1   S-Q-T-G-P-F-V-N-D-S-pT-Q-F-S-S-Q-R  
405 N15 2056    S-Q-T-G-P-F-V-N-D-S-T-Q-F-pS-S-Q-R  
406 N16 2056    S-Q-T-G-P-F-V-N-D-S-T-Q-F-S-pS-Q-R  
407 N17 1912.1    Q-T-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R-L  
408 N18 2082.2   Q-pT-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R-L  
409 N19 2082.1   Q-T-G-P-F-V-N-D-pS-T-Q-F-S-S-Q-R-L  
410 N20 2082.2   Q-T-G-P-F-V-N-D-S-pT-Q-F-S-S-Q-R-L  
411 N21 2082.1   Q-T-G-P-F-V-N-D-S-T-Q-F-pS-S-Q-R-L  
412 N22 2082.1   Q-T-G-P-F-V-N-D-S-T-Q-F-S-pS-Q-R-L  
413 N23 1912.1    T-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q  
414 N24 2082.2   pT-G-P-F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q  
415 N25 2082.1   T-G-P-F-V-N-D-pS-T-Q-F-S-S-Q-R-L-Q  
416 N26 2082.2   T-G-P-F-V-N-D-S-pT-Q-F-S-S-Q-R-L-Q  
417 N27 2082.1   T-G-P-F-V-N-D-S-T-Q-F-pS-S-Q-R-L-Q  
418 N28 2082.1   T-G-P-F-V-N-D-S-T-Q-F-S-pS-Q-R-L-Q  
419 N29 1912.1    G-P-F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q-T  
420 N30 2082.1   G-P-F-V-N-D-pS-T-Q-F-S-S-Q-R-L-Q-T  
421 O 1 2082.2   G-P-F-V-N-D-S-pT-Q-F-S-S-Q-R-L-Q-T  
422 O 2 2082.1   G-P-F-V-N-D-S-T-Q-F-pS-S-Q-R-L-Q-T  
423 O 3 2082.1   G-P-F-V-N-D-S-T-Q-F-S-pS-Q-R-L-Q-T  
424 O 4 2082.2   G-P-F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q-pT  
425 O 5 1970.1    P-F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q-T-D  
426 O 6 2140.1   P-F-V-N-D-pS-T-Q-F-S-S-Q-R-L-Q-T-D  
427 O 7 2140.2   P-F-V-N-D-S-pT-Q-F-S-S-Q-R-L-Q-T-D  
428 O 8 2140.1   P-F-V-N-D-S-T-Q-F-pS-S-Q-R-L-Q-T-D  
429 O 9 2140.1   P-F-V-N-D-S-T-Q-F-S-pS-Q-R-L-Q-T-D  
430 O10 2140.2   P-F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q-pT-D  
431 O11 1930.1    F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G  
432 O12 2100.1   F-V-N-D-pS-T-Q-F-S-S-Q-R-L-Q-T-D-G  
433 O13 2100.2   F-V-N-D-S-pT-Q-F-S-S-Q-R-L-Q-T-D-G  
434 O14 2100.1   F-V-N-D-S-T-Q-F-pS-S-Q-R-L-Q-T-D-G  
435 O15 2100.1   F-V-N-D-S-T-Q-F-S-pS-Q-R-L-Q-T-D-G  
436 O16 2100.2   F-V-N-D-S-T-Q-F-S-S-Q-R-L-Q-pT-D-G  
437 O17 1870     V-N-D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-S  
438 O18 2040    V-N-D-pS-T-Q-F-S-S-Q-R-L-Q-T-D-G-S  
439 O19 2040.1   V-N-D-S-pT-Q-F-S-S-Q-R-L-Q-T-D-G-S  
440 O20 2040    V-N-D-S-T-Q-F-pS-S-Q-R-L-Q-T-D-G-S  
441 O21 2040    V-N-D-S-T-Q-F-S-pS-Q-R-L-Q-T-D-G-S  
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442 O22 2040.1   V-N-D-S-T-Q-F-S-S-Q-R-L-Q-pT-D-G-S  
443 O23 2040    V-N-D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-pS  
444 O24 1842     N-D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A  
445 O25 2012    N-D-pS-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A  
446 O26 2012.1   N-D-S-pT-Q-F-S-S-Q-R-L-Q-T-D-G-S-A  
447 O27 2012    N-D-S-T-Q-F-pS-S-Q-R-L-Q-T-D-G-S-A  
448 O28 2012    N-D-S-T-Q-F-S-pS-Q-R-L-Q-T-D-G-S-A  
449 O29 2012.1   N-D-S-T-Q-F-S-S-Q-R-L-Q-pT-D-G-S-A  
450 O30 2012    N-D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-pS-A  
451 P 1 1829     D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T  
452 P 2 1999    D-pS-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T  
453 P 3 1999.1   D-S-pT-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T  
454 P 4 1999    D-S-T-Q-F-pS-S-Q-R-L-Q-T-D-G-S-A-T  
455 P 5 1999    D-S-T-Q-F-S-pS-Q-R-L-Q-T-D-G-S-A-T  
456 P 6 1999.1   D-S-T-Q-F-S-S-Q-R-L-Q-pT-D-G-S-A-T  
457 P 7 1999    D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-pS-A-T  
458 P 8 1829     D-S-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T  
459 P 9 1828     S-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T-N  
460 P10 1998    pS-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T-N  
461 P11 1998.1   S-pT-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T-N  
462 P12 1998    S-T-Q-F-pS-S-Q-R-L-Q-T-D-G-S-A-T-N  
463 P13 1998    S-T-Q-F-S-pS-Q-R-L-Q-T-D-G-S-A-T-N  
464 P14 1998.1   S-T-Q-F-S-S-Q-R-L-Q-pT-D-G-S-A-T-N  
465 P15 1998    S-T-Q-F-S-S-Q-R-L-Q-T-D-G-pS-A-T-N  
466 P16 1998.1   S-T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-pT-N  
467 P17 1856   T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T-N-D  
468 P18 2026.1   pT-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T-N-D  
469 P19 2026    T-Q-F-pS-S-Q-R-L-Q-T-D-G-S-A-T-N-D  
470 P20 2026    T-Q-F-S-pS-Q-R-L-Q-T-D-G-S-A-T-N-D  
471 P21 2026.1   T-Q-F-S-S-Q-R-L-Q-pT-D-G-S-A-T-N-D  
472 P22 2026    T-Q-F-S-S-Q-R-L-Q-T-D-G-pS-A-T-N-D  
473 P23 2026.1   T-Q-F-S-S-Q-R-L-Q-T-D-G-S-A-pT-N-D  
474 P24 1886.1    Q-F-S-S-Q-R-L-Q-T-D-G-S-A-T-N-D-M  
475 P25 2056.1   Q-F-pS-S-Q-R-L-Q-T-D-G-S-A-T-N-D-M  
476 P26 2056.1   Q-F-S-pS-Q-R-L-Q-T-D-G-S-A-T-N-D-M  
477 P27 2056.2   Q-F-S-S-Q-R-L-Q-pT-D-G-S-A-T-N-D-M  
478 P28 2056.1   Q-F-S-S-Q-R-L-Q-T-D-G-pS-A-T-N-D-M  
479 P29 2056.2   Q-F-S-S-Q-R-L-Q-T-D-G-S-A-pT-N-D-M  
480 P30 1887.1    F-S-S-Q-R-L-Q-T-D-G-S-A-T-N-D-M-E  
481 Q 1 2057.1   F-pS-S-Q-R-L-Q-T-D-G-S-A-T-N-D-M-E  
482 Q 2 2057.1   F-S-pS-Q-R-L-Q-T-D-G-S-A-T-N-D-M-E  
483 Q 3 2057.2   F-S-S-Q-R-L-Q-pT-D-G-S-A-T-N-D-M-E  
484 Q 4 2057.1   F-S-S-Q-R-L-Q-T-D-G-pS-A-T-N-D-M-E  
485 Q 5 2057.2   F-S-S-Q-R-L-Q-T-D-G-S-A-pT-N-D-M-E  
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7.1.2 Part 2 
Nr. Pos. Mol. Weight Sequence  
1 A 1 2039.5    G-N-E-P-A-R-S-F-K-S-R-A-L-N-H-V-K-K  
2 A 2 2209.5   G-N-E-P-A-R-pS-F-K-S-R-A-L-N-H-V-K-K  
3 A 3 2209.5   G-N-E-P-A-R-S-F-K-pS-R-A-L-N-H-V-K-K  
4 A 4 2082.5    E-P-A-R-S-F-K-S-R-A-L-N-H-V-K-K-V-D  
5 A 5 2252.5   E-P-A-R-pS-F-K-S-R-A-L-N-H-V-K-K-V-D  
6 A 6 2252.5   E-P-A-R-S-F-K-pS-R-A-L-N-H-V-K-K-V-D  
7 A 7 2070.5    A-R-S-F-K-S-R-A-L-N-H-V-K-K-V-D-D-V  
8 A 8 2240.5   A-R-pS-F-K-S-R-A-L-N-H-V-K-K-V-D-D-V  
9 A 9 2240.5   A-R-S-F-K-pS-R-A-L-N-H-V-K-K-V-D-D-V  
10 A10 2001.4    S-F-K-S-R-A-L-N-H-V-K-K-V-D-D-V-T-G  
11 A11 2171.4   pS-F-K-S-R-A-L-N-H-V-K-K-V-D-D-V-T-G  
12 A12 2171.4   S-F-K-pS-R-A-L-N-H-V-K-K-V-D-D-V-T-G  
13 A13 2171.5   S-F-K-S-R-A-L-N-H-V-K-K-V-D-D-V-pT-G  
14 A14 2024.4    K-S-R-A-L-N-H-V-K-K-V-D-D-V-T-G-E-K  
15 A15 2194.4   K-pS-R-A-L-N-H-V-K-K-V-D-D-V-T-G-E-K  
16 A16 2194.5   K-S-R-A-L-N-H-V-K-K-V-D-D-V-pT-G-E-K  
17 A17 2064.4    R-A-L-N-H-V-K-K-V-D-D-V-T-G-E-K-V-R  
18 A18 2234.5   R-A-L-N-H-V-K-K-V-D-D-V-pT-G-E-K-V-R  
19 A19 2037.3    L-N-H-V-K-K-V-D-D-V-T-G-E-K-V-R-E-A  
20 A20 2207.4   L-N-H-V-K-K-V-D-D-V-pT-G-E-K-V-R-E-A  
21 A21 2086.3    H-V-K-K-V-D-D-V-T-G-E-K-V-R-E-A-F-E  
22 A22 2256.4   H-V-K-K-V-D-D-V-pT-G-E-K-V-R-E-A-F-E  
23 A23 2125.4    K-K-V-D-D-V-T-G-E-K-V-R-E-A-F-E-Q-F  
24 A24 2295.5   K-K-V-D-D-V-pT-G-E-K-V-R-E-A-F-E-Q-F  
25 A25 2111.3    V-D-D-V-T-G-E-K-V-R-E-A-F-E-Q-F-L-E  
26 A26 2281.4   V-D-D-V-pT-G-E-K-V-R-E-A-F-E-Q-F-L-E  
27 A27 2159.4    D-V-T-G-E-K-V-R-E-A-F-E-Q-F-L-E-D-F  
28 A28 2329.5   D-V-pT-G-E-K-V-R-E-A-F-E-Q-F-L-E-D-F  
29 A29 2131.4    T-G-E-K-V-R-E-A-F-E-Q-F-L-E-D-F-S-V  
30 A30 2301.5   pT-G-E-K-V-R-E-A-F-E-Q-F-L-E-D-F-S-V  
31 A31 2301.4   T-G-E-K-V-R-E-A-F-E-Q-F-L-E-D-F-pS-V  
32 A32 2188.4    E-K-V-R-E-A-F-E-Q-F-L-E-D-F-S-V-Q-S  
33 A33 2358.4   E-K-V-R-E-A-F-E-Q-F-L-E-D-F-pS-V-Q-S  
34 A34 2358.4   E-K-V-R-E-A-F-E-Q-F-L-E-D-F-S-V-Q-pS  
35 A35 2147.3    V-R-E-A-F-E-Q-F-L-E-D-F-S-V-Q-S-T-D  
36 A36 2317.3   V-R-E-A-F-E-Q-F-L-E-D-F-pS-V-Q-S-T-D  
37 A37 2317.3   V-R-E-A-F-E-Q-F-L-E-D-F-S-V-Q-pS-T-D  
38 B 1 2317.4   V-R-E-A-F-E-Q-F-L-E-D-F-S-V-Q-S-pT-D  
39 B 2 2050.2    E-A-F-E-Q-F-L-E-D-F-S-V-Q-S-T-D-T-G  
40 B 3 2220.2   E-A-F-E-Q-F-L-E-D-F-pS-V-Q-S-T-D-T-G  
41 B 4 2220.2   E-A-F-E-Q-F-L-E-D-F-S-V-Q-pS-T-D-T-G  
42 B 5 2220.3   E-A-F-E-Q-F-L-E-D-F-S-V-Q-S-pT-D-T-G  
43 B 6 2220.3   E-A-F-E-Q-F-L-E-D-F-S-V-Q-S-T-D-pT-G  
44 B 7 2078.2    F-E-Q-F-L-E-D-F-S-V-Q-S-T-D-T-G-E-V  
45 B 8 2248.2   F-E-Q-F-L-E-D-F-pS-V-Q-S-T-D-T-G-E-V  
46 B 9 2248.2   F-E-Q-F-L-E-D-F-S-V-Q-pS-T-D-T-G-E-V  
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47 B10 2248.3   F-E-Q-F-L-E-D-F-S-V-Q-S-pT-D-T-G-E-V  
48 B11 2248.3   F-E-Q-F-L-E-D-F-S-V-Q-S-T-D-pT-G-E-V  
49 B12 2059.2    Q-F-L-E-D-F-S-V-Q-S-T-D-T-G-E-V-E-K  
50 B13 2229.2   Q-F-L-E-D-F-pS-V-Q-S-T-D-T-G-E-V-E-K  
51 B14 2229.2   Q-F-L-E-D-F-S-V-Q-pS-T-D-T-G-E-V-E-K  
52 B15 2229.3   Q-F-L-E-D-F-S-V-Q-S-pT-D-T-G-E-V-E-K  
53 B16 2229.3   Q-F-L-E-D-F-S-V-Q-S-T-D-pT-G-E-V-E-K  
54 B17 2046.2    L-E-D-F-S-V-Q-S-T-D-T-G-E-V-E-K-V-Y  
55 B18 2216.2   L-E-D-F-pS-V-Q-S-T-D-T-G-E-V-E-K-V-Y  
56 B19 2216.2   L-E-D-F-S-V-Q-pS-T-D-T-G-E-V-E-K-V-Y  
57 B20 2216.3   L-E-D-F-S-V-Q-S-pT-D-T-G-E-V-E-K-V-Y  
58 B21 2216.3   L-E-D-F-S-V-Q-S-T-D-pT-G-E-V-E-K-V-Y  
59 B22 2031.2    D-F-S-V-Q-S-T-D-T-G-E-V-E-K-V-Y-R-A  
60 B23 2201.2   D-F-pS-V-Q-S-T-D-T-G-E-V-E-K-V-Y-R-A  
61 B24 2201.2   D-F-S-V-Q-pS-T-D-T-G-E-V-E-K-V-Y-R-A  
62 B25 2201.3   D-F-S-V-Q-S-pT-D-T-G-E-V-E-K-V-Y-R-A  
63 B26 2201.3   D-F-S-V-Q-S-T-D-pT-G-E-V-E-K-V-Y-R-A  
64 B27 2010.2    S-V-Q-S-T-D-T-G-E-V-E-K-V-Y-R-A-Q-I  
65 B28 2180.2   pS-V-Q-S-T-D-T-G-E-V-E-K-V-Y-R-A-Q-I  
66 B29 2180.2   S-V-Q-pS-T-D-T-G-E-V-E-K-V-Y-R-A-Q-I  
67 B30 2180.3   S-V-Q-S-pT-D-T-G-E-V-E-K-V-Y-R-A-Q-I  
68 B31 2180.3   S-V-Q-S-T-D-pT-G-E-V-E-K-V-Y-R-A-Q-I  
69 B32 2100.3    Q-S-T-D-T-G-E-V-E-K-V-Y-R-A-Q-I-E-F  
70 B33 2270.3   Q-pS-T-D-T-G-E-V-E-K-V-Y-R-A-Q-I-E-F  
71 B34 2270.4   Q-S-pT-D-T-G-E-V-E-K-V-Y-R-A-Q-I-E-F  
72 B35 2270.4   Q-S-T-D-pT-G-E-V-E-K-V-Y-R-A-Q-I-E-F  
73 B36 2144.5    T-D-T-G-E-V-E-K-V-Y-R-A-Q-I-E-F-M-K  
74 B37 2314.6   pT-D-T-G-E-V-E-K-V-Y-R-A-Q-I-E-F-M-K  
75 C 1 2314.6   T-D-pT-G-E-V-E-K-V-Y-R-A-Q-I-E-F-M-K  
76 C 2 2204.7    T-G-E-V-E-K-V-Y-R-A-Q-I-E-F-M-K-I-Y  
77 C 3 2374.8   pT-G-E-V-E-K-V-Y-R-A-Q-I-E-F-M-K-I-Y  
78 C 4 2274.8    E-V-E-K-V-Y-R-A-Q-I-E-F-M-K-I-Y-D-L  
79 C 5 2261.8    E-K-V-Y-R-A-Q-I-E-F-M-K-I-Y-D-L-N-T  
80 C 6 2431.9   E-K-V-Y-R-A-Q-I-E-F-M-K-I-Y-D-L-N-pT  
81 C 7 2280.9    V-Y-R-A-Q-I-E-F-M-K-I-Y-D-L-N-T-I-Y  
82 C 8 2451    V-Y-R-A-Q-I-E-F-M-K-I-Y-D-L-N-pT-I-Y  
83 C 9 2246.9    R-A-Q-I-E-F-M-K-I-Y-D-L-N-T-I-Y-I-D  
84 C10 2417    R-A-Q-I-E-F-M-K-I-Y-D-L-N-pT-I-Y-I-D  
85 C11 2310.9    Q-I-E-F-M-K-I-Y-D-L-N-T-I-Y-I-D-Y-Q  
86 C12 2481    Q-I-E-F-M-K-I-Y-D-L-N-pT-I-Y-I-D-Y-Q  
87 C13 2319.9    E-F-M-K-I-Y-D-L-N-T-I-Y-I-D-Y-Q-H-L  
88 C14 2490    E-F-M-K-I-Y-D-L-N-pT-I-Y-I-D-Y-Q-H-L  
89 C15 2261.9    M-K-I-Y-D-L-N-T-I-Y-I-D-Y-Q-H-L-S-M  
90 C16 2432    M-K-I-Y-D-L-N-pT-I-Y-I-D-Y-Q-H-L-S-M  
91 C17 2287.8    I-Y-D-L-N-T-I-Y-I-D-Y-Q-H-L-S-M-R-E  
92 C18 2457.9   I-Y-D-L-N-pT-I-Y-I-D-Y-Q-H-L-S-M-R-E  
93 C19 2457.8   I-Y-D-L-N-T-I-Y-I-D-Y-Q-H-L-pS-M-R-E  
94 C20 2182.6    D-L-N-T-I-Y-I-D-Y-Q-H-L-S-M-R-E-N-G  
95 C21 2352.7   D-L-N-pT-I-Y-I-D-Y-Q-H-L-S-M-R-E-N-G  
96 C22 2352.6   D-L-N-T-I-Y-I-D-Y-Q-H-L-pS-M-R-E-N-G  
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97 C23 2138.6    N-T-I-Y-I-D-Y-Q-H-L-S-M-R-E-N-G-A-L  
98 C24 2308.7   N-pT-I-Y-I-D-Y-Q-H-L-S-M-R-E-N-G-A-L  
99 C25 2308.6   N-T-I-Y-I-D-Y-Q-H-L-pS-M-R-E-N-G-A-L  
100 C26 2125.7    I-Y-I-D-Y-Q-H-L-S-M-R-E-N-G-A-L-A-M  
101 C27 2295.7   I-Y-I-D-Y-Q-H-L-pS-M-R-E-N-G-A-L-A-M  
102 C28 2033.6    I-D-Y-Q-H-L-S-M-R-E-N-G-A-L-A-M-A-I  
103 C29 2203.6   I-D-Y-Q-H-L-pS-M-R-E-N-G-A-L-A-M-A-I  
104 C30 2021.5    Y-Q-H-L-S-M-R-E-N-G-A-L-A-M-A-I-S-E  
105 C31 2191.5   Y-Q-H-L-pS-M-R-E-N-G-A-L-A-M-A-I-S-E  
106 C32 2191.5   Y-Q-H-L-S-M-R-E-N-G-A-L-A-M-A-I-pS-E  
107 C33 2021.5    H-L-S-M-R-E-N-G-A-L-A-M-A-I-S-E-Q-Y  
108 C34 2191.5   H-L-pS-M-R-E-N-G-A-L-A-M-A-I-S-E-Q-Y  
109 C35 2191.5   H-L-S-M-R-E-N-G-A-L-A-M-A-I-pS-E-Q-Y  
110 C36 2090.6    S-M-R-E-N-G-A-L-A-M-A-I-S-E-Q-Y-Y-R  
111 C37 2260.6   pS-M-R-E-N-G-A-L-A-M-A-I-S-E-Q-Y-Y-R  
112 D 1 2260.6   S-M-R-E-N-G-A-L-A-M-A-I-pS-E-Q-Y-Y-R  
113 D 2 2132.7    R-E-N-G-A-L-A-M-A-I-S-E-Q-Y-Y-R-F-L  
114 D 3 2302.7   R-E-N-G-A-L-A-M-A-I-pS-E-Q-Y-Y-R-F-L  
115 D 4 2091.7    N-G-A-L-A-M-A-I-S-E-Q-Y-Y-R-F-L-P-F  
116 D 5 2261.7   N-G-A-L-A-M-A-I-pS-E-Q-Y-Y-R-F-L-P-F  
117 D 6 2161.8    A-L-A-M-A-I-S-E-Q-Y-Y-R-F-L-P-F-L-Q  
118 D 7 2331.8   A-L-A-M-A-I-pS-E-Q-Y-Y-R-F-L-P-F-L-Q  
119 D 8 2162.8    A-M-A-I-S-E-Q-Y-Y-R-F-L-P-F-L-Q-K-G  
120 D 9 2332.8   A-M-A-I-pS-E-Q-Y-Y-R-F-L-P-F-L-Q-K-G  
121 D10 2229.9    A-I-S-E-Q-Y-Y-R-F-L-P-F-L-Q-K-G-L-R  
122 D11 2399.9   A-I-pS-E-Q-Y-Y-R-F-L-P-F-L-Q-K-G-L-R  
123 D12 2300.9    S-E-Q-Y-Y-R-F-L-P-F-L-Q-K-G-L-R-R-V  
124 D13 2470.9   pS-E-Q-Y-Y-R-F-L-P-F-L-Q-K-G-L-R-R-V  
125 D14 2340     Q-Y-Y-R-F-L-P-F-L-Q-K-G-L-R-R-V-V-R  
126 D15 2340.1    Y-R-F-L-P-F-L-Q-K-G-L-R-R-V-V-R-K-Y  
127 D16 2188.9    F-L-P-F-L-Q-K-G-L-R-R-V-V-R-K-Y-A-P  
128 D17 2170.8    P-F-L-Q-K-G-L-R-R-V-V-R-K-Y-A-P-E-L  
129 D18 2153.8    L-Q-K-G-L-R-R-V-V-R-K-Y-A-P-E-L-L-N  
130 D19 2153.8    L-Q-K-G-L-R-R-V-V-R-K-Y-A-P-E-L-L-N  
131 D20 2100.7    K-G-L-R-R-V-V-R-K-Y-A-P-E-L-L-N-T-S  
132 D21 2270.8   K-G-L-R-R-V-V-R-K-Y-A-P-E-L-L-N-pT-S  
133 D22 2270.7   K-G-L-R-R-V-V-R-K-Y-A-P-E-L-L-N-T-pS  
134 D23 2117.6    L-R-R-V-V-R-K-Y-A-P-E-L-L-N-T-S-D-S  
135 D24 2287.7   L-R-R-V-V-R-K-Y-A-P-E-L-L-N-pT-S-D-S  
136 D25 2287.6   L-R-R-V-V-R-K-Y-A-P-E-L-L-N-T-pS-D-S  
137 D26 2287.6   L-R-R-V-V-R-K-Y-A-P-E-L-L-N-T-S-D-pS  
138 D27 2089.6    R-V-V-R-K-Y-A-P-E-L-L-N-T-S-D-S-L-K  
139 D28 2259.7   R-V-V-R-K-Y-A-P-E-L-L-N-pT-S-D-S-L-K  
140 D29 2259.6   R-V-V-R-K-Y-A-P-E-L-L-N-T-pS-D-S-L-K  
141 D30 2259.6   R-V-V-R-K-Y-A-P-E-L-L-N-T-S-D-pS-L-K  
142 D31 2077.6    V-R-K-Y-A-P-E-L-L-N-T-S-D-S-L-K-R-S  
143 D32 2247.7   V-R-K-Y-A-P-E-L-L-N-pT-S-D-S-L-K-R-S  
144 D33 2247.6   V-R-K-Y-A-P-E-L-L-N-T-pS-D-S-L-K-R-S  
145 D34 2247.6   V-R-K-Y-A-P-E-L-L-N-T-S-D-pS-L-K-R-S  
146 D35 2008.5    K-Y-A-P-E-L-L-N-T-S-D-S-L-K-R-S-E-G  
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147 D36 2178.6   K-Y-A-P-E-L-L-N-pT-S-D-S-L-K-R-S-E-G  
148 D37 2178.5   K-Y-A-P-E-L-L-N-T-pS-D-S-L-K-R-S-E-G  
149 E 1 2178.5   K-Y-A-P-E-L-L-N-T-S-D-pS-L-K-R-S-E-G  
150 E 2 2178.5   K-Y-A-P-E-L-L-N-T-S-D-S-L-K-R-pS-E-G  
151 E 3 1961.3    A-P-E-L-L-N-T-S-D-S-L-K-R-S-E-G-D-E  
152 E 4 2131.4   A-P-E-L-L-N-pT-S-D-S-L-K-R-S-E-G-D-E  
153 E 5 2131.3   A-P-E-L-L-N-T-pS-D-S-L-K-R-S-E-G-D-E  
154 E 6 2131.3   A-P-E-L-L-N-T-S-D-pS-L-K-R-S-E-G-D-E  
155 E 7 2131.3   A-P-E-L-L-N-T-S-D-S-L-K-R-pS-E-G-D-E  
156 E 8 1978.3    E-L-L-N-T-S-D-S-L-K-R-S-E-G-D-E-G-Q  
157 E 9 2148.4   E-L-L-N-pT-S-D-S-L-K-R-S-E-G-D-E-G-Q  
158 E10 2148.3   E-L-L-N-T-pS-D-S-L-K-R-S-E-G-D-E-G-Q  
159 E11 2148.3   E-L-L-N-T-S-D-pS-L-K-R-S-E-G-D-E-G-Q  
160 E12 2148.3   E-L-L-N-T-S-D-S-L-K-R-pS-E-G-D-E-G-Q  
161 E13 1922.2    L-N-T-S-D-S-L-K-R-S-E-G-D-E-G-Q-A-D  
162 E14 2092.3   L-N-pT-S-D-S-L-K-R-S-E-G-D-E-G-Q-A-D  
163 E15 2092.2   L-N-T-pS-D-S-L-K-R-S-E-G-D-E-G-Q-A-D  
164 E16 2092.2   L-N-T-S-D-pS-L-K-R-S-E-G-D-E-G-Q-A-D  
165 E17 2092.2   L-N-T-S-D-S-L-K-R-pS-E-G-D-E-G-Q-A-D  
166 E18 1939.1    T-S-D-S-L-K-R-S-E-G-D-E-G-Q-A-D-E-D  
167 E19 2109.2   pT-S-D-S-L-K-R-S-E-G-D-E-G-Q-A-D-E-D  
168 E20 2109.1   T-pS-D-S-L-K-R-S-E-G-D-E-G-Q-A-D-E-D  
169 E21 2109.1   T-S-D-pS-L-K-R-S-E-G-D-E-G-Q-A-D-E-D  
170 E22 2109.1   T-S-D-pS-L-K-R-S-E-G-D-E-G-Q-A-D-E-D  
171 E23 2109.1   T-S-D-S-L-K-R-pS-E-G-D-E-G-Q-A-D-E-D  
172 E24 2008.1    D-S-L-K-R-S-E-G-D-E-G-Q-A-D-E-D-E-Q  
173 E25 2178.1   D-pS-L-K-R-S-E-G-D-E-G-Q-A-D-E-D-E-Q  
174 E26 2178.1   D-S-L-K-R-pS-E-G-D-E-G-Q-A-D-E-D-E-Q  
175 E27 2049.1    L-K-R-S-E-G-D-E-G-Q-A-D-E-D-E-Q-Q-D  
176 E28 2219.1   L-K-R-pS-E-G-D-E-G-Q-A-D-E-D-E-Q-Q-D  
177 E29 2037.9    R-S-E-G-D-E-G-Q-A-D-E-D-E-Q-Q-D-D-D  
178 E30 2207.9   R-pS-E-G-D-E-G-Q-A-D-E-D-E-Q-Q-D-D-D  
179 E31 2039.9    E-G-D-E-G-Q-A-D-E-D-E-Q-Q-D-D-D-M-N  
180 E32 1997.9    D-E-G-Q-A-D-E-D-E-Q-Q-D-D-D-M-N-G-S  
181 E33 2167.9   D-E-G-Q-A-D-E-D-E-Q-Q-D-D-D-M-N-G-pS  
182 E34 1954     G-Q-A-D-E-D-E-Q-Q-D-D-D-M-N-G-S-S-L  
183 E35 2124    G-Q-A-D-E-D-E-Q-Q-D-D-D-M-N-G-pS-S-L  
184 E36 2124    G-Q-A-D-E-D-E-Q-Q-D-D-D-M-N-G-S-pS-L  
185 E37 2022.1    A-D-E-D-E-Q-Q-D-D-D-M-N-G-S-S-L-P-R 
186 F 1 2192.1   A-D-E-D-E-Q-Q-D-D-D-M-N-G-pS-S-L-P-R  
187 F 2 2192.1   A-D-E-D-E-Q-Q-D-D-D-M-N-G-S-pS-L-P-R  
188 F 3 2038.1    E-D-E-Q-Q-D-D-D-M-N-G-S-S-L-P-R-D-S 
189 F 4 2208.1   E-D-E-Q-Q-D-D-D-M-N-G-pS-S-L-P-R-D-S  
190 F 5 2208.1   E-D-E-Q-Q-D-D-D-M-N-G-S-pS-L-P-R-D-S  
191 F 6 2208.1   E-D-E-Q-Q-D-D-D-M-N-G-S-S-L-P-R-D-pS  
192 F 7 1938.1    E-Q-Q-D-D-D-M-N-G-S-S-L-P-R-D-S-G-S 
193 F 8 2108.1   E-Q-Q-D-D-D-M-N-G-pS-S-L-P-R-D-S-G-S  
194 F 9 2108.1   E-Q-Q-D-D-D-M-N-G-S-pS-L-P-R-D-S-G-S  
195 F10 2108.1   E-Q-Q-D-D-D-M-N-G-S-S-L-P-R-D-pS-G-S  
196 F11 2108.1   E-Q-Q-D-D-D-M-N-G-S-S-L-P-R-D-S-G-pS  
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197 F12 1839.1    Q-D-D-D-M-N-G-S-S-L-P-R-D-S-G-S-S-A  
198 F13 2009.1   Q-D-D-D-M-N-G-pS-S-L-P-R-D-S-G-S-S-A  
199 F14 2009.1   Q-D-D-D-M-N-G-S-pS-L-P-R-D-S-G-S-S-A  
200 F15 2009.1   Q-D-D-D-M-N-G-S-S-L-P-R-D-pS-G-S-S-A  
201 F16 2009.1   Q-D-D-D-M-N-G-S-S-L-P-R-D-S-G-pS-S-A  
202 F17 2009.1   Q-D-D-D-M-N-G-S-S-L-P-R-D-S-G-S-pS-A  
203 F18 1764.1    D-D-M-N-G-S-S-L-P-R-D-S-G-S-S-A-A-P  
204 F19 1934.1   D-D-M-N-G-pS-S-L-P-R-D-S-G-S-S-A-A-P 
205 F20 1934.1   D-D-M-N-G-S-pS-L-P-R-D-S-G-S-S-A-A-P 
206 F21 1934.1   D-D-M-N-G-S-S-L-P-R-D-pS-G-S-S-A-A-P 
207 F22 1934.1   D-D-M-N-G-S-S-L-P-R-D-S-G-pS-S-A-A-P 
208 F23 1934.1   D-D-M-N-G-S-S-L-P-R-D-S-G-S-pS-A-A-P 
209 F24 1705.1    M-N-G-S-S-L-P-R-D-S-G-S-S-A-A-P-G-N  
210 F25 1875.1   M-N-G-pS-S-L-P-R-D-S-G-S-S-A-A-P-G-N  
211 F26 1875.1   M-N-G-S-pS-L-P-R-D-S-G-S-S-A-A-P-G-N  
212 F27 1875.1   M-N-G-S-S-L-P-R-D-pS-G-S-S-A-A-P-G-N  
213 F28 1875.1   M-N-G-S-S-L-P-R-D-S-G-pS-S-A-A-P-G-N  
214 F29 1875.1   M-N-G-S-S-L-P-R-D-S-G-S-pS-A-A-P-G-N  
215 F30 1618     G-S-S-L-P-R-D-S-G-S-S-A-A-P-G-N-G-T  
216 F31 1788    G-pS-S-L-P-R-D-S-G-S-S-A-A-P-G-N-G-T  
217 F32 1788    G-S-pS-L-P-R-D-S-G-S-S-A-A-P-G-N-G-T  
218 F33 1788    G-S-S-L-P-R-D-pS-G-S-S-A-A-P-G-N-G-T  
219 F34 1788    G-S-S-L-P-R-D-S-G-pS-S-A-A-P-G-N-G-T  
220 F35 1788    G-S-S-L-P-R-D-S-G-S-pS-A-A-P-G-N-G-T  
221 F36 1788.1   G-S-S-L-P-R-D-S-G-S-S-A-A-P-G-N-G-pT  
222 F37 1632     S-L-P-R-D-S-G-S-S-A-A-P-G-N-G-T-S-A  
223 G 1 1802    pS-L-P-R-D-S-G-S-S-A-A-P-G-N-G-T-S-A  
224 G 2 1802    S-L-P-R-D-pS-G-S-S-A-A-P-G-N-G-T-S-A  
225 G 3 1802    S-L-P-R-D-S-G-pS-S-A-A-P-G-N-G-T-S-A  
226 G 4 1802    S-L-P-R-D-S-G-S-pS-A-A-P-G-N-G-T-S-A  
227 G 5 1802.1   S-L-P-R-D-S-G-S-S-A-A-P-G-N-G-pT-S-A  
228 G 6 1802    S-L-P-R-D-S-G-S-S-A-A-P-G-N-G-T-pS-A  
229 G 7 1634     P-R-D-S-G-S-S-A-A-P-G-N-G-T-S-A-M-A  
230 G 8 1804    P-R-D-pS-G-S-S-A-A-P-G-N-G-T-S-A-M-A  
231 G 9 1804    P-R-D-S-G-pS-S-A-A-P-G-N-G-T-S-A-M-A  
232 G10 1804    P-R-D-S-G-S-pS-A-A-P-G-N-G-T-S-A-M-A  
233 G11 1804.1   P-R-D-S-G-S-S-A-A-P-G-N-G-pT-S-A-M-A  
234 G12 1804    P-R-D-S-G-S-S-A-A-P-G-N-G-T-pS-A-M-A  
235 G13 1638     D-S-G-S-S-A-A-P-G-N-G-T-S-A-M-A-T-R  
236 G14 1808    D-pS-G-S-S-A-A-P-G-N-G-T-S-A-M-A-T-R 
237 G15 1808    D-S-G-pS-S-A-A-P-G-N-G-T-S-A-M-A-T-R 
238 G16 1808    D-S-G-S-pS-A-A-P-G-N-G-T-S-A-M-A-T-R 
239 G17 1808.1   D-S-G-S-S-A-A-P-G-N-G-pT-S-A-M-A-T-R 
240 G18 1808    D-S-G-S-S-A-A-P-G-N-G-T-pS-A-M-A-T-R 
241 G19 1808.1   D-S-G-S-S-A-A-P-G-N-G-T-S-A-M-A-pT-R 
242 G20 1636.1    G-S-S-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I  
243 G21 1806.1   G-pS-S-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I  
244 G22 1806.1   G-S-pS-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I  
245 G23 1806.2   G-S-S-A-A-P-G-N-G-pT-S-A-M-A-T-R-S-I  
246 G24 1806.1   G-S-S-A-A-P-G-N-G-T-pS-A-M-A-T-R-S-I  
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247 G25 1806.2   G-S-S-A-A-P-G-N-G-T-S-A-M-A-pT-R-S-I  
248 G26 1806.1   G-S-S-A-A-P-G-N-G-T-S-A-M-A-T-R-pS-I  
249 G27 1694.1    S-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-T  
250 G28 1864.1   pS-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-T  
251 G29 1864.2   S-A-A-P-G-N-G-pT-S-A-M-A-T-R-S-I-T-T  
252 G30 1864.1   S-A-A-P-G-N-G-T-pS-A-M-A-T-R-S-I-T-T  
253 G31 1864.2   S-A-A-P-G-N-G-T-S-A-M-A-pT-R-S-I-T-T  
254 G32 1864.1   S-A-A-P-G-N-G-T-S-A-M-A-T-R-pS-I-T-T  
255 G33 1864.2   S-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I-pT-T  
256 G34 1864.2   S-A-A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-pT  
257 G35 1724.1    A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-T-S-T  
258 G36 1894.2   A-P-G-N-G-pT-S-A-M-A-T-R-S-I-T-T-S-T  
259 G37 1894.1   A-P-G-N-G-T-pS-A-M-A-T-R-S-I-T-T-S-T  
260 H 1 1894.2   A-P-G-N-G-T-S-A-M-A-pT-R-S-I-T-T-S-T  
261 H 2 1894.1   A-P-G-N-G-T-S-A-M-A-T-R-pS-I-T-T-S-T  
262 H 3 1894.2   A-P-G-N-G-T-S-A-M-A-T-R-S-I-pT-T-S-T  
263 H 4 1894.2   A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-pT-S-T  
264 H 5 1894.1   A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-T-pS-T  
265 H 6 1894.2   A-P-G-N-G-T-S-A-M-A-T-R-S-I-T-T-S-pT  
266 H 7 1740.1    G-N-G-T-S-A-M-A-T-R-S-I-T-T-S-T-S-P  
267 H 8 1910.2   G-N-G-pT-S-A-M-A-T-R-S-I-T-T-S-T-S-P  
268 H 9 1910.1   G-N-G-T-pS-A-M-A-T-R-S-I-T-T-S-T-S-P  
269 H10 1910.2   G-N-G-T-S-A-M-A-pT-R-S-I-T-T-S-T-S-P  
270 H11 1910.1   G-N-G-T-S-A-M-A-T-R-pS-I-T-T-S-T-S-P  
271 H12 1910.2   G-N-G-T-S-A-M-A-T-R-S-I-pT-T-S-T-S-P  
272 H13 1910.2   G-N-G-T-S-A-M-A-T-R-S-I-T-pT-S-T-S-P  
273 H14 1910.1   G-N-G-T-S-A-M-A-T-R-S-I-T-T-pS-T-S-P  
274 H15 1910.2   G-N-G-T-S-A-M-A-T-R-S-I-T-T-S-pT-S-P  
275 H16 1910.1   G-N-G-T-S-A-M-A-T-R-S-I-T-T-S-T-pS-P  
276 H17 1826.1    G-T-S-A-M-A-T-R-S-I-T-T-S-T-S-P-E-Q  
277 H18 1996.2   G-pT-S-A-M-A-T-R-S-I-T-T-S-T-S-P-E-Q  
278 H19 1996.1   G-T-pS-A-M-A-T-R-S-I-T-T-S-T-S-P-E-Q  
279 H20 1996.2   G-T-S-A-M-A-pT-R-S-I-T-T-S-T-S-P-E-Q  
280 H21 1996.1   G-T-S-A-M-A-T-R-pS-I-T-T-S-T-S-P-E-Q  
281 H22 1996.2   G-T-S-A-M-A-T-R-S-I-pT-T-S-T-S-P-E-Q  
282 H23 1996.2   G-T-S-A-M-A-T-R-S-I-T-pT-S-T-S-P-E-Q  
283 H24 1996.1   G-T-S-A-M-A-T-R-S-I-T-T-pS-T-S-P-E-Q  
284 H25 1996.2   G-T-S-A-M-A-T-R-S-I-T-T-S-pT-S-P-E-Q  
285 H26 1996.1   G-T-S-A-M-A-T-R-S-I-T-T-S-T-pS-P-E-Q  
286 H27 1898.1    S-A-M-A-T-R-S-I-T-T-S-T-S-P-E-Q-T-E  
287 H28 2068.1   pS-A-M-A-T-R-S-I-T-T-S-T-S-P-E-Q-T-E  
288 H29 2068.2   S-A-M-A-pT-R-S-I-T-T-S-T-S-P-E-Q-T-E  
289 H30 2068.1   S-A-M-A-T-R-pS-I-T-T-S-T-S-P-E-Q-T-E  
290 H31 2068.2   S-A-M-A-T-R-S-I-pT-T-S-T-S-P-E-Q-T-E  
291 H32 2068.2   S-A-M-A-T-R-S-I-T-pT-S-T-S-P-E-Q-T-E  
292 H33 2068.1   S-A-M-A-T-R-S-I-T-T-pS-T-S-P-E-Q-T-E  
293 H34 2068.2   S-A-M-A-T-R-S-I-T-T-S-pT-S-P-E-Q-T-E  
294 H35 2068.1   S-A-M-A-T-R-S-I-T-T-S-T-pS-P-E-Q-T-E  
295 H36 2068.2   S-A-M-A-T-R-S-I-T-T-S-T-S-P-E-Q-pT-E  
296 H37 1995.2    M-A-T-R-S-I-T-T-S-T-S-P-E-Q-T-E-R-V  
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297 I 1 2165.3   M-A-pT-R-S-I-T-T-S-T-S-P-E-Q-T-E-R-V  
298 I 2 2165.2   M-A-T-R-pS-I-T-T-S-T-S-P-E-Q-T-E-R-V  
299 I 3 2165.3   M-A-T-R-S-I-pT-T-S-T-S-P-E-Q-T-E-R-V  
300 I 4 2165.3   M-A-T-R-S-I-T-pT-S-T-S-P-E-Q-T-E-R-V  
301 I 5 2165.2   M-A-T-R-S-I-T-T-pS-T-S-P-E-Q-T-E-R-V  
302 I 6 2165.3   M-A-T-R-S-I-T-T-S-pT-S-P-E-Q-T-E-R-V  
303 I 7 2165.2   M-A-T-R-S-I-T-T-S-T-pS-P-E-Q-T-E-R-V  
304 I 8 2165.3   M-A-T-R-S-I-T-T-S-T-S-P-E-Q-pT-E-R-V  
305 I 9 2068.2    T-R-S-I-T-T-S-T-S-P-E-Q-T-E-R-V-F-Q  
306 I10 2238.3   pT-R-S-I-T-T-S-T-S-P-E-Q-T-E-R-V-F-Q  
307 I11 2238.2   T-R-pS-I-T-T-S-T-S-P-E-Q-T-E-R-V-F-Q  
308 I12 2238.3   T-R-S-I-pT-T-S-T-S-P-E-Q-T-E-R-V-F-Q  
309 I13 2238.3   T-R-S-I-T-pT-S-T-S-P-E-Q-T-E-R-V-F-Q  
310 I14 2238.2   T-R-S-I-T-T-pS-T-S-P-E-Q-T-E-R-V-F-Q  
311 I15 2238.3   T-R-S-I-T-T-S-pT-S-P-E-Q-T-E-R-V-F-Q  
312 I16 2238.2   T-R-S-I-T-T-S-T-pS-P-E-Q-T-E-R-V-F-Q  
313 I17 2238.3   T-R-S-I-T-T-S-T-S-P-E-Q-pT-E-R-V-F-Q  
314 I18 2011.2    S-I-T-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S  
315 I19 2181.2   pS-I-T-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S  
316 I20 2181.3   S-I-pT-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S  
317 I21 2181.3   S-I-T-pT-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S  
318 I22 2181.2   S-I-T-T-pS-T-S-P-E-Q-T-E-R-V-F-Q-I-S  
319 I23 2181.3   S-I-T-T-S-pT-S-P-E-Q-T-E-R-V-F-Q-I-S  
320 I24 2181.2   S-I-T-T-S-T-pS-P-E-Q-T-E-R-V-F-Q-I-S  
321 I25 2181.3   S-I-T-T-S-T-S-P-E-Q-pT-E-R-V-F-Q-I-S  
322 I26 2181.2   S-I-T-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-pS  
323 I27 2105.3    T-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F  
324 I28 2275.4   pT-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F  
325 I29 2275.4   T-pT-S-T-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F  
326 I30 2275.3   T-T-pS-T-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F  
327 I31 2275.4   T-T-S-pT-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F  
328 I32 2275.3   T-T-S-T-pS-P-E-Q-T-E-R-V-F-Q-I-S-F-F  
329 I33 2275.4   T-T-S-T-S-P-E-Q-pT-E-R-V-F-Q-I-S-F-F  
330 I34 2275.3   T-T-S-T-S-P-E-Q-T-E-R-V-F-Q-I-pS-F-F  
331 I35 2130.4    S-T-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L  
332 I36 2300.4   pS-T-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L  
333 I37 2300.5   S-pT-S-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L  
334 J 1 2300.4   S-T-pS-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L  
335 J 2 2300.5   S-T-S-P-E-Q-pT-E-R-V-F-Q-I-S-F-F-N-L  
336 J 3 2300.4   S-T-S-P-E-Q-T-E-R-V-F-Q-I-pS-F-F-N-L  
337 J 4 2140.4    S-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L-P-T  
338 J 5 2310.4   pS-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L-P-T  
339 J 6 2310.5   S-P-E-Q-pT-E-R-V-F-Q-I-S-F-F-N-L-P-T  
340 J 7 2310.4   S-P-E-Q-T-E-R-V-F-Q-I-pS-F-F-N-L-P-T  
341 J 8 2310.5   S-P-E-Q-T-E-R-V-F-Q-I-S-F-F-N-L-P-pT  
342 J 9 2192.4    E-Q-T-E-R-V-F-Q-I-S-F-F-N-L-P-T-V-H  
343 J10 2362.5   E-Q-pT-E-R-V-F-Q-I-S-F-F-N-L-P-T-V-H  
344 J11 2362.4   E-Q-T-E-R-V-F-Q-I-pS-F-F-N-L-P-T-V-H  
345 J12 2362.5   E-Q-T-E-R-V-F-Q-I-S-F-F-N-L-P-pT-V-H  
346 J13 2204.6    T-E-R-V-F-Q-I-S-F-F-N-L-P-T-V-H-R-I  
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347 J14 2374.7   pT-E-R-V-F-Q-I-S-F-F-N-L-P-T-V-H-R-I  
348 J15 2374.6   T-E-R-V-F-Q-I-pS-F-F-N-L-P-T-V-H-R-I  
349 J16 2374.7   T-E-R-V-F-Q-I-S-F-F-N-L-P-pT-V-H-R-I  
350 J17 2245.7    R-V-F-Q-I-S-F-F-N-L-P-T-V-H-R-I-R-D  
351 J18 2415.7   R-V-F-Q-I-pS-F-F-N-L-P-T-V-H-R-I-R-D  
352 J19 2415.8   R-V-F-Q-I-S-F-F-N-L-P-pT-V-H-R-I-R-D  
353 J20 2259.8    F-Q-I-S-F-F-N-L-P-T-V-H-R-I-R-D-I-R  
354 J21 2429.8   F-Q-I-pS-F-F-N-L-P-T-V-H-R-I-R-D-I-R  
355 J22 2429.9   F-Q-I-S-F-F-N-L-P-pT-V-H-R-I-R-D-I-R  
356 J23 2200.7    I-S-F-F-N-L-P-T-V-H-R-I-R-D-I-R-S-E  
357 J24 2370.7   I-pS-F-F-N-L-P-T-V-H-R-I-R-D-I-R-S-E  
358 J25 2370.8   I-S-F-F-N-L-P-pT-V-H-R-I-R-D-I-R-S-E  
359 J26 2370.7   I-S-F-F-N-L-P-T-V-H-R-I-R-D-I-R-pS-E  
360 J27 2241.8    F-F-N-L-P-T-V-H-R-I-R-D-I-R-S-E-K-I  
361 J28 2411.9   F-F-N-L-P-pT-V-H-R-I-R-D-I-R-S-E-K-I  
362 J29 2411.8   F-F-N-L-P-T-V-H-R-I-R-D-I-R-pS-E-K-I  
363 J30 2091.6    N-L-P-T-V-H-R-I-R-D-I-R-S-E-K-I-G-S  
364 J31 2261.7   N-L-P-pT-V-H-R-I-R-D-I-R-S-E-K-I-G-S  
365 J32 2261.6   N-L-P-T-V-H-R-I-R-D-I-R-pS-E-K-I-G-S  
366 J33 2261.6   N-L-P-T-V-H-R-I-R-D-I-R-S-E-K-I-G-pS  
367 J34 2090.7    P-T-V-H-R-I-R-D-I-R-S-E-K-I-G-S-L-L  
368 J35 2260.8   P-pT-V-H-R-I-R-D-I-R-S-E-K-I-G-S-L-L  
369 J36 2260.7   P-T-V-H-R-I-R-D-I-R-pS-E-K-I-G-S-L-L  
370 J37 2260.7   P-T-V-H-R-I-R-D-I-R-S-E-K-I-G-pS-L-L  
371 K 1 2092.8    V-H-R-I-R-D-I-R-S-E-K-I-G-S-L-L-S-I  
372 K 2 2262.8   V-H-R-I-R-D-I-R-pS-E-K-I-G-S-L-L-S-I  
373 K 3 2262.8   V-H-R-I-R-D-I-R-S-E-K-I-G-pS-L-L-S-I  
374 K 4 2262.8   V-H-R-I-R-D-I-R-S-E-K-I-G-S-L-L-pS-I  
375 K 5 2000.8    R-I-R-D-I-R-S-E-K-I-G-S-L-L-S-I-S-G  
376 K 6 2170.8   R-I-R-D-I-R-pS-E-K-I-G-S-L-L-S-I-S-G  
377 K 7 2170.8   R-I-R-D-I-R-S-E-K-I-G-pS-L-L-S-I-S-G  
378 K 8 2170.8   R-I-R-D-I-R-S-E-K-I-G-S-L-L-pS-I-S-G  
379 K 9 2170.8   R-I-R-D-I-R-S-E-K-I-G-S-L-L-S-I-pS-G  
380 K10 1931.6    R-D-I-R-S-E-K-I-G-S-L-L-S-I-S-G-T-V  
381 K11 2101.6   R-D-I-R-pS-E-K-I-G-S-L-L-S-I-S-G-T-V  
382 K12 2101.6   R-D-I-R-S-E-K-I-G-pS-L-L-S-I-S-G-T-V  
383 K13 2101.6   R-D-I-R-S-E-K-I-G-S-L-L-pS-I-S-G-T-V  
384 K14 2101.6   R-D-I-R-S-E-K-I-G-S-L-L-S-I-pS-G-T-V  
385 K15 2101.7   R-D-I-R-S-E-K-I-G-S-L-L-S-I-S-G-pT-V  
386 K16 1917.6    I-R-S-E-K-I-G-S-L-L-S-I-S-G-T-V-T-R  
387 K17 2087.6   I-R-pS-E-K-I-G-S-L-L-S-I-S-G-T-V-T-R  
388 K18 2087.6   I-R-S-E-K-I-G-pS-L-L-S-I-S-G-T-V-T-R  
389 K19 2087.6   I-R-S-E-K-I-G-S-L-L-pS-I-S-G-T-V-T-R  
390 K20 2087.6   I-R-S-E-K-I-G-S-L-L-S-I-pS-G-T-V-T-R  
391 K21 2087.7   I-R-S-E-K-I-G-S-L-L-S-I-S-G-pT-V-T-R  
392 K22 2087.7   I-R-S-E-K-I-G-S-L-L-S-I-S-G-T-V-pT-R  
393 K23 1836.4    S-E-K-I-G-S-L-L-S-I-S-G-T-V-T-R-T-S  
394 K24 2006.4   pS-E-K-I-G-S-L-L-S-I-S-G-T-V-T-R-T-S  
395 K25 2006.4   S-E-K-I-G-pS-L-L-S-I-S-G-T-V-T-R-T-S  
396 K26 2006.4   S-E-K-I-G-S-L-L-pS-I-S-G-T-V-T-R-T-S  
Appendix 
 
 193 
397 K27 2006.4   S-E-K-I-G-S-L-L-S-I-pS-G-T-V-T-R-T-S  
398 K28 2006.5   S-E-K-I-G-S-L-L-S-I-S-G-pT-V-T-R-T-S  
399 K29 2006.5   S-E-K-I-G-S-L-L-S-I-S-G-T-V-pT-R-T-S  
400 K30 2006.5   S-E-K-I-G-S-L-L-S-I-S-G-T-V-T-R-pT-S  
401 K31 2006.4   S-E-K-I-G-S-L-L-S-I-S-G-T-V-T-R-T-pS  
402 K32 1848.4    K-I-G-S-L-L-S-I-S-G-T-V-T-R-T-S-E-V  
403 K33 2018.4   K-I-G-pS-L-L-S-I-S-G-T-V-T-R-T-S-E-V  
404 K34 2018.4   K-I-G-S-L-L-pS-I-S-G-T-V-T-R-T-S-E-V  
405 K35 2018.4   K-I-G-S-L-L-S-I-pS-G-T-V-T-R-T-S-E-V  
406 K36 2018.5   K-I-G-S-L-L-S-I-S-G-pT-V-T-R-T-S-E-V  
407 K37 2018.5   K-I-G-S-L-L-S-I-S-G-T-V-pT-R-T-S-E-V  
408 L 1 2018.5   K-I-G-S-L-L-S-I-S-G-T-V-T-R-pT-S-E-V  
409 L 2 2018.4   K-I-G-S-L-L-S-I-S-G-T-V-T-R-T-pS-E-V  
410 L 3 1860.3    G-S-L-L-S-I-S-G-T-V-T-R-T-S-E-V-R-P  
411 L 4 2030.3   G-pS-L-L-S-I-S-G-T-V-T-R-T-S-E-V-R-P  
412 L 5 2030.3   G-S-L-L-pS-I-S-G-T-V-T-R-T-S-E-V-R-P  
413 L 6 2030.3   G-S-L-L-S-I-pS-G-T-V-T-R-T-S-E-V-R-P  
414 L 7 2030.4   G-S-L-L-S-I-S-G-pT-V-T-R-T-S-E-V-R-P  
415 L 8 2030.4   G-S-L-L-S-I-S-G-T-V-pT-R-T-S-E-V-R-P  
416 L 9 2030.4   G-S-L-L-S-I-S-G-T-V-T-R-pT-S-E-V-R-P  
417 L10 2030.3   G-S-L-L-S-I-S-G-T-V-T-R-T-pS-E-V-R-P  
418 L11 1958.4    L-L-S-I-S-G-T-V-T-R-T-S-E-V-R-P-E-L  
419 L12 2128.4   L-L-pS-I-S-G-T-V-T-R-T-S-E-V-R-P-E-L  
420 L13 2128.4   L-L-S-I-pS-G-T-V-T-R-T-S-E-V-R-P-E-L  
421 L14 2128.5   L-L-S-I-S-G-pT-V-T-R-T-S-E-V-R-P-E-L  
422 L15 2128.5   L-L-S-I-S-G-T-V-pT-R-T-S-E-V-R-P-E-L  
423 L16 2128.5   L-L-S-I-S-G-T-V-T-R-pT-S-E-V-R-P-E-L  
424 L17 2128.4   L-L-S-I-S-G-T-V-T-R-T-pS-E-V-R-P-E-L  
425 L18 2023.4    S-I-S-G-T-V-T-R-T-S-E-V-R-P-E-L-Y-K  
426 L19 2193.4   pS-I-S-G-T-V-T-R-T-S-E-V-R-P-E-L-Y-K  
427 L20 2193.4   S-I-pS-G-T-V-T-R-T-S-E-V-R-P-E-L-Y-K  
428 L21 2193.5   S-I-S-G-pT-V-T-R-T-S-E-V-R-P-E-L-Y-K  
429 L22 2193.5   S-I-S-G-T-V-pT-R-T-S-E-V-R-P-E-L-Y-K  
430 L23 2193.5   S-I-S-G-T-V-T-R-pT-S-E-V-R-P-E-L-Y-K  
431 L24 2193.4   S-I-S-G-T-V-T-R-T-pS-E-V-R-P-E-L-Y-K  
432 L25 1981.3    S-G-T-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-S  
433 L26 2151.3   pS-G-T-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-S  
434 L27 2151.4   S-G-pT-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-S  
435 L28 2151.4   S-G-T-V-pT-R-T-S-E-V-R-P-E-L-Y-K-A-S  
436 L29 2151.4   S-G-T-V-T-R-pT-S-E-V-R-P-E-L-Y-K-A-S  
437 L30 2151.3   S-G-T-V-T-R-T-pS-E-V-R-P-E-L-Y-K-A-S  
438 L31 2151.3   S-G-T-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-pS  
439 L32 2085.4    T-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-T  
440 L33 2255.5   pT-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-T  
441 L34 2255.5   T-V-pT-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-T  
442 L35 2255.5   T-V-T-R-pT-S-E-V-R-P-E-L-Y-K-A-S-F-T  
443 L36 2255.4   T-V-T-R-T-pS-E-V-R-P-E-L-Y-K-A-S-F-T  
444 L37 2255.4   T-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-pS-F-T  
445 M 1 2255.5   T-V-T-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-pT  
446 M 2 2103.4    T-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-T-C-D  
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447 M 3 2273.5   pT-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-T-C-D  
448 M 4 2273.5   T-R-pT-S-E-V-R-P-E-L-Y-K-A-S-F-T-C-D  
449 M 5 2273.4   T-R-T-pS-E-V-R-P-E-L-Y-K-A-S-F-T-C-D  
450 M 6 2273.4   T-R-T-S-E-V-R-P-E-L-Y-K-A-pS-F-T-C-D  
451 M 7 2273.5   T-R-T-S-E-V-R-P-E-L-Y-K-A-S-F-pT-C-D  
452 M 8 2080.4    T-S-E-V-R-P-E-L-Y-K-A-S-F-T-C-D-M-C  
453 M 9 2250.5   pT-S-E-V-R-P-E-L-Y-K-A-S-F-T-C-D-M-C  
454 M10 2250.4   T-pS-E-V-R-P-E-L-Y-K-A-S-F-T-C-D-M-C  
455 M11 2250.4   T-S-E-V-R-P-E-L-Y-K-A-pS-F-T-C-D-M-C  
456 M12 2250.5   T-S-E-V-R-P-E-L-Y-K-A-S-F-pT-C-D-M-C  
457 M13 2119.5    E-V-R-P-E-L-Y-K-A-S-F-T-C-D-M-C-R-A  
458 M14 2289.5   E-V-R-P-E-L-Y-K-A-pS-F-T-C-D-M-C-R-A  
459 M15 2289.6   E-V-R-P-E-L-Y-K-A-S-F-pT-C-D-M-C-R-A  
460 M16 2103.6    R-P-E-L-Y-K-A-S-F-T-C-D-M-C-R-A-I-V  
461 M17 2273.6   R-P-E-L-Y-K-A-pS-F-T-C-D-M-C-R-A-I-V  
462 M18 2273.7   R-P-E-L-Y-K-A-S-F-pT-C-D-M-C-R-A-I-V  
463 M19 2079.5    E-L-Y-K-A-S-F-T-C-D-M-C-R-A-I-V-D-N  
464 M20 2249.5   E-L-Y-K-A-pS-F-T-C-D-M-C-R-A-I-V-D-N  
465 M21 2249.6   E-L-Y-K-A-S-F-pT-C-D-M-C-R-A-I-V-D-N  
466 M22 2065.4    Y-K-A-S-F-T-C-D-M-C-R-A-I-V-D-N-V-E  
467 M23 2235.4   Y-K-A-pS-F-T-C-D-M-C-R-A-I-V-D-N-V-E  
468 M24 2235.5   Y-K-A-S-F-pT-C-D-M-C-R-A-I-V-D-N-V-E  
469 M25 1989.2    A-S-F-T-C-D-M-C-R-A-I-V-D-N-V-E-Q-S  
470 M26 2159.2   A-pS-F-T-C-D-M-C-R-A-I-V-D-N-V-E-Q-S  
471 M27 2159.3   A-S-F-pT-C-D-M-C-R-A-I-V-D-N-V-E-Q-S  
472 M28 2159.2   A-S-F-T-C-D-M-C-R-A-I-V-D-N-V-E-Q-pS  
473 M29 2106.4    F-T-C-D-M-C-R-A-I-V-D-N-V-E-Q-S-F-K  
474 M30 2276.5   F-pT-C-D-M-C-R-A-I-V-D-N-V-E-Q-S-F-K  
475 M31 2276.4   F-T-C-D-M-C-R-A-I-V-D-N-V-E-Q-pS-F-K  
476 M32 2122.4    C-D-M-C-R-A-I-V-D-N-V-E-Q-S-F-K-Y-T  
477 M33 2292.4   C-D-M-C-R-A-I-V-D-N-V-E-Q-pS-F-K-Y-T  
478 M34 2292.5   C-D-M-C-R-A-I-V-D-N-V-E-Q-S-F-K-Y-pT  
479 M35 2130.4    M-C-R-A-I-V-D-N-V-E-Q-S-F-K-Y-T-E-P  
480 M36 2300.4   M-C-R-A-I-V-D-N-V-E-Q-pS-F-K-Y-T-E-P  
481 M37 2300.5   M-C-R-A-I-V-D-N-V-E-Q-S-F-K-Y-pT-E-P  
482 N 1 2144.4    R-A-I-V-D-N-V-E-Q-S-F-K-Y-T-E-P-T-F  
483 N 2 2314.4   R-A-I-V-D-N-V-E-Q-pS-F-K-Y-T-E-P-T-F  
484 N 3 2314.5   R-A-I-V-D-N-V-E-Q-S-F-K-Y-pT-E-P-T-F  
485 N 4 2314.5   R-A-I-V-D-N-V-E-Q-S-F-K-Y-T-E-P-pT-F  
486 N 5 2117.3    I-V-D-N-V-E-Q-S-F-K-Y-T-E-P-T-F-C-P  
487 N 6 2287.3   I-V-D-N-V-E-Q-pS-F-K-Y-T-E-P-T-F-C-P  
488 N 7 2287.4   I-V-D-N-V-E-Q-S-F-K-Y-pT-E-P-T-F-C-P  
489 N 8 2287.4   I-V-D-N-V-E-Q-S-F-K-Y-T-E-P-pT-F-C-P  
490 N 9 2116.2    D-N-V-E-Q-S-F-K-Y-T-E-P-T-F-C-P-N-P  
491 N10 2286.2   D-N-V-E-Q-pS-F-K-Y-T-E-P-T-F-C-P-N-P  
492 N11 2286.3   D-N-V-E-Q-S-F-K-Y-pT-E-P-T-F-C-P-N-P  
493 N12 2286.3   D-N-V-E-Q-S-F-K-Y-T-E-P-pT-F-C-P-N-P  
494 N13 2077.2    V-E-Q-S-F-K-Y-T-E-P-T-F-C-P-N-P-S-C  
495 N14 2247.2   V-E-Q-pS-F-K-Y-T-E-P-T-F-C-P-N-P-S-C  
496 N15 2247.3   V-E-Q-S-F-K-Y-pT-E-P-T-F-C-P-N-P-S-C  
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497 N16 2247.3   V-E-Q-S-F-K-Y-T-E-P-pT-F-C-P-N-P-S-C  
498 N17 2247.2   V-E-Q-S-F-K-Y-T-E-P-T-F-C-P-N-P-pS-C  
499 N18 2092.2    Q-S-F-K-Y-T-E-P-T-F-C-P-N-P-S-C-E-N  
500 N19 2262.2   Q-pS-F-K-Y-T-E-P-T-F-C-P-N-P-S-C-E-N  
501 N20 2262.3   Q-S-F-K-Y-pT-E-P-T-F-C-P-N-P-S-C-E-N  
502 N21 2262.3   Q-S-F-K-Y-T-E-P-pT-F-C-P-N-P-S-C-E-N  
503 N22 2262.2   Q-S-F-K-Y-T-E-P-T-F-C-P-N-P-pS-C-E-N  
504 N23 2104.3    F-K-Y-T-E-P-T-F-C-P-N-P-S-C-E-N-R-A  
505 N24 2274.4   F-K-Y-pT-E-P-T-F-C-P-N-P-S-C-E-N-R-A  
506 N25 2274.4   F-K-Y-T-E-P-pT-F-C-P-N-P-S-C-E-N-R-A  
507 N26 2274.3   F-K-Y-T-E-P-T-F-C-P-N-P-pS-C-E-N-R-A  
508 N27 2162.3    Y-T-E-P-T-F-C-P-N-P-S-C-E-N-R-A-F-W  
509 N28 2332.4   Y-pT-E-P-T-F-C-P-N-P-S-C-E-N-R-A-F-W  
510 N29 2332.4   Y-T-E-P-pT-F-C-P-N-P-S-C-E-N-R-A-F-W  
511 N30 2332.3   Y-T-E-P-T-F-C-P-N-P-pS-C-E-N-R-A-F-W  
512 N31 2112.3    E-P-T-F-C-P-N-P-S-C-E-N-R-A-F-W-T-L  
513 N32 2282.4   E-P-pT-F-C-P-N-P-S-C-E-N-R-A-F-W-T-L  
514 N33 2282.3   E-P-T-F-C-P-N-P-pS-C-E-N-R-A-F-W-T-L  
515 N34 2282.4   E-P-T-F-C-P-N-P-S-C-E-N-R-A-F-W-pT-L  
516 N35 2099.3    T-F-C-P-N-P-S-C-E-N-R-A-F-W-T-L-N-V  
517 N36 2269.4   pT-F-C-P-N-P-S-C-E-N-R-A-F-W-T-L-N-V  
518 N37 2269.3   T-F-C-P-N-P-pS-C-E-N-R-A-F-W-T-L-N-V  
519 O 1 2269.4   T-F-C-P-N-P-S-C-E-N-R-A-F-W-pT-L-N-V  
520 O 2 2108.3    C-P-N-P-S-C-E-N-R-A-F-W-T-L-N-V-T-R  
521 O 3 2278.3   C-P-N-P-pS-C-E-N-R-A-F-W-T-L-N-V-T-R  
522 O 4 2278.4   C-P-N-P-S-C-E-N-R-A-F-W-pT-L-N-V-T-R  
523 O 5 2278.4   C-P-N-P-S-C-E-N-R-A-F-W-T-L-N-V-pT-R  
524 O 6 2151.4    N-P-S-C-E-N-R-A-F-W-T-L-N-V-T-R-S-R  
525 O 7 2321.4   N-P-pS-C-E-N-R-A-F-W-T-L-N-V-T-R-S-R  
526 O 8 2321.5   N-P-S-C-E-N-R-A-F-W-pT-L-N-V-T-R-S-R  
527 O 9 2321.5   N-P-S-C-E-N-R-A-F-W-T-L-N-V-pT-R-S-R  
528 O10 2321.4   N-P-S-C-E-N-R-A-F-W-T-L-N-V-T-R-pS-R  
529 O11 2200.6    S-C-E-N-R-A-F-W-T-L-N-V-T-R-S-R-F-L  
530 O12 2370.6   pS-C-E-N-R-A-F-W-T-L-N-V-T-R-S-R-F-L  
531 O13 2370.7   S-C-E-N-R-A-F-W-pT-L-N-V-T-R-S-R-F-L  
532 O14 2370.7   S-C-E-N-R-A-F-W-T-L-N-V-pT-R-S-R-F-L  
533 O15 2370.6   S-C-E-N-R-A-F-W-T-L-N-V-T-R-pS-R-F-L  
534 O16 2311.7    E-N-R-A-F-W-T-L-N-V-T-R-S-R-F-L-D-W  
535 O17 2481.8   E-N-R-A-F-W-pT-L-N-V-T-R-S-R-F-L-D-W  
536 O18 2481.8   E-N-R-A-F-W-T-L-N-V-pT-R-S-R-F-L-D-W  
537 O19 2481.7   E-N-R-A-F-W-T-L-N-V-T-R-pS-R-F-L-D-W  
538 O20 2324.8    R-A-F-W-T-L-N-V-T-R-S-R-F-L-D-W-Q-K  
539 O21 2494.9   R-A-F-W-pT-L-N-V-T-R-S-R-F-L-D-W-Q-K 
540 O22 2494.9   R-A-F-W-T-L-N-V-pT-R-S-R-F-L-D-W-Q-K 
541 O23 2494.8   R-A-F-W-T-L-N-V-T-R-pS-R-F-L-D-W-Q-K 
542 O24 2352.8    F-W-T-L-N-V-T-R-S-R-F-L-D-W-Q-K-V-R  
543 O25 2522.9   F-W-pT-L-N-V-T-R-S-R-F-L-D-W-Q-K-V-R 
544 O26 2522.9   F-W-T-L-N-V-pT-R-S-R-F-L-D-W-Q-K-V-R 
545 O27 2522.8   F-W-T-L-N-V-T-R-pS-R-F-L-D-W-Q-K-V-R 
546 O28 2260.7    T-L-N-V-T-R-S-R-F-L-D-W-Q-K-V-R-I-Q  
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547 O29 2430.8   pT-L-N-V-T-R-S-R-F-L-D-W-Q-K-V-R-I-Q  
548 O30 2430.8   T-L-N-V-pT-R-S-R-F-L-D-W-Q-K-V-R-I-Q  
549 O31 2430.7   T-L-N-V-T-R-pS-R-F-L-D-W-Q-K-V-R-I-Q  
550 O32 2289.6    N-V-T-R-S-R-F-L-D-W-Q-K-V-R-I-Q-E-N  
551 O33 2459.7   N-V-pT-R-S-R-F-L-D-W-Q-K-V-R-I-Q-E-N  
552 O34 2459.6   N-V-T-R-pS-R-F-L-D-W-Q-K-V-R-I-Q-E-N  
553 O35 2261.6    T-R-S-R-F-L-D-W-Q-K-V-R-I-Q-E-N-A-N  
554 O36 2431.7   pT-R-S-R-F-L-D-W-Q-K-V-R-I-Q-E-N-A-N  
555 O37 2431.6   T-R-pS-R-F-L-D-W-Q-K-V-R-I-Q-E-N-A-N  
556 P 1 2246.6    S-R-F-L-D-W-Q-K-V-R-I-Q-E-N-A-N-E-I  
557 P 2 2416.6   pS-R-F-L-D-W-Q-K-V-R-I-Q-E-N-A-N-E-I  
558 P 3 2201.5    F-L-D-W-Q-K-V-R-I-Q-E-N-A-N-E-I-P-T  
559 P 4 2371.6   F-L-D-W-Q-K-V-R-I-Q-E-N-A-N-E-I-P-pT  
560 P 5 2085.3    D-W-Q-K-V-R-I-Q-E-N-A-N-E-I-P-T-G-S  
561 P 6 2255.4   D-W-Q-K-V-R-I-Q-E-N-A-N-E-I-P-pT-G-S  
562 P 7 2255.3   D-W-Q-K-V-R-I-Q-E-N-A-N-E-I-P-T-G-pS  
563 P 8 2012.3    Q-K-V-R-I-Q-E-N-A-N-E-I-P-T-G-S-M-P  
564 P 9 2182.4   Q-K-V-R-I-Q-E-N-A-N-E-I-P-pT-G-S-M-P  
565 P10 2182.3   Q-K-V-R-I-Q-E-N-A-N-E-I-P-T-G-pS-M-P  
566 P11 2013.3    V-R-I-Q-E-N-A-N-E-I-P-T-G-S-M-P-R-T  
567 P12 2183.4   V-R-I-Q-E-N-A-N-E-I-P-pT-G-S-M-P-R-T  
568 P13 2183.3   V-R-I-Q-E-N-A-N-E-I-P-T-G-pS-M-P-R-T  
569 P14 2183.4   V-R-I-Q-E-N-A-N-E-I-P-T-G-S-M-P-R-pT  
570 P15 1986.3    I-Q-E-N-A-N-E-I-P-T-G-S-M-P-R-T-L-D  
571 P16 2156.4   I-Q-E-N-A-N-E-I-P-pT-G-S-M-P-R-T-L-D  
572 P17 2156.3   I-Q-E-N-A-N-E-I-P-T-G-pS-M-P-R-T-L-D  
573 P18 2156.4   I-Q-E-N-A-N-E-I-P-T-G-S-M-P-R-pT-L-D  
574 P19 1957.3    E-N-A-N-E-I-P-T-G-S-M-P-R-T-L-D-V-I  
575 P20 2127.4   E-N-A-N-E-I-P-pT-G-S-M-P-R-T-L-D-V-I  
576 P21 2127.3   E-N-A-N-E-I-P-T-G-pS-M-P-R-T-L-D-V-I  
577 P22 2127.4   E-N-A-N-E-I-P-T-G-S-M-P-R-pT-L-D-V-I  
578 P23 1983.5    A-N-E-I-P-T-G-S-M-P-R-T-L-D-V-I-L-R  
579 P24 2153.6   A-N-E-I-P-pT-G-S-M-P-R-T-L-D-V-I-L-R  
580 P25 2153.5   A-N-E-I-P-T-G-pS-M-P-R-T-L-D-V-I-L-R  
581 P26 2153.6   A-N-E-I-P-T-G-S-M-P-R-pT-L-D-V-I-L-R  
582 P27 1970.5    E-I-P-T-G-S-M-P-R-T-L-D-V-I-L-R-G-D  
583 P28 2140.6   E-I-P-pT-G-S-M-P-R-T-L-D-V-I-L-R-G-D  
584 P29 2140.5   E-I-P-T-G-pS-M-P-R-T-L-D-V-I-L-R-G-D  
585 P30 2140.6   E-I-P-T-G-S-M-P-R-pT-L-D-V-I-L-R-G-D  
586 P31 1914.4    P-T-G-S-M-P-R-T-L-D-V-I-L-R-G-D-S-V  
587 P32 2084.5   P-pT-G-S-M-P-R-T-L-D-V-I-L-R-G-D-S-V  
588 P33 2084.4   P-T-G-pS-M-P-R-T-L-D-V-I-L-R-G-D-S-V  
589 P34 2084.5   P-T-G-S-M-P-R-pT-L-D-V-I-L-R-G-D-S-V  
590 P35 2084.4   P-T-G-S-M-P-R-T-L-D-V-I-L-R-G-D-pS-V  
591 P36 2001.5    G-S-M-P-R-T-L-D-V-I-L-R-G-D-S-V-E-R  
592 P37 2171.5   G-pS-M-P-R-T-L-D-V-I-L-R-G-D-S-V-E-R  
593 Q 1 2171.6   G-S-M-P-R-pT-L-D-V-I-L-R-G-D-S-V-E-R  
594 Q 2 2171.5   G-S-M-P-R-T-L-D-V-I-L-R-G-D-pS-V-E-R  
595 Q 3 2056.6    M-P-R-T-L-D-V-I-L-R-G-D-S-V-E-R-A-K  
596 Q 4 2226.7   M-P-R-pT-L-D-V-I-L-R-G-D-S-V-E-R-A-K  
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597 Q 5 2226.6   M-P-R-T-L-D-V-I-L-R-G-D-pS-V-E-R-A-K  
598 Q 6 1982.5    R-T-L-D-V-I-L-R-G-D-S-V-E-R-A-K-P-G  
599 Q 7 2152.6   R-pT-L-D-V-I-L-R-G-D-S-V-E-R-A-K-P-G  
600 Q 8 2152.5   R-T-L-D-V-I-L-R-G-D-pS-V-E-R-A-K-P-G  
601 Q 9 1996.5    L-D-V-I-L-R-G-D-S-V-E-R-A-K-P-G-D-R  
602 Q10 2166.5   L-D-V-I-L-R-G-D-pS-V-E-R-A-K-P-G-D-R  
603 Q11 1999.5    V-I-L-R-G-D-S-V-E-R-A-K-P-G-D-R-C-K  
604 Q12 2169.5   V-I-L-R-G-D-pS-V-E-R-A-K-P-G-D-R-C-K  
605 Q13 2035.5    L-R-G-D-S-V-E-R-A-K-P-G-D-R-C-K-F-T  
606 Q14 2205.5   L-R-G-D-pS-V-E-R-A-K-P-G-D-R-C-K-F-T  
607 Q15 2205.6   L-R-G-D-S-V-E-R-A-K-P-G-D-R-C-K-F-pT  
608 Q16 1922.3    G-D-S-V-E-R-A-K-P-G-D-R-C-K-F-T-G-V  
609 Q17 2179.4 G -D-S-pS-V-E-R-A-K-P-G-D-R-C-K-F-T-G-V  
610 Q18 2092.4   G-D-S-V-E-R-A-K-P-G-D-R-C-K-F-pT-G-V 
611 Q19 1992.4    S-V-E-R-A-K-P-G-D-R-C-K-F-T-G-V-E-I  
612 Q20 2162.4   pS-V-E-R-A-K-P-G-D-R-C-K-F-T-G-V-E-I  
613 Q21 2162.5   S-V-E-R-A-K-P-G-D-R-C-K-F-pT-G-V-E-I  
614 Q22 2004.4    E-R-A-K-P-G-D-R-C-K-F-T-G-V-E-I-V-V  
615 Q23 2174.5   E-R-A-K-P-G-D-R-C-K-F-pT-G-V-E-I-V-V  
616 Q24 1931.3    A-K-P-G-D-R-C-K-F-T-G-V-E-I-V-V-P-D  
617 Q25 2101.4   A-K-P-G-D-R-C-K-F-pT-G-V-E-I-V-V-P-D  
618 Q26 1932.2    P-G-D-R-C-K-F-T-G-V-E-I-V-V-P-D-V-T  
619 Q27 2102.3   P-G-D-R-C-K-F-pT-G-V-E-I-V-V-P-D-V-T  
620 Q28 2102.3   P-G-D-R-C-K-F-T-G-V-E-I-V-V-P-D-V-pT  
621 Q29 2019.3    D-R-C-K-F-T-G-V-E-I-V-V-P-D-V-T-Q-L  
622 Q30 2189.4   D-R-C-K-F-pT-G-V-E-I-V-V-P-D-V-T-Q-L  
623 Q31 2189.4   D-R-C-K-F-T-G-V-E-I-V-V-P-D-V-pT-Q-L  
624 Q32 1918.3    C-K-F-T-G-V-E-I-V-V-P-D-V-T-Q-L-G-L  
625 Q33 2088.4   C-K-F-pT-G-V-E-I-V-V-P-D-V-T-Q-L-G-L  
626 Q34 2088.4   C-K-F-T-G-V-E-I-V-V-P-D-V-pT-Q-L-G-L  
627 Q35 1841.2    F-T-G-V-E-I-V-V-P-D-V-T-Q-L-G-L-P-G  
628 Q36 2011.3   F-pT-G-V-E-I-V-V-P-D-V-T-Q-L-G-L-P-G  
629 Q37 2011.3   F-T-G-V-E-I-V-V-P-D-V-pT-Q-L-G-L-P-G  
630 R 1 1820.2    G-V-E-I-V-V-P-D-V-T-Q-L-G-L-P-G-V-K  
631 R 2 1990.3   G-V-E-I-V-V-P-D-V-pT-Q-L-G-L-P-G-V-K  
632 R 3 1848.2    E-I-V-V-P-D-V-T-Q-L-G-L-P-G-V-K-P-S  
633 R 4 2018.3   E-I-V-V-P-D-V-pT-Q-L-G-L-P-G-V-K-P-S  
634 R 5 2018.2   E-I-V-V-P-D-V-T-Q-L-G-L-P-G-V-K-P-pS  
635 R 6 1794.1    V-V-P-D-V-T-Q-L-G-L-P-G-V-K-P-S-S-T  
636 R 7 1964.2   V-V-P-D-V-pT-Q-L-G-L-P-G-V-K-P-S-S-T  
637 R 8 1964.1   V-V-P-D-V-T-Q-L-G-L-P-G-V-K-P-pS-S-T  
638 R 9 1964.1   V-V-P-D-V-T-Q-L-G-L-P-G-V-K-P-S-pS-T  
639 R10 1964.2   V-V-P-D-V-T-Q-L-G-L-P-G-V-K-P-S-S-pT  
640 R11 1824.2    P-D-V-T-Q-L-G-L-P-G-V-K-P-S-S-T-L-D  
641 R12 1994.3   P-D-V-pT-Q-L-G-L-P-G-V-K-P-S-S-T-L-D  
642 R13 1994.2   P-D-V-T-Q-L-G-L-P-G-V-K-P-pS-S-T-L-D  
643 R14 1994.2   P-D-V-T-Q-L-G-L-P-G-V-K-P-S-pS-T-L-D  
644 R15 1994.3   P-D-V-T-Q-L-G-L-P-G-V-K-P-S-S-pT-L-D  
645 R16 1869.3    V-T-Q-L-G-L-P-G-V-K-P-S-S-T-L-D-T-R  
646 R17 2039.4   V-pT-Q-L-G-L-P-G-V-K-P-S-S-T-L-D-T-R  
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647 R18 2039.3   V-T-Q-L-G-L-P-G-V-K-P-pS-S-T-L-D-T-R  
648 R19 2039.3   V-T-Q-L-G-L-P-G-V-K-P-S-pS-T-L-D-T-R  
649 R20 2039.4   V-T-Q-L-G-L-P-G-V-K-P-S-S-pT-L-D-T-R  
650 R21 2039.4   V-T-Q-L-G-L-P-G-V-K-P-S-S-T-L-D-pT-R  
651 R22 1839.4    Q-L-G-L-P-G-V-K-P-S-S-T-L-D-T-R-G-I  
652 R23 2009.4   Q-L-G-L-P-G-V-K-P-pS-S-T-L-D-T-R-G-I  
653 R24 2009.4   Q-L-G-L-P-G-V-K-P-S-pS-T-L-D-T-R-G-I  
654 R25 2009.5   Q-L-G-L-P-G-V-K-P-S-S-pT-L-D-T-R-G-I  
655 R26 2009.5   Q-L-G-L-P-G-V-K-P-S-S-T-L-D-pT-R-G-I  
656 R27 1813.4    G-L-P-G-V-K-P-S-S-T-L-D-T-R-G-I-S-K  
657 R28 1983.4   G-L-P-G-V-K-P-pS-S-T-L-D-T-R-G-I-S-K  
658 R29 1983.4   G-L-P-G-V-K-P-S-pS-T-L-D-T-R-G-I-S-K  
659 R30 1983.5   G-L-P-G-V-K-P-S-S-pT-L-D-T-R-G-I-S-K  
660 R31 1983.5   G-L-P-G-V-K-P-S-S-T-L-D-pT-R-G-I-S-K  
661 R32 1983.4   G-L-P-G-V-K-P-S-S-T-L-D-T-R-G-I-pS-K  
662 R33 1845.3    P-G-V-K-P-S-S-T-L-D-T-R-G-I-S-K-T-T  
663 R34 2015.3   P-G-V-K-P-pS-S-T-L-D-T-R-G-I-S-K-T-T  
664 R35 2015.3   P-G-V-K-P-S-pS-T-L-D-T-R-G-I-S-K-T-T  
665 R36 2015.4   P-G-V-K-P-S-S-pT-L-D-T-R-G-I-S-K-T-T  
666 R37 2015.4   P-G-V-K-P-S-S-T-L-D-pT-R-G-I-S-K-T-T  
667 S 1 2015.3   P-G-V-K-P-S-S-T-L-D-T-R-G-I-pS-K-T-T  
668 S 2 2015.4   P-G-V-K-P-S-S-T-L-D-T-R-G-I-S-K-pT-T  
669 S 3 2015.4   P-G-V-K-P-S-S-T-L-D-T-R-G-I-S-K-T-pT  
670 S 4 1877.3    V-K-P-S-S-T-L-D-T-R-G-I-S-K-T-T-E-G  
671 S 5 2047.3   V-K-P-pS-S-T-L-D-T-R-G-I-S-K-T-T-E-G  
672 S 6 2047.3   V-K-P-S-pS-T-L-D-T-R-G-I-S-K-T-T-E-G  
673 S 7 2047.4   V-K-P-S-S-pT-L-D-T-R-G-I-S-K-T-T-E-G  
674 S 8 2047.4   V-K-P-S-S-T-L-D-pT-R-G-I-S-K-T-T-E-G  
675 S 9 2047.3   V-K-P-S-S-T-L-D-T-R-G-I-pS-K-T-T-E-G  
676 S10 2047.4   V-K-P-S-S-T-L-D-T-R-G-I-S-K-pT-T-E-G  
677 S11 2047.4   V-K-P-S-S-T-L-D-T-R-G-I-S-K-T-pT-E-G  
678 S12 1877.3    P-S-S-T-L-D-T-R-G-I-S-K-T-T-E-G-L-N  
679 S13 2047.3   P-pS-S-T-L-D-T-R-G-I-S-K-T-T-E-G-L-N  
680 S14 2047.3   P-S-pS-T-L-D-T-R-G-I-S-K-T-T-E-G-L-N  
681 S15 2047.4   P-S-S-pT-L-D-T-R-G-I-S-K-T-T-E-G-L-N  
682 S16 2047.4   P-S-S-T-L-D-pT-R-G-I-S-K-T-T-E-G-L-N  
683 S17 2047.3   P-S-S-T-L-D-T-R-G-I-pS-K-T-T-E-G-L-N  
684 S18 2047.4   P-S-S-T-L-D-T-R-G-I-S-K-pT-T-E-G-L-N  
685 S19 2047.4   P-S-S-T-L-D-T-R-G-I-S-K-T-pT-E-G-L-N  
686 S20 1837.3    S-T-L-D-T-R-G-I-S-K-T-T-E-G-L-N-S-G  
687 S21 2007.3   pS-T-L-D-T-R-G-I-S-K-T-T-E-G-L-N-S-G  
688 S22 2007.4   S-pT-L-D-T-R-G-I-S-K-T-T-E-G-L-N-S-G  
689 S23 2007.4   S-T-L-D-pT-R-G-I-S-K-T-T-E-G-L-N-S-G  
690 S24 2007.3   S-T-L-D-T-R-G-I-pS-K-T-T-E-G-L-N-S-G  
691 S25 2007.4   S-T-L-D-T-R-G-I-S-K-pT-T-E-G-L-N-S-G  
692 S26 2007.4   S-T-L-D-T-R-G-I-S-K-T-pT-E-G-L-N-S-G  
693 S27 2007.3   S-T-L-D-T-R-G-I-S-K-T-T-E-G-L-N-pS-G  
694 S28 1849.3    L-D-T-R-G-I-S-K-T-T-E-G-L-N-S-G-V-T  
695 S29 2019.4   L-D-pT-R-G-I-S-K-T-T-E-G-L-N-S-G-V-T  
696 S30 2019.3   L-D-T-R-G-I-pS-K-T-T-E-G-L-N-S-G-V-T  
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697 S31 2019.4   L-D-T-R-G-I-S-K-pT-T-E-G-L-N-S-G-V-T  
698 S32 2019.4   L-D-T-R-G-I-S-K-T-pT-E-G-L-N-S-G-V-T  
699 S33 2019.3   L-D-T-R-G-I-S-K-T-T-E-G-L-N-pS-G-V-T  
700 S34 2019.4   L-D-T-R-G-I-S-K-T-T-E-G-L-N-S-G-V-pT  
701 S35 1791.3    T-R-G-I-S-K-T-T-E-G-L-N-S-G-V-T-G-L  
702 S36 1961.4   pT-R-G-I-S-K-T-T-E-G-L-N-S-G-V-T-G-L  
703 S37 1961.3   T-R-G-I-pS-K-T-T-E-G-L-N-S-G-V-T-G-L  
704 T 1 1961.4   T-R-G-I-S-K-pT-T-E-G-L-N-S-G-V-T-G-L  
705 T 2 1961.4   T-R-G-I-S-K-T-pT-E-G-L-N-S-G-V-T-G-L  
706 T 3 1961.3   T-R-G-I-S-K-T-T-E-G-L-N-pS-G-V-T-G-L  
707 T 4 1961.4   T-R-G-I-S-K-T-T-E-G-L-N-S-G-V-pT-G-L  
708 T 5 1777.3    G-I-S-K-T-T-E-G-L-N-S-G-V-T-G-L-R-S  
709 T 6 1947.3   G-I-pS-K-T-T-E-G-L-N-S-G-V-T-G-L-R-S  
710 T 7 1947.4   G-I-S-K-pT-T-E-G-L-N-S-G-V-T-G-L-R-S  
711 T 8 1947.4   G-I-S-K-T-pT-E-G-L-N-S-G-V-T-G-L-R-S  
712 T 9 1947.3   G-I-S-K-T-T-E-G-L-N-pS-G-V-T-G-L-R-S  
713 T10 1947.4   G-I-S-K-T-T-E-G-L-N-S-G-V-pT-G-L-R-S  
714 T11 1947.3   G-I-S-K-T-T-E-G-L-N-S-G-V-T-G-L-R-pS  
715 T12 1777.3    S-K-T-T-E-G-L-N-S-G-V-T-G-L-R-S-L-G  
716 T13 1947.3   pS-K-T-T-E-G-L-N-S-G-V-T-G-L-R-S-L-G  
717 T14 1947.4   S-K-pT-T-E-G-L-N-S-G-V-T-G-L-R-S-L-G  
718 T15 1947.4   S-K-T-pT-E-G-L-N-S-G-V-T-G-L-R-S-L-G  
719 T16 1947.3   S-K-T-T-E-G-L-N-pS-G-V-T-G-L-R-S-L-G  
720 T17 1947.4   S-K-T-T-E-G-L-N-S-G-V-pT-G-L-R-S-L-G  
721 T18 1947.3   S-K-T-T-E-G-L-N-S-G-V-T-G-L-R-pS-L-G  
722 T19 1817.3    T-T-E-G-L-N-S-G-V-T-G-L-R-S-L-G-V-R  
723 T20 1987.4   pT-T-E-G-L-N-S-G-V-T-G-L-R-S-L-G-V-R  
724 T21 1987.4   T-pT-E-G-L-N-S-G-V-T-G-L-R-S-L-G-V-R  
725 T22 1987.3   T-T-E-G-L-N-pS-G-V-T-G-L-R-S-L-G-V-R  
726 T23 1987.4   T-T-E-G-L-N-S-G-V-pT-G-L-R-S-L-G-V-R  
727 T24 1987.3   T-T-E-G-L-N-S-G-V-T-G-L-R-pS-L-G-V-R  
728 T25 1843.4    E-G-L-N-S-G-V-T-G-L-R-S-L-G-V-R-D-L  
729 T26 2013.4   E-G-L-N-pS-G-V-T-G-L-R-S-L-G-V-R-D-L  
730 T27 2013.5   E-G-L-N-S-G-V-pT-G-L-R-S-L-G-V-R-D-L  
731 T28 2013.4   E-G-L-N-S-G-V-T-G-L-R-pS-L-G-V-R-D-L  
732 T29 1921.5    L-N-S-G-V-T-G-L-R-S-L-G-V-R-D-L-T-Y  
733 T30 2091.5   L-N-pS-G-V-T-G-L-R-S-L-G-V-R-D-L-T-Y  
734 T31 2091.6   L-N-S-G-V-pT-G-L-R-S-L-G-V-R-D-L-T-Y  
735 T32 2091.5   L-N-S-G-V-T-G-L-R-pS-L-G-V-R-D-L-T-Y  
736 T33 2091.6   L-N-S-G-V-T-G-L-R-S-L-G-V-R-D-L-pT-Y  
737 T34 1935.6    S-G-V-T-G-L-R-S-L-G-V-R-D-L-T-Y-K-I  
738 T35 2105.6   pS-G-V-T-G-L-R-S-L-G-V-R-D-L-T-Y-K-I  
739 T36 2105.7   S-G-V-pT-G-L-R-S-L-G-V-R-D-L-T-Y-K-I  
740 T37 2105.6   S-G-V-T-G-L-R-pS-L-G-V-R-D-L-T-Y-K-I  
741 U 1 2105.7   S-G-V-T-G-L-R-S-L-G-V-R-D-L-pT-Y-K-I  
742 U 2 2025.7    V-T-G-L-R-S-L-G-V-R-D-L-T-Y-K-I-S-F  
743 U 3 2195.8   V-pT-G-L-R-S-L-G-V-R-D-L-T-Y-K-I-S-F  
744 U 4 2195.7   V-T-G-L-R-pS-L-G-V-R-D-L-T-Y-K-I-S-F  
745 U 5 2195.8   V-T-G-L-R-S-L-G-V-R-D-L-pT-Y-K-I-S-F  
746 U 6 2195.7   V-T-G-L-R-S-L-G-V-R-D-L-T-Y-K-I-pS-F  
Appendix 
 
 200 
747 U 7 2009.8    G-L-R-S-L-G-V-R-D-L-T-Y-K-I-S-F-L-A  
748 U 8 2179.8   G-L-R-pS-L-G-V-R-D-L-T-Y-K-I-S-F-L-A  
749 U 9 2179.9   G-L-R-S-L-G-V-R-D-L-pT-Y-K-I-S-F-L-A  
750 U10 2179.8   G-L-R-S-L-G-V-R-D-L-T-Y-K-I-pS-F-L-A  
751 U11 2079.7    R-S-L-G-V-R-D-L-T-Y-K-I-S-F-L-A-C-H  
752 U12 2249.7   R-pS-L-G-V-R-D-L-T-Y-K-I-S-F-L-A-C-H  
753 U13 2249.8   R-S-L-G-V-R-D-L-pT-Y-K-I-S-F-L-A-C-H  
754 U14 2249.7   R-S-L-G-V-R-D-L-T-Y-K-I-pS-F-L-A-C-H  
755 U15 2048.7    L-G-V-R-D-L-T-Y-K-I-S-F-L-A-C-H-V-I  
756 U16 2218.8   L-G-V-R-D-L-pT-Y-K-I-S-F-L-A-C-H-V-I  
757 U17 2218.7   L-G-V-R-D-L-T-Y-K-I-pS-F-L-A-C-H-V-I  
758 U18 2078.7    V-R-D-L-T-Y-K-I-S-F-L-A-C-H-V-I-S-I  
759 U19 2248.8   V-R-D-L-pT-Y-K-I-S-F-L-A-C-H-V-I-S-I  
760 U20 2248.7   V-R-D-L-T-Y-K-I-pS-F-L-A-C-H-V-I-S-I  
761 U21 2248.7   V-R-D-L-T-Y-K-I-S-F-L-A-C-H-V-I-pS-I  
762 U22 1967.6    D-L-T-Y-K-I-S-F-L-A-C-H-V-I-S-I-G-S  
763 U23 2137.7   D-L-pT-Y-K-I-S-F-L-A-C-H-V-I-S-I-G-S  
764 U24 2137.6   D-L-T-Y-K-I-pS-F-L-A-C-H-V-I-S-I-G-S  
765 U25 2137.6   D-L-T-Y-K-I-S-F-L-A-C-H-V-I-pS-I-G-S  
766 U26 2137.6   D-L-T-Y-K-I-S-F-L-A-C-H-V-I-S-I-G-pS  
767 U27 1966.6    T-Y-K-I-S-F-L-A-C-H-V-I-S-I-G-S-N-I  
768 U28 2136.7   pT-Y-K-I-S-F-L-A-C-H-V-I-S-I-G-S-N-I  
769 U29 2136.6   T-Y-K-I-pS-F-L-A-C-H-V-I-S-I-G-S-N-I  
770 U30 2136.6   T-Y-K-I-S-F-L-A-C-H-V-I-pS-I-G-S-N-I  
771 U31 2136.6   T-Y-K-I-S-F-L-A-C-H-V-I-S-I-G-pS-N-I  
772 U32 1830.5    K-I-S-F-L-A-C-H-V-I-S-I-G-S-N-I-G-A  
773 U33 2000.5   K-I-pS-F-L-A-C-H-V-I-S-I-G-S-N-I-G-A  
774 U34 2000.5   K-I-S-F-L-A-C-H-V-I-pS-I-G-S-N-I-G-A  
775 U35 2000.5   K-I-S-F-L-A-C-H-V-I-S-I-G-pS-N-I-G-A  
776 U36 1763.3    S-F-L-A-C-H-V-I-S-I-G-S-N-I-G-A-S-S  
777 U37 1933.3   pS-F-L-A-C-H-V-I-S-I-G-S-N-I-G-A-S-S  
 
7.1.3 Part 3 
Nr. Pos. Mol. Weight Sequence 
778 A 1 1933.3   S-F-L-A-C-H-V-I-pS-I-G-S-N-I-G-A-S-S  
779 A 2 1933.3   S-F-L-A-C-H-V-I-S-I-G-pS-N-I-G-A-S-S  
780 A 3 1933.3   S-F-L-A-C-H-V-I-S-I-G-S-N-I-G-A-pS-S  
781 A 4 1933.3   S-F-L-A-C-H-V-I-S-I-G-S-N-I-G-A-S-pS  
782 A 5 1741.2    L-A-C-H-V-I-S-I-G-S-N-I-G-A-S-S-P-D  
783 A 6 1911.2   L-A-C-H-V-I-pS-I-G-S-N-I-G-A-S-S-P-D  
784 A 7 1911.2   L-A-C-H-V-I-S-I-G-pS-N-I-G-A-S-S-P-D  
785 A 8 1911.2   L-A-C-H-V-I-S-I-G-S-N-I-G-A-pS-S-P-D  
786 A 9 1911.2   L-A-C-H-V-I-S-I-G-S-N-I-G-A-S-pS-P-D  
787 A10 1742.1    C-H-V-I-S-I-G-S-N-I-G-A-S-S-P-D-A-N  
788 A11 1912.1   C-H-V-I-pS-I-G-S-N-I-G-A-S-S-P-D-A-N  
789 A12 1912.1   C-H-V-I-S-I-G-pS-N-I-G-A-S-S-P-D-A-N  
790 A13 1912.1   C-H-V-I-S-I-G-S-N-I-G-A-pS-S-P-D-A-N  
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791 A14 1912.1   C-H-V-I-S-I-G-S-N-I-G-A-S-pS-P-D-A-N  
792 A15 1703.1    V-I-S-I-G-S-N-I-G-A-S-S-P-D-A-N-S-N  
793 A16 1873.1   V-I-pS-I-G-S-N-I-G-A-S-S-P-D-A-N-S-N  
794 A17 1873.1   V-I-S-I-G-pS-N-I-G-A-S-S-P-D-A-N-S-N  
795 A18 1873.1   V-I-S-I-G-S-N-I-G-A-pS-S-P-D-A-N-S-N  
796 A19 1873.1   V-I-S-I-G-S-N-I-G-A-S-pS-P-D-A-N-S-N  
797 A20 1873.1   V-I-S-I-G-S-N-I-G-A-S-S-P-D-A-N-pS-N  
798 A21 1761.1    S-I-G-S-N-I-G-A-S-S-P-D-A-N-S-N-N-R  
799 A22 1931.1   pS-I-G-S-N-I-G-A-S-S-P-D-A-N-S-N-N-R  
800 A23 1931.1   S-I-G-pS-N-I-G-A-S-S-P-D-A-N-S-N-N-R  
801 A24 1931.1   S-I-G-S-N-I-G-A-pS-S-P-D-A-N-S-N-N-R  
802 A25 1931.1   S-I-G-S-N-I-G-A-S-pS-P-D-A-N-S-N-N-R  
803 A26 1931.1   S-I-G-S-N-I-G-A-S-S-P-D-A-N-pS-N-N-R  
804 A27 1791     G-S-N-I-G-A-S-S-P-D-A-N-S-N-N-R-E-T  
805 A28 1961    G-pS-N-I-G-A-S-S-P-D-A-N-S-N-N-R-E-T  
806 A29 1961    G-S-N-I-G-A-pS-S-P-D-A-N-S-N-N-R-E-T  
807 A30 1961    G-S-N-I-G-A-S-pS-P-D-A-N-S-N-N-R-E-T  
808 A31 1961    G-S-N-I-G-A-S-S-P-D-A-N-pS-N-N-R-E-T  
809 A32 1961.1   G-S-N-I-G-A-S-S-P-D-A-N-S-N-N-R-E-pT  
810 A33 1889.1    N-I-G-A-S-S-P-D-A-N-S-N-N-R-E-T-E-L  
811 A34 2059.1   N-I-G-A-pS-S-P-D-A-N-S-N-N-R-E-T-E-L  
812 A35 2059.1   N-I-G-A-S-pS-P-D-A-N-S-N-N-R-E-T-E-L  
813 A36 2059.1   N-I-G-A-S-S-P-D-A-N-pS-N-N-R-E-T-E-L  
814 A37 2059.2   N-I-G-A-S-S-P-D-A-N-S-N-N-R-E-pT-E-L  
815 B 1 1921.1    G-A-S-S-P-D-A-N-S-N-N-R-E-T-E-L-Q-M  
816 B 2 2091.1   G-A-pS-S-P-D-A-N-S-N-N-R-E-T-E-L-Q-M 
817 B 3 2091.1   G-A-S-pS-P-D-A-N-S-N-N-R-E-T-E-L-Q-M 
818 B 4 2091.1   G-A-S-S-P-D-A-N-pS-N-N-R-E-T-E-L-Q-M 
819 B 5 2091.2   G-A-S-S-P-D-A-N-S-N-N-R-E-pT-E-L-Q-M 
820 B 6 1935.1    S-S-P-D-A-N-S-N-N-R-E-T-E-L-Q-M-A-A  
821 B 7 2105.1   pS-S-P-D-A-N-S-N-N-R-E-T-E-L-Q-M-A-A  
822 B 8 2105.1   S-pS-P-D-A-N-S-N-N-R-E-T-E-L-Q-M-A-A  
823 B 9 2105.1   S-S-P-D-A-N-pS-N-N-R-E-T-E-L-Q-M-A-A  
824 B10 2105.2   S-S-P-D-A-N-S-N-N-R-E-pT-E-L-Q-M-A-A  
825 B11 1988.2    P-D-A-N-S-N-N-R-E-T-E-L-Q-M-A-A-N-L  
826 B12 2158.2   P-D-A-N-pS-N-N-R-E-T-E-L-Q-M-A-A-N-L  
827 B13 2158.3   P-D-A-N-S-N-N-R-E-pT-E-L-Q-M-A-A-N-L  
828 B14 1975.2    A-N-S-N-N-R-E-T-E-L-Q-M-A-A-N-L-Q-A  
829 B15 2145.2   A-N-pS-N-N-R-E-T-E-L-Q-M-A-A-N-L-Q-A  
830 B16 2145.3   A-N-S-N-N-R-E-pT-E-L-Q-M-A-A-N-L-Q-A  
831 B17 2018.2    S-N-N-R-E-T-E-L-Q-M-A-A-N-L-Q-A-N-N  
832 B18 2188.2   pS-N-N-R-E-T-E-L-Q-M-A-A-N-L-Q-A-N-N  
833 B19 2188.3   S-N-N-R-E-pT-E-L-Q-M-A-A-N-L-Q-A-N-N  
834 B20 2079.3    N-R-E-T-E-L-Q-M-A-A-N-L-Q-A-N-N-V-Y  
835 B21 2249.4   N-R-E-pT-E-L-Q-M-A-A-N-L-Q-A-N-N-V-Y  
836 B22 2052.2    E-T-E-L-Q-M-A-A-N-L-Q-A-N-N-V-Y-Q-D  
837 B23 2222.3   E-pT-E-L-Q-M-A-A-N-L-Q-A-N-N-V-Y-Q-D  
838 B24 2065.2    E-L-Q-M-A-A-N-L-Q-A-N-N-V-Y-Q-D-N-E  
839 B25 2094.2    Q-M-A-A-N-L-Q-A-N-N-V-Y-Q-D-N-E-R-D 
840 B26 2092.1    A-A-N-L-Q-A-N-N-V-Y-Q-D-N-E-R-D-Q-E  
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841 B27 2196.2    N-L-Q-A-N-N-V-Y-Q-D-N-E-R-D-Q-E-V-F  
842 B28 2196.2    Q-A-N-N-V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N  
843 B29 2197.3    N-N-V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N-S-L  
844 B30 2367.3   N-N-V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N-pS-L  
845 B31 2143.3    V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N-S-L-S-S  
846 B32 2313.3   V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N-pS-L-S-S  
847 B33 2313.3   V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N-S-L-pS-S  
848 B34 2313.3   V-Y-Q-D-N-E-R-D-Q-E-V-F-L-N-S-L-S-pS  
849 B35 2125.2    Q-D-N-E-R-D-Q-E-V-F-L-N-S-L-S-S-D-E  
850 B36 2295.2   Q-D-N-E-R-D-Q-E-V-F-L-N-pS-L-S-S-D-E  
851 B37 2295.2   Q-D-N-E-R-D-Q-E-V-F-L-N-S-L-pS-S-D-E  
 
7.2 Phosphopeptides used in peptide pulldowns 
Name  Phospho-residue Sequence 
TD1   T150   YRAQIEFMKIYDLNTIYIDYQHLSMRENGA 
TD2   T247   GSSAAPGNGTSAMATRSITTSTSPEQTERV 
TD3   S324   TCDMCRAIVDNVEQSFKYTEPTFCPNPSCE 
TD4   S351   SCENRAFWTLNVTRSRFLDWQKVRIQENAN 
TD5   T398   DSVERAKPGDRCKFTGVEIVVPDVTQLGLP 
TD6a   S475   SNIGASSPDANSNNRETELQMAANLQANNV 
TD6b   T480   SNIGASSPDANSNNRETELQMAANLQANNV 
TD6c   S475/T480  SNIGASSPDANSNNRETELQMAANLQANNV 
TD7a  S255   AMATRSITTSTSPEQTERVFQISFFNLPTV 
TD7b  T259   AMATRSITTSTSPEQTERVFQISFFNLPTV 
TD7c  S255/T259  AMATRSITTSTSPEQTERVFQISFFNLPTV 
TD8   T376   QENANEIPTGSMPRTLDVILRGDSVERAKP 
TD9  T423   QLGLPGVKPSSTLDTRGISKTTEGLNSGVT 
TD10   S226/S227  ADEDEQQDDDMNGSSLPRDSGSSAAPGNGT 
TD11   T259/T272  EQTERVFQISFFNLPTVHRIRDIRSEKIGS
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